*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_CSA/ ULMN 3 1a79_00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 416 TYR~? 3.28 C4 A B 4 A 125 HIS A 454 HIS~? 3.31 C5 U B 3 A 156 LYS A 458 LYS~? 5.39 O4 U B 3 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 1a79_00 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_00 naa= 3 ULMN 3 1a79_01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 416 TYR~? 3.28 C4 A B 4 B 125 HIS A 454 HIS~? 3.31 C5 U B 3 B 156 LYS A 458 LYS~? 5.39 O4 U B 3 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 1a79_01 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_01 naa= 3 ULMN 3 1a79_02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 416 TYR~? 3.28 C4 A B 4 C 125 HIS A 454 HIS~? 3.31 C5 U B 3 C 156 LYS A 458 LYS~? 5.39 O4 U B 3 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 1a79_02 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_02 naa= 3 ULMN 3 1a79_03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 416 TYR~? 3.28 C4 A B 4 D 125 HIS A 454 HIS~? 3.31 C5 U B 3 D 156 LYS A 458 LYS~? 5.39 O4 U B 3 coo 54.10 1.42 85.16 54.14 4.17 85.62 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 coo 61.27 5.43 85.32 62.73 6.38 86.49 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 60.28 4.62 76.00 58.35 6.41 80.65 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 1a79_03 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_03 naa= 3 ULMN 3 1bd3_00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 390 ARG~? 22.44 N1 A B 4 A 141 THR A 383 THR~? 29.32 N6 A B 7 A 235 ASP A 345 ASP~? 24.06 C2 A B 4 coo 6.21 93.81 36.58 4.58 96.33 37.17 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo 6.80 92.87 28.33 4.91 92.74 27.40 -45.70 -35.28 -8.64 -46.29 -33.20 -8.69 coo 12.98 90.36 47.57 11.26 89.62 46.62 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 ULMN 3 1bd3_00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 518 ARG.? 16.31 O6 G B 2 A 141 THR A 508 THR~? 10.98 O6 G B 2 A 235 ASP A 526 ASP^? 28.45 O6 G B 2 coo 6.21 93.81 36.58 4.58 96.33 37.17 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 6.80 92.87 28.33 4.91 92.74 27.40 -12.37 -61.03 -6.50 -12.20 -59.82 -4.73 coo 12.98 90.36 47.57 11.26 89.62 46.62 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 1bd3_00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_00 naa= 3 ULMN 3 1bd3_01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 518 ARG.? 16.31 O6 G B 2 D 141 THR A 508 THR~? 10.98 O6 G B 2 D 235 ASP A 526 ASP^? 28.45 O6 G B 2 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -12.37 -61.03 -6.50 -12.20 -59.82 -4.73 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 1bd3_01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_01 naa= 3 ULMN 3 1bd3_02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 390 ARG~? 22.44 N1 A B 4 C 141 THR A 383 THR~? 29.32 N6 A B 7 C 235 ASP A 345 ASP~? 24.06 C2 A B 4 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -45.70 -35.28 -8.64 -46.29 -33.20 -8.69 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 ULMN 3 1bd3_02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 518 ARG.? 16.31 O6 G B 2 C 141 THR A 508 THR~? 10.98 O6 G B 2 C 235 ASP A 526 ASP^? 28.45 O6 G B 2 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -12.37 -61.03 -6.50 -12.20 -59.82 -4.73 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 1bd3_02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 2 hits 1bd3_02 naa= 3 ULMN 3 1bwl_01 NADPH DEHYDROGENASE 1 user 1 3 # 1 191 ASN A 415 ASN~? 2.88 O2 U B 3 194 HIS A 454 HIS~? 3.31 C5 U B 3 196 TYR A 416 TYR~? 3.28 C4 A B 4 coo 40.94 71.26 25.74 40.29 70.59 23.82 -11.62 -39.80 -10.44 -10.92 -39.73 -8.43 coo 38.86 67.47 19.31 37.78 65.73 19.79 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 41.10 73.64 20.13 38.52 73.39 19.02 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 1bwl_01 source 1bwl NADPH DEHYDROGENASE 1 : 1 hits 1bwl_01 naa= 3 ULMN 3 1gtx_00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 221 PHE~? 23.88 N1 A B 9 A 298 ASP A 259 ASP.? 23.89 N1 A B 9 A 329 LYS A 264 LYS~? 27.36 N1 A B 9 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 2.59 0.29 25.55 4.65 0.18 25.07 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 12.42 6.10 23.27 9.95 1.57 20.16 -41.84 -5.84 6.59 -43.28 -1.98 11.47 1gtx_00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_00 naa= 3 ULMN 3 1gtx_01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 221 PHE~? 23.88 N1 A B 9 B 298 ASP A 259 ASP.? 23.89 N1 A B 9 B 329 LYS A 264 LYS~? 27.36 N1 A B 9 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 -41.84 -5.84 6.59 -43.28 -1.98 11.47 1gtx_01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_01 naa= 3 ULMN 3 1gtx_02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 221 PHE~? 23.88 N1 A B 9 C 298 ASP A 259 ASP.? 23.89 N1 A B 9 C 329 LYS A 264 LYS~? 27.36 N1 A B 9 coo 17.41 60.57 64.39 18.40 58.12 65.34 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 24.10 66.43 63.33 24.18 64.30 63.40 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 27.64 56.61 58.17 22.18 57.92 60.36 -41.84 -5.84 6.59 -43.28 -1.98 11.47 1gtx_02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_02 naa= 3 ULMN 3 1gtx_03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 221 PHE~? 23.88 N1 A B 9 D 298 ASP A 259 ASP.? 23.89 N1 A B 9 D 329 LYS A 264 LYS~? 27.36 N1 A B 9 coo 35.44 53.35 83.81 35.65 54.53 81.28 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 29.72 46.46 83.60 30.79 47.36 81.99 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 36.89 44.91 74.55 37.33 48.94 79.01 -41.84 -5.84 6.59 -43.28 -1.98 11.47 1gtx_03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_03 naa= 3 ULMN 3 1j53_00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 457 GLU~? 3.32 N1 G B 2 A 61 GLU A 449 GLU.? 11.55 O2 U B 3 A 162 HIS A 454 HIS~? 3.31 C5 U B 3 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1j53_00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 1 hits 1j53_00 naa= 3 ULMN 3 1j7g_00 D-TYROSYL-TRNA(TYR) DEACYLASE user 1 3 # 1 A 78 GLN A 205 GLN~? 6.93 O2' A B 9 A 79 PHE A 206 PHE~? 11.98 C2 A B 9 A 80 THR A 202 THR~? 8.86 O2' A B 9 coo 18.18 6.97 -1.14 17.20 5.70 -2.56 -19.78 -15.45 26.53 -18.16 -16.55 27.40 coo 24.87 4.39 -2.11 26.74 2.89 -0.67 -24.24 -10.97 28.11 -26.44 -9.51 29.03 coo 21.26 8.65 -4.24 19.54 7.67 -5.04 -17.21 -12.36 25.70 -16.28 -12.03 27.61 1j7g_00 source 1j7g D-TYROSYL-TRNA(TYR) DEACYLASE : 1 hits 1j7g_00 naa= 3 ULMN 3 1muc_00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 270 LYS~? 23.81 O4 U B 8 A 169 LYS A 304 LYS~? 25.42 N1 A B 7 A 327 GLU A 267 GLU~? 24.62 O4 U B 8 coo 20.73 15.53 25.54 22.09 15.64 19.40 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 coo 24.31 10.25 23.71 29.02 12.05 20.75 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo 21.86 20.40 18.59 22.12 18.33 18.33 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 1muc_00 source 1muc MUCONATE LACTONIZING ENZYME : 1 hits 1muc_00 naa= 3 ULMN 3 1q6l_05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 488 ASP~? 18.76 O2 U B 1 A 68 ALA A 489 ALA~? 15.79 N2 G B 2 A 72 LEU A 444 LEU~? 14.23 N2 G B 2 coo 46.76 7.59 18.65 45.27 6.01 18.52 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 48.88 4.35 16.59 48.73 5.09 15.20 -2.47 -56.22 -20.66 -3.90 -55.94 -21.08 coo 53.89 6.25 15.09 52.88 7.92 14.14 -4.67 -51.47 -21.22 -2.66 -52.29 -21.01 1q6l_05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 1 hits 1q6l_05 naa= 3 ULMN 3 1qho_07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 533 ASP~? 24.95 O4 U B 1 A 260 ASP A 488 ASP~? 18.76 O2 U B 1 A 329 ASP A 473 ASP~? 22.60 N2 G B 2 coo 28.46 69.88 26.74 30.40 70.70 26.53 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 30.73 81.29 37.61 31.23 82.07 35.69 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1qho_07 source 1qho ALPHA-AMYLASE : 1 hits 1qho_07 naa= 3 ULMN 3 1t0u_01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 454 HIS~? 3.31 C5 U B 3 B 80 GLU A 457 GLU~? 3.32 N1 G B 2 B 223 ARG A 396 ARG~? 24.93 C2 A B 4 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 1t0u_01 source 1t0u URIDINE PHOSPHORYLASE : 1 hits 1t0u_01 naa= 3 ULMN 3 1ti6_06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 482 HIS.? 27.32 N2 G B 2 A 174 ASP A 484 ASP.? 22.65 O2 U B 1 A 404 TYR A 479 TYR.? 25.88 N2 G B 2 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ti6_06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_06 naa= 3 ULMN 3 1ti6_07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 482 HIS.? 27.32 N2 G B 2 C 174 ASP A 484 ASP.? 22.65 O2 U B 1 C 404 TYR A 479 TYR.? 25.88 N2 G B 2 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ti6_07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_07 naa= 3 ULMN 3 1ti6_08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 482 HIS.? 27.32 N2 G B 2 E 174 ASP A 484 ASP.? 22.65 O2 U B 1 E 404 TYR A 479 TYR.? 25.88 N2 G B 2 coo -7.53-107.59 75.19 -8.14-106.04 76.47 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo -3.55-105.39 83.13 -5.21-106.24 82.09 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ti6_08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_08 naa= 3 ULMN 3 1ti6_09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 482 HIS.? 27.32 N2 G B 2 G 174 ASP A 484 ASP.? 22.65 O2 U B 1 G 404 TYR A 479 TYR.? 25.88 N2 G B 2 coo 60.48-101.16 45.95 60.56-101.20 43.85 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 58.10-108.15 40.62 59.57-106.86 41.51 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ti6_09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_09 naa= 3 ULMN 3 1ti6_10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 482 HIS.? 27.32 N2 G B 2 I 174 ASP A 484 ASP.? 22.65 O2 U B 1 I 404 TYR A 479 TYR.? 25.88 N2 G B 2 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ti6_10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_10 naa= 3 ULMN 3 1ti6_11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 482 HIS.? 27.32 N2 G B 2 K 174 ASP A 484 ASP.? 22.65 O2 U B 1 K 404 TYR A 479 TYR.? 25.88 N2 G B 2 coo 100.18 26.45 -1.32 99.24 26.12 0.53 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 102.36 30.86 6.31 102.45 29.08 5.12 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ti6_11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 1 hits 1ti6_11 naa= 3 ULMN 3 2oat_03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 221 PHE~? 23.88 N1 A B 9 A 263 ASP A 259 ASP.? 23.89 N1 A B 9 A 292 LYS A 264 LYS~? 27.36 N1 A B 9 coo 51.51 50.32 16.39 52.13 49.68 13.75 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 54.43 44.82 23.74 55.21 45.06 21.80 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 63.95 45.30 16.71 59.11 49.15 16.05 -41.84 -5.84 6.59 -43.28 -1.98 11.47 2oat_03 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_03 naa= 3 ULMN 3 2oat_05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 221 PHE~? 23.88 N1 A B 9 C 263 ASP A 259 ASP.? 23.89 N1 A B 9 C 292 LYS A 264 LYS~? 27.36 N1 A B 9 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 19.84 12.02 9.33 18.68 11.23 7.75 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 12.82 3.49 4.98 17.80 5.59 1.90 -41.84 -5.84 6.59 -43.28 -1.98 11.47 2oat_05 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_05 naa= 3 ULMN 3 2tdt_00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 283 ASP~? 9.21 O2 U B 8 166 GLY A 362 GLY~? 9.16 C4' C B 5 169 GLU A 412 GLU.? 7.44 O2' U B 3 coo 8.28 6.87 1.62 10.08 5.77 1.34 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -16.83 -27.47 -7.16 -16.64 -28.16 -6.72 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 ULMN 3 2tdt_00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 512 ASP~? 14.88 O6 G B 2 166 GLY A 499 GLY~? 6.97 N2 G B 2 169 GLU A 449 GLU.? 11.55 O2 U B 3 coo 8.28 6.87 1.62 10.08 5.77 1.34 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 2tdt_00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 2 hits 2tdt_00 naa= 3 ULMN 2 132l_00 LYSOZYME user 1 2 # 1 A 35 GLU A 470 GLU~? 22.82 N2 G B 2 A 52 ASP A 473 ASP~? 22.60 N2 G B 2 coo 0.57 10.10 59.04 0.13 9.60 61.00 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -3.95 14.26 64.11 -2.90 13.35 65.69 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 132l_00 LYSOZYME user 2 2 # 2 A 35 GLU A 545 GLU~? 17.12 N3 U B 1 A 52 ASP A 491 ASP~? 15.62 O2 U B 1 coo 0.57 10.10 59.04 0.13 9.60 61.00 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -3.95 14.26 64.11 -2.90 13.35 65.69 2.02 -59.32 -18.53 4.01 -59.49 -17.81 132l_00 source 132l LYSOZYME : 2 hits 132l_00 naa= 2 ULMN 2 135l_00 LYSOZYME user 1 2 # 1 35 GLU A 545 GLU~? 17.12 N3 U B 1 52 ASP A 491 ASP~? 15.62 O2 U B 1 coo 11.73 12.37 28.72 9.72 13.02 28.94 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 9.54 19.42 32.23 7.70 18.49 32.58 2.02 -59.32 -18.53 4.01 -59.49 -17.81 135l_00 source 135l LYSOZYME : 1 hits 135l_00 naa= 2 ULMN 2 1a16_00 AMINOPEPTIDASE P user 1 2 # 1 361 HIS A 527 HIS~? 25.85 N2 G B 2 383 GLU A 466 GLU~? 26.72 N2 G B 2 coo 59.75 55.06 51.09 59.96 53.47 52.44 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 62.63 46.38 48.62 62.87 47.86 50.20 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 1a16_00 source 1a16 AMINOPEPTIDASE P : 1 hits 1a16_00 naa= 2 ULMN 2 1a26_00 POLY (ADP-RIBOSE) POLYMERASE user 1 2 # 1 907 TYR A 430 TYR~? 19.67 C2 A B 4 988 GLU A 391 GLU~? 23.54 N1 A B 4 coo 42.62 20.46 18.03 40.71 19.08 19.58 -27.09 -41.12 -16.90 -29.47 -39.88 -17.72 coo 38.29 21.82 26.74 37.66 20.24 25.49 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 1a26_00 source 1a26 POLY (ADP-RIBOSE) POLYMERASE : 1 hits 1a26_00 naa= 2 ULMN 2 1a2t_00 STAPHYLOCOCCAL NUCLEASE user 1 2 # 1 35 ARG A 354 ARG~? 17.55 O2' A B 4 87 ARG A 404 ARG~? 18.97 O2 U B 3 coo 7.06 18.55 19.42 4.23 17.64 18.60 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo 11.01 18.43 22.61 8.68 16.49 22.13 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 1a2t_00 source 1a2t STAPHYLOCOCCAL NUCLEASE : 1 hits 1a2t_00 naa= 2 ULMN 2 1a4g_00 NEURAMINIDASE user 1 2 # 1 A 148 ASP A 425 ASP.? 18.06 O4 U B 3 A 275 GLU A 432 GLU~? 22.16 O4 U B 3 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1a4g_00 NEURAMINIDASE user 2 2 # 2 A 148 ASP A 425 ASP.? 18.06 O4 U B 3 A 275 GLU A 522 GLU^? 23.38 O4 U B 3 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1a4g_00 NEURAMINIDASE user 3 2 # 3 A 148 ASP A 488 ASP~? 18.76 O2 U B 1 A 275 GLU A 545 GLU~? 17.12 N3 U B 1 coo 1.48 57.43 -11.18 0.69 58.45 -9.51 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -7.02 52.62 -6.46 -5.66 54.00 -5.65 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1a4g_00 source 1a4g NEURAMINIDASE : 3 hits 1a4g_00 naa= 2 ULMN 2 1a4g_01 NEURAMINIDASE user 1 2 # 1 B 148 ASP A 425 ASP.? 18.06 O4 U B 3 B 275 GLU A 432 GLU~? 22.16 O4 U B 3 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1a4g_01 NEURAMINIDASE user 2 2 # 2 B 148 ASP A 425 ASP.? 18.06 O4 U B 3 B 275 GLU A 522 GLU^? 23.38 O4 U B 3 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1a4g_01 NEURAMINIDASE user 3 2 # 3 B 148 ASP A 426 ASP.? 18.90 N1 A B 4 B 275 GLU A 391 GLU~? 23.54 N1 A B 4 coo 34.98 38.01 -27.14 34.06 39.37 -28.44 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 26.72 33.17 -32.28 27.02 35.22 -31.99 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 1a4g_01 source 1a4g NEURAMINIDASE : 3 hits 1a4g_01 naa= 2 ULMN 2 1a50_02 TRYPTOPHAN SYNTHASE user 1 2 # 1 B 87 LYS A 304 LYS~? 25.42 N1 A B 7 B 377 SER A 300 SER~? 23.48 N6 A B 7 coo 79.96 10.34 6.36 80.68 15.13 9.07 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo 87.05 10.11 10.96 86.59 11.97 12.49 -41.38 -17.70 -1.13 -43.08 -16.44 0.06 1a50_02 source 1a50 TRYPTOPHAN SYNTHASE : 1 hits 1a50_02 naa= 2 ULMN 2 1a69_00 PURINE NUCLEOSIDE PHOSPHORYLASE user 1 2 # 1 A 204 ASP A 233 ASP~? 18.81 O2 U B 8 A 217 ARG A 230 ARG~? 20.03 C2 A B 9 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1a69_00 PURINE NUCLEOSIDE PHOSPHORYLASE user 2 2 # 2 A 204 ASP A 259 ASP.? 23.89 N1 A B 9 A 217 ARG A 265 ARG~? 21.55 N1 A B 9 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -38.98 -7.64 12.61 -41.54 -9.16 13.48 ULMN 2 1a69_00 PURINE NUCLEOSIDE PHOSPHORYLASE user 3 2 # 3 A 204 ASP A 425 ASP.? 18.06 O4 U B 3 A 217 ARG A 431 ARG~? 16.75 O4 U B 3 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1a69_00 PURINE NUCLEOSIDE PHOSPHORYLASE user 4 2 # 4 A 204 ASP A 488 ASP~? 18.76 O2 U B 1 A 217 ARG A 541 ARG~? 18.28 O4 U B 1 coo -24.32 68.31 63.50 -22.74 69.45 64.25 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 ULMN 2 1a69_00 PURINE NUCLEOSIDE PHOSPHORYLASE user 5 2 # 5 A 204 ASP A 491 ASP~? 15.62 O2 U B 1 A 217 ARG A 541 ARG~? 18.28 O4 U B 1 coo -24.32 68.31 63.50 -22.74 69.45 64.25 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo -24.22 66.54 70.62 -24.40 68.56 68.30 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 ULMN 2 1a69_00 PURINE NUCLEOSIDE PHOSPHORYLASE user 6 2 # 6 A 204 ASP A 491 ASP~? 15.62 O2 U B 1 A 217 ARG A 548 ARG~? 15.11 O2 U B 1 coo -24.32 68.31 63.50 -22.74 69.45 64.25 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo -24.22 66.54 70.62 -24.40 68.56 68.30 7.33 -63.34 -13.62 6.31 -60.85 -15.12 1a69_00 source 1a69 PURINE NUCLEOSIDE PHOSPHORYLASE : 6 hits 1a69_00 naa= 2 ULMN 2 1a69_02 PURINE NUCLEOSIDE PHOSPHORYLASE user 1 2 # 1 C 204 ASP A 283 ASP~? 9.21 O2 U B 8 C 217 ARG A 288 ARG~? 3.45 C6 A B 7 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -21.54 -21.02 8.30 -20.02 -23.61 8.96 ULMN 2 1a69_02 PURINE NUCLEOSIDE PHOSPHORYLASE user 2 2 # 2 C 204 ASP A 312 ASP~? 21.35 C2 A B 7 C 217 ARG A 311 ARG.? 21.53 N1 A B 7 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -28.14 -16.31 -12.56 -31.15 -16.30 -12.01 ULMN 2 1a69_02 PURINE NUCLEOSIDE PHOSPHORYLASE user 3 2 # 3 C 204 ASP A 345 ASP~? 24.06 C2 A B 4 C 217 ARG A 311 ARG.? 21.53 N1 A B 7 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -28.14 -16.31 -12.56 -31.15 -16.30 -12.01 ULMN 2 1a69_02 PURINE NUCLEOSIDE PHOSPHORYLASE user 4 2 # 4 C 204 ASP A 426 ASP.? 18.90 N1 A B 4 C 217 ARG A 390 ARG~? 22.44 N1 A B 4 coo -3.24 84.82 92.39 -3.67 84.32 90.40 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo -8.68 83.28 98.52 -7.90 81.07 100.50 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 1a69_02 source 1a69 PURINE NUCLEOSIDE PHOSPHORYLASE : 4 hits 1a69_02 naa= 2 ULMN 2 1a7u_07 CHLOROPEROXIDASE T user 1 2 # 1 B 98 SER A 453 SER~? 2.96 N2 G B 2 B 257 HIS A 454 HIS~? 3.31 C5 U B 3 coo 28.35 71.07 3.94 30.08 69.46 4.49 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 coo 32.76 68.02 0.70 31.21 68.44 2.05 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1a7u_07 source 1a7u CHLOROPEROXIDASE T : 1 hits 1a7u_07 naa= 2 ULMN 2 1aam_00 ASPARTATE AMINOTRANSFERASE user 1 2 # 1 142 TRP A 534 TRP~? 20.57 N2 G B 2 223 ASP A 473 ASP~? 22.60 N2 G B 2 coo 127.19 33.46 26.14 126.78 36.79 28.15 -13.87 -64.07 -18.86 -17.27 -62.50 -17.72 coo 126.95 41.66 23.38 128.48 40.72 24.51 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1aam_00 source 1aam ASPARTATE AMINOTRANSFERASE : 1 hits 1aam_00 naa= 2 ULMN 2 1abr_00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 1 2 # 1 A 164 GLU A 351 GLU~? 20.29 O2' A B 4 A 167 ARG A 354 ARG~? 17.55 O2' A B 4 coo 62.73 6.07 37.74 64.13 7.43 36.88 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 64.19 10.87 39.90 66.62 8.97 39.90 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1abr_00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 2 2 # 2 A 164 GLU A 391 GLU~? 23.54 N1 A B 4 A 167 ARG A 390 ARG~? 22.44 N1 A B 4 coo 62.73 6.07 37.74 64.13 7.43 36.88 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 64.19 10.87 39.90 66.62 8.97 39.90 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 1abr_00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 3 2 # 3 A 164 GLU A 407 GLU~? 15.45 O2 U B 3 A 167 ARG A 404 ARG~? 18.97 O2 U B 3 coo 62.73 6.07 37.74 64.13 7.43 36.88 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 64.19 10.87 39.90 66.62 8.97 39.90 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 ULMN 2 1abr_00 ABRIN-A COMPLEXED WITH TWO SUGAR CHAuser 4 2 # 4 A 164 GLU A 545 GLU~? 17.12 N3 U B 1 A 167 ARG A 548 ARG~? 15.11 O2 U B 1 coo 62.73 6.07 37.74 64.13 7.43 36.88 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 64.19 10.87 39.90 66.62 8.97 39.90 7.33 -63.34 -13.62 6.31 -60.85 -15.12 1abr_00 source 1abr ABRIN-A COMPLEXED WITH TWO SUGAR CHAINS : 4 hits 1abr_00 naa= 2 ULMN 2 1af7_00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 1 2 # 1 98 ARG A 180 ARG.? 21.90 C2 A B 9 154 ASP A 193 ASP~? 20.25 C2 A B 9 coo 30.46 16.14 41.59 29.16 15.67 44.34 -20.54 -3.44 35.42 -23.45 -2.48 35.38 coo 29.87 29.36 46.86 29.51 27.55 47.90 -22.85 0.02 23.71 -22.18 1.98 24.08 ULMN 2 1af7_00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 2 2 # 2 98 ARG A 265 ARG~? 21.55 N1 A B 9 154 ASP A 298 ASP~? 21.17 O4 U B 8 coo 30.46 16.14 41.59 29.16 15.67 44.34 -38.98 -7.64 12.61 -41.54 -9.16 13.48 coo 29.87 29.36 46.86 29.51 27.55 47.90 -41.82 -17.47 4.14 -42.95 -17.27 5.91 ULMN 2 1af7_00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 3 2 # 3 98 ARG A 288 ARG~? 3.45 C6 A B 7 154 ASP A 321 ASP~? 8.41 N3 A B 7 coo 30.46 16.14 41.59 29.16 15.67 44.34 -21.54 -21.02 8.30 -20.02 -23.61 8.96 coo 29.87 29.36 46.86 29.51 27.55 47.90 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1af7_00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 4 2 # 4 98 ARG A 541 ARG~? 18.28 O4 U B 1 154 ASP A 533 ASP~? 24.95 O4 U B 1 coo 30.46 16.14 41.59 29.16 15.67 44.34 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 coo 29.87 29.36 46.86 29.51 27.55 47.90 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1af7_00 CHEMOTAXIS RECEPTOR METHYLTRANSFERASuser 5 2 # 5 98 ARG A 551 ARG.? 14.22 O4' U B 1 154 ASP A 491 ASP~? 15.62 O2 U B 1 coo 30.46 16.14 41.59 29.16 15.67 44.34 10.35 -61.35 -7.37 12.18 -59.05 -8.34 coo 29.87 29.36 46.86 29.51 27.55 47.90 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1af7_00 source 1af7 CHEMOTAXIS RECEPTOR METHYLTRANSFERASE CHER : 5 hits 1af7_00 naa= 2 ULMN 2 1agm_00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 1 2 # 1 179 GLU A 351 GLU~? 20.29 O2' A B 4 400 GLU A 407 GLU~? 15.45 O2 U B 3 coo 32.98 15.63 8.99 31.06 16.43 9.08 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 34.51 26.41 7.72 33.50 24.94 6.68 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1agm_00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 2 2 # 2 179 GLU A 407 GLU~? 15.45 O2 U B 3 400 GLU A 351 GLU~? 20.29 O2' A B 4 coo 32.98 15.63 8.99 31.06 16.43 9.08 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 34.51 26.41 7.72 33.50 24.94 6.68 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1agm_00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 3 2 # 3 179 GLU A 432 GLU~? 22.16 O4 U B 3 400 GLU A 470 GLU~? 22.82 N2 G B 2 coo 32.98 15.63 8.99 31.06 16.43 9.08 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 34.51 26.41 7.72 33.50 24.94 6.68 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1agm_00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 4 2 # 4 179 GLU A 432 GLU~? 22.16 O4 U B 3 400 GLU A 522 GLU^? 23.38 O4 U B 3 coo 32.98 15.63 8.99 31.06 16.43 9.08 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 34.51 26.41 7.72 33.50 24.94 6.68 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1agm_00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 5 2 # 5 179 GLU A 466 GLU~? 26.72 N2 G B 2 400 GLU A 432 GLU~? 22.16 O4 U B 3 coo 32.98 15.63 8.99 31.06 16.43 9.08 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 34.51 26.41 7.72 33.50 24.94 6.68 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1agm_00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 6 2 # 6 179 GLU A 466 GLU~? 26.72 N2 G B 2 400 GLU A 522 GLU^? 23.38 O4 U B 3 coo 32.98 15.63 8.99 31.06 16.43 9.08 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 34.51 26.41 7.72 33.50 24.94 6.68 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1agm_00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 7 2 # 7 179 GLU A 470 GLU~? 22.82 N2 G B 2 400 GLU A 432 GLU~? 22.16 O4 U B 3 coo 32.98 15.63 8.99 31.06 16.43 9.08 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 34.51 26.41 7.72 33.50 24.94 6.68 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1agm_00 GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-Guser 8 2 # 8 179 GLU A 522 GLU^? 23.38 O4 U B 3 400 GLU A 432 GLU~? 22.16 O4 U B 3 coo 32.98 15.63 8.99 31.06 16.43 9.08 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 34.51 26.41 7.72 33.50 24.94 6.68 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1agm_00 source 1agm GLUCOAMYLASE-471 (GLUCAN 1,4-ALPHA-GLUCOSIDASE: 8 hits 1agm_00 naa= 2 ULMN 2 1akd_00 CYTOCHROME P450CAM user 1 2 # 1 251 ASP A 200 ASP~? 9.45 O2' A B 9 252 THR A 202 THR~? 8.86 O2' A B 9 coo 22.35 20.89 12.77 23.04 22.54 13.90 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 17.85 20.47 14.62 16.85 19.84 12.80 -17.21 -12.36 25.70 -16.28 -12.03 27.61 ULMN 2 1akd_00 CYTOCHROME P450CAM user 2 2 # 2 251 ASP A 259 ASP.? 23.89 N1 A B 9 252 THR A 257 THR~? 19.75 N1 A B 9 coo 22.35 20.89 12.77 23.04 22.54 13.90 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 17.85 20.47 14.62 16.85 19.84 12.80 -42.71 -13.46 15.84 -41.70 -12.17 17.23 ULMN 2 1akd_00 CYTOCHROME P450CAM user 3 2 # 3 251 ASP A 279 ASP~? 17.12 C2 A B 7 252 THR A 278 THR~? 15.67 C2 A B 7 coo 22.35 20.89 12.77 23.04 22.54 13.90 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 17.85 20.47 14.62 16.85 19.84 12.80 -22.24 -12.38 -4.02 -21.46 -12.34 -6.04 ULMN 2 1akd_00 CYTOCHROME P450CAM user 4 2 # 4 251 ASP A 376 ASP~? 17.17 N1 A B 4 252 THR A 374 THR.? 15.78 N1 A B 4 coo 22.35 20.89 12.77 23.04 22.54 13.90 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 17.85 20.47 14.62 16.85 19.84 12.80 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 ULMN 2 1akd_00 CYTOCHROME P450CAM user 5 2 # 5 251 ASP A 426 ASP.? 18.90 N1 A B 4 252 THR A 374 THR.? 15.78 N1 A B 4 coo 22.35 20.89 12.77 23.04 22.54 13.90 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 17.85 20.47 14.62 16.85 19.84 12.80 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 ULMN 2 1akd_00 CYTOCHROME P450CAM user 6 2 # 6 251 ASP A 484 ASP.? 22.65 O2 U B 1 252 THR A 485 THR.? 14.93 O2 U B 1 coo 22.35 20.89 12.77 23.04 22.54 13.90 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo 17.85 20.47 14.62 16.85 19.84 12.80 6.28 -52.72 -20.02 4.64 -51.56 -19.13 ULMN 2 1akd_00 CYTOCHROME P450CAM user 7 2 # 7 251 ASP A 512 ASP~? 14.88 O6 G B 2 252 THR A 508 THR~? 10.98 O6 G B 2 coo 22.35 20.89 12.77 23.04 22.54 13.90 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 17.85 20.47 14.62 16.85 19.84 12.80 -12.37 -61.03 -6.50 -12.20 -59.82 -4.73 1akd_00 source 1akd CYTOCHROME P450CAM : 7 hits 1akd_00 naa= 2 ULMN 2 1amy_00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 2 # 1 179 ASP A 345 ASP~? 24.06 C2 A B 4 204 GLU A 341 GLU~? 25.67 N6 A B 7 coo -0.62 65.95 29.97 0.31 67.47 31.05 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 4.34 62.44 32.05 4.22 64.48 32.53 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1amy_00 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 2 # 2 179 ASP A 491 ASP~? 15.62 O2 U B 1 204 GLU A 545 GLU~? 17.12 N3 U B 1 coo -0.62 65.95 29.97 0.31 67.47 31.05 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 4.34 62.44 32.05 4.22 64.48 32.53 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1amy_00 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_00 naa= 2 ULMN 2 1aq0_02 1,3-1,4-BETA-GLUCANASE user 1 2 # 1 A 232 GLU A 351 GLU~? 20.29 O2' A B 4 A 288 GLU A 407 GLU~? 15.45 O2 U B 3 coo 5.76 85.47 37.35 6.76 85.56 39.24 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 13.49 92.75 43.16 12.39 91.15 42.33 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1aq0_02 1,3-1,4-BETA-GLUCANASE user 2 2 # 2 A 232 GLU A 407 GLU~? 15.45 O2 U B 3 A 288 GLU A 351 GLU~? 20.29 O2' A B 4 coo 5.76 85.47 37.35 6.76 85.56 39.24 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 13.49 92.75 43.16 12.39 91.15 42.33 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1aq0_02 1,3-1,4-BETA-GLUCANASE user 3 2 # 3 A 232 GLU A 432 GLU~? 22.16 O4 U B 3 A 288 GLU A 470 GLU~? 22.82 N2 G B 2 coo 5.76 85.47 37.35 6.76 85.56 39.24 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 13.49 92.75 43.16 12.39 91.15 42.33 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1aq0_02 1,3-1,4-BETA-GLUCANASE user 4 2 # 4 A 232 GLU A 432 GLU~? 22.16 O4 U B 3 A 288 GLU A 522 GLU^? 23.38 O4 U B 3 coo 5.76 85.47 37.35 6.76 85.56 39.24 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 13.49 92.75 43.16 12.39 91.15 42.33 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1aq0_02 1,3-1,4-BETA-GLUCANASE user 5 2 # 5 A 232 GLU A 470 GLU~? 22.82 N2 G B 2 A 288 GLU A 432 GLU~? 22.16 O4 U B 3 coo 5.76 85.47 37.35 6.76 85.56 39.24 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 13.49 92.75 43.16 12.39 91.15 42.33 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1aq0_02 1,3-1,4-BETA-GLUCANASE user 6 2 # 6 A 232 GLU A 522 GLU^? 23.38 O4 U B 3 A 288 GLU A 432 GLU~? 22.16 O4 U B 3 coo 5.76 85.47 37.35 6.76 85.56 39.24 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 13.49 92.75 43.16 12.39 91.15 42.33 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1aq0_02 source 1aq0 1,3-1,4-BETA-GLUCANASE : 6 hits 1aq0_02 naa= 2 ULMN 2 1aq0_03 1,3-1,4-BETA-GLUCANASE user 1 2 # 1 B 232 GLU A 351 GLU~? 20.29 O2' A B 4 B 288 GLU A 407 GLU~? 15.45 O2 U B 3 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1aq0_03 1,3-1,4-BETA-GLUCANASE user 2 2 # 2 B 232 GLU A 407 GLU~? 15.45 O2 U B 3 B 288 GLU A 351 GLU~? 20.29 O2' A B 4 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1aq0_03 1,3-1,4-BETA-GLUCANASE user 3 2 # 3 B 232 GLU A 432 GLU~? 22.16 O4 U B 3 B 288 GLU A 470 GLU~? 22.82 N2 G B 2 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1aq0_03 1,3-1,4-BETA-GLUCANASE user 4 2 # 4 B 232 GLU A 432 GLU~? 22.16 O4 U B 3 B 288 GLU A 522 GLU^? 23.38 O4 U B 3 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1aq0_03 1,3-1,4-BETA-GLUCANASE user 5 2 # 5 B 232 GLU A 470 GLU~? 22.82 N2 G B 2 B 288 GLU A 432 GLU~? 22.16 O4 U B 3 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1aq0_03 1,3-1,4-BETA-GLUCANASE user 6 2 # 6 B 232 GLU A 522 GLU^? 23.38 O4 U B 3 B 288 GLU A 432 GLU~? 22.16 O4 U B 3 coo -0.96 61.87 2.24 -2.27 63.48 2.70 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo -1.91 73.68 -0.16 -1.91 71.74 0.71 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1aq0_03 source 1aq0 1,3-1,4-BETA-GLUCANASE : 6 hits 1aq0_03 naa= 2 ULMN 2 1ar1_01 CYTOCHROME C OXIDASE user 1 2 # 1 A 278 GLU A 208 GLU~? 4.03 N1 A B 9 A 354 LYS A 330 LYS~? 6.92 N6 A B 7 coo 10.31 15.79 49.32 9.85 15.75 51.40 -24.90 -17.89 21.91 -24.90 -19.66 23.08 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 -28.12 -25.40 0.86 -29.08 -26.03 5.63 ULMN 2 1ar1_01 CYTOCHROME C OXIDASE user 2 2 # 2 A 278 GLU A 267 GLU~? 24.62 O4 U B 8 A 354 LYS A 338 LYS~? 26.90 N6 A B 7 coo 10.31 15.79 49.32 9.85 15.75 51.40 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 -37.84 -25.02 -10.54 -41.92 -21.39 -11.77 ULMN 2 1ar1_01 CYTOCHROME C OXIDASE user 3 2 # 3 A 278 GLU A 466 GLU~? 26.72 N2 G B 2 A 354 LYS A 537 LYS~? 23.79 O4 U B 1 coo 10.31 15.79 49.32 9.85 15.75 51.40 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 ULMN 2 1ar1_01 CYTOCHROME C OXIDASE user 4 2 # 4 A 278 GLU A 470 GLU~? 22.82 N2 G B 2 A 354 LYS A 536 LYS~? 26.44 O4 U B 1 coo 10.31 15.79 49.32 9.85 15.75 51.40 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 7.96 -2.29 39.09 7.97 -1.98 43.24 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 1ar1_01 source 1ar1 CYTOCHROME C OXIDASE : 4 hits 1ar1_01 naa= 2 ULMN 2 1ast_00 ASTACIN (E.C.3.4.24.21) user 1 2 # 1 93 GLU A 391 GLU~? 23.54 N1 A B 4 149 TYR A 430 TYR~? 19.67 C2 A B 4 coo 15.94 26.98 26.92 17.27 26.11 25.50 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 21.50 28.85 18.49 20.74 27.28 20.66 -27.09 -41.12 -16.90 -29.47 -39.88 -17.72 1ast_00 source 1ast ASTACIN (E.C.3.4.24.21) : 1 hits 1ast_00 naa= 2 ULMN 2 1aw8_00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 1 2 # 1 A 9 LYS A 196 LYS~? 19.45 O2' A B 9 B 58 TYR A 245 TYR~? 3.47 C5 A B 9 coo 52.74 47.41 27.36 54.00 51.99 23.19 -19.67 -3.42 20.50 -17.88 1.90 20.43 coo 60.69 34.67 32.44 62.26 33.65 34.50 -22.48 -17.46 16.07 -20.67 -19.47 15.36 ULMN 2 1aw8_00 L-ASPARTATE-ALPHA-DECARBOXYLASE user 2 2 # 2 A 9 LYS A 372 LYS~? 15.54 N6 A B 7 B 58 TYR A 416 TYR~? 3.28 C4 A B 4 coo 52.74 47.41 27.36 54.00 51.99 23.19 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 60.69 34.67 32.44 62.26 33.65 34.50 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 1aw8_00 source 1aw8 L-ASPARTATE-ALPHA-DECARBOXYLASE : 2 hits 1aw8_00 naa= 2 ULMN 2 1ax4_00 TRYPTOPHANASE user 1 2 # 1 A 132 PHE A 197 PHE~? 14.18 C2 A B 9 A 223 ASP A 200 ASP~? 9.45 O2' A B 9 coo 31.56 54.91 67.81 30.07 57.23 67.43 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo 30.70 47.50 67.53 29.83 49.47 67.39 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1ax4_00 TRYPTOPHANASE user 2 2 # 2 A 132 PHE A 221 PHE~? 23.88 N1 A B 9 A 223 ASP A 259 ASP.? 23.89 N1 A B 9 coo 31.56 54.91 67.81 30.07 57.23 67.43 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1ax4_00 TRYPTOPHANASE user 3 2 # 3 A 132 PHE A 224 PHE~? 18.04 N1 A B 9 A 223 ASP A 259 ASP.? 23.89 N1 A B 9 coo 31.56 54.91 67.81 30.07 57.23 67.43 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 30.70 47.50 67.53 29.83 49.47 67.39 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1ax4_00 TRYPTOPHANASE user 4 2 # 4 A 132 PHE A 285 PHE~? 4.61 O2 U B 8 A 223 ASP A 283 ASP~? 9.21 O2 U B 8 coo 31.56 54.91 67.81 30.07 57.23 67.43 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 30.70 47.50 67.53 29.83 49.47 67.39 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 1ax4_00 TRYPTOPHANASE user 5 2 # 5 A 132 PHE A 476 PHE~? 18.32 N2 G B 2 A 223 ASP A 473 ASP~? 22.60 N2 G B 2 coo 31.56 54.91 67.81 30.07 57.23 67.43 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo 30.70 47.50 67.53 29.83 49.47 67.39 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1ax4_00 TRYPTOPHANASE user 6 2 # 6 A 132 PHE A 476 PHE~? 18.32 N2 G B 2 A 223 ASP A 533 ASP~? 24.95 O4 U B 1 coo 31.56 54.91 67.81 30.07 57.23 67.43 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo 30.70 47.50 67.53 29.83 49.47 67.39 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1ax4_00 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_00 naa= 2 ULMN 2 1ax4_01 TRYPTOPHANASE user 1 2 # 1 B 132 PHE A 197 PHE~? 14.18 C2 A B 9 B 223 ASP A 200 ASP~? 9.45 O2' A B 9 coo 8.96 54.33 91.07 8.09 52.55 89.13 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo 10.43 61.66 91.81 9.80 60.04 90.61 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1ax4_01 TRYPTOPHANASE user 2 2 # 2 B 132 PHE A 221 PHE~? 23.88 N1 A B 9 B 223 ASP A 259 ASP.? 23.89 N1 A B 9 coo 8.96 54.33 91.07 8.09 52.55 89.13 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1ax4_01 TRYPTOPHANASE user 3 2 # 3 B 132 PHE A 224 PHE~? 18.04 N1 A B 9 B 223 ASP A 259 ASP.? 23.89 N1 A B 9 coo 8.96 54.33 91.07 8.09 52.55 89.13 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 10.43 61.66 91.81 9.80 60.04 90.61 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1ax4_01 TRYPTOPHANASE user 4 2 # 4 B 132 PHE A 285 PHE~? 4.61 O2 U B 8 B 223 ASP A 283 ASP~? 9.21 O2 U B 8 coo 8.96 54.33 91.07 8.09 52.55 89.13 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 10.43 61.66 91.81 9.80 60.04 90.61 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 1ax4_01 TRYPTOPHANASE user 5 2 # 5 B 132 PHE A 476 PHE~? 18.32 N2 G B 2 B 223 ASP A 473 ASP~? 22.60 N2 G B 2 coo 8.96 54.33 91.07 8.09 52.55 89.13 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo 10.43 61.66 91.81 9.80 60.04 90.61 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1ax4_01 TRYPTOPHANASE user 6 2 # 6 B 132 PHE A 476 PHE~? 18.32 N2 G B 2 B 223 ASP A 533 ASP~? 24.95 O4 U B 1 coo 8.96 54.33 91.07 8.09 52.55 89.13 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo 10.43 61.66 91.81 9.80 60.04 90.61 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1ax4_01 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_01 naa= 2 ULMN 2 1ax4_02 TRYPTOPHANASE user 1 2 # 1 C 132 PHE A 197 PHE~? 14.18 C2 A B 9 C 223 ASP A 200 ASP~? 9.45 O2' A B 9 coo -7.99 68.93 30.87 -7.11 66.46 31.77 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1ax4_02 TRYPTOPHANASE user 2 2 # 2 C 132 PHE A 221 PHE~? 23.88 N1 A B 9 C 223 ASP A 259 ASP.? 23.89 N1 A B 9 coo -7.99 68.93 30.87 -7.11 66.46 31.77 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1ax4_02 TRYPTOPHANASE user 3 2 # 3 C 132 PHE A 224 PHE~? 18.04 N1 A B 9 C 223 ASP A 259 ASP.? 23.89 N1 A B 9 coo -7.99 68.93 30.87 -7.11 66.46 31.77 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1ax4_02 TRYPTOPHANASE user 4 2 # 4 C 132 PHE A 285 PHE~? 4.61 O2 U B 8 C 223 ASP A 283 ASP~? 9.21 O2 U B 8 coo -7.99 68.93 30.87 -7.11 66.46 31.77 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 1ax4_02 TRYPTOPHANASE user 5 2 # 5 C 132 PHE A 476 PHE~? 18.32 N2 G B 2 C 223 ASP A 473 ASP~? 22.60 N2 G B 2 coo -7.99 68.93 30.87 -7.11 66.46 31.77 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1ax4_02 TRYPTOPHANASE user 6 2 # 6 C 132 PHE A 476 PHE~? 18.32 N2 G B 2 C 223 ASP A 533 ASP~? 24.95 O4 U B 1 coo -7.99 68.93 30.87 -7.11 66.46 31.77 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1ax4_02 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_02 naa= 2 ULMN 2 1ax4_03 TRYPTOPHANASE user 1 2 # 1 D 132 PHE A 197 PHE~? 14.18 C2 A B 9 D 223 ASP A 200 ASP~? 9.45 O2' A B 9 coo -30.45 58.28 51.78 -28.99 60.20 53.18 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1ax4_03 TRYPTOPHANASE user 2 2 # 2 D 132 PHE A 221 PHE~? 23.88 N1 A B 9 D 223 ASP A 259 ASP.? 23.89 N1 A B 9 coo -30.45 58.28 51.78 -28.99 60.20 53.18 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1ax4_03 TRYPTOPHANASE user 3 2 # 3 D 132 PHE A 224 PHE~? 18.04 N1 A B 9 D 223 ASP A 259 ASP.? 23.89 N1 A B 9 coo -30.45 58.28 51.78 -28.99 60.20 53.18 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1ax4_03 TRYPTOPHANASE user 4 2 # 4 D 132 PHE A 285 PHE~? 4.61 O2 U B 8 D 223 ASP A 283 ASP~? 9.21 O2 U B 8 coo -30.45 58.28 51.78 -28.99 60.20 53.18 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 1ax4_03 TRYPTOPHANASE user 5 2 # 5 D 132 PHE A 476 PHE~? 18.32 N2 G B 2 D 223 ASP A 473 ASP~? 22.60 N2 G B 2 coo -30.45 58.28 51.78 -28.99 60.20 53.18 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1ax4_03 TRYPTOPHANASE user 6 2 # 6 D 132 PHE A 476 PHE~? 18.32 N2 G B 2 D 223 ASP A 533 ASP~? 24.95 O4 U B 1 coo -30.45 58.28 51.78 -28.99 60.20 53.18 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1ax4_03 source 1ax4 TRYPTOPHANASE : 6 hits 1ax4_03 naa= 2 ULMN 2 1ay4_01 AROMATIC AMINO ACID AMINOTRANSFERASEuser 1 2 # 1 B 140 TRP A 534 TRP~? 20.57 N2 G B 2 B 222 ASP A 473 ASP~? 22.60 N2 G B 2 coo 103.45 44.39 16.20 102.66 41.02 14.32 -13.87 -64.07 -18.86 -17.27 -62.50 -17.72 coo 110.10 38.66 15.58 108.40 39.41 14.53 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1ay4_01 source 1ay4 AROMATIC AMINO ACID AMINOTRANSFERASE : 1 hits 1ay4_01 naa= 2 ULMN 2 1b2r_01 FERREDOXIN-NADP+ REDUCTASE user 1 2 # 1 A 80 SER A 530 SER~? 25.46 N2 G B 2 A 301 ALA A 469 ALA~? 22.09 N2 G B 2 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -18.33 -66.93 -18.45 -19.81 -66.03 -20.11 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -17.88 -59.65 -20.62 -18.93 -60.55 -21.31 ULMN 2 1b2r_01 FERREDOXIN-NADP+ REDUCTASE user 2 2 # 2 A 80 SER A 567 SER.? 20.68 O4 U B 1 A 301 ALA A 563 ALA~? 15.88 O4 U B 1 coo -23.71 50.30 -2.14 -22.50 48.72 -0.71 -12.85 -74.56 -0.21 -11.29 -73.03 0.90 coo -22.54 45.09 5.28 -22.99 46.36 4.56 -6.15 -70.58 -2.36 -4.88 -70.40 -1.53 1b2r_01 source 1b2r FERREDOXIN-NADP+ REDUCTASE : 2 hits 1b2r_01 naa= 2 ULMN 2 1b5t_00 METHYLENETETRAHYDROFOLATE REDUCTASE user 1 2 # 1 A 28 GLU A 391 GLU~? 23.54 N1 A B 4 A 120 ASP A 376 ASP~? 17.17 N1 A B 4 coo -6.26 14.85 21.66 -7.83 16.24 21.69 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -19.49 15.64 24.83 -18.39 16.64 23.30 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 1b5t_00 source 1b5t METHYLENETETRAHYDROFOLATE REDUCTASE : 1 hits 1b5t_00 naa= 2 ULMN 2 1b5t_01 METHYLENETETRAHYDROFOLATE REDUCTASE user 1 2 # 1 B 28 GLU A 391 GLU~? 23.54 N1 A B 4 B 120 ASP A 376 ASP~? 17.17 N1 A B 4 coo 19.99 54.72 24.39 18.91 52.94 24.71 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 19.27 43.87 32.88 18.74 43.97 30.83 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 1b5t_01 source 1b5t METHYLENETETRAHYDROFOLATE REDUCTASE : 1 hits 1b5t_01 naa= 2 ULMN 2 1b73_01 GLUTAMATE RACEMASE user 1 2 # 1 A 70 CYH A 405 CYH~? 14.40 N3 U B 3 A 178 CYH A 433 CYH~? 20.69 O4 U B 3 coo 25.47 34.55 31.10 26.63 32.36 29.45 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 coo 16.98 32.61 27.66 19.27 32.21 28.95 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 1b73_01 GLUTAMATE RACEMASE user 2 2 # 2 A 70 CYH A 433 CYH~? 20.69 O4 U B 3 A 178 CYH A 405 CYH~? 14.40 N3 U B 3 coo 25.47 34.55 31.10 26.63 32.36 29.45 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 coo 16.98 32.61 27.66 19.27 32.21 28.95 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 ULMN 2 1b73_01 GLUTAMATE RACEMASE user 3 2 # 3 A 70 CYH A 438 CYH~? 14.92 N3 U B 3 A 178 CYH A 433 CYH~? 20.69 O4 U B 3 coo 25.47 34.55 31.10 26.63 32.36 29.45 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 coo 16.98 32.61 27.66 19.27 32.21 28.95 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 1b73_01 source 1b73 GLUTAMATE RACEMASE : 3 hits 1b73_01 naa= 2 ULMN 2 1b7y_00 PHENYLALANYL-TRNA SYNTHETASE user 1 2 # 1 A 204 ARG A 311 ARG.? 21.53 N1 A B 7 A 314 ALA A 393 ALA~? 21.89 C2 A B 4 coo 11.90 60.00 22.81 13.91 61.27 20.88 -28.14 -16.31 -12.56 -31.15 -16.30 -12.01 coo 27.03 64.92 14.26 27.11 64.46 15.71 -32.51 -31.63 -15.83 -32.82 -31.01 -14.47 ULMN 2 1b7y_00 PHENYLALANYL-TRNA SYNTHETASE user 2 2 # 2 A 204 ARG A 396 ARG~? 24.93 C2 A B 4 A 314 ALA A 375 ALA.? 21.84 N1 A B 4 coo 11.90 60.00 22.81 13.91 61.27 20.88 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo 27.03 64.92 14.26 27.11 64.46 15.71 -34.96 -40.68 -8.92 -35.76 -41.10 -10.17 ULMN 2 1b7y_00 PHENYLALANYL-TRNA SYNTHETASE user 3 2 # 3 A 204 ARG A 404 ARG~? 18.97 O2 U B 3 A 314 ALA A 452 ALA~? 8.51 N2 G B 2 coo 11.90 60.00 22.81 13.91 61.27 20.88 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 coo 27.03 64.92 14.26 27.11 64.46 15.71 -8.76 -43.34 -13.26 -8.47 -43.16 -14.74 ULMN 2 1b7y_00 PHENYLALANYL-TRNA SYNTHETASE user 4 2 # 4 A 204 ARG A 431 ARG~? 16.75 O4 U B 3 A 314 ALA A 513 ALA~? 19.94 O6 G B 2 coo 11.90 60.00 22.81 13.91 61.27 20.88 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 27.03 64.92 14.26 27.11 64.46 15.71 -19.38 -65.23 -8.71 -19.08 -64.90 -10.15 ULMN 2 1b7y_00 PHENYLALANYL-TRNA SYNTHETASE user 5 2 # 5 A 204 ARG A 441 ARG.? 21.93 N2 G B 2 A 314 ALA A 409 ALA~? 10.24 O2 U B 3 coo 11.90 60.00 22.81 13.91 61.27 20.88 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo 27.03 64.92 14.26 27.11 64.46 15.71 -12.52 -39.70 -14.88 -12.84 -40.87 -15.81 ULMN 2 1b7y_00 PHENYLALANYL-TRNA SYNTHETASE user 6 2 # 6 A 204 ARG A 441 ARG.? 21.93 N2 G B 2 A 314 ALA A 452 ALA~? 8.51 N2 G B 2 coo 11.90 60.00 22.81 13.91 61.27 20.88 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo 27.03 64.92 14.26 27.11 64.46 15.71 -8.76 -43.34 -13.26 -8.47 -43.16 -14.74 ULMN 2 1b7y_00 PHENYLALANYL-TRNA SYNTHETASE user 7 2 # 7 A 204 ARG A 518 ARG.? 16.31 O6 G B 2 A 314 ALA A 428 ALA~? 20.19 O4 U B 3 coo 11.90 60.00 22.81 13.91 61.27 20.88 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 27.03 64.92 14.26 27.11 64.46 15.71 -27.79 -47.21 -14.49 -28.71 -48.42 -14.37 1b7y_00 source 1b7y PHENYLALANYL-TRNA SYNTHETASE : 7 hits 1b7y_00 naa= 2 ULMN 2 1b8g_00 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 A 145 TYR A 218 TYR~? 23.65 C2 A B 9 A 230 ASP A 190 ASP~? 22.39 C2 A B 9 coo 9.23 21.44 106.88 10.18 19.34 105.31 -39.15 -2.15 23.93 -37.86 0.21 23.20 coo 1.45 22.80 104.16 2.58 21.02 104.01 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1b8g_00 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 A 145 TYR A 262 TYR~? 21.79 O4 U B 8 A 230 ASP A 259 ASP.? 23.89 N1 A B 9 coo 9.23 21.44 106.88 10.18 19.34 105.31 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 1.45 22.80 104.16 2.58 21.02 104.01 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1b8g_00 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 2 # 3 A 145 TYR A 361 TYR~? 4.83 OP1 U B 6 A 230 ASP A 321 ASP~? 8.41 N3 A B 7 coo 9.23 21.44 106.88 10.18 19.34 105.31 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 1.45 22.80 104.16 2.58 21.02 104.01 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 1b8g_00 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 3 hits 1b8g_00 naa= 2 ULMN 2 1b8g_02 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 B 145 TYR A 218 TYR~? 23.65 C2 A B 9 B 230 ASP A 190 ASP~? 22.39 C2 A B 9 coo 11.81 13.41 73.03 10.00 13.03 75.12 -39.15 -2.15 23.93 -37.86 0.21 23.20 coo 19.17 11.01 76.14 17.26 10.42 76.77 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1b8g_02 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 2 # 2 B 145 TYR A 262 TYR~? 21.79 O4 U B 8 B 230 ASP A 259 ASP.? 23.89 N1 A B 9 coo 11.81 13.41 73.03 10.00 13.03 75.12 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 19.17 11.01 76.14 17.26 10.42 76.77 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1b8g_02 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 3 2 # 3 B 145 TYR A 361 TYR~? 4.83 OP1 U B 6 B 230 ASP A 321 ASP~? 8.41 N3 A B 7 coo 11.81 13.41 73.03 10.00 13.03 75.12 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 19.17 11.01 76.14 17.26 10.42 76.77 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 1b8g_02 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 3 hits 1b8g_02 naa= 2 ULMN 2 1b8g_06 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 A 273 LYS A 372 LYS~? 15.54 N6 A B 7 A 398 CYH A 303 CYH~? 19.60 N6 A B 7 coo 2.97 11.64 107.87 6.59 15.13 107.03 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 13.10 26.17 112.42 12.37 23.74 113.49 -36.71 -18.21 -3.45 -38.39 -20.40 -3.80 1b8g_06 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 1 hits 1b8g_06 naa= 2 ULMN 2 1b8g_07 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 2 # 1 B 273 LYS A 372 LYS~? 15.54 N6 A B 7 B 398 CYH A 303 CYH~? 19.60 N6 A B 7 coo 11.10 2.31 76.60 10.24 7.24 75.62 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 10.80 16.99 65.65 9.83 14.36 65.68 -36.71 -18.21 -3.45 -38.39 -20.40 -3.80 1b8g_07 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 1 hits 1b8g_07 naa= 2 ULMN 2 1b9h_00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 2 # 1 A 88 PHE A 221 PHE~? 23.88 N1 A B 9 A 159 ASP A 259 ASP.? 23.89 N1 A B 9 coo 13.91 34.58 14.67 12.95 36.00 12.47 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 20.97 28.40 16.26 20.19 30.15 15.34 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1b9h_00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 2 # 2 A 88 PHE A 234 PHE~? 13.85 O4 U B 8 A 159 ASP A 232 ASP~? 21.56 O2 U B 8 coo 13.91 34.58 14.67 12.95 36.00 12.47 -28.05 -7.34 7.82 -28.52 -9.83 6.65 coo 20.97 28.40 16.26 20.19 30.15 15.34 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 1b9h_00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 2 # 3 A 88 PHE A 476 PHE~? 18.32 N2 G B 2 A 159 ASP A 488 ASP~? 18.76 O2 U B 1 coo 13.91 34.58 14.67 12.95 36.00 12.47 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo 20.97 28.40 16.26 20.19 30.15 15.34 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 ULMN 2 1b9h_00 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 2 # 4 A 88 PHE A 531 PHE~? 20.43 O6 G B 2 A 159 ASP A 526 ASP^? 28.45 O6 G B 2 coo 13.91 34.58 14.67 12.95 36.00 12.47 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 coo 20.97 28.40 16.26 20.19 30.15 15.34 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 1b9h_00 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 4 hits 1b9h_00 naa= 2 ULMN 2 1be1_01 GLUTAMATE MUTASE user 1 2 # 1 14 ASP A 484 ASP.? 22.65 O2 U B 1 16 HIS A 482 HIS.? 27.32 N2 G B 2 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 5.38 -51.43 -31.03 5.15 -51.35 -33.11 ULMN 2 1be1_01 GLUTAMATE MUTASE user 2 2 # 2 14 ASP A 526 ASP^? 28.45 O6 G B 2 16 HIS A 527 HIS~? 25.85 N2 G B 2 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 1be1_01 source 1be1 GLUTAMATE MUTASE : 2 hits 1be1_01 naa= 2 ULMN 2 1bf2_02 ISOAMYLASE user 1 2 # 1 375 ASP A 174 ASP.? 19.36 O2' A B 9 435 GLU A 178 GLU.? 16.07 O2' A B 9 coo 88.62 69.90 41.16 89.05 70.67 43.04 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 89.52 76.11 40.17 89.01 75.16 41.97 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1bf2_02 ISOAMYLASE user 2 2 # 2 375 ASP A 491 ASP~? 15.62 O2 U B 1 435 GLU A 545 GLU~? 17.12 N3 U B 1 coo 88.62 69.90 41.16 89.05 70.67 43.04 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 89.52 76.11 40.17 89.01 75.16 41.97 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1bf2_02 source 1bf2 ISOAMYLASE : 2 hits 1bf2_02 naa= 2 ULMN 2 1bgl_00 BETA-GALACTOSIDASE user 1 2 # 1 A 461 GLU A 432 GLU~? 22.16 O4 U B 3 A 537 GLU A 436 GLU~? 23.50 O4 U B 3 coo 24.06 146.21 11.09 22.89 146.18 9.36 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 16.65 144.44 13.24 18.34 145.22 12.33 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1bgl_00 BETA-GALACTOSIDASE user 2 2 # 2 A 461 GLU A 436 GLU~? 23.50 O4 U B 3 A 537 GLU A 432 GLU~? 22.16 O4 U B 3 coo 24.06 146.21 11.09 22.89 146.18 9.36 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 16.65 144.44 13.24 18.34 145.22 12.33 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1bgl_00 BETA-GALACTOSIDASE user 3 2 # 3 A 461 GLU A 436 GLU~? 23.50 O4 U B 3 A 537 GLU A 470 GLU~? 22.82 N2 G B 2 coo 24.06 146.21 11.09 22.89 146.18 9.36 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 16.65 144.44 13.24 18.34 145.22 12.33 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1bgl_00 source 1bgl BETA-GALACTOSIDASE : 3 hits 1bgl_00 naa= 2 ULMN 2 1bhg_00 BETA-GLUCURONIDASE user 1 2 # 1 A 451 GLU A 432 GLU~? 22.16 O4 U B 3 A 540 GLU A 436 GLU~? 23.50 O4 U B 3 coo 81.34 87.29 87.22 82.36 86.09 88.61 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 79.94 80.46 88.84 81.11 81.36 87.27 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1bhg_00 BETA-GLUCURONIDASE user 2 2 # 2 A 451 GLU A 436 GLU~? 23.50 O4 U B 3 A 540 GLU A 432 GLU~? 22.16 O4 U B 3 coo 81.34 87.29 87.22 82.36 86.09 88.61 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 79.94 80.46 88.84 81.11 81.36 87.27 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1bhg_00 BETA-GLUCURONIDASE user 3 2 # 3 A 451 GLU A 466 GLU~? 26.72 N2 G B 2 A 540 GLU A 470 GLU~? 22.82 N2 G B 2 coo 81.34 87.29 87.22 82.36 86.09 88.61 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 79.94 80.46 88.84 81.11 81.36 87.27 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1bhg_00 BETA-GLUCURONIDASE user 4 2 # 4 A 451 GLU A 470 GLU~? 22.82 N2 G B 2 A 540 GLU A 466 GLU~? 26.72 N2 G B 2 coo 81.34 87.29 87.22 82.36 86.09 88.61 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 79.94 80.46 88.84 81.11 81.36 87.27 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 1bhg_00 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_00 naa= 2 ULMN 2 1bhg_01 BETA-GLUCURONIDASE user 1 2 # 1 B 451 GLU A 432 GLU~? 22.16 O4 U B 3 B 540 GLU A 436 GLU~? 23.50 O4 U B 3 coo 86.52 35.28 112.74 87.08 36.38 110.99 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 83.38 41.19 112.55 85.47 40.59 112.72 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1bhg_01 BETA-GLUCURONIDASE user 2 2 # 2 B 451 GLU A 436 GLU~? 23.50 O4 U B 3 B 540 GLU A 432 GLU~? 22.16 O4 U B 3 coo 86.52 35.28 112.74 87.08 36.38 110.99 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 83.38 41.19 112.55 85.47 40.59 112.72 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1bhg_01 BETA-GLUCURONIDASE user 3 2 # 3 B 451 GLU A 466 GLU~? 26.72 N2 G B 2 B 540 GLU A 470 GLU~? 22.82 N2 G B 2 coo 86.52 35.28 112.74 87.08 36.38 110.99 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 83.38 41.19 112.55 85.47 40.59 112.72 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1bhg_01 BETA-GLUCURONIDASE user 4 2 # 4 B 451 GLU A 470 GLU~? 22.82 N2 G B 2 B 540 GLU A 466 GLU~? 26.72 N2 G B 2 coo 86.52 35.28 112.74 87.08 36.38 110.99 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 83.38 41.19 112.55 85.47 40.59 112.72 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 1bhg_01 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_01 naa= 2 ULMN 2 1bjo_01 PHOSPHOSERINE AMINOTRANSFERASE user 1 2 # 1 B 102 TRP A 534 TRP~? 20.57 N2 G B 2 B 174 ASP A 473 ASP~? 22.60 N2 G B 2 coo 4.77 55.75 65.93 6.30 59.02 64.41 -13.87 -64.07 -18.86 -17.27 -62.50 -17.72 coo 2.21 52.73 59.53 3.97 53.77 60.07 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1bjo_01 source 1bjo PHOSPHOSERINE AMINOTRANSFERASE : 1 hits 1bjo_01 naa= 2 ULMN 2 1bjp_00 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 A 50 PHE A 197 PHE~? 14.18 C2 A B 9 B 39 ARG A 180 ARG.? 21.90 C2 A B 9 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -20.54 -3.44 35.42 -23.45 -2.48 35.38 ULMN 2 1bjp_00 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 A 50 PHE A 272 PHE~? 19.44 O4 U B 8 B 39 ARG A 230 ARG~? 20.03 C2 A B 9 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -30.89 -5.38 4.64 -32.03 -3.22 6.00 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1bjp_00 4-OXALOCROTONATE TAUTOMERASE user 3 2 # 3 A 50 PHE A 495 PHE~? 11.36 O2 U B 1 B 39 ARG A 541 ARG~? 18.28 O4 U B 1 coo -8.84 8.66 90.43 -10.27 8.22 88.05 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 ULMN 2 1bjp_00 4-OXALOCROTONATE TAUTOMERASE user 4 2 # 4 A 50 PHE A 495 PHE~? 11.36 O2 U B 1 B 39 ARG A 551 ARG.? 14.22 O4' U B 1 coo -8.84 8.66 90.43 -10.27 8.22 88.05 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo -12.95 6.84 81.25 -15.36 8.72 81.45 10.35 -61.35 -7.37 12.18 -59.05 -8.34 ULMN 2 1bjp_00 4-OXALOCROTONATE TAUTOMERASE user 5 2 # 5 A 50 PHE A 552 PHE~? 9.25 O2 U B 1 B 39 ARG A 548 ARG~? 15.11 O2 U B 1 coo -8.84 8.66 90.43 -10.27 8.22 88.05 5.76 -57.72 -6.14 7.98 -57.47 -7.85 coo -12.95 6.84 81.25 -15.36 8.72 81.45 7.33 -63.34 -13.62 6.31 -60.85 -15.12 1bjp_00 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 5 hits 1bjp_00 naa= 2 ULMN 2 1bjp_05 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 A 50 PHE A 197 PHE~? 14.18 C2 A B 9 B 39 ARG A 180 ARG.? 21.90 C2 A B 9 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -20.54 -3.44 35.42 -23.45 -2.48 35.38 ULMN 2 1bjp_05 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 A 50 PHE A 272 PHE~? 19.44 O4 U B 8 B 39 ARG A 230 ARG~? 20.03 C2 A B 9 coo -8.84 8.66 90.43 -10.27 8.22 88.05 -30.89 -5.38 4.64 -32.03 -3.22 6.00 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1bjp_05 4-OXALOCROTONATE TAUTOMERASE user 3 2 # 3 A 50 PHE A 495 PHE~? 11.36 O2 U B 1 B 39 ARG A 541 ARG~? 18.28 O4 U B 1 coo -8.84 8.66 90.43 -10.27 8.22 88.05 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo -12.95 6.84 81.25 -15.36 8.72 81.45 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 ULMN 2 1bjp_05 4-OXALOCROTONATE TAUTOMERASE user 4 2 # 4 A 50 PHE A 495 PHE~? 11.36 O2 U B 1 B 39 ARG A 551 ARG.? 14.22 O4' U B 1 coo -8.84 8.66 90.43 -10.27 8.22 88.05 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo -12.95 6.84 81.25 -15.36 8.72 81.45 10.35 -61.35 -7.37 12.18 -59.05 -8.34 ULMN 2 1bjp_05 4-OXALOCROTONATE TAUTOMERASE user 5 2 # 5 A 50 PHE A 552 PHE~? 9.25 O2 U B 1 B 39 ARG A 548 ARG~? 15.11 O2 U B 1 coo -8.84 8.66 90.43 -10.27 8.22 88.05 5.76 -57.72 -6.14 7.98 -57.47 -7.85 coo -12.95 6.84 81.25 -15.36 8.72 81.45 7.33 -63.34 -13.62 6.31 -60.85 -15.12 1bjp_05 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 5 hits 1bjp_05 naa= 2 ULMN 2 1bjp_06 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 B 1 PRO A 169 PRO~? 18.04 O2' A B 9 B 50 PHE A 272 PHE~? 19.44 O4 U B 8 coo -15.48 1.51 87.57 -13.84 2.98 87.27 -20.02 -0.85 26.27 -17.89 -0.21 26.44 coo 1.73 -12.31 75.00 0.52 -13.19 77.35 -30.89 -5.38 4.64 -32.03 -3.22 6.00 ULMN 2 1bjp_06 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 B 1 PRO A 481 PRO.? 24.09 N2 G B 2 B 50 PHE A 552 PHE~? 9.25 O2 U B 1 coo -15.48 1.51 87.57 -13.84 2.98 87.27 -0.22 -52.13 -30.51 1.19 -53.77 -29.91 coo 1.73 -12.31 75.00 0.52 -13.19 77.35 5.76 -57.72 -6.14 7.98 -57.47 -7.85 1bjp_06 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 2 hits 1bjp_06 naa= 2 ULMN 2 1bjp_07 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 C 1 PRO A 169 PRO~? 18.04 O2' A B 9 C 50 PHE A 272 PHE~? 19.44 O4 U B 8 coo -1.04 -15.72 39.11 0.69 -14.29 39.31 -20.02 -0.85 26.27 -17.89 -0.21 26.44 coo -11.95 3.44 51.82 -13.09 2.37 49.45 -30.89 -5.38 4.64 -32.03 -3.22 6.00 ULMN 2 1bjp_07 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 C 1 PRO A 481 PRO.? 24.09 N2 G B 2 C 50 PHE A 552 PHE~? 9.25 O2 U B 1 coo -1.04 -15.72 39.11 0.69 -14.29 39.31 -0.22 -52.13 -30.51 1.19 -53.77 -29.91 coo -11.95 3.44 51.82 -13.09 2.37 49.45 5.76 -57.72 -6.14 7.98 -57.47 -7.85 1bjp_07 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 2 hits 1bjp_07 naa= 2 ULMN 2 1bjp_08 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 D 1 PRO A 169 PRO~? 18.04 O2' A B 9 D 50 PHE A 272 PHE~? 19.44 O4 U B 8 coo -14.38 -5.86 49.10 -13.60 -3.76 48.78 -20.02 -0.85 26.27 -17.89 -0.21 26.44 coo 7.23 -10.13 36.48 6.65 -11.47 38.96 -30.89 -5.38 4.64 -32.03 -3.22 6.00 ULMN 2 1bjp_08 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 D 1 PRO A 481 PRO.? 24.09 N2 G B 2 D 50 PHE A 552 PHE~? 9.25 O2 U B 1 coo -14.38 -5.86 49.10 -13.60 -3.76 48.78 -0.22 -52.13 -30.51 1.19 -53.77 -29.91 coo 7.23 -10.13 36.48 6.65 -11.47 38.96 5.76 -57.72 -6.14 7.98 -57.47 -7.85 1bjp_08 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 2 hits 1bjp_08 naa= 2 ULMN 2 1bjp_09 4-OXALOCROTONATE TAUTOMERASE user 1 2 # 1 E 1 PRO A 169 PRO~? 18.04 O2' A B 9 E 50 PHE A 272 PHE~? 19.44 O4 U B 8 coo 13.77 -7.39 -4.94 13.14 -5.26 -4.80 -20.02 -0.85 26.27 -17.89 -0.21 26.44 coo -8.19 -9.44 7.68 -7.65 -10.85 5.31 -30.89 -5.38 4.64 -32.03 -3.22 6.00 ULMN 2 1bjp_09 4-OXALOCROTONATE TAUTOMERASE user 2 2 # 2 E 1 PRO A 481 PRO.? 24.09 N2 G B 2 E 50 PHE A 552 PHE~? 9.25 O2 U B 1 coo 13.77 -7.39 -4.94 13.14 -5.26 -4.80 -0.22 -52.13 -30.51 1.19 -53.77 -29.91 coo -8.19 -9.44 7.68 -7.65 -10.85 5.31 5.76 -57.72 -6.14 7.98 -57.47 -7.85 1bjp_09 source 1bjp 4-OXALOCROTONATE TAUTOMERASE : 2 hits 1bjp_09 naa= 2 ULMN 2 1bmt_03 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 2 # 1 B 757 ASP A 425 ASP.? 18.06 O4 U B 3 B 759 HIS A 462 HIS~? 12.61 O4 U B 3 coo -2.30 64.08 6.41 -0.36 64.72 6.26 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 1.96 66.39 3.07 2.10 68.48 3.58 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 1bmt_03 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 1 hits 1bmt_03 naa= 2 ULMN 2 1bo1_00 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 1 2 # 1 A 150 LYS A 544 LYS~? 22.64 O4 U B 1 A 278 ASP A 477 ASP~? 24.62 N2 G B 2 coo 43.46 54.32 43.90 48.56 57.30 46.35 2.51 -69.72 -14.20 -0.06 -70.01 -19.70 coo 55.33 66.46 41.57 56.47 67.38 40.06 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 1bo1_00 source 1bo1 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE IIBETA : 1 hits 1bo1_00 naa= 2 ULMN 2 1bo1_01 PHOSPHATIDYLINOSITOL PHOSPHATE KINASuser 1 2 # 1 B 150 LYS A 544 LYS~? 22.64 O4 U B 1 B 278 ASP A 477 ASP~? 24.62 N2 G B 2 coo 35.25 10.18 29.50 33.26 8.54 24.76 2.51 -69.72 -14.20 -0.06 -70.01 -19.70 coo 23.28 1.35 20.09 22.28 1.00 18.22 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 1bo1_01 source 1bo1 PHOSPHATIDYLINOSITOL PHOSPHATE KINASE IIBETA : 1 hits 1bo1_01 naa= 2 ULMN 2 1bs0_02 8-AMINO-7-OXONANOATE SYNTHASE user 1 2 # 1 A 207 HIS A 326 HIS~? 3.28 C5 A B 7 A 238 PHE A 285 PHE~? 4.61 O2 U B 8 coo 7.97 -2.54 48.09 8.96 -2.14 46.28 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo -0.08 -11.37 45.74 -2.10 -10.61 47.41 -17.29 -15.05 9.64 -14.77 -15.72 10.64 ULMN 2 1bs0_02 8-AMINO-7-OXONANOATE SYNTHASE user 2 2 # 2 A 207 HIS A 352 HIS~? 21.18 O2' A B 4 A 238 PHE A 342 PHE~? 19.62 N1 A B 7 coo 7.97 -2.54 48.09 8.96 -2.14 46.28 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 coo -0.08 -11.37 45.74 -2.10 -10.61 47.41 -30.61 -20.23 -12.56 -30.03 -19.19 -10.05 ULMN 2 1bs0_02 8-AMINO-7-OXONANOATE SYNTHASE user 3 2 # 3 A 207 HIS A 454 HIS~? 3.31 C5 U B 3 A 238 PHE A 460 PHE~? 11.81 N2 G B 2 coo 7.97 -2.54 48.09 8.96 -2.14 46.28 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo -0.08 -11.37 45.74 -2.10 -10.61 47.41 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 ULMN 2 1bs0_02 8-AMINO-7-OXONANOATE SYNTHASE user 4 2 # 4 A 207 HIS A 496 HIS.? 9.17 O2 U B 1 A 238 PHE A 451 PHE~? 4.67 O2 U B 3 coo 7.97 -2.54 48.09 8.96 -2.14 46.28 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo -0.08 -11.37 45.74 -2.10 -10.61 47.41 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 ULMN 2 1bs0_02 8-AMINO-7-OXONANOATE SYNTHASE user 5 2 # 5 A 207 HIS A 496 HIS.? 9.17 O2 U B 1 A 238 PHE A 552 PHE~? 9.25 O2 U B 1 coo 7.97 -2.54 48.09 8.96 -2.14 46.28 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo -0.08 -11.37 45.74 -2.10 -10.61 47.41 5.76 -57.72 -6.14 7.98 -57.47 -7.85 1bs0_02 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 5 hits 1bs0_02 naa= 2 ULMN 2 1bu7_00 CYTOCHROME P450 user 1 2 # 1 A 267 GLU A 267 GLU~? 24.62 O4 U B 8 A 268 THR A 263 THR~? 26.03 O4 U B 8 coo 45.43 74.80 39.41 46.09 75.11 37.45 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 coo 45.81 71.19 43.26 47.70 70.19 43.25 -43.81 -9.09 6.81 -45.49 -9.19 5.45 ULMN 2 1bu7_00 CYTOCHROME P450 user 2 2 # 2 A 267 GLU A 560 GLU~? 13.58 O4 U B 1 A 268 THR A 561 THR~? 10.68 O4 U B 1 coo 45.43 74.80 39.41 46.09 75.11 37.45 -4.75 -65.37 1.07 -4.31 -67.34 1.74 coo 45.81 71.19 43.26 47.70 70.19 43.25 -7.66 -65.21 -2.98 -8.57 -63.47 -3.90 1bu7_00 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_00 naa= 2 ULMN 2 1bu7_01 CYTOCHROME P450 user 1 2 # 1 B 267 GLU A 267 GLU~? 24.62 O4 U B 8 B 268 THR A 263 THR~? 26.03 O4 U B 8 coo 37.51 113.26 46.73 39.45 112.75 46.09 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 coo 37.20 116.32 52.00 35.18 117.07 52.13 -43.81 -9.09 6.81 -45.49 -9.19 5.45 ULMN 2 1bu7_01 CYTOCHROME P450 user 2 2 # 2 B 267 GLU A 351 GLU~? 20.29 O2' A B 4 B 268 THR A 349 THR~? 23.30 O2' A B 4 coo 37.51 113.26 46.73 39.45 112.75 46.09 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 37.20 116.32 52.00 35.18 117.07 52.13 -22.17 -25.42 -19.90 -22.55 -23.33 -20.27 ULMN 2 1bu7_01 CYTOCHROME P450 user 3 2 # 3 B 267 GLU A 371 GLU~? 9.29 O2 C B 5 B 268 THR A 374 THR.? 15.78 N1 A B 4 coo 37.51 113.26 46.73 39.45 112.75 46.09 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 37.20 116.32 52.00 35.18 117.07 52.13 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 ULMN 2 1bu7_01 CYTOCHROME P450 user 4 2 # 4 B 267 GLU A 545 GLU~? 17.12 N3 U B 1 B 268 THR A 543 THR~? 19.49 O4 U B 1 coo 37.51 113.26 46.73 39.45 112.75 46.09 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 37.20 116.32 52.00 35.18 117.07 52.13 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 ULMN 2 1bu7_01 CYTOCHROME P450 user 5 2 # 5 B 267 GLU A 560 GLU~? 13.58 O4 U B 1 B 268 THR A 561 THR~? 10.68 O4 U B 1 coo 37.51 113.26 46.73 39.45 112.75 46.09 -4.75 -65.37 1.07 -4.31 -67.34 1.74 coo 37.20 116.32 52.00 35.18 117.07 52.13 -7.66 -65.21 -2.98 -8.57 -63.47 -3.90 1bu7_01 source 1bu7 CYTOCHROME P450 : 5 hits 1bu7_01 naa= 2 ULMN 2 1bu7_04 CYTOCHROME P450 user 1 2 # 1 A 269 THR A 410 THR~? 10.69 O2 U B 3 A 409 GLU A 449 GLU.? 11.55 O2 U B 3 coo 44.86 72.34 46.76 46.06 72.57 48.57 -8.78 -38.96 -14.99 -8.22 -38.93 -17.11 coo 45.56 75.42 52.98 46.85 76.54 51.76 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 1bu7_04 source 1bu7 CYTOCHROME P450 : 1 hits 1bu7_04 naa= 2 ULMN 2 1bu7_05 CYTOCHROME P450 user 1 2 # 1 B 269 THR A 368 THR~? 9.37 O2' C B 5 B 409 GLU A 371 GLU~? 9.29 O2 C B 5 coo 37.77 113.78 54.79 36.33 112.76 56.05 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 coo 36.78 108.70 59.19 35.94 108.22 57.32 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1bu7_05 CYTOCHROME P450 user 2 2 # 2 B 269 THR A 410 THR~? 10.69 O2 U B 3 B 409 GLU A 449 GLU.? 11.55 O2 U B 3 coo 37.77 113.78 54.79 36.33 112.76 56.05 -8.78 -38.96 -14.99 -8.22 -38.93 -17.11 coo 36.78 108.70 59.19 35.94 108.22 57.32 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 1bu7_05 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_05 naa= 2 ULMN 2 1bvv_00 ENDO-1,4-BETA-XYLANASE user 1 2 # 1 78 GLU A 436 GLU~? 23.50 O4 U B 3 172 GLU A 470 GLU~? 22.82 N2 G B 2 coo 29.78 23.72 34.61 31.02 22.02 34.93 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 36.89 20.40 30.23 35.07 20.37 31.31 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1bvv_00 ENDO-1,4-BETA-XYLANASE user 2 2 # 2 78 GLU A 470 GLU~? 22.82 N2 G B 2 172 GLU A 436 GLU~? 23.50 O4 U B 3 coo 29.78 23.72 34.61 31.02 22.02 34.93 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 36.89 20.40 30.23 35.07 20.37 31.31 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 1bvv_00 source 1bvv ENDO-1,4-BETA-XYLANASE : 2 hits 1bvv_00 naa= 2 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 1 2 # 1 A 325 ASP A 190 ASP~? 22.39 C2 A B 9 A 350 LEU A 168 LEU.? 13.91 O2' A B 9 coo 31.05 49.37 64.51 31.97 51.11 63.85 -31.44 0.79 27.21 -33.43 0.08 27.41 coo 17.08 44.76 64.40 16.58 45.38 62.42 -16.38 -3.81 26.35 -17.47 -5.60 25.81 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 2 2 # 2 A 325 ASP A 193 ASP~? 20.25 C2 A B 9 A 350 LEU A 223 LEU~? 13.97 C2 A B 9 coo 31.05 49.37 64.51 31.97 51.11 63.85 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 17.08 44.76 64.40 16.58 45.38 62.42 -33.24 -8.02 19.00 -32.17 -8.88 20.71 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 3 2 # 3 A 325 ASP A 200 ASP~? 9.45 O2' A B 9 A 350 LEU A 185 LEU~? 14.08 C2 A B 9 coo 31.05 49.37 64.51 31.97 51.11 63.85 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 17.08 44.76 64.40 16.58 45.38 62.42 -30.93 -8.72 27.48 -31.10 -9.12 25.35 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 4 2 # 4 A 325 ASP A 200 ASP~? 9.45 O2' A B 9 A 350 LEU A 189 LEU~? 16.68 C2 A B 9 coo 31.05 49.37 64.51 31.97 51.11 63.85 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 17.08 44.76 64.40 16.58 45.38 62.42 -31.54 -3.59 24.24 -31.74 -5.46 23.15 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 5 2 # 5 A 325 ASP A 232 ASP~? 21.56 O2 U B 8 A 350 LEU A 194 LEU~? 13.92 C2 A B 9 coo 31.05 49.37 64.51 31.97 51.11 63.85 -24.56 0.12 7.49 -25.80 1.40 6.37 coo 17.08 44.76 64.40 16.58 45.38 62.42 -26.41 -3.70 20.59 -27.33 -5.63 20.13 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 6 2 # 6 A 325 ASP A 232 ASP~? 21.56 O2 U B 8 A 350 LEU A 246 LEU~? 8.12 C2 A B 9 coo 31.05 49.37 64.51 31.97 51.11 63.85 -24.56 0.12 7.49 -25.80 1.40 6.37 coo 17.08 44.76 64.40 16.58 45.38 62.42 -25.82 -11.65 17.32 -27.01 -10.39 18.64 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 7 2 # 7 A 325 ASP A 232 ASP~? 21.56 O2 U B 8 A 350 LEU A 269 LEU~? 15.46 O4 U B 8 coo 31.05 49.37 64.51 31.97 51.11 63.85 -24.56 0.12 7.49 -25.80 1.40 6.37 coo 17.08 44.76 64.40 16.58 45.38 62.42 -34.40 -10.02 6.25 -32.98 -11.27 7.25 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 8 2 # 8 A 325 ASP A 260 ASP.? 30.95 O4 U B 8 A 350 LEU A 255 LEU~? 15.96 O4 U B 8 coo 31.05 49.37 64.51 31.97 51.11 63.85 -48.66 -5.55 12.81 -49.71 -4.82 11.14 coo 17.08 44.76 64.40 16.58 45.38 62.42 -38.64 -16.44 11.03 -37.80 -15.89 9.09 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 9 2 # 9 A 325 ASP A 279 ASP~? 17.12 C2 A B 7 A 350 LEU A 237 LEU~? 11.73 O2 U B 8 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 17.08 44.76 64.40 16.58 45.38 62.42 -23.73 -8.13 12.88 -23.76 -7.02 14.77 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 10 2 # 10 A 325 ASP A 279 ASP~? 17.12 C2 A B 7 A 350 LEU A 269 LEU~? 15.46 O4 U B 8 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 17.08 44.76 64.40 16.58 45.38 62.42 -34.40 -10.02 6.25 -32.98 -11.27 7.25 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 11 2 # 11 A 325 ASP A 279 ASP~? 17.12 C2 A B 7 A 350 LEU A 294 LEU~? 11.24 N6 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 17.08 44.76 64.40 16.58 45.38 62.42 -31.42 -20.65 2.22 -30.60 -19.93 0.35 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 12 2 # 12 A 325 ASP A 279 ASP~? 17.12 C2 A B 7 A 350 LEU A 305 LEU~? 15.30 N1 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 17.08 44.76 64.40 16.58 45.38 62.42 -32.20 -15.57 -1.13 -32.34 -14.53 0.75 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 13 2 # 13 A 325 ASP A 283 ASP~? 9.21 O2 U B 8 A 350 LEU A 269 LEU~? 15.46 O4 U B 8 coo 31.05 49.37 64.51 31.97 51.11 63.85 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 17.08 44.76 64.40 16.58 45.38 62.42 -34.40 -10.02 6.25 -32.98 -11.27 7.25 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 14 2 # 14 A 325 ASP A 283 ASP~? 9.21 O2 U B 8 A 350 LEU A 294 LEU~? 11.24 N6 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 17.08 44.76 64.40 16.58 45.38 62.42 -31.42 -20.65 2.22 -30.60 -19.93 0.35 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 15 2 # 15 A 325 ASP A 283 ASP~? 9.21 O2 U B 8 A 350 LEU A 305 LEU~? 15.30 N1 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 17.08 44.76 64.40 16.58 45.38 62.42 -32.20 -15.57 -1.13 -32.34 -14.53 0.75 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 16 2 # 16 A 325 ASP A 283 ASP~? 9.21 O2 U B 8 A 350 LEU A 309 LEU.? 14.77 N1 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 17.08 44.76 64.40 16.58 45.38 62.42 -27.47 -16.86 -7.24 -27.07 -18.25 -5.60 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 17 2 # 17 A 325 ASP A 283 ASP~? 9.21 O2 U B 8 A 350 LEU A 315 LEU~? 16.51 C2 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 17.08 44.76 64.40 16.58 45.38 62.42 -22.44 -18.38 -10.73 -24.05 -19.64 -9.97 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 18 2 # 18 A 325 ASP A 321 ASP~? 8.41 N3 A B 7 A 350 LEU A 294 LEU~? 11.24 N6 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo 17.08 44.76 64.40 16.58 45.38 62.42 -31.42 -20.65 2.22 -30.60 -19.93 0.35 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 19 2 # 19 A 325 ASP A 345 ASP~? 24.06 C2 A B 4 A 350 LEU A 309 LEU.? 14.77 N1 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 17.08 44.76 64.40 16.58 45.38 62.42 -27.47 -16.86 -7.24 -27.07 -18.25 -5.60 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 20 2 # 20 A 325 ASP A 376 ASP~? 17.17 N1 A B 4 A 350 LEU A 397 LEU~? 16.63 C2 A B 4 coo 31.05 49.37 64.51 31.97 51.11 63.85 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 17.08 44.76 64.40 16.58 45.38 62.42 -26.68 -32.45 -15.38 -25.20 -31.84 -13.94 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 21 2 # 21 A 325 ASP A 426 ASP.? 18.90 N1 A B 4 A 350 LEU A 337 LEU~? 21.08 N6 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 17.08 44.76 64.40 16.58 45.38 62.42 -35.92 -28.81 -9.22 -34.60 -29.36 -10.88 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 22 2 # 22 A 325 ASP A 426 ASP.? 18.90 N1 A B 4 A 350 LEU A 397 LEU~? 16.63 C2 A B 4 coo 31.05 49.37 64.51 31.97 51.11 63.85 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 17.08 44.76 64.40 16.58 45.38 62.42 -26.68 -32.45 -15.38 -25.20 -31.84 -13.94 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 23 2 # 23 A 325 ASP A 473 ASP~? 22.60 N2 G B 2 A 350 LEU A 439 LEU.? 13.42 N2 G B 2 coo 31.05 49.37 64.51 31.97 51.11 63.85 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 17.08 44.76 64.40 16.58 45.38 62.42 -14.61 -47.32 -19.28 -14.96 -45.67 -17.90 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 24 2 # 24 A 325 ASP A 477 ASP~? 24.62 N2 G B 2 A 350 LEU A 467 LEU~? 20.13 N2 G B 2 coo 31.05 49.37 64.51 31.97 51.11 63.85 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 17.08 44.76 64.40 16.58 45.38 62.42 -20.94 -53.65 -20.26 -21.79 -52.07 -21.49 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 25 2 # 25 A 325 ASP A 477 ASP~? 24.62 N2 G B 2 A 350 LEU A 468 LEU~? 17.46 N2 G B 2 coo 31.05 49.37 64.51 31.97 51.11 63.85 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 17.08 44.76 64.40 16.58 45.38 62.42 -19.18 -57.57 -16.85 -18.04 -58.18 -15.13 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 26 2 # 26 A 325 ASP A 488 ASP~? 18.76 O2 U B 1 A 350 LEU A 507 LEU~? 11.48 O4 U B 1 coo 31.05 49.37 64.51 31.97 51.11 63.85 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 17.08 44.76 64.40 16.58 45.38 62.42 -8.80 -61.88 -8.90 -7.96 -63.82 -8.44 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 27 2 # 27 A 325 ASP A 491 ASP~? 15.62 O2 U B 1 A 350 LEU A 443 LEU~? 13.05 N2 G B 2 coo 31.05 49.37 64.51 31.97 51.11 63.85 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 17.08 44.76 64.40 16.58 45.38 62.42 -9.87 -51.42 -19.82 -12.04 -51.54 -19.56 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 28 2 # 28 A 325 ASP A 491 ASP~? 15.62 O2 U B 1 A 350 LEU A 507 LEU~? 11.48 O4 U B 1 coo 31.05 49.37 64.51 31.97 51.11 63.85 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 17.08 44.76 64.40 16.58 45.38 62.42 -8.80 -61.88 -8.90 -7.96 -63.82 -8.44 ULMN 2 1bvz_00 ALPHA-AMYLASE II user 29 2 # 29 A 325 ASP A 533 ASP~? 24.95 O4 U B 1 A 350 LEU A 565 LEU~? 18.02 O4 U B 1 coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 17.08 44.76 64.40 16.58 45.38 62.42 -11.42 -69.79 -4.60 -13.25 -69.56 -5.77 1bvz_00 source 1bvz ALPHA-AMYLASE II : 29 hits 1bvz_00 naa= 2 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 1 2 # 1 B 325 ASP A 190 ASP~? 22.39 C2 A B 9 B 350 LEU A 168 LEU.? 13.91 O2' A B 9 coo 25.90 8.19 53.87 25.36 6.97 52.29 -31.44 0.79 27.21 -33.43 0.08 27.41 coo 39.81 12.72 56.17 40.30 13.16 54.11 -16.38 -3.81 26.35 -17.47 -5.60 25.81 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 2 2 # 2 B 325 ASP A 193 ASP~? 20.25 C2 A B 9 B 350 LEU A 223 LEU~? 13.97 C2 A B 9 coo 25.90 8.19 53.87 25.36 6.97 52.29 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 39.81 12.72 56.17 40.30 13.16 54.11 -33.24 -8.02 19.00 -32.17 -8.88 20.71 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 3 2 # 3 B 325 ASP A 200 ASP~? 9.45 O2' A B 9 B 350 LEU A 185 LEU~? 14.08 C2 A B 9 coo 25.90 8.19 53.87 25.36 6.97 52.29 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 39.81 12.72 56.17 40.30 13.16 54.11 -30.93 -8.72 27.48 -31.10 -9.12 25.35 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 4 2 # 4 B 325 ASP A 200 ASP~? 9.45 O2' A B 9 B 350 LEU A 189 LEU~? 16.68 C2 A B 9 coo 25.90 8.19 53.87 25.36 6.97 52.29 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 39.81 12.72 56.17 40.30 13.16 54.11 -31.54 -3.59 24.24 -31.74 -5.46 23.15 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 5 2 # 5 B 325 ASP A 232 ASP~? 21.56 O2 U B 8 B 350 LEU A 194 LEU~? 13.92 C2 A B 9 coo 25.90 8.19 53.87 25.36 6.97 52.29 -24.56 0.12 7.49 -25.80 1.40 6.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -26.41 -3.70 20.59 -27.33 -5.63 20.13 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 6 2 # 6 B 325 ASP A 232 ASP~? 21.56 O2 U B 8 B 350 LEU A 246 LEU~? 8.12 C2 A B 9 coo 25.90 8.19 53.87 25.36 6.97 52.29 -24.56 0.12 7.49 -25.80 1.40 6.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -25.82 -11.65 17.32 -27.01 -10.39 18.64 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 7 2 # 7 B 325 ASP A 232 ASP~? 21.56 O2 U B 8 B 350 LEU A 269 LEU~? 15.46 O4 U B 8 coo 25.90 8.19 53.87 25.36 6.97 52.29 -24.56 0.12 7.49 -25.80 1.40 6.37 coo 39.81 12.72 56.17 40.30 13.16 54.11 -34.40 -10.02 6.25 -32.98 -11.27 7.25 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 8 2 # 8 B 325 ASP A 260 ASP.? 30.95 O4 U B 8 B 350 LEU A 255 LEU~? 15.96 O4 U B 8 coo 25.90 8.19 53.87 25.36 6.97 52.29 -48.66 -5.55 12.81 -49.71 -4.82 11.14 coo 39.81 12.72 56.17 40.30 13.16 54.11 -38.64 -16.44 11.03 -37.80 -15.89 9.09 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 9 2 # 9 B 325 ASP A 279 ASP~? 17.12 C2 A B 7 B 350 LEU A 237 LEU~? 11.73 O2 U B 8 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 39.81 12.72 56.17 40.30 13.16 54.11 -23.73 -8.13 12.88 -23.76 -7.02 14.77 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 10 2 # 10 B 325 ASP A 279 ASP~? 17.12 C2 A B 7 B 350 LEU A 269 LEU~? 15.46 O4 U B 8 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 39.81 12.72 56.17 40.30 13.16 54.11 -34.40 -10.02 6.25 -32.98 -11.27 7.25 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 11 2 # 11 B 325 ASP A 279 ASP~? 17.12 C2 A B 7 B 350 LEU A 294 LEU~? 11.24 N6 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 39.81 12.72 56.17 40.30 13.16 54.11 -31.42 -20.65 2.22 -30.60 -19.93 0.35 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 12 2 # 12 B 325 ASP A 279 ASP~? 17.12 C2 A B 7 B 350 LEU A 305 LEU~? 15.30 N1 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 39.81 12.72 56.17 40.30 13.16 54.11 -32.20 -15.57 -1.13 -32.34 -14.53 0.75 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 13 2 # 13 B 325 ASP A 283 ASP~? 9.21 O2 U B 8 B 350 LEU A 269 LEU~? 15.46 O4 U B 8 coo 25.90 8.19 53.87 25.36 6.97 52.29 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 39.81 12.72 56.17 40.30 13.16 54.11 -34.40 -10.02 6.25 -32.98 -11.27 7.25 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 14 2 # 14 B 325 ASP A 283 ASP~? 9.21 O2 U B 8 B 350 LEU A 294 LEU~? 11.24 N6 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 39.81 12.72 56.17 40.30 13.16 54.11 -31.42 -20.65 2.22 -30.60 -19.93 0.35 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 15 2 # 15 B 325 ASP A 283 ASP~? 9.21 O2 U B 8 B 350 LEU A 305 LEU~? 15.30 N1 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 39.81 12.72 56.17 40.30 13.16 54.11 -32.20 -15.57 -1.13 -32.34 -14.53 0.75 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 16 2 # 16 B 325 ASP A 283 ASP~? 9.21 O2 U B 8 B 350 LEU A 309 LEU.? 14.77 N1 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 39.81 12.72 56.17 40.30 13.16 54.11 -27.47 -16.86 -7.24 -27.07 -18.25 -5.60 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 17 2 # 17 B 325 ASP A 283 ASP~? 9.21 O2 U B 8 B 350 LEU A 315 LEU~? 16.51 C2 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 39.81 12.72 56.17 40.30 13.16 54.11 -22.44 -18.38 -10.73 -24.05 -19.64 -9.97 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 18 2 # 18 B 325 ASP A 321 ASP~? 8.41 N3 A B 7 B 350 LEU A 294 LEU~? 11.24 N6 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo 39.81 12.72 56.17 40.30 13.16 54.11 -31.42 -20.65 2.22 -30.60 -19.93 0.35 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 19 2 # 19 B 325 ASP A 345 ASP~? 24.06 C2 A B 4 B 350 LEU A 309 LEU.? 14.77 N1 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 39.81 12.72 56.17 40.30 13.16 54.11 -27.47 -16.86 -7.24 -27.07 -18.25 -5.60 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 20 2 # 20 B 325 ASP A 376 ASP~? 17.17 N1 A B 4 B 350 LEU A 397 LEU~? 16.63 C2 A B 4 coo 25.90 8.19 53.87 25.36 6.97 52.29 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 39.81 12.72 56.17 40.30 13.16 54.11 -26.68 -32.45 -15.38 -25.20 -31.84 -13.94 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 21 2 # 21 B 325 ASP A 426 ASP.? 18.90 N1 A B 4 B 350 LEU A 337 LEU~? 21.08 N6 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 39.81 12.72 56.17 40.30 13.16 54.11 -35.92 -28.81 -9.22 -34.60 -29.36 -10.88 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 22 2 # 22 B 325 ASP A 426 ASP.? 18.90 N1 A B 4 B 350 LEU A 397 LEU~? 16.63 C2 A B 4 coo 25.90 8.19 53.87 25.36 6.97 52.29 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 39.81 12.72 56.17 40.30 13.16 54.11 -26.68 -32.45 -15.38 -25.20 -31.84 -13.94 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 23 2 # 23 B 325 ASP A 473 ASP~? 22.60 N2 G B 2 B 350 LEU A 439 LEU.? 13.42 N2 G B 2 coo 25.90 8.19 53.87 25.36 6.97 52.29 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 39.81 12.72 56.17 40.30 13.16 54.11 -14.61 -47.32 -19.28 -14.96 -45.67 -17.90 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 24 2 # 24 B 325 ASP A 477 ASP~? 24.62 N2 G B 2 B 350 LEU A 467 LEU~? 20.13 N2 G B 2 coo 25.90 8.19 53.87 25.36 6.97 52.29 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 39.81 12.72 56.17 40.30 13.16 54.11 -20.94 -53.65 -20.26 -21.79 -52.07 -21.49 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 25 2 # 25 B 325 ASP A 477 ASP~? 24.62 N2 G B 2 B 350 LEU A 468 LEU~? 17.46 N2 G B 2 coo 25.90 8.19 53.87 25.36 6.97 52.29 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 39.81 12.72 56.17 40.30 13.16 54.11 -19.18 -57.57 -16.85 -18.04 -58.18 -15.13 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 26 2 # 26 B 325 ASP A 488 ASP~? 18.76 O2 U B 1 B 350 LEU A 507 LEU~? 11.48 O4 U B 1 coo 25.90 8.19 53.87 25.36 6.97 52.29 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 39.81 12.72 56.17 40.30 13.16 54.11 -8.80 -61.88 -8.90 -7.96 -63.82 -8.44 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 27 2 # 27 B 325 ASP A 491 ASP~? 15.62 O2 U B 1 B 350 LEU A 443 LEU~? 13.05 N2 G B 2 coo 25.90 8.19 53.87 25.36 6.97 52.29 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 39.81 12.72 56.17 40.30 13.16 54.11 -9.87 -51.42 -19.82 -12.04 -51.54 -19.56 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 28 2 # 28 B 325 ASP A 491 ASP~? 15.62 O2 U B 1 B 350 LEU A 507 LEU~? 11.48 O4 U B 1 coo 25.90 8.19 53.87 25.36 6.97 52.29 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 39.81 12.72 56.17 40.30 13.16 54.11 -8.80 -61.88 -8.90 -7.96 -63.82 -8.44 ULMN 2 1bvz_01 ALPHA-AMYLASE II user 29 2 # 29 B 325 ASP A 533 ASP~? 24.95 O4 U B 1 B 350 LEU A 565 LEU~? 18.02 O4 U B 1 coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 39.81 12.72 56.17 40.30 13.16 54.11 -11.42 -69.79 -4.60 -13.25 -69.56 -5.77 1bvz_01 source 1bvz ALPHA-AMYLASE II : 29 hits 1bvz_01 naa= 2 ULMN 2 1bvz_04 ALPHA-AMYLASE II user 1 2 # 1 A 325 ASP A 174 ASP.? 19.36 O2' A B 9 A 354 GLU A 178 GLU.? 16.07 O2' A B 9 coo 31.05 49.37 64.51 31.97 51.11 63.85 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 29.07 50.42 58.36 29.02 52.18 59.49 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1bvz_04 ALPHA-AMYLASE II user 2 2 # 2 A 325 ASP A 345 ASP~? 24.06 C2 A B 4 A 354 GLU A 341 GLU~? 25.67 N6 A B 7 coo 31.05 49.37 64.51 31.97 51.11 63.85 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 29.07 50.42 58.36 29.02 52.18 59.49 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1bvz_04 ALPHA-AMYLASE II user 3 2 # 3 A 325 ASP A 491 ASP~? 15.62 O2 U B 1 A 354 GLU A 545 GLU~? 17.12 N3 U B 1 coo 31.05 49.37 64.51 31.97 51.11 63.85 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 29.07 50.42 58.36 29.02 52.18 59.49 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1bvz_04 source 1bvz ALPHA-AMYLASE II : 3 hits 1bvz_04 naa= 2 ULMN 2 1bvz_05 ALPHA-AMYLASE II user 1 2 # 1 B 325 ASP A 174 ASP.? 19.36 O2' A B 9 B 354 GLU A 178 GLU.? 16.07 O2' A B 9 coo 25.90 8.19 53.87 25.36 6.97 52.29 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 27.87 10.66 47.95 27.82 8.60 48.27 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1bvz_05 ALPHA-AMYLASE II user 2 2 # 2 B 325 ASP A 345 ASP~? 24.06 C2 A B 4 B 354 GLU A 341 GLU~? 25.67 N6 A B 7 coo 25.90 8.19 53.87 25.36 6.97 52.29 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 27.87 10.66 47.95 27.82 8.60 48.27 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1bvz_05 ALPHA-AMYLASE II user 3 2 # 3 B 325 ASP A 491 ASP~? 15.62 O2 U B 1 B 354 GLU A 545 GLU~? 17.12 N3 U B 1 coo 25.90 8.19 53.87 25.36 6.97 52.29 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 27.87 10.66 47.95 27.82 8.60 48.27 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1bvz_05 source 1bvz ALPHA-AMYLASE II : 3 hits 1bvz_05 naa= 2 ULMN 2 1bya_00 BETA-AMYLASE (E.C.3.2.1.2) user 1 2 # 1 101 ASP A 200 ASP~? 9.45 O2' A B 9 186 GLU A 187 GLU~? 20.71 C2 A B 9 coo -0.56 17.74 21.75 0.00 19.22 23.13 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 6.70 33.61 26.27 5.12 32.50 27.11 -28.60 -2.71 32.18 -27.08 -3.13 33.60 ULMN 2 1bya_00 BETA-AMYLASE (E.C.3.2.1.2) user 2 2 # 2 101 ASP A 381 ASP.? 22.82 N6 A B 7 186 GLU A 371 GLU~? 9.29 O2 C B 5 coo -0.56 17.74 21.75 0.00 19.22 23.13 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 coo 6.70 33.61 26.27 5.12 32.50 27.11 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1bya_00 BETA-AMYLASE (E.C.3.2.1.2) user 3 2 # 3 101 ASP A 425 ASP.? 18.06 O4 U B 3 186 GLU A 436 GLU~? 23.50 O4 U B 3 coo -0.56 17.74 21.75 0.00 19.22 23.13 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 6.70 33.61 26.27 5.12 32.50 27.11 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1bya_00 BETA-AMYLASE (E.C.3.2.1.2) user 4 2 # 4 101 ASP A 426 ASP.? 18.90 N1 A B 4 186 GLU A 522 GLU^? 23.38 O4 U B 3 coo -0.56 17.74 21.75 0.00 19.22 23.13 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 6.70 33.61 26.27 5.12 32.50 27.11 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1bya_00 BETA-AMYLASE (E.C.3.2.1.2) user 5 2 # 5 101 ASP A 473 ASP~? 22.60 N2 G B 2 186 GLU A 522 GLU^? 23.38 O4 U B 3 coo -0.56 17.74 21.75 0.00 19.22 23.13 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 6.70 33.61 26.27 5.12 32.50 27.11 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1bya_00 source 1bya BETA-AMYLASE (E.C.3.2.1.2) : 5 hits 1bya_00 naa= 2 ULMN 2 1bzy_14 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 C 105 CYH A 363 CYH~? 7.33 N3 A B 4 C 137 ASP A 321 ASP~? 8.41 N3 A B 7 coo 13.83 89.09 94.43 15.92 89.35 96.30 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 coo 5.10 82.97 88.07 6.79 81.71 87.85 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1bzy_14 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 C 105 CYH A 510 CYH~? 17.27 O4 U B 1 C 137 ASP A 526 ASP^? 28.45 O6 G B 2 coo 13.83 89.09 94.43 15.92 89.35 96.30 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo 5.10 82.97 88.07 6.79 81.71 87.85 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 ULMN 2 1bzy_14 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 C 105 CYH A 511 CYH~? 14.88 O4 U B 1 C 137 ASP A 533 ASP~? 24.95 O4 U B 1 coo 13.83 89.09 94.43 15.92 89.35 96.30 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 coo 5.10 82.97 88.07 6.79 81.71 87.85 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1bzy_14 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 3 hits 1bzy_14 naa= 2 ULMN 2 1bzy_15 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 D 105 CYH A 363 CYH~? 7.33 N3 A B 4 D 137 ASP A 321 ASP~? 8.41 N3 A B 7 coo -10.58 118.36 90.34 -12.93 118.38 91.82 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1bzy_15 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 D 105 CYH A 510 CYH~? 17.27 O4 U B 1 D 137 ASP A 526 ASP^? 28.45 O6 G B 2 coo -10.58 118.36 90.34 -12.93 118.38 91.82 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 ULMN 2 1bzy_15 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 3 2 # 3 D 105 CYH A 511 CYH~? 14.88 O4 U B 1 D 137 ASP A 533 ASP~? 24.95 O4 U B 1 coo -10.58 118.36 90.34 -12.93 118.38 91.82 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1bzy_15 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 3 hits 1bzy_15 naa= 2 ULMN 2 1bzy_16 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 A 104 TYR A 262 TYR~? 21.79 O4 U B 8 A 137 ASP A 298 ASP~? 21.17 O4 U B 8 coo 6.06 82.60 40.26 8.21 81.19 41.35 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 11.51 80.72 44.41 10.38 78.98 44.80 -41.82 -17.47 4.14 -42.95 -17.27 5.91 1bzy_16 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_16 naa= 2 ULMN 2 1bzy_17 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 B 104 TYR A 262 TYR~? 21.79 O4 U B 8 B 137 ASP A 298 ASP~? 21.17 O4 U B 8 coo 7.21 118.18 38.45 4.99 119.76 39.04 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 1.33 120.54 41.38 2.37 122.32 41.83 -41.82 -17.47 4.14 -42.95 -17.27 5.91 1bzy_17 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_17 naa= 2 ULMN 2 1bzy_18 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 C 104 TYR A 262 TYR~? 21.79 O4 U B 8 C 137 ASP A 298 ASP~? 21.17 O4 U B 8 coo 9.22 87.61 91.72 7.84 85.28 91.02 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 5.10 82.97 88.07 6.79 81.71 87.85 -41.82 -17.47 4.14 -42.95 -17.27 5.91 1bzy_18 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_18 naa= 2 ULMN 2 1bzy_19 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 D 104 TYR A 262 TYR~? 21.79 O4 U B 8 D 137 ASP A 298 ASP~? 21.17 O4 U B 8 coo -5.64 119.47 88.35 -4.20 121.69 87.46 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo -0.72 123.60 84.94 -2.32 124.82 84.32 -41.82 -17.47 4.14 -42.95 -17.27 5.91 1bzy_19 source 1bzy HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 1 hits 1bzy_19 naa= 2 ULMN 2 1c3j_00 BETA-GLUCOSYLTRANSFERASE user 1 2 # 1 A 22 GLU A 391 GLU~? 23.54 N1 A B 4 A 100 ASP A 426 ASP.? 18.90 N1 A B 4 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 ULMN 2 1c3j_00 BETA-GLUCOSYLTRANSFERASE user 2 2 # 2 A 22 GLU A 412 GLU.? 7.44 O2' U B 3 A 100 ASP A 359 ASP~? 8.63 O2' A B 4 coo 12.93 -8.26 7.64 14.85 -9.21 7.82 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 coo 20.71 -13.59 6.11 21.09 -14.85 7.76 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 1c3j_00 source 1c3j BETA-GLUCOSYLTRANSFERASE : 2 hits 1c3j_00 naa= 2 ULMN 2 1c4t_00 DIHYDROLIPOAMIDE SUCCINYLTRANSFERASEuser 1 2 # 1 A 375 HIS A 326 HIS~? 3.28 C5 A B 7 C 323 THR A 368 THR~? 9.37 O2' C B 5 coo 17.15 114.64 90.83 16.04 113.80 92.40 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 9.83 104.32 92.97 10.90 105.81 91.83 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 1c4t_00 source 1c4t DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE : 1 hits 1c4t_00 naa= 2 ULMN 2 1c4t_03 DIHYDROLIPOAMIDE SUCCINYLTRANSFERASEuser 1 2 # 1 A 375 HIS A 326 HIS~? 3.28 C5 A B 7 C 323 THR A 368 THR~? 9.37 O2' C B 5 coo 17.15 114.64 90.83 16.04 113.80 92.40 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 9.83 104.32 92.97 10.90 105.81 91.83 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 1c4t_03 source 1c4t DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE : 1 hits 1c4t_03 naa= 2 ULMN 2 1c9u_00 SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROuser 1 2 # 1 A 144 HIS A 462 HIS~? 12.61 O4 U B 3 A 163 ASP A 425 ASP.? 18.06 O4 U B 3 coo -1.62 24.04 7.39 -0.21 25.28 6.44 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo -7.14 26.54 6.91 -5.10 26.92 6.49 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 1c9u_00 source 1c9u SOLUBLE QUINOPROTEIN GLUCOSE DEHYDROGENASE : 1 hits 1c9u_00 naa= 2 ULMN 2 1ca2_00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 106 GLU A 449 GLU.? 11.55 O2 U B 3 199 THR A 410 THR~? 10.69 O2 U B 3 coo -5.18 -6.65 17.84 -4.18 -4.84 17.57 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 -8.78 -38.96 -14.99 -8.22 -38.93 -17.11 1ca2_00 source 1ca2 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 1 hits 1ca2_00 naa= 2 ULMN 2 1ca2_01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 64 HIS A 326 HIS~? 3.28 C5 A B 7 199 THR A 368 THR~? 9.37 O2' C B 5 coo -0.75 -0.87 9.12 -1.30 1.12 9.42 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 ULMN 2 1ca2_01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 2 2 # 2 64 HIS A 420 HIS~? 9.42 N1 A B 4 199 THR A 368 THR~? 9.37 O2' C B 5 coo -0.75 -0.87 9.12 -1.30 1.12 9.42 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 ULMN 2 1ca2_01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 3 2 # 3 64 HIS A 539 HIS~? 18.96 O4 U B 1 199 THR A 561 THR~? 10.68 O4 U B 1 coo -0.75 -0.87 9.12 -1.30 1.12 9.42 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 -7.66 -65.21 -2.98 -8.57 -63.47 -3.90 ULMN 2 1ca2_01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 4 2 # 4 64 HIS A 547 HIS~? 18.58 O4 U B 1 199 THR A 543 THR~? 19.49 O4 U B 1 coo -0.75 -0.87 9.12 -1.30 1.12 9.42 8.28 -67.57 -10.72 8.13 -67.19 -12.78 coo -2.11 -0.86 19.01 -3.95 -2.03 19.08 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 1ca2_01 source 1ca2 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 4 hits 1ca2_01 naa= 2 ULMN 2 1ca3_00 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 A 106 GLU A 449 GLU.? 11.55 O2 U B 3 A 199 THR A 410 THR~? 10.69 O2 U B 3 coo -5.31 -6.51 17.94 -4.14 -4.86 17.52 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 -8.78 -38.96 -14.99 -8.22 -38.93 -17.11 1ca3_00 source 1ca3 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 1 hits 1ca3_00 naa= 2 ULMN 2 1ca3_01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 1 2 # 1 A 64 HIS A 454 HIS~? 3.31 C5 U B 3 A 199 THR A 410 THR~? 10.69 O2 U B 3 coo 0.41 -0.63 8.41 1.49 1.00 7.81 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 -8.78 -38.96 -14.99 -8.22 -38.93 -17.11 ULMN 2 1ca3_01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 2 2 # 2 A 64 HIS A 482 HIS.? 27.32 N2 G B 2 A 199 THR A 485 THR.? 14.93 O2 U B 1 coo 0.41 -0.63 8.41 1.49 1.00 7.81 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 6.28 -52.72 -20.02 4.64 -51.56 -19.13 ULMN 2 1ca3_01 CARBONIC ANHYDRASE II (CARBONATE DEHuser 3 2 # 3 A 64 HIS A 539 HIS~? 18.96 O4 U B 1 A 199 THR A 561 THR~? 10.68 O4 U B 1 coo 0.41 -0.63 8.41 1.49 1.00 7.81 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 coo -2.15 -1.17 19.07 -3.99 -2.15 19.07 -7.66 -65.21 -2.98 -8.57 -63.47 -3.90 1ca3_01 source 1ca3 CARBONIC ANHYDRASE II (CARBONATE DEHYDRATASE) : 3 hits 1ca3_01 naa= 2 ULMN 2 1cbg_01 CYANOGENIC BETA-GLUCOSIDASE user 1 2 # 1 183 GLU A 432 GLU~? 22.16 O4 U B 3 397 GLU A 436 GLU~? 23.50 O4 U B 3 coo 39.31 34.78 85.95 38.51 34.50 84.04 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 42.23 29.47 82.87 40.46 30.21 83.67 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1cbg_01 CYANOGENIC BETA-GLUCOSIDASE user 2 2 # 2 183 GLU A 436 GLU~? 23.50 O4 U B 3 397 GLU A 432 GLU~? 22.16 O4 U B 3 coo 39.31 34.78 85.95 38.51 34.50 84.04 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 42.23 29.47 82.87 40.46 30.21 83.67 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1cbg_01 CYANOGENIC BETA-GLUCOSIDASE user 3 2 # 3 183 GLU A 466 GLU~? 26.72 N2 G B 2 397 GLU A 470 GLU~? 22.82 N2 G B 2 coo 39.31 34.78 85.95 38.51 34.50 84.04 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 42.23 29.47 82.87 40.46 30.21 83.67 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1cbg_01 CYANOGENIC BETA-GLUCOSIDASE user 4 2 # 4 183 GLU A 470 GLU~? 22.82 N2 G B 2 397 GLU A 466 GLU~? 26.72 N2 G B 2 coo 39.31 34.78 85.95 38.51 34.50 84.04 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 42.23 29.47 82.87 40.46 30.21 83.67 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 1cbg_01 source 1cbg CYANOGENIC BETA-GLUCOSIDASE : 4 hits 1cbg_01 naa= 2 ULMN 2 1cbx_00 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 2 # 1 127 ARG A 431 ARG~? 16.75 O4 U B 3 270 GLU A 522 GLU^? 23.38 O4 U B 3 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1cbx_00 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 1 hits 1cbx_00 naa= 2 ULMN 2 1cdg_02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 2 # 1 229 ASP A 345 ASP~? 24.06 C2 A B 4 257 GLU A 341 GLU~? 25.67 N6 A B 7 coo 45.62 80.42 43.69 45.65 82.01 45.07 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 48.97 85.16 40.39 47.18 86.25 40.47 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1cdg_02 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 2 # 2 229 ASP A 491 ASP~? 15.62 O2 U B 1 257 GLU A 545 GLU~? 17.12 N3 U B 1 coo 45.62 80.42 43.69 45.65 82.01 45.07 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 48.97 85.16 40.39 47.18 86.25 40.47 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1cdg_02 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 2 hits 1cdg_02 naa= 2 ULMN 2 1cev_00 ARGINASE user 1 2 # 1 A 126 ASP A 376 ASP~? 17.17 N1 A B 4 A 271 GLU A 371 GLU~? 9.29 O2 C B 5 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1cev_00 ARGINASE user 2 2 # 2 A 126 ASP A 488 ASP~? 18.76 O2 U B 1 A 271 GLU A 545 GLU~? 17.12 N3 U B 1 coo 56.42 -26.69 44.89 57.03 -25.42 43.36 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 61.43 -23.42 38.04 59.66 -23.99 37.00 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1cev_00 source 1cev ARGINASE : 2 hits 1cev_00 naa= 2 ULMN 2 1cev_01 ARGINASE user 1 2 # 1 B 126 ASP A 376 ASP~? 17.17 N1 A B 4 B 271 GLU A 371 GLU~? 9.29 O2 C B 5 coo 88.66 4.10 42.84 87.11 4.00 41.44 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 82.56 6.85 36.70 83.82 5.71 35.47 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1cev_01 ARGINASE user 2 2 # 2 B 126 ASP A 488 ASP~? 18.76 O2 U B 1 B 271 GLU A 545 GLU~? 17.12 N3 U B 1 coo 88.66 4.10 42.84 87.11 4.00 41.44 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 82.56 6.85 36.70 83.82 5.71 35.47 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1cev_01 source 1cev ARGINASE : 2 hits 1cev_01 naa= 2 ULMN 2 1cev_02 ARGINASE user 1 2 # 1 C 126 ASP A 376 ASP~? 17.17 N1 A B 4 C 271 GLU A 371 GLU~? 9.29 O2 C B 5 coo 45.89 16.49 45.35 46.56 15.26 43.82 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 45.78 10.17 38.80 46.02 11.92 37.61 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1cev_02 ARGINASE user 2 2 # 2 C 126 ASP A 488 ASP~? 18.76 O2 U B 1 C 271 GLU A 545 GLU~? 17.12 N3 U B 1 coo 45.89 16.49 45.35 46.56 15.26 43.82 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 45.78 10.17 38.80 46.02 11.92 37.61 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1cev_02 source 1cev ARGINASE : 2 hits 1cev_02 naa= 2 ULMN 2 1cev_03 ARGINASE user 1 2 # 1 D 126 ASP A 376 ASP~? 17.17 N1 A B 4 D 271 GLU A 371 GLU~? 9.29 O2 C B 5 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1cev_03 ARGINASE user 2 2 # 2 D 126 ASP A 488 ASP~? 18.76 O2 U B 1 D 271 GLU A 545 GLU~? 17.12 N3 U B 1 coo 56.62 -22.51 83.64 56.67 -21.03 85.13 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 53.70 -16.83 90.05 54.85 -18.21 91.20 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1cev_03 source 1cev ARGINASE : 2 hits 1cev_03 naa= 2 ULMN 2 1cev_04 ARGINASE user 1 2 # 1 E 126 ASP A 376 ASP~? 17.17 N1 A B 4 E 271 GLU A 371 GLU~? 9.29 O2 C B 5 coo 45.56 20.87 83.32 46.70 20.05 84.89 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 51.57 20.36 90.15 49.76 20.10 91.22 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1cev_04 ARGINASE user 2 2 # 2 E 126 ASP A 488 ASP~? 18.76 O2 U B 1 E 271 GLU A 545 GLU~? 17.12 N3 U B 1 coo 45.56 20.87 83.32 46.70 20.05 84.89 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 51.57 20.36 90.15 49.76 20.10 91.22 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1cev_04 source 1cev ARGINASE : 2 hits 1cev_04 naa= 2 ULMN 2 1cev_05 ARGINASE user 1 2 # 1 F 126 ASP A 376 ASP~? 17.17 N1 A B 4 F 271 GLU A 371 GLU~? 9.29 O2 C B 5 coo 88.43 8.76 85.43 87.07 8.09 86.86 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 84.65 3.46 91.79 85.25 5.11 93.00 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1cev_05 ARGINASE user 2 2 # 2 F 126 ASP A 488 ASP~? 18.76 O2 U B 1 F 271 GLU A 545 GLU~? 17.12 N3 U B 1 coo 88.43 8.76 85.43 87.07 8.09 86.86 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 84.65 3.46 91.79 85.25 5.11 93.00 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1cev_05 source 1cev ARGINASE : 2 hits 1cev_05 naa= 2 ULMN 2 1cg6_00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 1 2 # 1 A 220 ASP A 233 ASP~? 18.81 O2 U B 8 A 222 ASP A 232 ASP~? 21.56 O2 U B 8 coo 58.27 13.03 22.20 58.95 14.66 23.40 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 57.70 19.17 20.72 57.19 20.68 22.14 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 1cg6_00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 2 2 # 2 A 220 ASP A 259 ASP.? 23.89 N1 A B 9 A 222 ASP A 260 ASP.? 30.95 O4 U B 8 coo 58.27 13.03 22.20 58.95 14.66 23.40 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 57.70 19.17 20.72 57.19 20.68 22.14 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 1cg6_00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 3 2 # 3 A 220 ASP A 260 ASP.? 30.95 O4 U B 8 A 222 ASP A 259 ASP.? 23.89 N1 A B 9 coo 58.27 13.03 22.20 58.95 14.66 23.40 -48.66 -5.55 12.81 -49.71 -4.82 11.14 coo 57.70 19.17 20.72 57.19 20.68 22.14 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1cg6_00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 4 2 # 4 A 220 ASP A 426 ASP.? 18.90 N1 A B 4 A 222 ASP A 376 ASP~? 17.17 N1 A B 4 coo 58.27 13.03 22.20 58.95 14.66 23.40 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 57.70 19.17 20.72 57.19 20.68 22.14 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1cg6_00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 5 2 # 5 A 220 ASP A 426 ASP.? 18.90 N1 A B 4 A 222 ASP A 425 ASP.? 18.06 O4 U B 3 coo 58.27 13.03 22.20 58.95 14.66 23.40 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 57.70 19.17 20.72 57.19 20.68 22.14 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1cg6_00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 6 2 # 6 A 220 ASP A 473 ASP~? 22.60 N2 G B 2 A 222 ASP A 477 ASP~? 24.62 N2 G B 2 coo 58.27 13.03 22.20 58.95 14.66 23.40 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 57.70 19.17 20.72 57.19 20.68 22.14 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 ULMN 2 1cg6_00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 7 2 # 7 A 220 ASP A 477 ASP~? 24.62 N2 G B 2 A 222 ASP A 473 ASP~? 22.60 N2 G B 2 coo 58.27 13.03 22.20 58.95 14.66 23.40 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 57.70 19.17 20.72 57.19 20.68 22.14 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1cg6_00 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSuser 8 2 # 8 A 220 ASP A 488 ASP~? 18.76 O2 U B 1 A 222 ASP A 491 ASP~? 15.62 O2 U B 1 coo 58.27 13.03 22.20 58.95 14.66 23.40 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 57.70 19.17 20.72 57.19 20.68 22.14 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1cg6_00 source 1cg6 5'-DEOXY-5'-METHYLTHIOADENOSINE PHOSPHORYLASE : 8 hits 1cg6_00 naa= 2 ULMN 2 1chk_00 CHITOSANASE user 1 2 # 1 B 22 GLU A 187 GLU~? 20.71 C2 A B 9 B 40 ASP A 174 ASP.? 19.36 O2' A B 9 coo 8.24 11.09 5.99 6.67 9.69 5.66 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -15.98 -5.04 37.28 -14.70 -6.54 36.49 ULMN 2 1chk_00 CHITOSANASE user 2 2 # 2 B 22 GLU A 225 GLU~? 23.05 C2 A B 9 B 40 ASP A 232 ASP~? 21.56 O2 U B 8 coo 8.24 11.09 5.99 6.67 9.69 5.66 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 1chk_00 CHITOSANASE user 3 2 # 3 B 22 GLU A 225 GLU~? 23.05 C2 A B 9 B 40 ASP A 260 ASP.? 30.95 O4 U B 8 coo 8.24 11.09 5.99 6.67 9.69 5.66 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 1.69 -0.80 10.40 3.84 -0.49 10.37 -48.66 -5.55 12.81 -49.71 -4.82 11.14 1chk_00 source 1chk CHITOSANASE : 3 hits 1chk_00 naa= 2 ULMN 2 1chk_01 CHITOSANASE user 1 2 # 1 A 22 GLU A 225 GLU~? 23.05 C2 A B 9 A 40 ASP A 232 ASP~? 21.56 O2 U B 8 coo 44.97 21.98 32.76 46.32 21.69 34.45 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 57.72 22.56 24.95 56.25 21.01 24.85 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 1chk_01 CHITOSANASE user 2 2 # 2 A 22 GLU A 267 GLU~? 24.62 O4 U B 8 A 40 ASP A 260 ASP.? 30.95 O4 U B 8 coo 44.97 21.98 32.76 46.32 21.69 34.45 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 coo 57.72 22.56 24.95 56.25 21.01 24.85 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 1chk_01 CHITOSANASE user 3 2 # 3 A 22 GLU A 371 GLU~? 9.29 O2 C B 5 A 40 ASP A 425 ASP.? 18.06 O4 U B 3 coo 44.97 21.98 32.76 46.32 21.69 34.45 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 57.72 22.56 24.95 56.25 21.01 24.85 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1chk_01 CHITOSANASE user 4 2 # 4 A 22 GLU A 391 GLU~? 23.54 N1 A B 4 A 40 ASP A 345 ASP~? 24.06 C2 A B 4 coo 44.97 21.98 32.76 46.32 21.69 34.45 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 57.72 22.56 24.95 56.25 21.01 24.85 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 ULMN 2 1chk_01 CHITOSANASE user 5 2 # 5 A 22 GLU A 391 GLU~? 23.54 N1 A B 4 A 40 ASP A 381 ASP.? 22.82 N6 A B 7 coo 44.97 21.98 32.76 46.32 21.69 34.45 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 57.72 22.56 24.95 56.25 21.01 24.85 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 ULMN 2 1chk_01 CHITOSANASE user 6 2 # 6 A 22 GLU A 436 GLU~? 23.50 O4 U B 3 A 40 ASP A 473 ASP~? 22.60 N2 G B 2 coo 44.97 21.98 32.76 46.32 21.69 34.45 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 57.72 22.56 24.95 56.25 21.01 24.85 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1chk_01 CHITOSANASE user 7 2 # 7 A 22 GLU A 457 GLU~? 3.32 N1 G B 2 A 40 ASP A 512 ASP~? 14.88 O6 G B 2 coo 44.97 21.98 32.76 46.32 21.69 34.45 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 57.72 22.56 24.95 56.25 21.01 24.85 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 ULMN 2 1chk_01 CHITOSANASE user 8 2 # 8 A 22 GLU A 560 GLU~? 13.58 O4 U B 1 A 40 ASP A 512 ASP~? 14.88 O6 G B 2 coo 44.97 21.98 32.76 46.32 21.69 34.45 -4.75 -65.37 1.07 -4.31 -67.34 1.74 coo 57.72 22.56 24.95 56.25 21.01 24.85 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 1chk_01 source 1chk CHITOSANASE : 8 hits 1chk_01 naa= 2 ULMN 2 1chm_04 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 2 # 1 A 331 HIS A 462 HIS~? 12.61 O4 U B 3 A 358 GLU A 436 GLU~? 23.50 O4 U B 3 coo 32.65 64.88 45.53 33.25 66.88 46.21 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 27.06 50.43 44.36 27.99 52.27 44.74 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1chm_04 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 2 # 2 A 331 HIS A 496 HIS.? 9.17 O2 U B 1 A 358 GLU A 545 GLU~? 17.12 N3 U B 1 coo 32.65 64.88 45.53 33.25 66.88 46.21 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 27.06 50.43 44.36 27.99 52.27 44.74 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1chm_04 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 2 hits 1chm_04 naa= 2 ULMN 2 1chm_05 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 2 # 1 B 331 HIS A 352 HIS~? 21.18 O2' A B 4 B 358 GLU A 407 GLU~? 15.45 O2 U B 3 coo 38.59 73.13 46.90 37.84 71.22 47.24 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 coo 44.05 87.61 48.73 43.15 85.67 48.52 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1chm_05 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 2 # 2 B 331 HIS A 496 HIS.? 9.17 O2 U B 1 B 358 GLU A 545 GLU~? 17.12 N3 U B 1 coo 38.59 73.13 46.90 37.84 71.22 47.24 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 44.05 87.61 48.73 43.15 85.67 48.52 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1chm_05 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 2 hits 1chm_05 naa= 2 ULMN 2 1cl1_00 CYSTATHIONINE BETA-LYASE user 1 2 # 1 A 111 TYR A 218 TYR~? 23.65 C2 A B 9 A 185 ASP A 190 ASP~? 22.39 C2 A B 9 coo -6.99 5.69 52.91 -8.09 7.69 51.31 -39.15 -2.15 23.93 -37.86 0.21 23.20 coo -0.22 4.86 55.08 -1.23 6.48 54.18 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1cl1_00 CYSTATHIONINE BETA-LYASE user 2 2 # 2 A 111 TYR A 262 TYR~? 21.79 O4 U B 8 A 185 ASP A 259 ASP.? 23.89 N1 A B 9 coo -6.99 5.69 52.91 -8.09 7.69 51.31 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo -0.22 4.86 55.08 -1.23 6.48 54.18 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1cl1_00 CYSTATHIONINE BETA-LYASE user 3 2 # 3 A 111 TYR A 361 TYR~? 4.83 OP1 U B 6 A 185 ASP A 321 ASP~? 8.41 N3 A B 7 coo -6.99 5.69 52.91 -8.09 7.69 51.31 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo -0.22 4.86 55.08 -1.23 6.48 54.18 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1cl1_00 CYSTATHIONINE BETA-LYASE user 4 2 # 4 A 111 TYR A 361 TYR~? 4.83 OP1 U B 6 A 185 ASP A 359 ASP~? 8.63 O2' A B 4 coo -6.99 5.69 52.91 -8.09 7.69 51.31 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo -0.22 4.86 55.08 -1.23 6.48 54.18 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 1cl1_00 source 1cl1 CYSTATHIONINE BETA-LYASE : 4 hits 1cl1_00 naa= 2 ULMN 2 1cl1_02 CYSTATHIONINE BETA-LYASE user 1 2 # 1 B 111 TYR A 218 TYR~? 23.65 C2 A B 9 B 185 ASP A 190 ASP~? 22.39 C2 A B 9 coo -8.78 52.08 24.38 -9.63 50.05 26.11 -39.15 -2.15 23.93 -37.86 0.21 23.20 coo -2.31 52.89 21.38 -3.20 51.27 22.38 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1cl1_02 CYSTATHIONINE BETA-LYASE user 2 2 # 2 B 111 TYR A 262 TYR~? 21.79 O4 U B 8 B 185 ASP A 259 ASP.? 23.89 N1 A B 9 coo -8.78 52.08 24.38 -9.63 50.05 26.11 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo -2.31 52.89 21.38 -3.20 51.27 22.38 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1cl1_02 CYSTATHIONINE BETA-LYASE user 3 2 # 3 B 111 TYR A 361 TYR~? 4.83 OP1 U B 6 B 185 ASP A 321 ASP~? 8.41 N3 A B 7 coo -8.78 52.08 24.38 -9.63 50.05 26.11 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo -2.31 52.89 21.38 -3.20 51.27 22.38 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1cl1_02 CYSTATHIONINE BETA-LYASE user 4 2 # 4 B 111 TYR A 361 TYR~? 4.83 OP1 U B 6 B 185 ASP A 359 ASP~? 8.63 O2' A B 4 coo -8.78 52.08 24.38 -9.63 50.05 26.11 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo -2.31 52.89 21.38 -3.20 51.27 22.38 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 1cl1_02 source 1cl1 CYSTATHIONINE BETA-LYASE : 4 hits 1cl1_02 naa= 2 ULMN 2 1coy_01 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 2 # 1 447 HIS A 420 HIS~? 9.42 N1 A B 4 485 ASN A 424 ASN~? 14.16 N1 A B 4 coo -15.81 17.12 25.99 -13.91 16.92 26.88 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo -13.17 13.85 30.36 -11.76 15.41 30.53 -25.68 -44.49 -8.34 -27.48 -44.07 -7.29 1coy_01 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 1 hits 1coy_01 naa= 2 ULMN 2 1cqg_00 REF-1 PEPTIDE user 1 2 # 1 A 32 CYH A 281 CYH~? 10.64 C2 A B 7 A 35 ALA A 324 ALA~? 7.80 C2 A B 7 coo 10.88 10.50 2.65 10.80 11.19 -0.01 -21.84 -15.78 -0.10 -24.15 -16.31 -1.64 coo 5.86 10.20 0.80 6.89 9.09 0.56 -19.52 -20.29 -0.49 -19.10 -19.31 -1.56 ULMN 2 1cqg_00 REF-1 PEPTIDE user 2 2 # 2 A 32 CYH A 303 CYH~? 19.60 N6 A B 7 A 35 ALA A 302 ALA~? 15.97 N6 A B 7 coo 10.88 10.50 2.65 10.80 11.19 -0.01 -36.71 -18.21 -3.45 -38.39 -20.40 -3.80 coo 5.86 10.20 0.80 6.89 9.09 0.56 -35.99 -17.79 0.27 -36.00 -19.17 0.93 ULMN 2 1cqg_00 REF-1 PEPTIDE user 3 2 # 3 A 32 CYH A 357 CYH~? 11.67 N3 A B 4 A 35 ALA A 414 ALA~? 9.06 O2 U B 3 coo 10.88 10.50 2.65 10.80 11.19 -0.01 -15.20 -30.19 -11.77 -17.54 -31.24 -12.82 coo 5.86 10.20 0.80 6.89 9.09 0.56 -13.88 -35.45 -10.58 -14.01 -34.71 -11.91 ULMN 2 1cqg_00 REF-1 PEPTIDE user 4 2 # 4 A 32 CYH A 363 CYH~? 7.33 N3 A B 4 A 35 ALA A 414 ALA~? 9.06 O2 U B 3 coo 10.88 10.50 2.65 10.80 11.19 -0.01 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 coo 5.86 10.20 0.80 6.89 9.09 0.56 -13.88 -35.45 -10.58 -14.01 -34.71 -11.91 ULMN 2 1cqg_00 REF-1 PEPTIDE user 5 2 # 5 A 32 CYH A 405 CYH~? 14.40 N3 U B 3 A 35 ALA A 409 ALA~? 10.24 O2 U B 3 coo 10.88 10.50 2.65 10.80 11.19 -0.01 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 coo 5.86 10.20 0.80 6.89 9.09 0.56 -12.52 -39.70 -14.88 -12.84 -40.87 -15.81 1cqg_00 source 1cqg REF-1 PEPTIDE : 5 hits 1cqg_00 naa= 2 ULMN 2 1cs1_04 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 A 87 PHE A 221 PHE~? 23.88 N1 A B 9 A 173 ASP A 233 ASP~? 18.81 O2 U B 8 coo 17.25 11.19 35.89 19.13 13.25 35.57 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 24.35 4.55 25.11 25.94 3.23 25.53 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1cs1_04 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 A 87 PHE A 224 PHE~? 18.04 N1 A B 9 A 173 ASP A 233 ASP~? 18.81 O2 U B 8 coo 17.25 11.19 35.89 19.13 13.25 35.57 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 24.35 4.55 25.11 25.94 3.23 25.53 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1cs1_04 CYSTATHIONINE GAMMA-SYNTHASE user 3 2 # 3 A 87 PHE A 285 PHE~? 4.61 O2 U B 8 A 173 ASP A 200 ASP~? 9.45 O2' A B 9 coo 17.25 11.19 35.89 19.13 13.25 35.57 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 24.35 4.55 25.11 25.94 3.23 25.53 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1cs1_04 CYSTATHIONINE GAMMA-SYNTHASE user 4 2 # 4 A 87 PHE A 285 PHE~? 4.61 O2 U B 8 A 173 ASP A 279 ASP~? 17.12 C2 A B 7 coo 17.25 11.19 35.89 19.13 13.25 35.57 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 24.35 4.55 25.11 25.94 3.23 25.53 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1cs1_04 CYSTATHIONINE GAMMA-SYNTHASE user 5 2 # 5 A 87 PHE A 346 PHE~? 20.00 C2 A B 7 A 173 ASP A 321 ASP~? 8.41 N3 A B 7 coo 17.25 11.19 35.89 19.13 13.25 35.57 -23.89 -21.28 -14.48 -21.57 -19.76 -14.21 coo 24.35 4.55 25.11 25.94 3.23 25.53 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1cs1_04 CYSTATHIONINE GAMMA-SYNTHASE user 6 2 # 6 A 87 PHE A 451 PHE~? 4.67 O2 U B 3 A 173 ASP A 359 ASP~? 8.63 O2' A B 4 coo 17.25 11.19 35.89 19.13 13.25 35.57 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo 24.35 4.55 25.11 25.94 3.23 25.53 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 1cs1_04 CYSTATHIONINE GAMMA-SYNTHASE user 7 2 # 7 A 87 PHE A 460 PHE~? 11.81 N2 G B 2 A 173 ASP A 488 ASP~? 18.76 O2 U B 1 coo 17.25 11.19 35.89 19.13 13.25 35.57 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 coo 24.35 4.55 25.11 25.94 3.23 25.53 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 ULMN 2 1cs1_04 CYSTATHIONINE GAMMA-SYNTHASE user 8 2 # 8 A 87 PHE A 460 PHE~? 11.81 N2 G B 2 A 173 ASP A 533 ASP~? 24.95 O4 U B 1 coo 17.25 11.19 35.89 19.13 13.25 35.57 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 coo 24.35 4.55 25.11 25.94 3.23 25.53 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1cs1_04 CYSTATHIONINE GAMMA-SYNTHASE user 9 2 # 9 A 87 PHE A 495 PHE~? 11.36 O2 U B 1 A 173 ASP A 484 ASP.? 22.65 O2 U B 1 coo 17.25 11.19 35.89 19.13 13.25 35.57 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo 24.35 4.55 25.11 25.94 3.23 25.53 7.90 -50.74 -23.88 8.67 -50.47 -25.84 1cs1_04 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_04 naa= 2 ULMN 2 1cs1_05 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 B 87 PHE A 221 PHE~? 23.88 N1 A B 9 B 173 ASP A 233 ASP~? 18.81 O2 U B 8 coo 84.13 3.94 45.72 82.40 5.78 46.90 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1cs1_05 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 B 87 PHE A 224 PHE~? 18.04 N1 A B 9 B 173 ASP A 233 ASP~? 18.81 O2 U B 8 coo 84.13 3.94 45.72 82.40 5.78 46.90 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1cs1_05 CYSTATHIONINE GAMMA-SYNTHASE user 3 2 # 3 B 87 PHE A 285 PHE~? 4.61 O2 U B 8 B 173 ASP A 200 ASP~? 9.45 O2' A B 9 coo 84.13 3.94 45.72 82.40 5.78 46.90 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1cs1_05 CYSTATHIONINE GAMMA-SYNTHASE user 4 2 # 4 B 87 PHE A 285 PHE~? 4.61 O2 U B 8 B 173 ASP A 279 ASP~? 17.12 C2 A B 7 coo 84.13 3.94 45.72 82.40 5.78 46.90 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1cs1_05 CYSTATHIONINE GAMMA-SYNTHASE user 5 2 # 5 B 87 PHE A 346 PHE~? 20.00 C2 A B 7 B 173 ASP A 321 ASP~? 8.41 N3 A B 7 coo 84.13 3.94 45.72 82.40 5.78 46.90 -23.89 -21.28 -14.48 -21.57 -19.76 -14.21 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1cs1_05 CYSTATHIONINE GAMMA-SYNTHASE user 6 2 # 6 B 87 PHE A 451 PHE~? 4.67 O2 U B 3 B 173 ASP A 359 ASP~? 8.63 O2' A B 4 coo 84.13 3.94 45.72 82.40 5.78 46.90 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 1cs1_05 CYSTATHIONINE GAMMA-SYNTHASE user 7 2 # 7 B 87 PHE A 460 PHE~? 11.81 N2 G B 2 B 173 ASP A 533 ASP~? 24.95 O4 U B 1 coo 84.13 3.94 45.72 82.40 5.78 46.90 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1cs1_05 CYSTATHIONINE GAMMA-SYNTHASE user 8 2 # 8 B 87 PHE A 495 PHE~? 11.36 O2 U B 1 B 173 ASP A 484 ASP.? 22.65 O2 U B 1 coo 84.13 3.94 45.72 82.40 5.78 46.90 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 7.90 -50.74 -23.88 8.67 -50.47 -25.84 1cs1_05 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1cs1_05 naa= 2 ULMN 2 1cs1_06 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 C 87 PHE A 221 PHE~? 23.88 N1 A B 9 C 173 ASP A 233 ASP~? 18.81 O2 U B 8 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1cs1_06 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 C 87 PHE A 224 PHE~? 18.04 N1 A B 9 C 173 ASP A 190 ASP~? 22.39 C2 A B 9 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1cs1_06 CYSTATHIONINE GAMMA-SYNTHASE user 3 2 # 3 C 87 PHE A 224 PHE~? 18.04 N1 A B 9 C 173 ASP A 233 ASP~? 18.81 O2 U B 8 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1cs1_06 CYSTATHIONINE GAMMA-SYNTHASE user 4 2 # 4 C 87 PHE A 285 PHE~? 4.61 O2 U B 8 C 173 ASP A 200 ASP~? 9.45 O2' A B 9 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1cs1_06 CYSTATHIONINE GAMMA-SYNTHASE user 5 2 # 5 C 87 PHE A 285 PHE~? 4.61 O2 U B 8 C 173 ASP A 279 ASP~? 17.12 C2 A B 7 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1cs1_06 CYSTATHIONINE GAMMA-SYNTHASE user 6 2 # 6 C 87 PHE A 346 PHE~? 20.00 C2 A B 7 C 173 ASP A 321 ASP~? 8.41 N3 A B 7 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -23.89 -21.28 -14.48 -21.57 -19.76 -14.21 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1cs1_06 CYSTATHIONINE GAMMA-SYNTHASE user 7 2 # 7 C 87 PHE A 451 PHE~? 4.67 O2 U B 3 C 173 ASP A 359 ASP~? 8.63 O2' A B 4 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 1cs1_06 CYSTATHIONINE GAMMA-SYNTHASE user 8 2 # 8 C 87 PHE A 460 PHE~? 11.81 N2 G B 2 C 173 ASP A 533 ASP~? 24.95 O4 U B 1 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1cs1_06 CYSTATHIONINE GAMMA-SYNTHASE user 9 2 # 9 C 87 PHE A 495 PHE~? 11.36 O2 U B 1 C 173 ASP A 484 ASP.? 22.65 O2 U B 1 coo 19.15 -10.36 50.07 20.63 -12.70 49.62 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 7.90 -50.74 -23.88 8.67 -50.47 -25.84 1cs1_06 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 9 hits 1cs1_06 naa= 2 ULMN 2 1cs1_07 CYSTATHIONINE GAMMA-SYNTHASE user 1 2 # 1 D 87 PHE A 221 PHE~? 23.88 N1 A B 9 D 173 ASP A 233 ASP~? 18.81 O2 U B 8 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 71.60 6.14 19.25 70.26 6.87 20.69 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1cs1_07 CYSTATHIONINE GAMMA-SYNTHASE user 2 2 # 2 D 87 PHE A 224 PHE~? 18.04 N1 A B 9 D 173 ASP A 233 ASP~? 18.81 O2 U B 8 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 71.60 6.14 19.25 70.26 6.87 20.69 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1cs1_07 CYSTATHIONINE GAMMA-SYNTHASE user 3 2 # 3 D 87 PHE A 285 PHE~? 4.61 O2 U B 8 D 173 ASP A 200 ASP~? 9.45 O2' A B 9 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 71.60 6.14 19.25 70.26 6.87 20.69 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1cs1_07 CYSTATHIONINE GAMMA-SYNTHASE user 4 2 # 4 D 87 PHE A 285 PHE~? 4.61 O2 U B 8 D 173 ASP A 279 ASP~? 17.12 C2 A B 7 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 71.60 6.14 19.25 70.26 6.87 20.69 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1cs1_07 CYSTATHIONINE GAMMA-SYNTHASE user 5 2 # 5 D 87 PHE A 346 PHE~? 20.00 C2 A B 7 D 173 ASP A 321 ASP~? 8.41 N3 A B 7 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -23.89 -21.28 -14.48 -21.57 -19.76 -14.21 coo 71.60 6.14 19.25 70.26 6.87 20.69 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1cs1_07 CYSTATHIONINE GAMMA-SYNTHASE user 6 2 # 6 D 87 PHE A 451 PHE~? 4.67 O2 U B 3 D 173 ASP A 359 ASP~? 8.63 O2' A B 4 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo 71.60 6.14 19.25 70.26 6.87 20.69 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 1cs1_07 CYSTATHIONINE GAMMA-SYNTHASE user 7 2 # 7 D 87 PHE A 460 PHE~? 11.81 N2 G B 2 D 173 ASP A 533 ASP~? 24.95 O4 U B 1 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 coo 71.60 6.14 19.25 70.26 6.87 20.69 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1cs1_07 CYSTATHIONINE GAMMA-SYNTHASE user 8 2 # 8 D 87 PHE A 495 PHE~? 11.36 O2 U B 1 D 173 ASP A 484 ASP.? 22.65 O2 U B 1 coo 80.50 -4.92 21.57 78.55 -6.75 20.71 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo 71.60 6.14 19.25 70.26 6.87 20.69 7.90 -50.74 -23.88 8.67 -50.47 -25.84 1cs1_07 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 8 hits 1cs1_07 naa= 2 ULMN 2 1ctn_01 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 2 # 1 313 ASP A 345 ASP~? 24.06 C2 A B 4 315 GLU A 341 GLU~? 25.67 N6 A B 7 coo 32.46 99.13 19.34 30.94 100.38 20.07 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 32.04 94.22 18.23 30.57 94.75 16.88 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1ctn_01 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 2 # 2 313 ASP A 491 ASP~? 15.62 O2 U B 1 315 GLU A 545 GLU~? 17.12 N3 U B 1 coo 32.46 99.13 19.34 30.94 100.38 20.07 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 32.04 94.22 18.23 30.57 94.75 16.88 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1ctn_01 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 2 hits 1ctn_01 naa= 2 ULMN 2 1ctn_02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 2 # 1 311 ASP A 200 ASP~? 9.45 O2' A B 9 315 GLU A 178 GLU.? 16.07 O2' A B 9 coo 31.76 104.69 22.47 30.78 102.79 22.26 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 32.04 94.22 18.23 30.57 94.75 16.88 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1ctn_02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 2 # 2 311 ASP A 259 ASP.? 23.89 N1 A B 9 315 GLU A 225 GLU~? 23.05 C2 A B 9 coo 31.76 104.69 22.47 30.78 102.79 22.26 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 32.04 94.22 18.23 30.57 94.75 16.88 -36.18 -1.53 15.48 -36.93 -1.10 13.54 ULMN 2 1ctn_02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 2 # 3 311 ASP A 425 ASP.? 18.06 O4 U B 3 315 GLU A 432 GLU~? 22.16 O4 U B 3 coo 31.76 104.69 22.47 30.78 102.79 22.26 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 32.04 94.22 18.23 30.57 94.75 16.88 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1ctn_02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 2 # 4 311 ASP A 425 ASP.? 18.06 O4 U B 3 315 GLU A 522 GLU^? 23.38 O4 U B 3 coo 31.76 104.69 22.47 30.78 102.79 22.26 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 32.04 94.22 18.23 30.57 94.75 16.88 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1ctn_02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 5 2 # 5 311 ASP A 473 ASP~? 22.60 N2 G B 2 315 GLU A 466 GLU~? 26.72 N2 G B 2 coo 31.76 104.69 22.47 30.78 102.79 22.26 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 32.04 94.22 18.23 30.57 94.75 16.88 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1ctn_02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 6 2 # 6 311 ASP A 488 ASP~? 18.76 O2 U B 1 315 GLU A 545 GLU~? 17.12 N3 U B 1 coo 31.76 104.69 22.47 30.78 102.79 22.26 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 32.04 94.22 18.23 30.57 94.75 16.88 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1ctn_02 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 7 2 # 7 311 ASP A 526 ASP^? 28.45 O6 G B 2 315 GLU A 522 GLU^? 23.38 O4 U B 3 coo 31.76 104.69 22.47 30.78 102.79 22.26 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo 32.04 94.22 18.23 30.57 94.75 16.88 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1ctn_02 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 7 hits 1ctn_02 naa= 2 ULMN 2 1cz1_01 EXO-B-(1,3)-GLUCANASE user 1 2 # 1 A 192 GLU A 432 GLU~? 22.16 O4 U B 3 A 292 GLU A 436 GLU~? 23.50 O4 U B 3 coo 29.26 36.42 59.28 31.05 37.29 58.52 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 34.58 32.58 59.98 33.75 33.73 58.43 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1cz1_01 EXO-B-(1,3)-GLUCANASE user 2 2 # 2 A 192 GLU A 436 GLU~? 23.50 O4 U B 3 A 292 GLU A 432 GLU~? 22.16 O4 U B 3 coo 29.26 36.42 59.28 31.05 37.29 58.52 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 34.58 32.58 59.98 33.75 33.73 58.43 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1cz1_01 EXO-B-(1,3)-GLUCANASE user 3 2 # 3 A 192 GLU A 466 GLU~? 26.72 N2 G B 2 A 292 GLU A 470 GLU~? 22.82 N2 G B 2 coo 29.26 36.42 59.28 31.05 37.29 58.52 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 34.58 32.58 59.98 33.75 33.73 58.43 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1cz1_01 EXO-B-(1,3)-GLUCANASE user 4 2 # 4 A 192 GLU A 470 GLU~? 22.82 N2 G B 2 A 292 GLU A 466 GLU~? 26.72 N2 G B 2 coo 29.26 36.42 59.28 31.05 37.29 58.52 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 34.58 32.58 59.98 33.75 33.73 58.43 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 1cz1_01 source 1cz1 EXO-B-(1,3)-GLUCANASE : 4 hits 1cz1_01 naa= 2 ULMN 2 1czf_02 POLYGALACTURONASE II user 1 2 # 1 B 180 ASP A 488 ASP~? 18.76 O2 U B 1 B 201 ASP A 491 ASP~? 15.62 O2 U B 1 coo 56.34 26.92 42.01 57.88 28.32 41.72 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 55.85 31.42 43.00 57.45 32.12 41.78 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1czf_02 source 1czf POLYGALACTURONASE II : 1 hits 1czf_02 naa= 2 ULMN 2 1d2h_03 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 D 175 LYS A 450 LYS.? 2.98 O2' G B 2 D 242 TYR A 501 TYR~? 3.43 C5 G B 2 coo 42.47 -13.94 -26.29 40.06 -18.13 -24.28 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 coo 40.50 -10.52 -19.51 39.83 -12.81 -18.07 -4.81 -51.44 -6.29 -2.96 -50.88 -4.27 1d2h_03 source 1d2h GLYCINE N-METHYLTRANSFERASE : 1 hits 1d2h_03 naa= 2 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 1 2 # 1 A 153 ARG A 265 ARG~? 21.55 N1 A B 9 A 160 LYS A 231 LYS~? 21.79 O2 U B 8 coo 11.64 53.62 31.80 11.17 52.00 34.34 -38.98 -7.64 12.61 -41.54 -9.16 13.48 coo 5.78 61.30 21.65 8.04 62.89 17.54 -28.35 -2.55 6.15 -27.54 -2.37 -0.06 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 2 2 # 2 A 153 ARG A 288 ARG~? 3.45 C6 A B 7 A 160 LYS A 236 LYS~? 15.40 O2 U B 8 coo 11.64 53.62 31.80 11.17 52.00 34.34 -21.54 -21.02 8.30 -20.02 -23.61 8.96 coo 5.78 61.30 21.65 8.04 62.89 17.54 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 3 2 # 3 A 153 ARG A 517 ARG.? 17.55 O4 U B 1 A 160 LYS A 521 LYS^? 31.39 O6 G B 2 coo 11.64 53.62 31.80 11.17 52.00 34.34 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 coo 5.78 61.30 21.65 8.04 62.89 17.54 -27.98 -64.66 -13.31 -32.01 -68.20 -11.05 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 4 2 # 4 A 153 ARG A 518 ARG.? 16.31 O6 G B 2 A 160 LYS A 536 LYS~? 26.44 O4 U B 1 coo 11.64 53.62 31.80 11.17 52.00 34.34 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 5.78 61.30 21.65 8.04 62.89 17.54 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 5 2 # 5 A 153 ARG A 541 ARG~? 18.28 O4 U B 1 A 160 LYS A 556 LYS~? 9.38 OP2 U B 1 coo 11.64 53.62 31.80 11.17 52.00 34.34 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 coo 5.78 61.30 21.65 8.04 62.89 17.54 0.47 -62.65 -2.47 5.80 -61.35 0.58 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 6 2 # 6 A 153 ARG A 541 ARG~? 18.28 O4 U B 1 A 160 LYS A 557 LYS~? 2.76 O4 U B 1 coo 11.64 53.62 31.80 11.17 52.00 34.34 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 coo 5.78 61.30 21.65 8.04 62.89 17.54 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 7 2 # 7 A 153 ARG A 546 ARG~? 20.83 O4 U B 1 A 160 LYS A 536 LYS~? 26.44 O4 U B 1 coo 11.64 53.62 31.80 11.17 52.00 34.34 3.56 -71.20 -7.93 4.10 -73.33 -10.06 coo 5.78 61.30 21.65 8.04 62.89 17.54 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 8 2 # 8 A 153 ARG A 546 ARG~? 20.83 O4 U B 1 A 160 LYS A 557 LYS~? 2.76 O4 U B 1 coo 11.64 53.62 31.80 11.17 52.00 34.34 3.56 -71.20 -7.93 4.10 -73.33 -10.06 coo 5.78 61.30 21.65 8.04 62.89 17.54 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 9 2 # 9 A 153 ARG A 551 ARG.? 14.22 O4' U B 1 A 160 LYS A 544 LYS~? 22.64 O4 U B 1 coo 11.64 53.62 31.80 11.17 52.00 34.34 10.35 -61.35 -7.37 12.18 -59.05 -8.34 coo 5.78 61.30 21.65 8.04 62.89 17.54 2.51 -69.72 -14.20 -0.06 -70.01 -19.70 ULMN 2 1db3_02 GDP-MANNOSE 4,6-DEHYDRATASE user 10 2 # 10 A 153 ARG A 566 ARG~? 21.74 O4 U B 1 A 160 LYS A 537 LYS~? 23.79 O4 U B 1 coo 11.64 53.62 31.80 11.17 52.00 34.34 -7.26 -74.81 -5.17 -4.76 -76.37 -4.31 coo 5.78 61.30 21.65 8.04 62.89 17.54 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 1db3_02 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 10 hits 1db3_02 naa= 2 ULMN 2 1db3_03 GDP-MANNOSE 4,6-DEHYDRATASE user 1 2 # 1 A 156 TYR A 361 TYR~? 4.83 OP1 U B 6 A 160 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 11.64 63.07 23.95 11.76 62.47 21.20 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 5.78 61.30 21.65 8.04 62.89 17.54 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1db3_03 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 1 hits 1db3_03 naa= 2 ULMN 2 1dci_00 DIENOYL-COA ISOMERASE user 1 2 # 1 A 196 GLU A 187 GLU~? 20.71 C2 A B 9 A 204 ASP A 190 ASP~? 22.39 C2 A B 9 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo 91.55 34.15 2.80 89.93 32.93 2.11 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1dci_00 DIENOYL-COA ISOMERASE user 2 2 # 2 A 196 GLU A 341 GLU~? 25.67 N6 A B 7 A 204 ASP A 345 ASP~? 24.06 C2 A B 4 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 91.55 34.15 2.80 89.93 32.93 2.11 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 ULMN 2 1dci_00 DIENOYL-COA ISOMERASE user 3 2 # 3 A 196 GLU A 371 GLU~? 9.29 O2 C B 5 A 204 ASP A 376 ASP~? 17.17 N1 A B 4 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 91.55 34.15 2.80 89.93 32.93 2.11 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1dci_00 DIENOYL-COA ISOMERASE user 4 2 # 4 A 196 GLU A 470 GLU~? 22.82 N2 G B 2 A 204 ASP A 473 ASP~? 22.60 N2 G B 2 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 91.55 34.15 2.80 89.93 32.93 2.11 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1dci_00 source 1dci DIENOYL-COA ISOMERASE : 4 hits 1dci_00 naa= 2 ULMN 2 1dci_01 DIENOYL-COA ISOMERASE user 1 2 # 1 B 196 GLU A 187 GLU~? 20.71 C2 A B 9 B 204 ASP A 190 ASP~? 22.39 C2 A B 9 coo 117.17 62.16 2.87 115.86 61.14 1.55 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo 114.89 59.78 9.34 114.72 61.90 9.19 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1dci_01 DIENOYL-COA ISOMERASE user 2 2 # 2 B 196 GLU A 371 GLU~? 9.29 O2 C B 5 B 204 ASP A 376 ASP~? 17.17 N1 A B 4 coo 117.17 62.16 2.87 115.86 61.14 1.55 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 114.89 59.78 9.34 114.72 61.90 9.19 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1dci_01 DIENOYL-COA ISOMERASE user 3 2 # 3 B 196 GLU A 470 GLU~? 22.82 N2 G B 2 B 204 ASP A 473 ASP~? 22.60 N2 G B 2 coo 117.17 62.16 2.87 115.86 61.14 1.55 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 114.89 59.78 9.34 114.72 61.90 9.19 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1dci_01 source 1dci DIENOYL-COA ISOMERASE : 3 hits 1dci_01 naa= 2 ULMN 2 1dci_02 DIENOYL-COA ISOMERASE user 1 2 # 1 C 196 GLU A 187 GLU~? 20.71 C2 A B 9 C 204 ASP A 190 ASP~? 22.39 C2 A B 9 coo 127.57 24.91 0.86 127.56 26.90 0.05 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo 125.57 26.17 7.79 127.49 25.34 7.72 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1dci_02 DIENOYL-COA ISOMERASE user 2 2 # 2 C 196 GLU A 371 GLU~? 9.29 O2 C B 5 C 204 ASP A 376 ASP~? 17.17 N1 A B 4 coo 127.57 24.91 0.86 127.56 26.90 0.05 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 125.57 26.17 7.79 127.49 25.34 7.72 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1dci_02 DIENOYL-COA ISOMERASE user 3 2 # 3 C 196 GLU A 470 GLU~? 22.82 N2 G B 2 C 204 ASP A 473 ASP~? 22.60 N2 G B 2 coo 127.57 24.91 0.86 127.56 26.90 0.05 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 125.57 26.17 7.79 127.49 25.34 7.72 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1dci_02 source 1dci DIENOYL-COA ISOMERASE : 3 hits 1dci_02 naa= 2 ULMN 2 1dci_03 DIENOYL-COA ISOMERASE user 1 2 # 1 A 176 ASP A 174 ASP.? 19.36 O2' A B 9 A 196 GLU A 178 GLU.? 16.07 O2' A B 9 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1dci_03 DIENOYL-COA ISOMERASE user 2 2 # 2 A 176 ASP A 345 ASP~? 24.06 C2 A B 4 A 196 GLU A 341 GLU~? 25.67 N6 A B 7 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dci_03 DIENOYL-COA ISOMERASE user 3 2 # 3 A 176 ASP A 491 ASP~? 15.62 O2 U B 1 A 196 GLU A 545 GLU~? 17.12 N3 U B 1 coo 96.44 30.26 -3.26 95.11 31.92 -3.28 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 90.70 34.85 -4.41 92.58 34.16 -5.05 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1dci_03 source 1dci DIENOYL-COA ISOMERASE : 3 hits 1dci_03 naa= 2 ULMN 2 1dci_04 DIENOYL-COA ISOMERASE user 1 2 # 1 B 176 ASP A 174 ASP.? 19.36 O2' A B 9 B 196 GLU A 178 GLU.? 16.07 O2' A B 9 coo 110.25 59.26 2.17 112.32 59.63 2.53 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 117.17 62.16 2.87 115.86 61.14 1.55 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1dci_04 DIENOYL-COA ISOMERASE user 2 2 # 2 B 176 ASP A 345 ASP~? 24.06 C2 A B 4 B 196 GLU A 341 GLU~? 25.67 N6 A B 7 coo 110.25 59.26 2.17 112.32 59.63 2.53 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 117.17 62.16 2.87 115.86 61.14 1.55 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dci_04 DIENOYL-COA ISOMERASE user 3 2 # 3 B 176 ASP A 491 ASP~? 15.62 O2 U B 1 B 196 GLU A 545 GLU~? 17.12 N3 U B 1 coo 110.25 59.26 2.17 112.32 59.63 2.53 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 117.17 62.16 2.87 115.86 61.14 1.55 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1dci_04 source 1dci DIENOYL-COA ISOMERASE : 3 hits 1dci_04 naa= 2 ULMN 2 1dci_05 DIENOYL-COA ISOMERASE user 1 2 # 1 C 176 ASP A 174 ASP.? 19.36 O2' A B 9 C 196 GLU A 178 GLU.? 16.07 O2' A B 9 coo 128.37 32.38 2.45 127.70 30.37 2.17 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 127.57 24.91 0.86 127.56 26.90 0.05 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1dci_05 DIENOYL-COA ISOMERASE user 2 2 # 2 C 176 ASP A 345 ASP~? 24.06 C2 A B 4 C 196 GLU A 341 GLU~? 25.67 N6 A B 7 coo 128.37 32.38 2.45 127.70 30.37 2.17 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 127.57 24.91 0.86 127.56 26.90 0.05 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dci_05 DIENOYL-COA ISOMERASE user 3 2 # 3 C 176 ASP A 491 ASP~? 15.62 O2 U B 1 C 196 GLU A 545 GLU~? 17.12 N3 U B 1 coo 128.37 32.38 2.45 127.70 30.37 2.17 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 127.57 24.91 0.86 127.56 26.90 0.05 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1dci_05 source 1dci DIENOYL-COA ISOMERASE : 3 hits 1dci_05 naa= 2 ULMN 2 1dek_00 DEOXYNUCLEOSIDE MONOPHOSPHATE KINASEuser 1 2 # 1 A 68 ARG A 314 ARG~? 20.43 C2 A B 7 A 206 HIS A 352 HIS~? 21.18 O2' A B 4 coo 43.62 6.34 2.39 44.53 4.47 4.58 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 coo 54.10 -0.86 -3.09 55.51 0.68 -2.87 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 ULMN 2 1dek_00 DEOXYNUCLEOSIDE MONOPHOSPHATE KINASEuser 2 2 # 2 A 68 ARG A 390 ARG~? 22.44 N1 A B 4 A 206 HIS A 420 HIS~? 9.42 N1 A B 4 coo 43.62 6.34 2.39 44.53 4.47 4.58 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo 54.10 -0.86 -3.09 55.51 0.68 -2.87 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1dek_00 DEOXYNUCLEOSIDE MONOPHOSPHATE KINASEuser 3 2 # 3 A 68 ARG A 396 ARG~? 24.93 C2 A B 4 A 206 HIS A 352 HIS~? 21.18 O2' A B 4 coo 43.62 6.34 2.39 44.53 4.47 4.58 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo 54.10 -0.86 -3.09 55.51 0.68 -2.87 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 ULMN 2 1dek_00 DEOXYNUCLEOSIDE MONOPHOSPHATE KINASEuser 4 2 # 4 A 68 ARG A 431 ARG~? 16.75 O4 U B 3 A 206 HIS A 527 HIS~? 25.85 N2 G B 2 coo 43.62 6.34 2.39 44.53 4.47 4.58 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 54.10 -0.86 -3.09 55.51 0.68 -2.87 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 1dek_00 source 1dek DEOXYNUCLEOSIDE MONOPHOSPHATE KINASE : 4 hits 1dek_00 naa= 2 ULMN 2 1dfo_08 SERINE HYDROXYMETHYLTRANSFERASE user 1 2 # 1 A 203 HIS A 496 HIS.? 9.17 O2 U B 1 A 234 PRO A 483 PRO.? 22.54 O2 U B 1 coo 6.89 92.05 42.22 8.64 90.94 42.56 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 12.67 104.20 50.99 13.64 103.14 49.30 5.73 -56.34 -26.78 5.23 -54.25 -26.18 1dfo_08 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_08 naa= 2 ULMN 2 1dfo_09 SERINE HYDROXYMETHYLTRANSFERASE user 1 2 # 1 B 203 HIS A 496 HIS.? 9.17 O2 U B 1 B 234 PRO A 483 PRO.? 22.54 O2 U B 1 coo 19.31 99.02 77.11 17.71 100.31 76.67 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 24.28 99.99 61.88 23.82 101.66 63.27 5.73 -56.34 -26.78 5.23 -54.25 -26.18 1dfo_09 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_09 naa= 2 ULMN 2 1dfo_10 SERINE HYDROXYMETHYLTRANSFERASE user 1 2 # 1 C 203 HIS A 496 HIS.? 9.17 O2 U B 1 C 234 PRO A 483 PRO.? 22.54 O2 U B 1 coo 28.39 51.38 77.52 28.92 52.50 75.82 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 23.65 39.23 68.10 25.58 40.32 68.07 5.73 -56.34 -26.78 5.23 -54.25 -26.18 1dfo_10 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_10 naa= 2 ULMN 2 1dfo_11 SERINE HYDROXYMETHYLTRANSFERASE user 1 2 # 1 D 203 HIS A 496 HIS.? 9.17 O2 U B 1 D 234 PRO A 483 PRO.? 22.54 O2 U B 1 coo 3.73 44.27 49.83 3.38 42.95 51.43 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 19.52 43.51 52.76 18.11 41.83 52.49 5.73 -56.34 -26.78 5.23 -54.25 -26.18 1dfo_11 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 1 hits 1dfo_11 naa= 2 ULMN 2 1dhf_00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 1 2 # 1 A 22 LEU A 373 LEU~? 18.02 C2 A B 4 A 30 GLU A 341 GLU~? 25.67 N6 A B 7 coo 30.17 24.15 15.83 30.23 26.01 16.90 -30.88 -34.35 -10.59 -31.00 -32.31 -11.32 coo 32.29 33.65 17.58 30.85 33.19 19.08 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dhf_00 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 2 2 # 2 A 22 LEU A 373 LEU~? 18.02 C2 A B 4 A 30 GLU A 391 GLU~? 23.54 N1 A B 4 coo 30.17 24.15 15.83 30.23 26.01 16.90 -30.88 -34.35 -10.59 -31.00 -32.31 -11.32 coo 32.29 33.65 17.58 30.85 33.19 19.08 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 1dhf_00 source 1dhf DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) ( DHFR ): 2 hits 1dhf_00 naa= 2 ULMN 2 1dhf_01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 1 2 # 1 B 22 LEU A 353 LEU~? 16.08 C2 A B 4 B 30 GLU A 407 GLU~? 15.45 O2 U B 3 coo 3.16 26.59 72.60 5.24 26.56 72.94 -18.98 -28.80 -16.91 -19.62 -30.83 -16.41 coo 10.81 21.08 75.40 10.64 21.05 73.28 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1dhf_01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 2 2 # 2 B 22 LEU A 373 LEU~? 18.02 C2 A B 4 B 30 GLU A 341 GLU~? 25.67 N6 A B 7 coo 3.16 26.59 72.60 5.24 26.56 72.94 -30.88 -34.35 -10.59 -31.00 -32.31 -11.32 coo 10.81 21.08 75.40 10.64 21.05 73.28 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dhf_01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 3 2 # 3 B 22 LEU A 373 LEU~? 18.02 C2 A B 4 B 30 GLU A 391 GLU~? 23.54 N1 A B 4 coo 3.16 26.59 72.60 5.24 26.56 72.94 -30.88 -34.35 -10.59 -31.00 -32.31 -11.32 coo 10.81 21.08 75.40 10.64 21.05 73.28 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1dhf_01 DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3user 4 2 # 4 B 22 LEU A 427 LEU~? 15.44 N1 A B 4 B 30 GLU A 371 GLU~? 9.29 O2 C B 5 coo 3.16 26.59 72.60 5.24 26.56 72.94 -27.01 -43.01 -12.14 -27.37 -41.02 -11.26 coo 10.81 21.08 75.40 10.64 21.05 73.28 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 1dhf_01 source 1dhf DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) ( DHFR ): 4 hits 1dhf_01 naa= 2 ULMN 2 1dhr_01 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 2 # 1 143 MET A 277 MET~? 13.70 N1 A B 7 150 LYS A 270 LYS~? 23.81 O4 U B 8 coo 37.65 50.92 20.81 37.17 52.95 24.29 -25.60 -11.62 -2.44 -27.60 -14.18 -1.91 coo 27.04 52.42 22.30 26.88 49.99 27.00 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 ULMN 2 1dhr_01 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 2 # 2 143 MET A 494 MET~? 11.93 O4 U B 1 150 LYS A 487 LYS.? 20.83 N3 U B 1 coo 37.65 50.92 20.81 37.17 52.95 24.29 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 coo 27.04 52.42 22.30 26.88 49.99 27.00 3.85 -58.89 -22.81 2.77 -64.79 -20.79 ULMN 2 1dhr_01 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 2 # 3 143 MET A 506 MET~? 12.19 N2 G B 2 150 LYS A 537 LYS~? 23.79 O4 U B 1 coo 37.65 50.92 20.81 37.17 52.95 24.29 -11.31 -58.69 -11.53 -9.09 -57.54 -14.90 coo 27.04 52.42 22.30 26.88 49.99 27.00 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 1dhr_01 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 3 hits 1dhr_01 naa= 2 ULMN 2 1dhr_02 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 2 # 1 146 TYR A 361 TYR~? 4.83 OP1 U B 6 150 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 32.88 50.55 24.33 31.89 51.78 26.65 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 27.04 52.42 22.30 26.88 49.99 27.00 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1dhr_02 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 1 hits 1dhr_02 naa= 2 ULMN 2 1dki_00 PYROGENIC EXOTOXIN B ZYMOGEN user 1 2 # 1 A 47 SER A 423 SER~? 9.25 O4 U B 3 A 195 HIS A 420 HIS~? 9.42 N1 A B 4 coo 12.79 51.33 47.24 11.27 51.71 49.09 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 coo 6.89 53.17 51.84 5.28 52.04 51.10 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1dki_00 PYROGENIC EXOTOXIN B ZYMOGEN user 2 2 # 2 A 47 SER A 530 SER~? 25.46 N2 G B 2 A 195 HIS A 527 HIS~? 25.85 N2 G B 2 coo 12.79 51.33 47.24 11.27 51.71 49.09 -18.33 -66.93 -18.45 -19.81 -66.03 -20.11 coo 6.89 53.17 51.84 5.28 52.04 51.10 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 ULMN 2 1dki_00 PYROGENIC EXOTOXIN B ZYMOGEN user 3 2 # 3 A 47 SER A 550 SER~? 14.27 O4 U B 1 A 195 HIS A 547 HIS~? 18.58 O4 U B 1 coo 12.79 51.33 47.24 11.27 51.71 49.09 4.96 -63.97 -4.54 6.61 -65.75 -4.82 coo 6.89 53.17 51.84 5.28 52.04 51.10 8.28 -67.57 -10.72 8.13 -67.19 -12.78 1dki_00 source 1dki PYROGENIC EXOTOXIN B ZYMOGEN : 3 hits 1dki_00 naa= 2 ULMN 2 1dki_01 PYROGENIC EXOTOXIN B ZYMOGEN user 1 2 # 1 B 47 SER A 423 SER~? 9.25 O4 U B 3 B 195 HIS A 420 HIS~? 9.42 N1 A B 4 coo 16.23 58.54 15.32 17.91 59.41 13.76 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 coo 22.52 60.88 11.88 23.73 59.16 11.84 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1dki_01 PYROGENIC EXOTOXIN B ZYMOGEN user 2 2 # 2 B 47 SER A 530 SER~? 25.46 N2 G B 2 B 195 HIS A 527 HIS~? 25.85 N2 G B 2 coo 16.23 58.54 15.32 17.91 59.41 13.76 -18.33 -66.93 -18.45 -19.81 -66.03 -20.11 coo 22.52 60.88 11.88 23.73 59.16 11.84 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 1dki_01 source 1dki PYROGENIC EXOTOXIN B ZYMOGEN : 2 hits 1dki_01 naa= 2 ULMN 2 1dki_02 PYROGENIC EXOTOXIN B ZYMOGEN user 1 2 # 1 C 47 SER A 423 SER~? 9.25 O4 U B 3 C 195 HIS A 420 HIS~? 9.42 N1 A B 4 coo 15.03 7.88 55.93 16.55 7.09 57.68 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 coo 20.94 5.82 60.35 22.10 7.55 60.60 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1dki_02 PYROGENIC EXOTOXIN B ZYMOGEN user 2 2 # 2 C 47 SER A 530 SER~? 25.46 N2 G B 2 C 195 HIS A 527 HIS~? 25.85 N2 G B 2 coo 15.03 7.88 55.93 16.55 7.09 57.68 -18.33 -66.93 -18.45 -19.81 -66.03 -20.11 coo 20.94 5.82 60.35 22.10 7.55 60.60 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 ULMN 2 1dki_02 PYROGENIC EXOTOXIN B ZYMOGEN user 3 2 # 3 C 47 SER A 550 SER~? 14.27 O4 U B 1 C 195 HIS A 547 HIS~? 18.58 O4 U B 1 coo 15.03 7.88 55.93 16.55 7.09 57.68 4.96 -63.97 -4.54 6.61 -65.75 -4.82 coo 20.94 5.82 60.35 22.10 7.55 60.60 8.28 -67.57 -10.72 8.13 -67.19 -12.78 1dki_02 source 1dki PYROGENIC EXOTOXIN B ZYMOGEN : 3 hits 1dki_02 naa= 2 ULMN 2 1dki_03 PYROGENIC EXOTOXIN B ZYMOGEN user 1 2 # 1 D 47 SER A 423 SER~? 9.25 O4 U B 3 D 195 HIS A 420 HIS~? 9.42 N1 A B 4 coo 16.46 15.02 24.07 15.39 14.45 21.96 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 coo 11.72 12.50 18.71 9.94 13.57 19.04 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1dki_03 PYROGENIC EXOTOXIN B ZYMOGEN user 2 2 # 2 D 47 SER A 530 SER~? 25.46 N2 G B 2 D 195 HIS A 527 HIS~? 25.85 N2 G B 2 coo 16.46 15.02 24.07 15.39 14.45 21.96 -18.33 -66.93 -18.45 -19.81 -66.03 -20.11 coo 11.72 12.50 18.71 9.94 13.57 19.04 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 1dki_03 source 1dki PYROGENIC EXOTOXIN B ZYMOGEN : 2 hits 1dki_03 naa= 2 ULMN 2 1do6_00 SUPEROXIDE REDUCTASE user 1 2 # 1 A 14 GLU A 267 GLU~? 24.62 O4 U B 8 A 15 LYS A 268 LYS~? 23.13 O4 U B 8 coo 15.56 66.39 46.83 16.55 67.03 48.58 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 coo 13.82 63.46 43.85 10.37 63.35 40.79 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 1do6_00 SUPEROXIDE REDUCTASE user 2 2 # 2 A 14 GLU A 341 GLU~? 25.67 N6 A B 7 A 15 LYS A 338 LYS~? 26.90 N6 A B 7 coo 15.56 66.39 46.83 16.55 67.03 48.58 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 13.82 63.46 43.85 10.37 63.35 40.79 -37.84 -25.02 -10.54 -41.92 -21.39 -11.77 ULMN 2 1do6_00 SUPEROXIDE REDUCTASE user 3 2 # 3 A 14 GLU A 371 GLU~? 9.29 O2 C B 5 A 15 LYS A 372 LYS~? 15.54 N6 A B 7 coo 15.56 66.39 46.83 16.55 67.03 48.58 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 13.82 63.46 43.85 10.37 63.35 40.79 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 ULMN 2 1do6_00 SUPEROXIDE REDUCTASE user 4 2 # 4 A 14 GLU A 560 GLU~? 13.58 O4 U B 1 A 15 LYS A 557 LYS~? 2.76 O4 U B 1 coo 15.56 66.39 46.83 16.55 67.03 48.58 -4.75 -65.37 1.07 -4.31 -67.34 1.74 coo 13.82 63.46 43.85 10.37 63.35 40.79 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 1do6_00 source 1do6 SUPEROXIDE REDUCTASE : 4 hits 1do6_00 naa= 2 ULMN 2 1do6_01 SUPEROXIDE REDUCTASE user 1 2 # 1 B 14 GLU A 208 GLU~? 4.03 N1 A B 9 B 15 LYS A 209 LYS~? 11.26 C2 A B 9 coo 3.80 36.92 67.05 5.24 35.66 66.06 -24.90 -17.89 21.91 -24.90 -19.66 23.08 coo 8.60 35.79 69.51 9.86 31.93 65.43 -27.43 -16.88 26.23 -24.36 -18.13 30.86 1do6_01 source 1do6 SUPEROXIDE REDUCTASE : 1 hits 1do6_01 naa= 2 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 1 2 # 1 A 291 HIS A 326 HIS~? 3.28 C5 A B 7 B 76 GLU A 449 GLU.? 11.55 O2 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 77.60 2.15 30.40 76.57 1.77 32.21 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 2 2 # 2 A 291 HIS A 352 HIS~? 21.18 O2' A B 4 B 76 GLU A 432 GLU~? 22.16 O4 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 coo 77.60 2.15 30.40 76.57 1.77 32.21 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 3 2 # 3 A 291 HIS A 462 HIS~? 12.61 O4 U B 3 B 76 GLU A 341 GLU~? 25.67 N6 A B 7 coo 72.33 2.23 1.35 73.00 2.99 3.18 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 77.60 2.15 30.40 76.57 1.77 32.21 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 4 2 # 4 A 291 HIS A 462 HIS~? 12.61 O4 U B 3 B 76 GLU A 545 GLU~? 17.12 N3 U B 1 coo 72.33 2.23 1.35 73.00 2.99 3.18 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 77.60 2.15 30.40 76.57 1.77 32.21 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 5 2 # 5 A 291 HIS A 482 HIS.? 27.32 N2 G B 2 B 76 GLU A 407 GLU~? 15.45 O2 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 77.60 2.15 30.40 76.57 1.77 32.21 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 6 2 # 6 A 291 HIS A 482 HIS.? 27.32 N2 G B 2 B 76 GLU A 436 GLU~? 23.50 O4 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 77.60 2.15 30.40 76.57 1.77 32.21 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 7 2 # 7 A 291 HIS A 496 HIS.? 9.17 O2 U B 1 B 76 GLU A 466 GLU~? 26.72 N2 G B 2 coo 72.33 2.23 1.35 73.00 2.99 3.18 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 77.60 2.15 30.40 76.57 1.77 32.21 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 8 2 # 8 A 291 HIS A 527 HIS~? 25.85 N2 G B 2 B 76 GLU A 371 GLU~? 9.29 O2 C B 5 coo 72.33 2.23 1.35 73.00 2.99 3.18 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 77.60 2.15 30.40 76.57 1.77 32.21 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 9 2 # 9 A 291 HIS A 527 HIS~? 25.85 N2 G B 2 B 76 GLU A 449 GLU.? 11.55 O2 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 77.60 2.15 30.40 76.57 1.77 32.21 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1dtw_00 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 10 2 # 10 A 291 HIS A 547 HIS~? 18.58 O4 U B 1 B 76 GLU A 449 GLU.? 11.55 O2 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 8.28 -67.57 -10.72 8.13 -67.19 -12.78 coo 77.60 2.15 30.40 76.57 1.77 32.21 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 1dtw_00 source 1dtw BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE B: 10 hits 1dtw_00 naa= 2 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 1 2 # 1 A 291 HIS A 326 HIS~? 3.28 C5 A B 7 B 76 GLU A 449 GLU.? 11.55 O2 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 77.60 2.15 30.40 76.57 1.77 32.21 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 2 2 # 2 A 291 HIS A 352 HIS~? 21.18 O2' A B 4 B 76 GLU A 432 GLU~? 22.16 O4 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 coo 77.60 2.15 30.40 76.57 1.77 32.21 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 3 2 # 3 A 291 HIS A 462 HIS~? 12.61 O4 U B 3 B 76 GLU A 341 GLU~? 25.67 N6 A B 7 coo 72.33 2.23 1.35 73.00 2.99 3.18 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 77.60 2.15 30.40 76.57 1.77 32.21 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 4 2 # 4 A 291 HIS A 462 HIS~? 12.61 O4 U B 3 B 76 GLU A 545 GLU~? 17.12 N3 U B 1 coo 72.33 2.23 1.35 73.00 2.99 3.18 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 77.60 2.15 30.40 76.57 1.77 32.21 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 5 2 # 5 A 291 HIS A 482 HIS.? 27.32 N2 G B 2 B 76 GLU A 407 GLU~? 15.45 O2 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 77.60 2.15 30.40 76.57 1.77 32.21 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 6 2 # 6 A 291 HIS A 482 HIS.? 27.32 N2 G B 2 B 76 GLU A 436 GLU~? 23.50 O4 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 77.60 2.15 30.40 76.57 1.77 32.21 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 7 2 # 7 A 291 HIS A 496 HIS.? 9.17 O2 U B 1 B 76 GLU A 466 GLU~? 26.72 N2 G B 2 coo 72.33 2.23 1.35 73.00 2.99 3.18 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 77.60 2.15 30.40 76.57 1.77 32.21 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 8 2 # 8 A 291 HIS A 527 HIS~? 25.85 N2 G B 2 B 76 GLU A 371 GLU~? 9.29 O2 C B 5 coo 72.33 2.23 1.35 73.00 2.99 3.18 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 77.60 2.15 30.40 76.57 1.77 32.21 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 9 2 # 9 A 291 HIS A 527 HIS~? 25.85 N2 G B 2 B 76 GLU A 449 GLU.? 11.55 O2 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 77.60 2.15 30.40 76.57 1.77 32.21 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1dtw_01 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 10 2 # 10 A 291 HIS A 547 HIS~? 18.58 O4 U B 1 B 76 GLU A 449 GLU.? 11.55 O2 U B 3 coo 72.33 2.23 1.35 73.00 2.99 3.18 8.28 -67.57 -10.72 8.13 -67.19 -12.78 coo 77.60 2.15 30.40 76.57 1.77 32.21 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 1dtw_01 source 1dtw BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE B: 10 hits 1dtw_01 naa= 2 ULMN 2 1dtw_02 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 1 2 # 1 B 76 GLU A 432 GLU~? 22.16 O4 U B 3 B 146 HIS A 527 HIS~? 25.85 N2 G B 2 coo 77.60 2.15 30.40 76.57 1.77 32.21 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 83.37 -3.72 40.67 81.39 -4.21 40.17 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 ULMN 2 1dtw_02 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 2 2 # 2 B 76 GLU A 457 GLU~? 3.32 N1 G B 2 B 146 HIS A 496 HIS.? 9.17 O2 U B 1 coo 77.60 2.15 30.40 76.57 1.77 32.21 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 83.37 -3.72 40.67 81.39 -4.21 40.17 1.07 -50.04 -13.54 1.05 -47.95 -13.74 ULMN 2 1dtw_02 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 3 2 # 3 B 76 GLU A 470 GLU~? 22.82 N2 G B 2 B 146 HIS A 527 HIS~? 25.85 N2 G B 2 coo 77.60 2.15 30.40 76.57 1.77 32.21 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 83.37 -3.72 40.67 81.39 -4.21 40.17 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 ULMN 2 1dtw_02 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 4 2 # 4 B 76 GLU A 522 GLU^? 23.38 O4 U B 3 B 146 HIS A 462 HIS~? 12.61 O4 U B 3 coo 77.60 2.15 30.40 76.57 1.77 32.21 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 83.37 -3.72 40.67 81.39 -4.21 40.17 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1dtw_02 BRANCHED-CHAIN ALPHA-KETO ACID DEHYDuser 5 2 # 5 B 76 GLU A 560 GLU~? 13.58 O4 U B 1 B 146 HIS A 539 HIS~? 18.96 O4 U B 1 coo 77.60 2.15 30.40 76.57 1.77 32.21 -4.75 -65.37 1.07 -4.31 -67.34 1.74 coo 83.37 -3.72 40.67 81.39 -4.21 40.17 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 1dtw_02 source 1dtw BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE B: 5 hits 1dtw_02 naa= 2 ULMN 2 1dub_06 2-ENOYL-COA HYDRATASE user 1 2 # 1 A 164 GLU A 178 GLU.? 16.07 O2' A B 9 A 172 GLY A 177 GLY.? 19.15 O2' A B 9 coo 65.46 104.88 175.81 64.47 105.72 174.12 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 65.25 99.24 172.80 64.76 99.68 172.43 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1dub_06 2-ENOYL-COA HYDRATASE user 2 2 # 2 A 164 GLU A 225 GLU~? 23.05 C2 A B 9 A 172 GLY A 229 GLY~? 19.93 O4 U B 8 coo 65.46 104.88 175.81 64.47 105.72 174.12 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 65.25 99.24 172.80 64.76 99.68 172.43 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1dub_06 2-ENOYL-COA HYDRATASE user 3 2 # 3 A 164 GLU A 457 GLU~? 3.32 N1 G B 2 A 172 GLY A 499 GLY~? 6.97 N2 G B 2 coo 65.46 104.88 175.81 64.47 105.72 174.12 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 65.25 99.24 172.80 64.76 99.68 172.43 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 ULMN 2 1dub_06 2-ENOYL-COA HYDRATASE user 4 2 # 4 A 164 GLU A 522 GLU^? 23.38 O4 U B 3 A 172 GLY A 523 GLY.? 29.31 O4 U B 3 coo 65.46 104.88 175.81 64.47 105.72 174.12 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 65.25 99.24 172.80 64.76 99.68 172.43 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1dub_06 source 1dub 2-ENOYL-COA HYDRATASE : 4 hits 1dub_06 naa= 2 ULMN 2 1dub_07 2-ENOYL-COA HYDRATASE user 1 2 # 1 B 164 GLU A 178 GLU.? 16.07 O2' A B 9 B 172 GLY A 177 GLY.? 19.15 O2' A B 9 coo 88.14 113.46 145.73 86.79 113.92 147.30 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 88.37 107.75 148.54 88.01 108.21 149.05 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1dub_07 2-ENOYL-COA HYDRATASE user 2 2 # 2 B 164 GLU A 225 GLU~? 23.05 C2 A B 9 B 172 GLY A 229 GLY~? 19.93 O4 U B 8 coo 88.14 113.46 145.73 86.79 113.92 147.30 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 88.37 107.75 148.54 88.01 108.21 149.05 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1dub_07 2-ENOYL-COA HYDRATASE user 3 2 # 3 B 164 GLU A 522 GLU^? 23.38 O4 U B 3 B 172 GLY A 523 GLY.? 29.31 O4 U B 3 coo 88.14 113.46 145.73 86.79 113.92 147.30 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 88.37 107.75 148.54 88.01 108.21 149.05 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1dub_07 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_07 naa= 2 ULMN 2 1dub_08 2-ENOYL-COA HYDRATASE user 1 2 # 1 C 164 GLU A 178 GLU.? 16.07 O2' A B 9 C 172 GLY A 177 GLY.? 19.15 O2' A B 9 coo 51.71 102.03 140.09 53.02 103.62 140.54 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 56.53 97.84 139.65 56.86 98.55 139.57 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1dub_08 2-ENOYL-COA HYDRATASE user 2 2 # 2 C 164 GLU A 225 GLU~? 23.05 C2 A B 9 C 172 GLY A 229 GLY~? 19.93 O4 U B 8 coo 51.71 102.03 140.09 53.02 103.62 140.54 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 56.53 97.84 139.65 56.86 98.55 139.57 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1dub_08 2-ENOYL-COA HYDRATASE user 3 2 # 3 C 164 GLU A 457 GLU~? 3.32 N1 G B 2 C 172 GLY A 499 GLY~? 6.97 N2 G B 2 coo 51.71 102.03 140.09 53.02 103.62 140.54 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 56.53 97.84 139.65 56.86 98.55 139.57 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 ULMN 2 1dub_08 2-ENOYL-COA HYDRATASE user 4 2 # 4 C 164 GLU A 522 GLU^? 23.38 O4 U B 3 C 172 GLY A 523 GLY.? 29.31 O4 U B 3 coo 51.71 102.03 140.09 53.02 103.62 140.54 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 56.53 97.84 139.65 56.86 98.55 139.57 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1dub_08 source 1dub 2-ENOYL-COA HYDRATASE : 4 hits 1dub_08 naa= 2 ULMN 2 1dub_09 2-ENOYL-COA HYDRATASE user 1 2 # 1 D 164 GLU A 178 GLU.? 16.07 O2' A B 9 D 172 GLY A 177 GLY.? 19.15 O2' A B 9 coo 91.47 83.05 136.24 90.35 81.38 136.84 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 86.64 87.31 136.66 86.30 86.60 136.64 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1dub_09 2-ENOYL-COA HYDRATASE user 2 2 # 2 D 164 GLU A 225 GLU~? 23.05 C2 A B 9 D 172 GLY A 229 GLY~? 19.93 O4 U B 8 coo 91.47 83.05 136.24 90.35 81.38 136.84 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 86.64 87.31 136.66 86.30 86.60 136.64 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1dub_09 2-ENOYL-COA HYDRATASE user 3 2 # 3 D 164 GLU A 457 GLU~? 3.32 N1 G B 2 D 172 GLY A 499 GLY~? 6.97 N2 G B 2 coo 91.47 83.05 136.24 90.35 81.38 136.84 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 86.64 87.31 136.66 86.30 86.60 136.64 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 ULMN 2 1dub_09 2-ENOYL-COA HYDRATASE user 4 2 # 4 D 164 GLU A 474 GLU~? 16.68 N2 G B 2 D 172 GLY A 478 GLY.? 19.78 N2 G B 2 coo 91.47 83.05 136.24 90.35 81.38 136.84 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 86.64 87.31 136.66 86.30 86.60 136.64 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1dub_09 2-ENOYL-COA HYDRATASE user 5 2 # 5 D 164 GLU A 522 GLU^? 23.38 O4 U B 3 D 172 GLY A 523 GLY.? 29.31 O4 U B 3 coo 91.47 83.05 136.24 90.35 81.38 136.84 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 86.64 87.31 136.66 86.30 86.60 136.64 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1dub_09 source 1dub 2-ENOYL-COA HYDRATASE : 5 hits 1dub_09 naa= 2 ULMN 2 1dub_10 2-ENOYL-COA HYDRATASE user 1 2 # 1 E 164 GLU A 178 GLU.? 16.07 O2' A B 9 E 172 GLY A 177 GLY.? 19.15 O2' A B 9 coo 84.40 80.02 173.80 85.08 79.06 172.03 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 84.01 85.71 170.92 84.43 85.28 170.44 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1dub_10 2-ENOYL-COA HYDRATASE user 2 2 # 2 E 164 GLU A 225 GLU~? 23.05 C2 A B 9 E 172 GLY A 229 GLY~? 19.93 O4 U B 8 coo 84.40 80.02 173.80 85.08 79.06 172.03 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 84.01 85.71 170.92 84.43 85.28 170.44 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1dub_10 2-ENOYL-COA HYDRATASE user 3 2 # 3 E 164 GLU A 457 GLU~? 3.32 N1 G B 2 E 172 GLY A 499 GLY~? 6.97 N2 G B 2 coo 84.40 80.02 173.80 85.08 79.06 172.03 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 84.01 85.71 170.92 84.43 85.28 170.44 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 ULMN 2 1dub_10 2-ENOYL-COA HYDRATASE user 4 2 # 4 E 164 GLU A 522 GLU^? 23.38 O4 U B 3 E 172 GLY A 523 GLY.? 29.31 O4 U B 3 coo 84.40 80.02 173.80 85.08 79.06 172.03 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 84.01 85.71 170.92 84.43 85.28 170.44 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1dub_10 source 1dub 2-ENOYL-COA HYDRATASE : 4 hits 1dub_10 naa= 2 ULMN 2 1dub_11 2-ENOYL-COA HYDRATASE user 1 2 # 1 F 164 GLU A 178 GLU.? 16.07 O2' A B 9 F 172 GLY A 177 GLY.? 19.15 O2' A B 9 coo 56.75 71.71 148.46 58.44 71.01 149.54 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 57.02 77.49 151.32 57.42 77.01 151.76 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1dub_11 2-ENOYL-COA HYDRATASE user 2 2 # 2 F 164 GLU A 225 GLU~? 23.05 C2 A B 9 F 172 GLY A 229 GLY~? 19.93 O4 U B 8 coo 56.75 71.71 148.46 58.44 71.01 149.54 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 57.02 77.49 151.32 57.42 77.01 151.76 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1dub_11 2-ENOYL-COA HYDRATASE user 3 2 # 3 F 164 GLU A 457 GLU~? 3.32 N1 G B 2 F 172 GLY A 499 GLY~? 6.97 N2 G B 2 coo 56.75 71.71 148.46 58.44 71.01 149.54 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 57.02 77.49 151.32 57.42 77.01 151.76 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 ULMN 2 1dub_11 2-ENOYL-COA HYDRATASE user 4 2 # 4 F 164 GLU A 522 GLU^? 23.38 O4 U B 3 F 172 GLY A 523 GLY.? 29.31 O4 U B 3 coo 56.75 71.71 148.46 58.44 71.01 149.54 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 57.02 77.49 151.32 57.42 77.01 151.76 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1dub_11 source 1dub 2-ENOYL-COA HYDRATASE : 4 hits 1dub_11 naa= 2 ULMN 2 1dub_12 2-ENOYL-COA HYDRATASE user 1 2 # 1 A 144 GLU A 432 GLU~? 22.16 O4 U B 3 A 164 GLU A 436 GLU~? 23.50 O4 U B 3 coo 61.78 103.61 169.93 62.63 102.26 171.29 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 65.46 104.88 175.81 64.47 105.72 174.12 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1dub_12 2-ENOYL-COA HYDRATASE user 2 2 # 2 A 144 GLU A 436 GLU~? 23.50 O4 U B 3 A 164 GLU A 432 GLU~? 22.16 O4 U B 3 coo 61.78 103.61 169.93 62.63 102.26 171.29 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 65.46 104.88 175.81 64.47 105.72 174.12 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1dub_12 2-ENOYL-COA HYDRATASE user 3 2 # 3 A 144 GLU A 466 GLU~? 26.72 N2 G B 2 A 164 GLU A 470 GLU~? 22.82 N2 G B 2 coo 61.78 103.61 169.93 62.63 102.26 171.29 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 65.46 104.88 175.81 64.47 105.72 174.12 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1dub_12 2-ENOYL-COA HYDRATASE user 4 2 # 4 A 144 GLU A 470 GLU~? 22.82 N2 G B 2 A 164 GLU A 466 GLU~? 26.72 N2 G B 2 coo 61.78 103.61 169.93 62.63 102.26 171.29 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 65.46 104.88 175.81 64.47 105.72 174.12 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 1dub_12 source 1dub 2-ENOYL-COA HYDRATASE : 4 hits 1dub_12 naa= 2 ULMN 2 1dup_00 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 1 2 # 1 A 90 ASP A 232 ASP~? 21.56 O2 U B 8 A 92 ASP A 233 ASP~? 18.81 O2 U B 8 coo -8.87 38.72 40.39 -9.52 40.07 38.79 -24.56 0.12 7.49 -25.80 1.40 6.37 coo -10.84 34.98 43.59 -11.99 36.29 42.41 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1dup_00 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 2 2 # 2 A 90 ASP A 260 ASP.? 30.95 O4 U B 8 A 92 ASP A 259 ASP.? 23.89 N1 A B 9 coo -8.87 38.72 40.39 -9.52 40.07 38.79 -48.66 -5.55 12.81 -49.71 -4.82 11.14 coo -10.84 34.98 43.59 -11.99 36.29 42.41 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1dup_00 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 3 2 # 3 A 90 ASP A 376 ASP~? 17.17 N1 A B 4 A 92 ASP A 426 ASP.? 18.90 N1 A B 4 coo -8.87 38.72 40.39 -9.52 40.07 38.79 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo -10.84 34.98 43.59 -11.99 36.29 42.41 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 ULMN 2 1dup_00 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 4 2 # 4 A 90 ASP A 425 ASP.? 18.06 O4 U B 3 A 92 ASP A 426 ASP.? 18.90 N1 A B 4 coo -8.87 38.72 40.39 -9.52 40.07 38.79 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo -10.84 34.98 43.59 -11.99 36.29 42.41 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 ULMN 2 1dup_00 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 5 2 # 5 A 90 ASP A 491 ASP~? 15.62 O2 U B 1 A 92 ASP A 488 ASP~? 18.76 O2 U B 1 coo -8.87 38.72 40.39 -9.52 40.07 38.79 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo -10.84 34.98 43.59 -11.99 36.29 42.41 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 1dup_00 source 1dup DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLA: 5 hits 1dup_00 naa= 2 ULMN 2 1dup_01 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 1 2 # 1 A 72 SER A 423 SER~? 9.25 O4 U B 3 A 76 HIS A 420 HIS~? 9.42 N1 A B 4 coo 11.50 47.01 28.96 12.65 48.90 29.65 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 coo 13.10 51.11 23.65 14.00 52.57 22.47 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1dup_01 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 2 2 # 2 A 72 SER A 530 SER~? 25.46 N2 G B 2 A 76 HIS A 527 HIS~? 25.85 N2 G B 2 coo 11.50 47.01 28.96 12.65 48.90 29.65 -18.33 -66.93 -18.45 -19.81 -66.03 -20.11 coo 13.10 51.11 23.65 14.00 52.57 22.47 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 ULMN 2 1dup_01 DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTuser 3 2 # 3 A 72 SER A 550 SER~? 14.27 O4 U B 1 A 76 HIS A 547 HIS~? 18.58 O4 U B 1 coo 11.50 47.01 28.96 12.65 48.90 29.65 4.96 -63.97 -4.54 6.61 -65.75 -4.82 coo 13.10 51.11 23.65 14.00 52.57 22.47 8.28 -67.57 -10.72 8.13 -67.19 -12.78 1dup_01 source 1dup DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLA: 3 hits 1dup_01 naa= 2 ULMN 2 1dve_01 HEME OXYGENASE-1 user 1 2 # 1 A 140 ASP A 260 ASP.? 30.95 O4 U B 8 A 144 GLY A 261 GLY~? 25.55 O4 U B 8 coo 50.80 17.38-128.07 52.55 18.37-127.41 -48.66 -5.55 12.81 -49.71 -4.82 11.14 coo 48.41 20.84-131.50 47.60 20.71-131.72 -44.19 -6.16 11.65 -44.45 -6.91 11.63 ULMN 2 1dve_01 HEME OXYGENASE-1 user 2 2 # 2 A 140 ASP A 359 ASP~? 8.63 O2' A B 4 A 144 GLY A 362 GLY~? 9.16 C4' C B 5 coo 50.80 17.38-128.07 52.55 18.37-127.41 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 48.41 20.84-131.50 47.60 20.71-131.72 -16.83 -27.47 -7.16 -16.64 -28.16 -6.72 ULMN 2 1dve_01 HEME OXYGENASE-1 user 3 2 # 3 A 140 ASP A 477 ASP~? 24.62 N2 G B 2 A 144 GLY A 478 GLY.? 19.78 N2 G B 2 coo 50.80 17.38-128.07 52.55 18.37-127.41 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 48.41 20.84-131.50 47.60 20.71-131.72 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1dve_01 HEME OXYGENASE-1 user 4 2 # 4 A 140 ASP A 488 ASP~? 18.76 O2 U B 1 A 144 GLY A 478 GLY.? 19.78 N2 G B 2 coo 50.80 17.38-128.07 52.55 18.37-127.41 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 48.41 20.84-131.50 47.60 20.71-131.72 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1dve_01 HEME OXYGENASE-1 user 5 2 # 5 A 140 ASP A 488 ASP~? 18.76 O2 U B 1 A 144 GLY A 486 GLY.? 16.78 O2 U B 1 coo 50.80 17.38-128.07 52.55 18.37-127.41 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 48.41 20.84-131.50 47.60 20.71-131.72 4.98 -56.31 -20.25 4.98 -55.96 -21.01 1dve_01 source 1dve HEME OXYGENASE-1 : 5 hits 1dve_01 naa= 2 ULMN 2 1dw9_00 CYANATE LYASE user 1 2 # 1 A 99 GLU A 187 GLU~? 20.71 C2 A B 9 F 96 ARG A 180 ARG.? 21.90 C2 A B 9 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -20.54 -3.44 35.42 -23.45 -2.48 35.38 ULMN 2 1dw9_00 CYANATE LYASE user 2 2 # 2 A 99 GLU A 341 GLU~? 25.67 N6 A B 7 F 96 ARG A 396 ARG~? 24.93 C2 A B 4 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1dw9_00 CYANATE LYASE user 3 2 # 3 A 99 GLU A 351 GLU~? 20.29 O2' A B 4 F 96 ARG A 354 ARG~? 17.55 O2' A B 4 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1dw9_00 CYANATE LYASE user 4 2 # 4 A 99 GLU A 391 GLU~? 23.54 N1 A B 4 F 96 ARG A 390 ARG~? 22.44 N1 A B 4 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 1dw9_00 CYANATE LYASE user 5 2 # 5 A 99 GLU A 407 GLU~? 15.45 O2 U B 3 F 96 ARG A 404 ARG~? 18.97 O2 U B 3 coo -18.15 16.27 32.38 -18.04 15.42 34.32 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo -16.38 12.12 38.65 -17.03 14.40 36.67 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 1dw9_00 source 1dw9 CYANATE LYASE : 5 hits 1dw9_00 naa= 2 ULMN 2 1dw9_01 CYANATE LYASE user 1 2 # 1 B 96 ARG A 180 ARG.? 21.90 C2 A B 9 G 99 GLU A 187 GLU~? 20.71 C2 A B 9 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -20.54 -3.44 35.42 -23.45 -2.48 35.38 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -28.60 -2.71 32.18 -27.08 -3.13 33.60 ULMN 2 1dw9_01 CYANATE LYASE user 2 2 # 2 B 96 ARG A 354 ARG~? 17.55 O2' A B 4 G 99 GLU A 351 GLU~? 20.29 O2' A B 4 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1dw9_01 CYANATE LYASE user 3 2 # 3 B 96 ARG A 390 ARG~? 22.44 N1 A B 4 G 99 GLU A 391 GLU~? 23.54 N1 A B 4 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1dw9_01 CYANATE LYASE user 4 2 # 4 B 96 ARG A 396 ARG~? 24.93 C2 A B 4 G 99 GLU A 341 GLU~? 25.67 N6 A B 7 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dw9_01 CYANATE LYASE user 5 2 # 5 B 96 ARG A 404 ARG~? 18.97 O2 U B 3 G 99 GLU A 407 GLU~? 15.45 O2 U B 3 coo -21.00 -10.04 38.88 -20.40 -12.38 36.91 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 coo -19.35 -14.32 32.66 -19.46 -13.42 34.59 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 1dw9_01 source 1dw9 CYANATE LYASE : 5 hits 1dw9_01 naa= 2 ULMN 2 1dw9_02 CYANATE LYASE user 1 2 # 1 B 99 GLU A 187 GLU~? 20.71 C2 A B 9 G 96 ARG A 180 ARG.? 21.90 C2 A B 9 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -20.54 -3.44 35.42 -23.45 -2.48 35.38 ULMN 2 1dw9_02 CYANATE LYASE user 2 2 # 2 B 99 GLU A 341 GLU~? 25.67 N6 A B 7 G 96 ARG A 396 ARG~? 24.93 C2 A B 4 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1dw9_02 CYANATE LYASE user 3 2 # 3 B 99 GLU A 351 GLU~? 20.29 O2' A B 4 G 96 ARG A 354 ARG~? 17.55 O2' A B 4 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1dw9_02 CYANATE LYASE user 4 2 # 4 B 99 GLU A 391 GLU~? 23.54 N1 A B 4 G 96 ARG A 390 ARG~? 22.44 N1 A B 4 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 1dw9_02 CYANATE LYASE user 5 2 # 5 B 99 GLU A 407 GLU~? 15.45 O2 U B 3 G 96 ARG A 404 ARG~? 18.97 O2 U B 3 coo -24.88 -6.19 37.18 -25.14 -8.31 37.00 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo -24.24 -13.76 35.70 -24.73 -11.01 36.97 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 1dw9_02 source 1dw9 CYANATE LYASE : 5 hits 1dw9_02 naa= 2 ULMN 2 1dw9_03 CYANATE LYASE user 1 2 # 1 C 99 GLU A 187 GLU~? 20.71 C2 A B 9 E 96 ARG A 180 ARG.? 21.90 C2 A B 9 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -20.54 -3.44 35.42 -23.45 -2.48 35.38 ULMN 2 1dw9_03 CYANATE LYASE user 2 2 # 2 C 99 GLU A 341 GLU~? 25.67 N6 A B 7 E 96 ARG A 396 ARG~? 24.93 C2 A B 4 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1dw9_03 CYANATE LYASE user 3 2 # 3 C 99 GLU A 351 GLU~? 20.29 O2' A B 4 E 96 ARG A 354 ARG~? 17.55 O2' A B 4 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1dw9_03 CYANATE LYASE user 4 2 # 4 C 99 GLU A 391 GLU~? 23.54 N1 A B 4 E 96 ARG A 390 ARG~? 22.44 N1 A B 4 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 1dw9_03 CYANATE LYASE user 5 2 # 5 C 99 GLU A 407 GLU~? 15.45 O2 U B 3 E 96 ARG A 404 ARG~? 18.97 O2 U B 3 coo -20.36 -17.29 8.77 -21.11 -18.70 10.17 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo -24.30 -21.14 14.16 -22.82 -20.30 11.65 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 1dw9_03 source 1dw9 CYANATE LYASE : 5 hits 1dw9_03 naa= 2 ULMN 2 1dw9_04 CYANATE LYASE user 1 2 # 1 D 96 ARG A 180 ARG.? 21.90 C2 A B 9 I 99 GLU A 187 GLU~? 20.71 C2 A B 9 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -20.54 -3.44 35.42 -23.45 -2.48 35.38 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -28.60 -2.71 32.18 -27.08 -3.13 33.60 ULMN 2 1dw9_04 CYANATE LYASE user 2 2 # 2 D 96 ARG A 354 ARG~? 17.55 O2' A B 4 I 99 GLU A 351 GLU~? 20.29 O2' A B 4 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1dw9_04 CYANATE LYASE user 3 2 # 3 D 96 ARG A 390 ARG~? 22.44 N1 A B 4 I 99 GLU A 391 GLU~? 23.54 N1 A B 4 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1dw9_04 CYANATE LYASE user 4 2 # 4 D 96 ARG A 396 ARG~? 24.93 C2 A B 4 I 99 GLU A 341 GLU~? 25.67 N6 A B 7 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dw9_04 CYANATE LYASE user 5 2 # 5 D 96 ARG A 404 ARG~? 18.97 O2 U B 3 I 99 GLU A 407 GLU~? 15.45 O2 U B 3 coo -13.55 23.07 13.84 -15.10 22.15 11.37 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 coo -17.67 19.16 8.58 -16.84 20.55 9.92 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 1dw9_04 source 1dw9 CYANATE LYASE : 5 hits 1dw9_04 naa= 2 ULMN 2 1dw9_05 CYANATE LYASE user 1 2 # 1 D 99 GLU A 187 GLU~? 20.71 C2 A B 9 I 96 ARG A 180 ARG.? 21.90 C2 A B 9 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -20.54 -3.44 35.42 -23.45 -2.48 35.38 ULMN 2 1dw9_05 CYANATE LYASE user 2 2 # 2 D 99 GLU A 341 GLU~? 25.67 N6 A B 7 I 96 ARG A 396 ARG~? 24.93 C2 A B 4 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1dw9_05 CYANATE LYASE user 3 2 # 3 D 99 GLU A 351 GLU~? 20.29 O2' A B 4 I 96 ARG A 354 ARG~? 17.55 O2' A B 4 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1dw9_05 CYANATE LYASE user 4 2 # 4 D 99 GLU A 391 GLU~? 23.54 N1 A B 4 I 96 ARG A 390 ARG~? 22.44 N1 A B 4 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 1dw9_05 CYANATE LYASE user 5 2 # 5 D 99 GLU A 407 GLU~? 15.45 O2 U B 3 I 96 ARG A 404 ARG~? 18.97 O2 U B 3 coo -9.50 19.20 15.72 -9.80 19.81 13.72 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo -12.12 20.77 8.60 -10.73 20.87 11.34 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 1dw9_05 source 1dw9 CYANATE LYASE : 5 hits 1dw9_05 naa= 2 ULMN 2 1dw9_06 CYANATE LYASE user 1 2 # 1 H 99 GLU A 187 GLU~? 20.71 C2 A B 9 J 96 ARG A 180 ARG.? 21.90 C2 A B 9 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -20.54 -3.44 35.42 -23.45 -2.48 35.38 ULMN 2 1dw9_06 CYANATE LYASE user 2 2 # 2 H 99 GLU A 341 GLU~? 25.67 N6 A B 7 J 96 ARG A 396 ARG~? 24.93 C2 A B 4 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1dw9_06 CYANATE LYASE user 3 2 # 3 H 99 GLU A 351 GLU~? 20.29 O2' A B 4 J 96 ARG A 354 ARG~? 17.55 O2' A B 4 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1dw9_06 CYANATE LYASE user 4 2 # 4 H 99 GLU A 391 GLU~? 23.54 N1 A B 4 J 96 ARG A 390 ARG~? 22.44 N1 A B 4 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 1dw9_06 CYANATE LYASE user 5 2 # 5 H 99 GLU A 407 GLU~? 15.45 O2 U B 3 J 96 ARG A 404 ARG~? 18.97 O2 U B 3 coo -23.85 -1.67 -1.43 -23.09 -0.05 -2.54 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo -19.46 3.79 -4.44 -21.42 1.50 -4.05 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 1dw9_06 source 1dw9 CYANATE LYASE : 5 hits 1dw9_06 naa= 2 ULMN 2 1dw9_07 CYANATE LYASE user 1 2 # 1 H 96 ARG A 180 ARG.? 21.90 C2 A B 9 J 99 GLU A 187 GLU~? 20.71 C2 A B 9 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -20.54 -3.44 35.42 -23.45 -2.48 35.38 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -28.60 -2.71 32.18 -27.08 -3.13 33.60 ULMN 2 1dw9_07 CYANATE LYASE user 2 2 # 2 H 96 ARG A 354 ARG~? 17.55 O2' A B 4 J 99 GLU A 351 GLU~? 20.29 O2' A B 4 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1dw9_07 CYANATE LYASE user 3 2 # 3 H 96 ARG A 390 ARG~? 22.44 N1 A B 4 J 99 GLU A 391 GLU~? 23.54 N1 A B 4 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1dw9_07 CYANATE LYASE user 4 2 # 4 H 96 ARG A 396 ARG~? 24.93 C2 A B 4 J 99 GLU A 341 GLU~? 25.67 N6 A B 7 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dw9_07 CYANATE LYASE user 5 2 # 5 H 96 ARG A 404 ARG~? 18.97 O2 U B 3 J 99 GLU A 407 GLU~? 15.45 O2 U B 3 coo -18.96 -2.03 -4.48 -16.97 0.27 -4.13 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 coo -14.45 3.47 -1.63 -15.24 1.91 -2.68 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 1dw9_07 source 1dw9 CYANATE LYASE : 5 hits 1dw9_07 naa= 2 ULMN 2 1dw9_08 CYANATE LYASE user 1 2 # 1 A 96 ARG A 180 ARG.? 21.90 C2 A B 9 F 99 GLU A 187 GLU~? 20.71 C2 A B 9 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -20.54 -3.44 35.42 -23.45 -2.48 35.38 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -28.60 -2.71 32.18 -27.08 -3.13 33.60 ULMN 2 1dw9_08 CYANATE LYASE user 2 2 # 2 A 96 ARG A 354 ARG~? 17.55 O2' A B 4 F 99 GLU A 351 GLU~? 20.29 O2' A B 4 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1dw9_08 CYANATE LYASE user 3 2 # 3 A 96 ARG A 390 ARG~? 22.44 N1 A B 4 F 99 GLU A 391 GLU~? 23.54 N1 A B 4 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1dw9_08 CYANATE LYASE user 4 2 # 4 A 96 ARG A 396 ARG~? 24.93 C2 A B 4 F 99 GLU A 341 GLU~? 25.67 N6 A B 7 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1dw9_08 CYANATE LYASE user 5 2 # 5 A 96 ARG A 404 ARG~? 18.97 O2 U B 3 F 99 GLU A 407 GLU~? 15.45 O2 U B 3 coo -13.18 15.76 35.37 -12.72 12.99 36.60 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 coo -12.53 8.23 36.79 -12.25 10.29 36.64 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 1dw9_08 source 1dw9 CYANATE LYASE : 5 hits 1dw9_08 naa= 2 ULMN 2 1dxe_00 2-DEHYDRO-3-DEOXY-GALACTARATE ALDOLAuser 1 2 # 1 A 50 HIS A 326 HIS~? 3.28 C5 A B 7 A 75 ARG A 288 ARG~? 3.45 C6 A B 7 coo 49.44 33.50 29.05 49.41 32.89 31.06 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 49.71 39.84 30.43 47.41 37.86 29.89 -21.54 -21.02 8.30 -20.02 -23.61 8.96 ULMN 2 1dxe_00 2-DEHYDRO-3-DEOXY-GALACTARATE ALDOLAuser 2 2 # 2 A 50 HIS A 462 HIS~? 12.61 O4 U B 3 A 75 ARG A 431 ARG~? 16.75 O4 U B 3 coo 49.44 33.50 29.05 49.41 32.89 31.06 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 49.71 39.84 30.43 47.41 37.86 29.89 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 1dxe_00 source 1dxe 2-DEHYDRO-3-DEOXY-GALACTARATE ALDOLASE : 2 hits 1dxe_00 naa= 2 ULMN 2 1dxe_01 2-DEHYDRO-3-DEOXY-GALACTARATE ALDOLAuser 1 2 # 1 B 50 HIS A 326 HIS~? 3.28 C5 A B 7 B 75 ARG A 288 ARG~? 3.45 C6 A B 7 coo 49.21 39.89 -6.15 49.17 40.48 -8.16 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 49.93 33.53 -7.53 47.50 35.35 -7.05 -21.54 -21.02 8.30 -20.02 -23.61 8.96 ULMN 2 1dxe_01 2-DEHYDRO-3-DEOXY-GALACTARATE ALDOLAuser 2 2 # 2 B 50 HIS A 462 HIS~? 12.61 O4 U B 3 B 75 ARG A 431 ARG~? 16.75 O4 U B 3 coo 49.21 39.89 -6.15 49.17 40.48 -8.16 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 49.93 33.53 -7.53 47.50 35.35 -7.05 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 1dxe_01 source 1dxe 2-DEHYDRO-3-DEOXY-GALACTARATE ALDOLASE : 2 hits 1dxe_01 naa= 2 ULMN 2 1e1a_00 DIISOPROPYLFLUOROPHOSPHATASE user 1 2 # 1 A 37 GLU A 457 GLU~? 3.32 N1 G B 2 A 287 HIS A 454 HIS~? 3.31 C5 U B 3 coo -0.12 -1.99 23.42 -0.66 -3.31 21.87 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 2.10 -8.19 20.43 3.55 -6.67 20.40 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 ULMN 2 1e1a_00 DIISOPROPYLFLUOROPHOSPHATASE user 2 2 # 2 A 37 GLU A 522 GLU^? 23.38 O4 U B 3 A 287 HIS A 527 HIS~? 25.85 N2 G B 2 coo -0.12 -1.99 23.42 -0.66 -3.31 21.87 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 2.10 -8.19 20.43 3.55 -6.67 20.40 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 ULMN 2 1e1a_00 DIISOPROPYLFLUOROPHOSPHATASE user 3 2 # 3 A 37 GLU A 545 GLU~? 17.12 N3 U B 1 A 287 HIS A 547 HIS~? 18.58 O4 U B 1 coo -0.12 -1.99 23.42 -0.66 -3.31 21.87 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 2.10 -8.19 20.43 3.55 -6.67 20.40 8.28 -67.57 -10.72 8.13 -67.19 -12.78 1e1a_00 source 1e1a DIISOPROPYLFLUOROPHOSPHATASE : 3 hits 1e1a_00 naa= 2 ULMN 2 1eb6_00 NEUTRAL PROTEASE II user 1 2 # 1 A 106 TYR A 218 TYR~? 23.65 C2 A B 9 A 129 GLU A 225 GLU~? 23.05 C2 A B 9 coo 8.57 -0.34 51.10 11.35 -0.27 51.24 -39.15 -2.15 23.93 -37.86 0.21 23.20 coo 10.94 7.38 49.06 9.46 8.67 48.23 -36.18 -1.53 15.48 -36.93 -1.10 13.54 ULMN 2 1eb6_00 NEUTRAL PROTEASE II user 2 2 # 2 A 106 TYR A 245 TYR~? 3.47 C5 A B 9 A 129 GLU A 208 GLU~? 4.03 N1 A B 9 coo 8.57 -0.34 51.10 11.35 -0.27 51.24 -22.48 -17.46 16.07 -20.67 -19.47 15.36 coo 10.94 7.38 49.06 9.46 8.67 48.23 -24.90 -17.89 21.91 -24.90 -19.66 23.08 ULMN 2 1eb6_00 NEUTRAL PROTEASE II user 3 2 # 3 A 106 TYR A 416 TYR~? 3.28 C4 A B 4 A 129 GLU A 412 GLU.? 7.44 O2' U B 3 coo 8.57 -0.34 51.10 11.35 -0.27 51.24 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 coo 10.94 7.38 49.06 9.46 8.67 48.23 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 ULMN 2 1eb6_00 NEUTRAL PROTEASE II user 4 2 # 4 A 106 TYR A 525 TYR^? 33.09 N2 G B 2 A 129 GLU A 522 GLU^? 23.38 O4 U B 3 coo 8.57 -0.34 51.10 11.35 -0.27 51.24 -31.10 -64.72 -19.95 -33.38 -64.72 -21.56 coo 10.94 7.38 49.06 9.46 8.67 48.23 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1eb6_00 source 1eb6 NEUTRAL PROTEASE II : 4 hits 1eb6_00 naa= 2 ULMN 2 1ebf_00 HOMOSERINE DEHYDROGENASE user 1 2 # 1 A 219 ASP A 193 ASP~? 20.25 C2 A B 9 A 223 LYS A 196 LYS~? 19.45 O2' A B 9 coo 60.73 18.76 -7.87 61.76 20.28 -6.83 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 62.58 16.80 -0.96 62.41 22.46 -3.81 -19.67 -3.42 20.50 -17.88 1.90 20.43 ULMN 2 1ebf_00 HOMOSERINE DEHYDROGENASE user 2 2 # 2 A 219 ASP A 533 ASP~? 24.95 O4 U B 1 A 223 LYS A 536 LYS~? 26.44 O4 U B 1 coo 60.73 18.76 -7.87 61.76 20.28 -6.83 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 62.58 16.80 -0.96 62.41 22.46 -3.81 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 ULMN 2 1ebf_00 HOMOSERINE DEHYDROGENASE user 3 2 # 3 A 219 ASP A 533 ASP~? 24.95 O4 U B 1 A 223 LYS A 537 LYS~? 23.79 O4 U B 1 coo 60.73 18.76 -7.87 61.76 20.28 -6.83 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 62.58 16.80 -0.96 62.41 22.46 -3.81 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 1ebf_00 source 1ebf HOMOSERINE DEHYDROGENASE : 3 hits 1ebf_00 naa= 2 ULMN 2 1ebf_01 HOMOSERINE DEHYDROGENASE user 1 2 # 1 B 219 ASP A 193 ASP~? 20.25 C2 A B 9 B 223 LYS A 196 LYS~? 19.45 O2' A B 9 coo 59.29 40.80 28.55 60.72 39.27 28.67 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 63.53 41.41 22.67 60.48 36.70 25.37 -19.67 -3.42 20.50 -17.88 1.90 20.43 ULMN 2 1ebf_01 HOMOSERINE DEHYDROGENASE user 2 2 # 2 B 219 ASP A 533 ASP~? 24.95 O4 U B 1 B 223 LYS A 536 LYS~? 26.44 O4 U B 1 coo 59.29 40.80 28.55 60.72 39.27 28.67 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 63.53 41.41 22.67 60.48 36.70 25.37 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 ULMN 2 1ebf_01 HOMOSERINE DEHYDROGENASE user 3 2 # 3 B 219 ASP A 533 ASP~? 24.95 O4 U B 1 B 223 LYS A 537 LYS~? 23.79 O4 U B 1 coo 59.29 40.80 28.55 60.72 39.27 28.67 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 63.53 41.41 22.67 60.48 36.70 25.37 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 1ebf_01 source 1ebf HOMOSERINE DEHYDROGENASE : 3 hits 1ebf_01 naa= 2 ULMN 2 1ecm_00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 1 2 # 1 A 28 ARG A 314 ARG~? 20.43 C2 A B 7 B 11 ARG A 311 ARG.? 21.53 N1 A B 7 coo 30.98 29.88 30.84 29.10 29.68 28.40 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 coo 30.95 31.29 19.13 28.16 32.11 18.14 -28.14 -16.31 -12.56 -31.15 -16.30 -12.01 ULMN 2 1ecm_00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 2 2 # 2 A 28 ARG A 396 ARG~? 24.93 C2 A B 4 B 11 ARG A 390 ARG~? 22.44 N1 A B 4 coo 30.98 29.88 30.84 29.10 29.68 28.40 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo 30.95 31.29 19.13 28.16 32.11 18.14 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 1ecm_00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 3 2 # 3 A 28 ARG A 518 ARG.? 16.31 O6 G B 2 B 11 ARG A 431 ARG~? 16.75 O4 U B 3 coo 30.98 29.88 30.84 29.10 29.68 28.40 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 30.95 31.29 19.13 28.16 32.11 18.14 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1ecm_00 ENDO-OXABICYCLIC TRANSITION STATE ANuser 4 2 # 4 A 28 ARG A 566 ARG~? 21.74 O4 U B 1 B 11 ARG A 546 ARG~? 20.83 O4 U B 1 coo 30.98 29.88 30.84 29.10 29.68 28.40 -7.26 -74.81 -5.17 -4.76 -76.37 -4.31 coo 30.95 31.29 19.13 28.16 32.11 18.14 3.56 -71.20 -7.93 4.10 -73.33 -10.06 1ecm_00 source 1ecm ENDO-OXABICYCLIC TRANSITION STATE ANALOGUE : 4 hits 1ecm_00 naa= 2 ULMN 2 1ecm_01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 1 2 # 1 A 11 ARG A 311 ARG.? 21.53 N1 A B 7 B 28 ARG A 314 ARG~? 20.43 C2 A B 7 coo 32.63 17.54 55.00 30.02 17.07 56.50 -28.14 -16.31 -12.56 -31.15 -16.30 -12.01 coo 31.11 19.53 43.50 29.63 19.98 46.20 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1ecm_01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 2 2 # 2 A 11 ARG A 390 ARG~? 22.44 N1 A B 4 B 28 ARG A 396 ARG~? 24.93 C2 A B 4 coo 32.63 17.54 55.00 30.02 17.07 56.50 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo 31.11 19.53 43.50 29.63 19.98 46.20 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1ecm_01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 3 2 # 3 A 11 ARG A 431 ARG~? 16.75 O4 U B 3 B 28 ARG A 518 ARG.? 16.31 O6 G B 2 coo 32.63 17.54 55.00 30.02 17.07 56.50 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 31.11 19.53 43.50 29.63 19.98 46.20 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 ULMN 2 1ecm_01 ENDO-OXABICYCLIC TRANSITION STATE ANuser 4 2 # 4 A 11 ARG A 546 ARG~? 20.83 O4 U B 1 B 28 ARG A 566 ARG~? 21.74 O4 U B 1 coo 32.63 17.54 55.00 30.02 17.07 56.50 3.56 -71.20 -7.93 4.10 -73.33 -10.06 coo 31.11 19.53 43.50 29.63 19.98 46.20 -7.26 -74.81 -5.17 -4.76 -76.37 -4.31 1ecm_01 source 1ecm ENDO-OXABICYCLIC TRANSITION STATE ANALOGUE : 4 hits 1ecm_01 naa= 2 ULMN 2 1ef8_03 METHYLMALONYL COA DECARBOXYLASE user 1 2 # 1 A 113 GLU A 187 GLU~? 20.71 C2 A B 9 A 133 PRO A 169 PRO~? 18.04 O2' A B 9 coo 17.89 4.28 6.66 17.21 3.76 4.71 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo 25.19 8.51 2.90 27.26 7.49 2.69 -20.02 -0.85 26.27 -17.89 -0.21 26.44 ULMN 2 1ef8_03 METHYLMALONYL COA DECARBOXYLASE user 2 2 # 2 A 113 GLU A 436 GLU~? 23.50 O4 U B 3 A 133 PRO A 464 PRO~? 20.27 O4 U B 3 coo 17.89 4.28 6.66 17.21 3.76 4.71 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 25.19 8.51 2.90 27.26 7.49 2.69 -24.71 -53.19 -17.60 -23.64 -54.68 -16.31 ULMN 2 1ef8_03 METHYLMALONYL COA DECARBOXYLASE user 3 2 # 3 A 113 GLU A 470 GLU~? 22.82 N2 G B 2 A 133 PRO A 464 PRO~? 20.27 O4 U B 3 coo 17.89 4.28 6.66 17.21 3.76 4.71 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 25.19 8.51 2.90 27.26 7.49 2.69 -24.71 -53.19 -17.60 -23.64 -54.68 -16.31 1ef8_03 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_03 naa= 2 ULMN 2 1ef8_04 METHYLMALONYL COA DECARBOXYLASE user 1 2 # 1 B 113 GLU A 187 GLU~? 20.71 C2 A B 9 B 133 PRO A 169 PRO~? 18.04 O2' A B 9 coo 14.64 32.39 9.30 13.61 33.26 7.68 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo 9.44 37.34 14.98 10.09 39.37 15.91 -20.02 -0.85 26.27 -17.89 -0.21 26.44 ULMN 2 1ef8_04 METHYLMALONYL COA DECARBOXYLASE user 2 2 # 2 B 113 GLU A 436 GLU~? 23.50 O4 U B 3 B 133 PRO A 464 PRO~? 20.27 O4 U B 3 coo 14.64 32.39 9.30 13.61 33.26 7.68 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 9.44 37.34 14.98 10.09 39.37 15.91 -24.71 -53.19 -17.60 -23.64 -54.68 -16.31 ULMN 2 1ef8_04 METHYLMALONYL COA DECARBOXYLASE user 3 2 # 3 B 113 GLU A 470 GLU~? 22.82 N2 G B 2 B 133 PRO A 464 PRO~? 20.27 O4 U B 3 coo 14.64 32.39 9.30 13.61 33.26 7.68 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 9.44 37.34 14.98 10.09 39.37 15.91 -24.71 -53.19 -17.60 -23.64 -54.68 -16.31 1ef8_04 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_04 naa= 2 ULMN 2 1ef8_05 METHYLMALONYL COA DECARBOXYLASE user 1 2 # 1 C 113 GLU A 187 GLU~? 20.71 C2 A B 9 C 133 PRO A 169 PRO~? 18.04 O2' A B 9 coo -3.18 14.73 22.76 -5.01 14.47 21.69 -28.60 -2.71 32.18 -27.08 -3.13 33.60 coo -2.61 5.73 24.31 -3.35 4.61 26.16 -20.02 -0.85 26.27 -17.89 -0.21 26.44 ULMN 2 1ef8_05 METHYLMALONYL COA DECARBOXYLASE user 2 2 # 2 C 113 GLU A 436 GLU~? 23.50 O4 U B 3 C 133 PRO A 464 PRO~? 20.27 O4 U B 3 coo -3.18 14.73 22.76 -5.01 14.47 21.69 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -2.61 5.73 24.31 -3.35 4.61 26.16 -24.71 -53.19 -17.60 -23.64 -54.68 -16.31 ULMN 2 1ef8_05 METHYLMALONYL COA DECARBOXYLASE user 3 2 # 3 C 113 GLU A 470 GLU~? 22.82 N2 G B 2 C 133 PRO A 464 PRO~? 20.27 O4 U B 3 coo -3.18 14.73 22.76 -5.01 14.47 21.69 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -2.61 5.73 24.31 -3.35 4.61 26.16 -24.71 -53.19 -17.60 -23.64 -54.68 -16.31 1ef8_05 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_05 naa= 2 ULMN 2 1els_02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 1 2 # 1 191 HIS A 326 HIS~? 3.28 C5 A B 7 345 LYS A 450 LYS.? 2.98 O2' G B 2 coo 87.80 42.73 46.74 88.64 40.96 46.01 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 103.59 43.46 23.85 98.61 47.18 23.58 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 ULMN 2 1els_02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 2 2 # 2 191 HIS A 352 HIS~? 21.18 O2' A B 4 345 LYS A 270 LYS~? 23.81 O4 U B 8 coo 87.80 42.73 46.74 88.64 40.96 46.01 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 coo 103.59 43.46 23.85 98.61 47.18 23.58 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 1els_02 source 1els ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-GLYCERATE : 2 hits 1els_02 naa= 2 ULMN 2 1els_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 1 2 # 1 242 LYS A 209 LYS~? 11.26 C2 A B 9 345 LYS A 284 LYS.? 5.29 OP1 U B 8 coo 99.58 55.20 43.27 102.49 58.24 46.31 -27.43 -16.88 26.23 -24.36 -18.13 30.86 coo 103.59 43.46 23.85 98.61 47.18 23.58 -16.65 -16.94 5.44 -12.34 -19.40 9.40 ULMN 2 1els_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 2 2 # 2 242 LYS A 212 LYS.? 5.77 N6 A B 9 345 LYS A 268 LYS~? 23.13 O4 U B 8 coo 99.58 55.20 43.27 102.49 58.24 46.31 -32.17 -17.64 24.03 -27.48 -21.87 22.97 coo 103.59 43.46 23.85 98.61 47.18 23.58 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 1els_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 3 2 # 3 242 LYS A 236 LYS~? 15.40 O2 U B 8 345 LYS A 330 LYS~? 6.92 N6 A B 7 coo 99.58 55.20 43.27 102.49 58.24 46.31 -21.15 -5.56 9.63 -19.04 -2.89 13.94 coo 103.59 43.46 23.85 98.61 47.18 23.58 -28.12 -25.40 0.86 -29.08 -26.03 5.63 ULMN 2 1els_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 4 2 # 4 242 LYS A 268 LYS~? 23.13 O4 U B 8 345 LYS A 330 LYS~? 6.92 N6 A B 7 coo 99.58 55.20 43.27 102.49 58.24 46.31 -36.22 -5.92 4.46 -36.10 -1.68 8.58 coo 103.59 43.46 23.85 98.61 47.18 23.58 -28.12 -25.40 0.86 -29.08 -26.03 5.63 ULMN 2 1els_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 5 2 # 5 242 LYS A 556 LYS~? 9.38 OP2 U B 1 345 LYS A 458 LYS~? 5.39 O4 U B 3 coo 99.58 55.20 43.27 102.49 58.24 46.31 0.47 -62.65 -2.47 5.80 -61.35 0.58 coo 103.59 43.46 23.85 98.61 47.18 23.58 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 1els_03 source 1els ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-GLYCERATE : 5 hits 1els_03 naa= 2 ULMN 2 1emd_02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 2 # 1 150 ASP A 174 ASP.? 19.36 O2' A B 9 178 SER A 172 SER~? 16.88 O2' A B 9 coo 6.83 2.75 19.17 7.40 0.75 19.11 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -20.21 -2.49 31.33 -19.35 -3.14 29.13 ULMN 2 1emd_02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 2 # 2 150 ASP A 259 ASP.? 23.89 N1 A B 9 178 SER A 254 SER~? 17.72 O4 U B 8 coo 6.83 2.75 19.17 7.40 0.75 19.11 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -38.02 -12.50 13.78 -37.98 -10.97 11.92 ULMN 2 1emd_02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 3 2 # 3 150 ASP A 279 ASP~? 17.12 C2 A B 7 178 SER A 275 SER~? 20.51 N3 U B 8 coo 6.83 2.75 19.17 7.40 0.75 19.11 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -28.36 -6.45 -2.72 -28.17 -5.12 -0.71 ULMN 2 1emd_02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 4 2 # 4 150 ASP A 283 ASP~? 9.21 O2 U B 8 178 SER A 238 SER~? 10.39 N3 U B 8 coo 6.83 2.75 19.17 7.40 0.75 19.11 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -22.98 -10.82 9.36 -25.25 -10.60 8.53 ULMN 2 1emd_02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 5 2 # 5 150 ASP A 381 ASP.? 22.82 N6 A B 7 178 SER A 377 SER~? 20.10 O2 C B 5 coo 6.83 2.75 19.17 7.40 0.75 19.11 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -36.34 -43.17 -2.56 -34.94 -43.93 -0.70 ULMN 2 1emd_02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 6 2 # 6 150 ASP A 425 ASP.? 18.06 O4 U B 3 178 SER A 423 SER~? 9.25 O4 U B 3 coo 6.83 2.75 19.17 7.40 0.75 19.11 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 ULMN 2 1emd_02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 7 2 # 7 150 ASP A 426 ASP.? 18.90 N1 A B 4 178 SER A 377 SER~? 20.10 O2 C B 5 coo 6.83 2.75 19.17 7.40 0.75 19.11 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -36.34 -43.17 -2.56 -34.94 -43.93 -0.70 ULMN 2 1emd_02 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 8 2 # 8 150 ASP A 473 ASP~? 22.60 N2 G B 2 178 SER A 530 SER~? 25.46 N2 G B 2 coo 6.83 2.75 19.17 7.40 0.75 19.11 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 9.80 -4.98 22.55 11.39 -5.35 24.35 -18.33 -66.93 -18.45 -19.81 -66.03 -20.11 1emd_02 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 8 hits 1emd_02 naa= 2 ULMN 2 1eq2_10 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 A 140 TYR A 361 TYR~? 4.83 OP1 U B 6 A 144 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 29.60 38.99 53.89 30.10 37.88 51.36 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 32.73 32.94 54.42 29.29 32.83 50.35 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1eq2_10 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_10 naa= 2 ULMN 2 1eq2_18 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 2 # 1 I 140 TYR A 361 TYR~? 4.83 OP1 U B 6 I 144 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 16.78 87.76 12.19 16.39 88.69 9.59 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 13.67 93.83 12.65 17.08 93.94 8.58 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1eq2_18 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 1 hits 1eq2_18 naa= 2 ULMN 2 1eso_00 CU, ZN SUPEROXIDE DISMUTASE user 1 2 # 1 61 HIS A 326 HIS~? 3.28 C5 A B 7 141 ARG A 288 ARG~? 3.45 C6 A B 7 coo 9.30 6.84 14.05 8.96 5.17 15.26 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 16.06 0.88 14.70 16.24 4.03 14.68 -21.54 -21.02 8.30 -20.02 -23.61 8.96 1eso_00 source 1eso CU, ZN SUPEROXIDE DISMUTASE : 1 hits 1eso_00 naa= 2 ULMN 2 1eug_00 GLYCOSYLASE user 1 2 # 1 A 64 ASP A 312 ASP~? 21.35 C2 A B 7 A 187 HIS A 352 HIS~? 21.18 O2' A B 4 coo 8.78 5.95 13.35 7.37 7.06 12.26 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo 16.78 -0.75 14.60 15.02 -0.07 15.53 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 ULMN 2 1eug_00 GLYCOSYLASE user 2 2 # 2 A 64 ASP A 345 ASP~? 24.06 C2 A B 4 A 187 HIS A 352 HIS~? 21.18 O2' A B 4 coo 8.78 5.95 13.35 7.37 7.06 12.26 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 16.78 -0.75 14.60 15.02 -0.07 15.53 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 ULMN 2 1eug_00 GLYCOSYLASE user 3 2 # 3 A 64 ASP A 425 ASP.? 18.06 O4 U B 3 A 187 HIS A 420 HIS~? 9.42 N1 A B 4 coo 8.78 5.95 13.35 7.37 7.06 12.26 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 16.78 -0.75 14.60 15.02 -0.07 15.53 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1eug_00 GLYCOSYLASE user 4 2 # 4 A 64 ASP A 426 ASP.? 18.90 N1 A B 4 A 187 HIS A 420 HIS~? 9.42 N1 A B 4 coo 8.78 5.95 13.35 7.37 7.06 12.26 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 16.78 -0.75 14.60 15.02 -0.07 15.53 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1eug_00 source 1eug GLYCOSYLASE : 4 hits 1eug_00 naa= 2 ULMN 2 1evy_00 GLYCEROL-3-PHOSPHATE DEHYDROGENASE user 1 2 # 1 A 210 LYS A 220 LYS~? 19.55 N1 A B 9 A 267 THR A 257 THR~? 19.75 N1 A B 9 coo 41.87 54.40 8.08 43.44 49.84 12.08 -37.45 -8.35 20.48 -41.74 -12.81 21.44 coo 41.37 47.71 7.16 41.46 49.18 8.80 -42.71 -13.46 15.84 -41.70 -12.17 17.23 1evy_00 source 1evy GLYCEROL-3-PHOSPHATE DEHYDROGENASE : 1 hits 1evy_00 naa= 2 ULMN 2 1ey2_00 HOMOGENTISATE 1,2-DIOXYGENASE user 1 2 # 1 A 292 HIS A 539 HIS~? 18.96 O4 U B 1 A 365 HIS A 547 HIS~? 18.58 O4 U B 1 coo 23.28 112.91 32.74 23.69 111.49 34.23 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 coo 18.69 108.01 46.85 20.59 108.88 46.65 8.28 -67.57 -10.72 8.13 -67.19 -12.78 ULMN 2 1ey2_00 HOMOGENTISATE 1,2-DIOXYGENASE user 2 2 # 2 A 292 HIS A 547 HIS~? 18.58 O4 U B 1 A 365 HIS A 539 HIS~? 18.96 O4 U B 1 coo 23.28 112.91 32.74 23.69 111.49 34.23 8.28 -67.57 -10.72 8.13 -67.19 -12.78 coo 18.69 108.01 46.85 20.59 108.88 46.65 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 1ey2_00 source 1ey2 HOMOGENTISATE 1,2-DIOXYGENASE : 2 hits 1ey2_00 naa= 2 ULMN 2 1f7l_02 HOLO-(ACYL CARRIER PROTEIN) SYNTHASEuser 1 2 # 1 A 62 LYS A 437 LYS~? 23.48 O4 U B 3 A 105 HIS A 420 HIS~? 9.42 N1 A B 4 coo 9.16 8.08 45.36 8.29 5.91 51.34 -18.39 -44.32 -24.62 -24.23 -41.99 -25.00 coo -7.37 8.81 56.82 -6.87 10.59 55.84 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1f7l_02 HOLO-(ACYL CARRIER PROTEIN) SYNTHASEuser 2 2 # 2 A 62 LYS A 487 LYS.? 20.83 N3 U B 1 A 105 HIS A 539 HIS~? 18.96 O4 U B 1 coo 9.16 8.08 45.36 8.29 5.91 51.34 3.85 -58.89 -22.81 2.77 -64.79 -20.79 coo -7.37 8.81 56.82 -6.87 10.59 55.84 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 1f7l_02 source 1f7l HOLO-(ACYL CARRIER PROTEIN) SYNTHASE : 2 hits 1f7l_02 naa= 2 ULMN 2 1f80_02 ACYL CARRIER PROTEIN user 1 2 # 1 C 62 LYS A 437 LYS~? 23.48 O4 U B 3 C 105 HIS A 420 HIS~? 9.42 N1 A B 4 coo 19.95 18.98 4.81 18.82 20.94 10.49 -18.39 -44.32 -24.62 -24.23 -41.99 -25.00 coo 34.93 19.72 17.37 34.72 18.17 15.98 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1f80_02 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_02 naa= 2 ULMN 2 1f8r_00 L-AMINO ACID OXIDASE user 1 2 # 1 A 223 HIS A 454 HIS~? 3.31 C5 U B 3 A 326 LYS A 557 LYS~? 2.76 O4 U B 1 coo 32.14 47.24 95.55 33.29 47.43 93.81 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 31.81 59.38 82.93 29.11 53.63 83.59 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 1f8r_00 source 1f8r L-AMINO ACID OXIDASE : 1 hits 1f8r_00 naa= 2 ULMN 2 1f8r_01 L-AMINO ACID OXIDASE user 1 2 # 1 B 223 HIS A 454 HIS~? 3.31 C5 U B 3 B 326 LYS A 557 LYS~? 2.76 O4 U B 1 coo 26.95 108.36 54.79 28.84 107.50 55.13 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 31.78 95.33 65.42 31.80 101.69 65.97 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 1f8r_01 source 1f8r L-AMINO ACID OXIDASE : 1 hits 1f8r_01 naa= 2 ULMN 2 1f8r_02 L-AMINO ACID OXIDASE user 1 2 # 1 C 223 HIS A 454 HIS~? 3.31 C5 U B 3 C 326 LYS A 557 LYS~? 2.76 O4 U B 1 coo 33.25 74.67 113.67 31.48 75.77 113.48 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 25.07 80.73 99.44 29.33 83.19 103.51 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 1f8r_02 source 1f8r L-AMINO ACID OXIDASE : 1 hits 1f8r_02 naa= 2 ULMN 2 1f8r_03 L-AMINO ACID OXIDASE user 1 2 # 1 D 223 HIS A 454 HIS~? 3.31 C5 U B 3 D 326 LYS A 557 LYS~? 2.76 O4 U B 1 coo 4.66 85.67 46.64 3.37 85.25 48.25 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 8.23 80.75 63.06 6.88 77.61 57.64 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 1f8r_03 source 1f8r L-AMINO ACID OXIDASE : 1 hits 1f8r_03 naa= 2 ULMN 2 1fc4_06 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 2 # 1 A 213 HIS A 454 HIS~? 3.31 C5 U B 3 A 244 LYS A 450 LYS.? 2.98 O2' G B 2 coo 5.16 41.69 14.03 4.79 43.69 14.54 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 1fc4_06 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_06 naa= 2 ULMN 2 1fc4_07 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 2 # 1 B 213 HIS A 454 HIS~? 3.31 C5 U B 3 B 244 LYS A 450 LYS.? 2.98 O2' G B 2 coo 3.62 52.84 45.72 3.44 50.81 45.25 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 1fc4_07 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_07 naa= 2 ULMN 2 1fc4_08 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 2 # 1 A 136 HIS A 462 HIS~? 12.61 O4 U B 3 A 210 ASP A 425 ASP.? 18.06 O4 U B 3 coo 11.28 44.53 18.60 9.91 46.00 19.20 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1fc4_08 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 2 # 2 A 136 HIS A 482 HIS.? 27.32 N2 G B 2 A 210 ASP A 484 ASP.? 22.65 O2 U B 1 coo 11.28 44.53 18.60 9.91 46.00 19.20 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 10.51 37.86 19.71 9.07 39.38 20.04 7.90 -50.74 -23.88 8.67 -50.47 -25.84 ULMN 2 1fc4_08 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 2 # 3 A 136 HIS A 527 HIS~? 25.85 N2 G B 2 A 210 ASP A 526 ASP^? 28.45 O6 G B 2 coo 11.28 44.53 18.60 9.91 46.00 19.20 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 10.51 37.86 19.71 9.07 39.38 20.04 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 1fc4_08 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_08 naa= 2 ULMN 2 1fc4_09 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 2 # 1 B 136 HIS A 462 HIS~? 12.61 O4 U B 3 B 210 ASP A 425 ASP.? 18.06 O4 U B 3 coo 10.08 50.18 41.78 8.91 48.61 41.04 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1fc4_09 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 2 # 2 B 136 HIS A 482 HIS.? 27.32 N2 G B 2 B 210 ASP A 484 ASP.? 22.65 O2 U B 1 coo 10.08 50.18 41.78 8.91 48.61 41.04 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 9.06 56.85 40.30 7.71 55.27 39.90 7.90 -50.74 -23.88 8.67 -50.47 -25.84 ULMN 2 1fc4_09 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 2 # 3 B 136 HIS A 527 HIS~? 25.85 N2 G B 2 B 210 ASP A 526 ASP^? 28.45 O6 G B 2 coo 10.08 50.18 41.78 8.91 48.61 41.04 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 9.06 56.85 40.30 7.71 55.27 39.90 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 1fc4_09 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 3 hits 1fc4_09 naa= 2 ULMN 2 1fft_02 UBIQUINOL OXIDASE user 1 2 # 1 A 286 GLU A 208 GLU~? 4.03 N1 A B 9 A 362 LYS A 330 LYS~? 6.92 N6 A B 7 coo 44.33 299.22 203.95 43.60 300.74 202.69 -24.90 -17.89 21.91 -24.90 -19.66 23.08 coo 34.33 303.48 222.19 37.83 307.04 219.88 -28.12 -25.40 0.86 -29.08 -26.03 5.63 ULMN 2 1fft_02 UBIQUINOL OXIDASE user 2 2 # 2 A 286 GLU A 267 GLU~? 24.62 O4 U B 8 A 362 LYS A 338 LYS~? 26.90 N6 A B 7 coo 44.33 299.22 203.95 43.60 300.74 202.69 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 coo 34.33 303.48 222.19 37.83 307.04 219.88 -37.84 -25.02 -10.54 -41.92 -21.39 -11.77 ULMN 2 1fft_02 UBIQUINOL OXIDASE user 3 2 # 3 A 286 GLU A 466 GLU~? 26.72 N2 G B 2 A 362 LYS A 537 LYS~? 23.79 O4 U B 1 coo 44.33 299.22 203.95 43.60 300.74 202.69 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 34.33 303.48 222.19 37.83 307.04 219.88 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 1fft_02 source 1fft UBIQUINOL OXIDASE : 3 hits 1fft_02 naa= 2 ULMN 2 1fft_03 UBIQUINOL OXIDASE user 1 2 # 1 F 286 GLU A 208 GLU~? 4.03 N1 A B 9 F 362 LYS A 330 LYS~? 6.92 N6 A B 7 coo -1.93 167.64 87.36 -2.65 169.16 86.08 -24.90 -17.89 21.91 -24.90 -19.66 23.08 coo -12.12 171.74 105.52 -8.57 175.32 103.28 -28.12 -25.40 0.86 -29.08 -26.03 5.63 ULMN 2 1fft_03 UBIQUINOL OXIDASE user 2 2 # 2 F 286 GLU A 267 GLU~? 24.62 O4 U B 8 F 362 LYS A 338 LYS~? 26.90 N6 A B 7 coo -1.93 167.64 87.36 -2.65 169.16 86.08 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 coo -12.12 171.74 105.52 -8.57 175.32 103.28 -37.84 -25.02 -10.54 -41.92 -21.39 -11.77 ULMN 2 1fft_03 UBIQUINOL OXIDASE user 3 2 # 3 F 286 GLU A 466 GLU~? 26.72 N2 G B 2 F 362 LYS A 537 LYS~? 23.79 O4 U B 1 coo -1.93 167.64 87.36 -2.65 169.16 86.08 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -12.12 171.74 105.52 -8.57 175.32 103.28 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 1fft_03 source 1fft UBIQUINOL OXIDASE : 3 hits 1fft_03 naa= 2 ULMN 2 1fiq_01 XANTHINE OXIDASE user 1 2 # 1 C 880 ARG A 230 ARG~? 20.03 C2 A B 9 C1261 GLU A 225 GLU~? 23.05 C2 A B 9 coo 31.02 9.69 109.34 29.24 7.24 108.82 -30.18 1.36 11.96 -29.08 0.35 14.66 coo 26.56 13.30 104.79 26.46 12.34 106.65 -36.18 -1.53 15.48 -36.93 -1.10 13.54 ULMN 2 1fiq_01 XANTHINE OXIDASE user 2 2 # 2 C 880 ARG A 354 ARG~? 17.55 O2' A B 4 C1261 GLU A 407 GLU~? 15.45 O2 U B 3 coo 31.02 9.69 109.34 29.24 7.24 108.82 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo 26.56 13.30 104.79 26.46 12.34 106.65 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1fiq_01 XANTHINE OXIDASE user 3 2 # 3 C 880 ARG A 392 ARG~? 29.32 C2 A B 4 C1261 GLU A 341 GLU~? 25.67 N6 A B 7 coo 31.02 9.69 109.34 29.24 7.24 108.82 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 coo 26.56 13.30 104.79 26.46 12.34 106.65 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1fiq_01 XANTHINE OXIDASE user 4 2 # 4 C 880 ARG A 431 ARG~? 16.75 O4 U B 3 C1261 GLU A 432 GLU~? 22.16 O4 U B 3 coo 31.02 9.69 109.34 29.24 7.24 108.82 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 26.56 13.30 104.79 26.46 12.34 106.65 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1fiq_01 XANTHINE OXIDASE user 5 2 # 5 C 880 ARG A 441 ARG.? 21.93 N2 G B 2 C1261 GLU A 474 GLU~? 16.68 N2 G B 2 coo 31.02 9.69 109.34 29.24 7.24 108.82 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo 26.56 13.30 104.79 26.46 12.34 106.65 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 1fiq_01 source 1fiq XANTHINE OXIDASE : 5 hits 1fiq_01 naa= 2 ULMN 2 1fiq_02 XANTHINE OXIDASE user 1 2 # 1 C 767 GLN A 276 GLN~? 19.14 O2 U B 8 C 912 ARG A 314 ARG~? 20.43 C2 A B 7 coo 19.15 19.42 110.70 21.10 18.89 110.04 -24.81 -5.96 0.11 -23.22 -4.85 -0.80 coo 26.51 17.67 102.36 24.83 17.76 99.83 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1fiq_02 XANTHINE OXIDASE user 2 2 # 2 C 767 GLN A 295 GLN~? 9.64 N6 A B 7 C 912 ARG A 288 ARG~? 3.45 C6 A B 7 coo 19.15 19.42 110.70 21.10 18.89 110.04 -33.09 -24.48 7.27 -31.59 -25.59 8.28 coo 26.51 17.67 102.36 24.83 17.76 99.83 -21.54 -21.02 8.30 -20.02 -23.61 8.96 1fiq_02 source 1fiq XANTHINE OXIDASE : 2 hits 1fiq_02 naa= 2 ULMN 2 1fps_00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 1 2 # 1 126 ARG A 431 ARG~? 16.75 O4 U B 3 253 PHE A 531 PHE~? 20.43 O6 G B 2 coo 11.87 35.64 105.40 9.89 33.34 105.30 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 10.33 21.73 96.74 11.72 23.84 97.98 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 ULMN 2 1fps_00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 2 2 # 2 126 ARG A 441 ARG.? 21.93 N2 G B 2 253 PHE A 460 PHE~? 11.81 N2 G B 2 coo 11.87 35.64 105.40 9.89 33.34 105.30 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo 10.33 21.73 96.74 11.72 23.84 97.98 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 ULMN 2 1fps_00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 3 2 # 3 126 ARG A 518 ARG.? 16.31 O6 G B 2 253 PHE A 476 PHE~? 18.32 N2 G B 2 coo 11.87 35.64 105.40 9.89 33.34 105.30 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 10.33 21.73 96.74 11.72 23.84 97.98 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 ULMN 2 1fps_00 AVIAN FARNESYL DIPHOSPHATE SYNTHASE user 4 2 # 4 126 ARG A 541 ARG~? 18.28 O4 U B 1 253 PHE A 460 PHE~? 11.81 N2 G B 2 coo 11.87 35.64 105.40 9.89 33.34 105.30 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 coo 10.33 21.73 96.74 11.72 23.84 97.98 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 1fps_00 source 1fps AVIAN FARNESYL DIPHOSPHATE SYNTHASE (FPS) (E.C: 4 hits 1fps_00 naa= 2 ULMN 2 1fq0_00 KDPG ALDOLASE user 1 2 # 1 A 45 GLU A 225 GLU~? 23.05 C2 A B 9 A 133 LYS A 268 LYS~? 23.13 O4 U B 8 coo 24.81 25.32 38.82 23.00 25.16 37.74 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 18.26 19.92 32.68 20.05 22.35 36.35 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 1fq0_00 KDPG ALDOLASE user 2 2 # 2 A 45 GLU A 545 GLU~? 17.12 N3 U B 1 A 133 LYS A 487 LYS.? 20.83 N3 U B 1 coo 24.81 25.32 38.82 23.00 25.16 37.74 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 18.26 19.92 32.68 20.05 22.35 36.35 3.85 -58.89 -22.81 2.77 -64.79 -20.79 1fq0_00 source 1fq0 KDPG ALDOLASE : 2 hits 1fq0_00 naa= 2 ULMN 2 1fq0_01 KDPG ALDOLASE user 1 2 # 1 B 45 GLU A 225 GLU~? 23.05 C2 A B 9 B 133 LYS A 268 LYS~? 23.13 O4 U B 8 coo 3.94 6.65 13.38 3.87 8.55 14.36 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 4.24 17.15 12.78 2.73 12.27 13.50 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 1fq0_01 KDPG ALDOLASE user 2 2 # 2 B 45 GLU A 545 GLU~? 17.12 N3 U B 1 B 133 LYS A 487 LYS.? 20.83 N3 U B 1 coo 3.94 6.65 13.38 3.87 8.55 14.36 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 4.24 17.15 12.78 2.73 12.27 13.50 3.85 -58.89 -22.81 2.77 -64.79 -20.79 1fq0_01 source 1fq0 KDPG ALDOLASE : 2 hits 1fq0_01 naa= 2 ULMN 2 1fq0_02 KDPG ALDOLASE user 1 2 # 1 C 45 GLU A 225 GLU~? 23.05 C2 A B 9 C 133 LYS A 268 LYS~? 23.13 O4 U B 8 coo 8.38 43.77 10.65 8.15 42.35 12.20 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 12.43 39.26 19.13 9.45 41.97 16.24 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 1fq0_02 KDPG ALDOLASE user 2 2 # 2 C 45 GLU A 545 GLU~? 17.12 N3 U B 1 C 133 LYS A 487 LYS.? 20.83 N3 U B 1 coo 8.38 43.77 10.65 8.15 42.35 12.20 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 12.43 39.26 19.13 9.45 41.97 16.24 3.85 -58.89 -22.81 2.77 -64.79 -20.79 1fq0_02 source 1fq0 KDPG ALDOLASE : 2 hits 1fq0_02 naa= 2 ULMN 2 1fsg_04 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 A 118 TYR A 262 TYR~? 21.79 O4 U B 8 A 150 ASP A 298 ASP~? 21.17 O4 U B 8 coo 17.05 41.72 -19.12 16.18 39.08 -18.77 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 -41.82 -17.47 4.14 -42.95 -17.27 5.91 ULMN 2 1fsg_04 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 A 118 TYR A 413 TYR.? 4.41 O2' A B 4 A 150 ASP A 359 ASP~? 8.63 O2' A B 4 coo 17.05 41.72 -19.12 16.18 39.08 -18.77 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 coo 16.21 35.12 -15.07 14.15 35.53 -14.99 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 1fsg_04 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1fsg_04 naa= 2 ULMN 2 1fsg_05 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 1 2 # 1 C 118 TYR A 262 TYR~? 21.79 O4 U B 8 C 150 ASP A 298 ASP~? 21.17 O4 U B 8 coo 21.17 33.18 32.58 18.59 34.12 32.22 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 15.48 36.57 28.52 14.54 34.69 28.40 -41.82 -17.47 4.14 -42.95 -17.27 5.91 ULMN 2 1fsg_05 HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTuser 2 2 # 2 C 118 TYR A 413 TYR.? 4.41 O2' A B 4 C 150 ASP A 359 ASP~? 8.63 O2' A B 4 coo 21.17 33.18 32.58 18.59 34.12 32.22 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 coo 15.48 36.57 28.52 14.54 34.69 28.40 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 1fsg_05 source 1fsg HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE: 2 hits 1fsg_05 naa= 2 ULMN 2 1fua_00 L-FUCULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 73 GLU A 522 GLU^? 23.38 O4 U B 3 113 TYR A 479 TYR.? 25.88 N2 G B 2 coo -24.82 41.20 27.84 -23.33 41.85 29.24 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo -9.67 68.24 34.92 -8.38 68.44 32.44 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1fua_00 source 1fua L-FUCULOSE-1-PHOSPHATE ALDOLASE : 1 hits 1fua_00 naa= 2 ULMN 2 1g64_00 COB(I)ALAMIN ADENOSYLTRANSFERASE user 1 2 # 1 A 41 LYS A 236 LYS~? 15.40 O2 U B 8 A 43 THR A 239 THR~? 10.72 O2 U B 8 coo 3.40 35.69 42.25 -0.97 35.48 38.92 -21.15 -5.56 9.63 -19.04 -2.89 13.94 coo 3.69 33.32 46.92 2.58 31.52 46.50 -19.36 -10.64 8.19 -19.30 -8.96 6.83 ULMN 2 1g64_00 COB(I)ALAMIN ADENOSYLTRANSFERASE user 2 2 # 2 A 41 LYS A 264 LYS~? 27.36 N1 A B 9 A 43 THR A 263 THR~? 26.03 O4 U B 8 coo 3.40 35.69 42.25 -0.97 35.48 38.92 -41.84 -5.84 6.59 -43.28 -1.98 11.47 coo 3.69 33.32 46.92 2.58 31.52 46.50 -43.81 -9.09 6.81 -45.49 -9.19 5.45 ULMN 2 1g64_00 COB(I)ALAMIN ADENOSYLTRANSFERASE user 3 2 # 3 A 41 LYS A 372 LYS~? 15.54 N6 A B 7 A 43 THR A 368 THR~? 9.37 O2' C B 5 coo 3.40 35.69 42.25 -0.97 35.48 38.92 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 3.69 33.32 46.92 2.58 31.52 46.50 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 ULMN 2 1g64_00 COB(I)ALAMIN ADENOSYLTRANSFERASE user 4 2 # 4 A 41 LYS A 372 LYS~? 15.54 N6 A B 7 A 43 THR A 374 THR.? 15.78 N1 A B 4 coo 3.40 35.69 42.25 -0.97 35.48 38.92 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 3.69 33.32 46.92 2.58 31.52 46.50 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 ULMN 2 1g64_00 COB(I)ALAMIN ADENOSYLTRANSFERASE user 5 2 # 5 A 41 LYS A 521 LYS^? 31.39 O6 G B 2 A 43 THR A 520 THR.? 24.39 O6 G B 2 coo 3.40 35.69 42.25 -0.97 35.48 38.92 -27.98 -64.66 -13.31 -32.01 -68.20 -11.05 coo 3.69 33.32 46.92 2.58 31.52 46.50 -24.42 -64.64 -12.07 -23.58 -66.57 -11.57 ULMN 2 1g64_00 COB(I)ALAMIN ADENOSYLTRANSFERASE user 6 2 # 6 A 41 LYS A 544 LYS~? 22.64 O4 U B 1 A 43 THR A 543 THR~? 19.49 O4 U B 1 coo 3.40 35.69 42.25 -0.97 35.48 38.92 2.51 -69.72 -14.20 -0.06 -70.01 -19.70 coo 3.69 33.32 46.92 2.58 31.52 46.50 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 ULMN 2 1g64_00 COB(I)ALAMIN ADENOSYLTRANSFERASE user 7 2 # 7 A 41 LYS A 557 LYS~? 2.76 O4 U B 1 A 43 THR A 561 THR~? 10.68 O4 U B 1 coo 3.40 35.69 42.25 -0.97 35.48 38.92 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 coo 3.69 33.32 46.92 2.58 31.52 46.50 -7.66 -65.21 -2.98 -8.57 -63.47 -3.90 1g64_00 source 1g64 COB(I)ALAMIN ADENOSYLTRANSFERASE : 7 hits 1g64_00 naa= 2 ULMN 2 1g64_01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 1 2 # 1 B 241 LYS A 201 LYS~? 2.54 O3' A B 9 B 243 THR A 202 THR~? 8.86 O2' A B 9 coo 11.27 29.31 41.91 14.46 29.97 38.30 -15.93 -12.79 22.15 -13.89 -17.99 22.17 coo 11.07 31.88 46.68 12.01 33.74 46.14 -17.21 -12.36 25.70 -16.28 -12.03 27.61 ULMN 2 1g64_01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 2 2 # 2 B 241 LYS A 236 LYS~? 15.40 O2 U B 8 B 243 THR A 239 THR~? 10.72 O2 U B 8 coo 11.27 29.31 41.91 14.46 29.97 38.30 -21.15 -5.56 9.63 -19.04 -2.89 13.94 coo 11.07 31.88 46.68 12.01 33.74 46.14 -19.36 -10.64 8.19 -19.30 -8.96 6.83 ULMN 2 1g64_01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 3 2 # 3 B 241 LYS A 264 LYS~? 27.36 N1 A B 9 B 243 THR A 263 THR~? 26.03 O4 U B 8 coo 11.27 29.31 41.91 14.46 29.97 38.30 -41.84 -5.84 6.59 -43.28 -1.98 11.47 coo 11.07 31.88 46.68 12.01 33.74 46.14 -43.81 -9.09 6.81 -45.49 -9.19 5.45 ULMN 2 1g64_01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 4 2 # 4 B 241 LYS A 372 LYS~? 15.54 N6 A B 7 B 243 THR A 368 THR~? 9.37 O2' C B 5 coo 11.27 29.31 41.91 14.46 29.97 38.30 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 11.07 31.88 46.68 12.01 33.74 46.14 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 ULMN 2 1g64_01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 5 2 # 5 B 241 LYS A 372 LYS~? 15.54 N6 A B 7 B 243 THR A 374 THR.? 15.78 N1 A B 4 coo 11.27 29.31 41.91 14.46 29.97 38.30 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 11.07 31.88 46.68 12.01 33.74 46.14 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 ULMN 2 1g64_01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 6 2 # 6 B 241 LYS A 521 LYS^? 31.39 O6 G B 2 B 243 THR A 520 THR.? 24.39 O6 G B 2 coo 11.27 29.31 41.91 14.46 29.97 38.30 -27.98 -64.66 -13.31 -32.01 -68.20 -11.05 coo 11.07 31.88 46.68 12.01 33.74 46.14 -24.42 -64.64 -12.07 -23.58 -66.57 -11.57 ULMN 2 1g64_01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 7 2 # 7 B 241 LYS A 544 LYS~? 22.64 O4 U B 1 B 243 THR A 543 THR~? 19.49 O4 U B 1 coo 11.27 29.31 41.91 14.46 29.97 38.30 2.51 -69.72 -14.20 -0.06 -70.01 -19.70 coo 11.07 31.88 46.68 12.01 33.74 46.14 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 ULMN 2 1g64_01 COB(I)ALAMIN ADENOSYLTRANSFERASE user 8 2 # 8 B 241 LYS A 557 LYS~? 2.76 O4 U B 1 B 243 THR A 561 THR~? 10.68 O4 U B 1 coo 11.27 29.31 41.91 14.46 29.97 38.30 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 coo 11.07 31.88 46.68 12.01 33.74 46.14 -7.66 -65.21 -2.98 -8.57 -63.47 -3.90 1g64_01 source 1g64 COB(I)ALAMIN ADENOSYLTRANSFERASE : 8 hits 1g64_01 naa= 2 ULMN 2 1gdh_02 D-GLYCERATE DEHYDROGENASE (APO FORM)user 1 2 # 1 A 269 GLU A 457 GLU~? 3.32 N1 G B 2 A 287 HIS A 454 HIS~? 3.31 C5 U B 3 coo 23.48 10.69 22.39 22.24 12.31 21.83 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 20.16 15.49 22.94 18.67 14.36 21.99 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1gdh_02 source 1gdh D-GLYCERATE DEHYDROGENASE (APO FORM) (E.C.1.1.: 1 hits 1gdh_02 naa= 2 ULMN 2 1gdh_03 D-GLYCERATE DEHYDROGENASE (APO FORM)user 1 2 # 1 B 269 GLU A 457 GLU~? 3.32 N1 G B 2 B 287 HIS A 454 HIS~? 3.31 C5 U B 3 coo 37.72 45.90 19.85 36.33 45.31 18.40 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 34.65 43.41 15.42 33.80 45.28 15.03 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1gdh_03 source 1gdh D-GLYCERATE DEHYDROGENASE (APO FORM) (E.C.1.1.: 1 hits 1gdh_03 naa= 2 ULMN 2 1ge7_00 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 A 100 PHE A 206 PHE~? 11.98 C2 A B 9 A 118 GLU A 187 GLU~? 20.71 C2 A B 9 coo 25.28 13.65 -10.03 22.92 15.15 -10.20 -24.24 -10.97 28.11 -26.44 -9.51 29.03 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -28.60 -2.71 32.18 -27.08 -3.13 33.60 ULMN 2 1ge7_00 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 2 2 # 2 A 100 PHE A 272 PHE~? 19.44 O4 U B 8 A 118 GLU A 267 GLU~? 24.62 O4 U B 8 coo 25.28 13.65 -10.03 22.92 15.15 -10.20 -30.89 -5.38 4.64 -32.03 -3.22 6.00 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 ULMN 2 1ge7_00 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 3 2 # 3 A 100 PHE A 342 PHE~? 19.62 N1 A B 7 A 118 GLU A 341 GLU~? 25.67 N6 A B 7 coo 25.28 13.65 -10.03 22.92 15.15 -10.20 -30.61 -20.23 -12.56 -30.03 -19.19 -10.05 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1ge7_00 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 4 2 # 4 A 100 PHE A 451 PHE~? 4.67 O2 U B 3 A 118 GLU A 449 GLU.? 11.55 O2 U B 3 coo 25.28 13.65 -10.03 22.92 15.15 -10.20 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1ge7_00 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 5 2 # 5 A 100 PHE A 460 PHE~? 11.81 N2 G B 2 A 118 GLU A 457 GLU~? 3.32 N1 G B 2 coo 25.28 13.65 -10.03 22.92 15.15 -10.20 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 ULMN 2 1ge7_00 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 6 2 # 6 A 100 PHE A 460 PHE~? 11.81 N2 G B 2 A 118 GLU A 474 GLU~? 16.68 N2 G B 2 coo 25.28 13.65 -10.03 22.92 15.15 -10.20 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 ULMN 2 1ge7_00 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 7 2 # 7 A 100 PHE A 498 PHE~? 4.65 O2' G B 2 A 118 GLU A 449 GLU.? 11.55 O2 U B 3 coo 25.28 13.65 -10.03 22.92 15.15 -10.20 -1.63 -46.37 -9.92 -0.18 -44.21 -8.91 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 1ge7_00 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 7 hits 1ge7_00 naa= 2 ULMN 2 1ge7_01 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 B 100 PHE A 272 PHE~? 19.44 O4 U B 8 B 118 GLU A 267 GLU~? 24.62 O4 U B 8 coo 3.67 17.54 51.97 6.00 19.03 52.32 -30.89 -5.38 4.64 -32.03 -3.22 6.00 coo 4.10 21.86 44.74 2.66 21.47 43.23 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 ULMN 2 1ge7_01 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 2 2 # 2 B 100 PHE A 342 PHE~? 19.62 N1 A B 7 B 118 GLU A 341 GLU~? 25.67 N6 A B 7 coo 3.67 17.54 51.97 6.00 19.03 52.32 -30.61 -20.23 -12.56 -30.03 -19.19 -10.05 coo 4.10 21.86 44.74 2.66 21.47 43.23 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1ge7_01 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 3 2 # 3 B 100 PHE A 451 PHE~? 4.67 O2 U B 3 B 118 GLU A 449 GLU.? 11.55 O2 U B 3 coo 3.67 17.54 51.97 6.00 19.03 52.32 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo 4.10 21.86 44.74 2.66 21.47 43.23 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1ge7_01 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 4 2 # 4 B 100 PHE A 460 PHE~? 11.81 N2 G B 2 B 118 GLU A 457 GLU~? 3.32 N1 G B 2 coo 3.67 17.54 51.97 6.00 19.03 52.32 -13.61 -54.68 -14.10 -11.98 -55.22 -16.28 coo 4.10 21.86 44.74 2.66 21.47 43.23 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 ULMN 2 1ge7_01 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 5 2 # 5 B 100 PHE A 498 PHE~? 4.65 O2' G B 2 B 118 GLU A 449 GLU.? 11.55 O2 U B 3 coo 3.67 17.54 51.97 6.00 19.03 52.32 -1.63 -46.37 -9.92 -0.18 -44.21 -8.91 coo 4.10 21.86 44.74 2.66 21.47 43.23 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 1ge7_01 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 5 hits 1ge7_01 naa= 2 ULMN 2 1ge7_02 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 A 118 GLU A 466 GLU~? 26.72 N2 G B 2 A 133 TYR A 525 TYR^? 33.09 N2 G B 2 coo 24.89 18.10 -2.89 26.39 17.70 -1.45 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 26.98 8.80 3.58 27.20 8.50 0.81 -31.10 -64.72 -19.95 -33.38 -64.72 -21.56 1ge7_02 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 1 hits 1ge7_02 naa= 2 ULMN 2 1ge7_03 PEPTIDYL-LYS METALLOENDOPEPTIDASE user 1 2 # 1 B 118 GLU A 466 GLU~? 26.72 N2 G B 2 B 133 TYR A 525 TYR^? 33.09 N2 G B 2 coo 4.10 21.86 44.74 2.66 21.47 43.23 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 1.98 12.55 38.35 1.73 12.30 41.13 -31.10 -64.72 -19.95 -33.38 -64.72 -21.56 1ge7_03 source 1ge7 PEPTIDYL-LYS METALLOENDOPEPTIDASE : 1 hits 1ge7_03 naa= 2 ULMN 2 1ghs_02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 2 # 1 B 231 GLU A 351 GLU~? 20.29 O2' A B 4 B 288 GLU A 407 GLU~? 15.45 O2 U B 3 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1ghs_02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 2 # 2 B 231 GLU A 407 GLU~? 15.45 O2 U B 3 B 288 GLU A 351 GLU~? 20.29 O2' A B 4 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1ghs_02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 2 # 3 B 231 GLU A 432 GLU~? 22.16 O4 U B 3 B 288 GLU A 470 GLU~? 22.82 N2 G B 2 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1ghs_02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 2 # 4 B 231 GLU A 432 GLU~? 22.16 O4 U B 3 B 288 GLU A 522 GLU^? 23.38 O4 U B 3 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1ghs_02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 5 2 # 5 B 231 GLU A 470 GLU~? 22.82 N2 G B 2 B 288 GLU A 432 GLU~? 22.16 O4 U B 3 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1ghs_02 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 6 2 # 6 B 231 GLU A 522 GLU^? 23.38 O4 U B 3 B 288 GLU A 432 GLU~? 22.16 O4 U B 3 coo 47.83 -0.67 47.15 49.17 -0.90 48.81 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 47.02 -1.91 59.02 47.41 -1.07 57.09 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1ghs_02 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 6 hits 1ghs_02 naa= 2 ULMN 2 1ghs_03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 2 # 1 A 231 GLU A 351 GLU~? 20.29 O2' A B 4 A 288 GLU A 407 GLU~? 15.45 O2 U B 3 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1ghs_03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 2 2 # 2 A 231 GLU A 407 GLU~? 15.45 O2 U B 3 A 288 GLU A 351 GLU~? 20.29 O2' A B 4 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1ghs_03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 3 2 # 3 A 231 GLU A 432 GLU~? 22.16 O4 U B 3 A 288 GLU A 470 GLU~? 22.82 N2 G B 2 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1ghs_03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 4 2 # 4 A 231 GLU A 432 GLU~? 22.16 O4 U B 3 A 288 GLU A 522 GLU^? 23.38 O4 U B 3 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1ghs_03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 5 2 # 5 A 231 GLU A 470 GLU~? 22.82 N2 G B 2 A 288 GLU A 432 GLU~? 22.16 O4 U B 3 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1ghs_03 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 6 2 # 6 A 231 GLU A 522 GLU^? 23.38 O4 U B 3 A 288 GLU A 432 GLU~? 22.16 O4 U B 3 coo 56.45 0.46 86.18 56.87 -0.85 87.80 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 54.40 -0.12 97.85 55.58 0.51 96.24 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1ghs_03 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 6 hits 1ghs_03 naa= 2 ULMN 2 1gpj_01 GLUTAMYL-TRNA REDUCTASE user 1 2 # 1 A 48 SER A 377 SER~? 20.10 O2 C B 5 A 84 HIS A 420 HIS~? 9.42 N1 A B 4 coo 73.61 56.25 53.64 74.51 58.42 54.29 -36.34 -43.17 -2.56 -34.94 -43.93 -0.70 coo 60.00 60.51 47.62 61.47 59.95 49.01 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1gpj_01 GLUTAMYL-TRNA REDUCTASE user 2 2 # 2 A 48 SER A 445 SER~? 14.11 N2 G B 2 A 84 HIS A 454 HIS~? 3.31 C5 U B 3 coo 73.61 56.25 53.64 74.51 58.42 54.29 -4.27 -47.21 -20.02 -5.51 -46.10 -21.77 coo 60.00 60.51 47.62 61.47 59.95 49.01 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 ULMN 2 1gpj_01 GLUTAMYL-TRNA REDUCTASE user 3 2 # 3 A 48 SER A 453 SER~? 2.96 N2 G B 2 A 84 HIS A 462 HIS~? 12.61 O4 U B 3 coo 73.61 56.25 53.64 74.51 58.42 54.29 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 coo 60.00 60.51 47.62 61.47 59.95 49.01 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gpj_01 GLUTAMYL-TRNA REDUCTASE user 4 2 # 4 A 48 SER A 515 SER~? 19.83 O4 U B 1 A 84 HIS A 539 HIS~? 18.96 O4 U B 1 coo 73.61 56.25 53.64 74.51 58.42 54.29 -18.72 -69.11 -4.92 -17.74 -67.34 -3.57 coo 60.00 60.51 47.62 61.47 59.95 49.01 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 ULMN 2 1gpj_01 GLUTAMYL-TRNA REDUCTASE user 5 2 # 5 A 48 SER A 550 SER~? 14.27 O4 U B 1 A 84 HIS A 539 HIS~? 18.96 O4 U B 1 coo 73.61 56.25 53.64 74.51 58.42 54.29 4.96 -63.97 -4.54 6.61 -65.75 -4.82 coo 60.00 60.51 47.62 61.47 59.95 49.01 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 ULMN 2 1gpj_01 GLUTAMYL-TRNA REDUCTASE user 6 2 # 6 A 48 SER A 554 SER~? 4.73 N3 U B 1 A 84 HIS A 454 HIS~? 3.31 C5 U B 3 coo 73.61 56.25 53.64 74.51 58.42 54.29 -0.46 -57.65 -4.36 0.71 -56.86 -6.34 coo 60.00 60.51 47.62 61.47 59.95 49.01 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1gpj_01 source 1gpj GLUTAMYL-TRNA REDUCTASE : 6 hits 1gpj_01 naa= 2 ULMN 2 1grc_05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 2 # 1 B 108 HIS A 326 HIS~? 3.28 C5 A B 7 B 144 ASP A 283 ASP~? 9.21 O2 U B 8 coo 41.00 107.18 12.86 42.70 107.82 11.96 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 31.60 110.69 6.14 29.69 109.74 5.94 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 1grc_05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 2 # 2 B 108 HIS A 352 HIS~? 21.18 O2' A B 4 B 144 ASP A 359 ASP~? 8.63 O2' A B 4 coo 41.00 107.18 12.86 42.70 107.82 11.96 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 coo 31.60 110.69 6.14 29.69 109.74 5.94 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 1grc_05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 2 # 3 B 108 HIS A 482 HIS.? 27.32 N2 G B 2 B 144 ASP A 488 ASP~? 18.76 O2 U B 1 coo 41.00 107.18 12.86 42.70 107.82 11.96 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 31.60 110.69 6.14 29.69 109.74 5.94 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 ULMN 2 1grc_05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 4 2 # 4 B 108 HIS A 496 HIS.? 9.17 O2 U B 1 B 144 ASP A 484 ASP.? 22.65 O2 U B 1 coo 41.00 107.18 12.86 42.70 107.82 11.96 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 31.60 110.69 6.14 29.69 109.74 5.94 7.90 -50.74 -23.88 8.67 -50.47 -25.84 ULMN 2 1grc_05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 5 2 # 5 B 108 HIS A 496 HIS.? 9.17 O2 U B 1 B 144 ASP A 488 ASP~? 18.76 O2 U B 1 coo 41.00 107.18 12.86 42.70 107.82 11.96 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 31.60 110.69 6.14 29.69 109.74 5.94 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 ULMN 2 1grc_05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 6 2 # 6 B 108 HIS A 527 HIS~? 25.85 N2 G B 2 B 144 ASP A 533 ASP~? 24.95 O4 U B 1 coo 41.00 107.18 12.86 42.70 107.82 11.96 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 31.60 110.69 6.14 29.69 109.74 5.94 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1grc_05 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 7 2 # 7 B 108 HIS A 539 HIS~? 18.96 O4 U B 1 B 144 ASP A 533 ASP~? 24.95 O4 U B 1 coo 41.00 107.18 12.86 42.70 107.82 11.96 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 coo 31.60 110.69 6.14 29.69 109.74 5.94 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1grc_05 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 7 hits 1grc_05 naa= 2 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 A 117 GLU A 341 GLU~? 25.67 N6 A B 7 A 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 A 117 GLU A 351 GLU~? 20.29 O2' A B 4 A 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 A 117 GLU A 351 GLU~? 20.29 O2' A B 4 A 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 A 117 GLU A 371 GLU~? 9.29 O2 C B 5 A 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 A 117 GLU A 391 GLU~? 23.54 N1 A B 4 A 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 A 117 GLU A 432 GLU~? 22.16 O4 U B 3 A 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 A 117 GLU A 436 GLU~? 23.50 O4 U B 3 A 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 A 117 GLU A 436 GLU~? 23.50 O4 U B 3 A 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 A 117 GLU A 449 GLU.? 11.55 O2 U B 3 A 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 A 117 GLU A 466 GLU~? 26.72 N2 G B 2 A 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 A 117 GLU A 470 GLU~? 22.82 N2 G B 2 A 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -26.84 69.09 69.06 -26.63 69.70 67.04 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -46.59 50.85 67.63 -45.19 49.65 68.72 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_00 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 A 117 GLU A 545 GLU~? 17.12 N3 U B 1 A 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -26.84 69.09 69.06 -26.63 69.70 67.04 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -46.59 50.85 67.63 -45.19 49.65 68.72 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_00 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_00 naa= 2 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 B 117 GLU A 341 GLU~? 25.67 N6 A B 7 B 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 B 117 GLU A 351 GLU~? 20.29 O2' A B 4 B 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 B 117 GLU A 351 GLU~? 20.29 O2' A B 4 B 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 B 117 GLU A 371 GLU~? 9.29 O2 C B 5 B 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 B 117 GLU A 391 GLU~? 23.54 N1 A B 4 B 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 B 117 GLU A 432 GLU~? 22.16 O4 U B 3 B 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 B 117 GLU A 436 GLU~? 23.50 O4 U B 3 B 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 B 117 GLU A 436 GLU~? 23.50 O4 U B 3 B 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 B 117 GLU A 449 GLU.? 11.55 O2 U B 3 B 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 B 117 GLU A 466 GLU~? 26.72 N2 G B 2 B 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 B 117 GLU A 470 GLU~? 22.82 N2 G B 2 B 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -1.79 41.80 68.17 -1.22 41.21 66.22 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -20.24 61.05 64.55 -21.33 59.84 65.93 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_01 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 B 117 GLU A 545 GLU~? 17.12 N3 U B 1 B 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -1.79 41.80 68.17 -1.22 41.21 66.22 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -20.24 61.05 64.55 -21.33 59.84 65.93 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_01 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_01 naa= 2 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 C 117 GLU A 341 GLU~? 25.67 N6 A B 7 C 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 C 117 GLU A 351 GLU~? 20.29 O2' A B 4 C 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 C 117 GLU A 351 GLU~? 20.29 O2' A B 4 C 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 C 117 GLU A 371 GLU~? 9.29 O2 C B 5 C 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 C 117 GLU A 391 GLU~? 23.54 N1 A B 4 C 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 C 117 GLU A 432 GLU~? 22.16 O4 U B 3 C 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 C 117 GLU A 436 GLU~? 23.50 O4 U B 3 C 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 C 117 GLU A 436 GLU~? 23.50 O4 U B 3 C 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 C 117 GLU A 449 GLU.? 11.55 O2 U B 3 C 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 C 117 GLU A 466 GLU~? 26.72 N2 G B 2 C 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 C 117 GLU A 470 GLU~? 22.82 N2 G B 2 C 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -28.87 16.75 72.09 -29.49 15.92 70.20 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -9.92 34.54 65.04 -11.08 35.85 66.27 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_02 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 C 117 GLU A 545 GLU~? 17.12 N3 U B 1 C 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -28.87 16.75 72.09 -29.49 15.92 70.20 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -9.92 34.54 65.04 -11.08 35.85 66.27 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_02 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_02 naa= 2 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 D 117 GLU A 341 GLU~? 25.67 N6 A B 7 D 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 D 117 GLU A 351 GLU~? 20.29 O2' A B 4 D 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 D 117 GLU A 351 GLU~? 20.29 O2' A B 4 D 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 D 117 GLU A 371 GLU~? 9.29 O2 C B 5 D 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 D 117 GLU A 391 GLU~? 23.54 N1 A B 4 D 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 D 117 GLU A 432 GLU~? 22.16 O4 U B 3 D 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 D 117 GLU A 436 GLU~? 23.50 O4 U B 3 D 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 D 117 GLU A 436 GLU~? 23.50 O4 U B 3 D 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 D 117 GLU A 449 GLU.? 11.55 O2 U B 3 D 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 D 117 GLU A 466 GLU~? 26.72 N2 G B 2 D 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 D 117 GLU A 470 GLU~? 22.82 N2 G B 2 D 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -53.93 44.08 73.08 -54.84 44.43 71.23 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -36.31 24.35 68.07 -34.99 25.71 69.07 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_03 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 D 117 GLU A 545 GLU~? 17.12 N3 U B 1 D 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -53.93 44.08 73.08 -54.84 44.43 71.23 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -36.31 24.35 68.07 -34.99 25.71 69.07 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_03 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_03 naa= 2 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 E 117 GLU A 341 GLU~? 25.67 N6 A B 7 E 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 E 117 GLU A 351 GLU~? 20.29 O2' A B 4 E 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 E 117 GLU A 351 GLU~? 20.29 O2' A B 4 E 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 E 117 GLU A 371 GLU~? 9.29 O2 C B 5 E 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 E 117 GLU A 391 GLU~? 23.54 N1 A B 4 E 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 E 117 GLU A 432 GLU~? 22.16 O4 U B 3 E 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 E 117 GLU A 436 GLU~? 23.50 O4 U B 3 E 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 E 117 GLU A 436 GLU~? 23.50 O4 U B 3 E 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 E 117 GLU A 449 GLU.? 11.55 O2 U B 3 E 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 E 117 GLU A 466 GLU~? 26.72 N2 G B 2 E 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 E 117 GLU A 470 GLU~? 22.82 N2 G B 2 E 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -21.36 92.92 67.45 -22.82 92.33 66.01 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -6.51 111.39 54.71 -6.90 112.52 56.48 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_04 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 E 117 GLU A 545 GLU~? 17.12 N3 U B 1 E 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -21.36 92.92 67.45 -22.82 92.33 66.01 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -6.51 111.39 54.71 -6.90 112.52 56.48 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_04 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_04 naa= 2 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 F 117 GLU A 341 GLU~? 25.67 N6 A B 7 F 171 GLU A 432 GLU~? 22.16 O4 U B 3 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 F 117 GLU A 341 GLU~? 25.67 N6 A B 7 F 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 F 117 GLU A 351 GLU~? 20.29 O2' A B 4 F 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 F 117 GLU A 351 GLU~? 20.29 O2' A B 4 F 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 F 117 GLU A 371 GLU~? 9.29 O2 C B 5 F 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 F 117 GLU A 391 GLU~? 23.54 N1 A B 4 F 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 F 117 GLU A 432 GLU~? 22.16 O4 U B 3 F 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 F 117 GLU A 436 GLU~? 23.50 O4 U B 3 F 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 F 117 GLU A 436 GLU~? 23.50 O4 U B 3 F 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 F 117 GLU A 449 GLU.? 11.55 O2 U B 3 F 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 F 117 GLU A 466 GLU~? 26.72 N2 G B 2 F 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 F 117 GLU A 470 GLU~? 22.82 N2 G B 2 F 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -41.57 119.98 82.85 -43.21 120.52 81.59 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -29.32 100.98 68.24 -27.58 102.15 68.60 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_05 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 F 117 GLU A 545 GLU~? 17.12 N3 U B 1 F 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -41.57 119.98 82.85 -43.21 120.52 81.59 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -29.32 100.98 68.24 -27.58 102.15 68.60 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_05 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 13 hits 1gt7_05 naa= 2 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 G 117 GLU A 341 GLU~? 25.67 N6 A B 7 G 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 G 117 GLU A 351 GLU~? 20.29 O2' A B 4 G 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 G 117 GLU A 351 GLU~? 20.29 O2' A B 4 G 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 G 117 GLU A 371 GLU~? 9.29 O2 C B 5 G 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 G 117 GLU A 391 GLU~? 23.54 N1 A B 4 G 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 G 117 GLU A 432 GLU~? 22.16 O4 U B 3 G 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 G 117 GLU A 436 GLU~? 23.50 O4 U B 3 G 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 G 117 GLU A 436 GLU~? 23.50 O4 U B 3 G 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 G 117 GLU A 449 GLU.? 11.55 O2 U B 3 G 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 G 117 GLU A 466 GLU~? 26.72 N2 G B 2 G 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 G 117 GLU A 470 GLU~? 22.82 N2 G B 2 G 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -17.54 145.16 69.99 -18.24 146.04 68.15 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -36.98 127.38 75.58 -35.31 126.04 75.81 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_06 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 G 117 GLU A 545 GLU~? 17.12 N3 U B 1 G 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -17.54 145.16 69.99 -18.24 146.04 68.15 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -36.98 127.38 75.58 -35.31 126.04 75.81 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_06 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_06 naa= 2 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 H 117 GLU A 341 GLU~? 25.67 N6 A B 7 H 171 GLU A 432 GLU~? 22.16 O4 U B 3 coo 2.65 118.13 54.75 2.20 117.91 52.65 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 H 117 GLU A 341 GLU~? 25.67 N6 A B 7 H 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 2.65 118.13 54.75 2.20 117.91 52.65 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 H 117 GLU A 351 GLU~? 20.29 O2' A B 4 H 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo 2.65 118.13 54.75 2.20 117.91 52.65 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 H 117 GLU A 351 GLU~? 20.29 O2' A B 4 H 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 2.65 118.13 54.75 2.20 117.91 52.65 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 H 117 GLU A 391 GLU~? 23.54 N1 A B 4 H 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 2.65 118.13 54.75 2.20 117.91 52.65 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 H 117 GLU A 432 GLU~? 22.16 O4 U B 3 H 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 2.65 118.13 54.75 2.20 117.91 52.65 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 H 117 GLU A 436 GLU~? 23.50 O4 U B 3 H 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 2.65 118.13 54.75 2.20 117.91 52.65 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 H 117 GLU A 436 GLU~? 23.50 O4 U B 3 H 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 2.65 118.13 54.75 2.20 117.91 52.65 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 H 117 GLU A 449 GLU.? 11.55 O2 U B 3 H 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo 2.65 118.13 54.75 2.20 117.91 52.65 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 H 117 GLU A 466 GLU~? 26.72 N2 G B 2 H 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo 2.65 118.13 54.75 2.20 117.91 52.65 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 H 117 GLU A 470 GLU~? 22.82 N2 G B 2 H 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo 2.65 118.13 54.75 2.20 117.91 52.65 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -14.22 137.71 62.12 -14.71 136.33 63.70 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_07 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 H 117 GLU A 545 GLU~? 17.12 N3 U B 1 H 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo 2.65 118.13 54.75 2.20 117.91 52.65 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -14.22 137.71 62.12 -14.71 136.33 63.70 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_07 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_07 naa= 2 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 I 117 GLU A 341 GLU~? 25.67 N6 A B 7 I 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 21.75 35.77 66.58 21.06 37.00 64.94 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 39.40 18.83 55.43 40.64 19.47 57.06 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 I 117 GLU A 351 GLU~? 20.29 O2' A B 4 I 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo 21.75 35.77 66.58 21.06 37.00 64.94 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 39.40 18.83 55.43 40.64 19.47 57.06 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 I 117 GLU A 351 GLU~? 20.29 O2' A B 4 I 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 21.75 35.77 66.58 21.06 37.00 64.94 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 39.40 18.83 55.43 40.64 19.47 57.06 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 I 117 GLU A 371 GLU~? 9.29 O2 C B 5 I 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo 21.75 35.77 66.58 21.06 37.00 64.94 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 39.40 18.83 55.43 40.64 19.47 57.06 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 I 117 GLU A 391 GLU~? 23.54 N1 A B 4 I 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 21.75 35.77 66.58 21.06 37.00 64.94 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 39.40 18.83 55.43 40.64 19.47 57.06 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 I 117 GLU A 432 GLU~? 22.16 O4 U B 3 I 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 21.75 35.77 66.58 21.06 37.00 64.94 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 39.40 18.83 55.43 40.64 19.47 57.06 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 I 117 GLU A 436 GLU~? 23.50 O4 U B 3 I 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 21.75 35.77 66.58 21.06 37.00 64.94 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 39.40 18.83 55.43 40.64 19.47 57.06 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 I 117 GLU A 436 GLU~? 23.50 O4 U B 3 I 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 21.75 35.77 66.58 21.06 37.00 64.94 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 39.40 18.83 55.43 40.64 19.47 57.06 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 I 117 GLU A 449 GLU.? 11.55 O2 U B 3 I 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo 21.75 35.77 66.58 21.06 37.00 64.94 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo 39.40 18.83 55.43 40.64 19.47 57.06 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 I 117 GLU A 466 GLU~? 26.72 N2 G B 2 I 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo 21.75 35.77 66.58 21.06 37.00 64.94 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 39.40 18.83 55.43 40.64 19.47 57.06 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 I 117 GLU A 470 GLU~? 22.82 N2 G B 2 I 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo 21.75 35.77 66.58 21.06 37.00 64.94 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 39.40 18.83 55.43 40.64 19.47 57.06 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_08 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 I 117 GLU A 545 GLU~? 17.12 N3 U B 1 I 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo 21.75 35.77 66.58 21.06 37.00 64.94 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 39.40 18.83 55.43 40.64 19.47 57.06 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_08 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_08 naa= 2 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 J 117 GLU A 341 GLU~? 25.67 N6 A B 7 J 171 GLU A 432 GLU~? 22.16 O4 U B 3 coo 49.72 57.74 77.19 50.16 59.17 75.67 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 29.89 43.66 65.68 31.09 41.98 66.25 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 J 117 GLU A 341 GLU~? 25.67 N6 A B 7 J 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 49.72 57.74 77.19 50.16 59.17 75.67 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 29.89 43.66 65.68 31.09 41.98 66.25 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 J 117 GLU A 351 GLU~? 20.29 O2' A B 4 J 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo 49.72 57.74 77.19 50.16 59.17 75.67 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 29.89 43.66 65.68 31.09 41.98 66.25 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 J 117 GLU A 351 GLU~? 20.29 O2' A B 4 J 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 49.72 57.74 77.19 50.16 59.17 75.67 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 29.89 43.66 65.68 31.09 41.98 66.25 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 J 117 GLU A 371 GLU~? 9.29 O2 C B 5 J 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo 49.72 57.74 77.19 50.16 59.17 75.67 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 29.89 43.66 65.68 31.09 41.98 66.25 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 J 117 GLU A 391 GLU~? 23.54 N1 A B 4 J 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 49.72 57.74 77.19 50.16 59.17 75.67 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 29.89 43.66 65.68 31.09 41.98 66.25 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 J 117 GLU A 432 GLU~? 22.16 O4 U B 3 J 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 49.72 57.74 77.19 50.16 59.17 75.67 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 29.89 43.66 65.68 31.09 41.98 66.25 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 J 117 GLU A 436 GLU~? 23.50 O4 U B 3 J 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 49.72 57.74 77.19 50.16 59.17 75.67 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 29.89 43.66 65.68 31.09 41.98 66.25 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 J 117 GLU A 436 GLU~? 23.50 O4 U B 3 J 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 49.72 57.74 77.19 50.16 59.17 75.67 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 29.89 43.66 65.68 31.09 41.98 66.25 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 J 117 GLU A 449 GLU.? 11.55 O2 U B 3 J 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo 49.72 57.74 77.19 50.16 59.17 75.67 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo 29.89 43.66 65.68 31.09 41.98 66.25 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 J 117 GLU A 466 GLU~? 26.72 N2 G B 2 J 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo 49.72 57.74 77.19 50.16 59.17 75.67 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 29.89 43.66 65.68 31.09 41.98 66.25 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 J 117 GLU A 470 GLU~? 22.82 N2 G B 2 J 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo 49.72 57.74 77.19 50.16 59.17 75.67 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 29.89 43.66 65.68 31.09 41.98 66.25 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_09 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 J 117 GLU A 545 GLU~? 17.12 N3 U B 1 J 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo 49.72 57.74 77.19 50.16 59.17 75.67 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 29.89 43.66 65.68 31.09 41.98 66.25 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_09 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 13 hits 1gt7_09 naa= 2 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 K 117 GLU A 341 GLU~? 25.67 N6 A B 7 K 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 73.94 31.71 67.00 74.74 32.13 65.03 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 56.59 52.03 70.37 55.28 50.47 70.94 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 K 117 GLU A 351 GLU~? 20.29 O2' A B 4 K 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo 73.94 31.71 67.00 74.74 32.13 65.03 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 56.59 52.03 70.37 55.28 50.47 70.94 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 K 117 GLU A 351 GLU~? 20.29 O2' A B 4 K 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 73.94 31.71 67.00 74.74 32.13 65.03 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 56.59 52.03 70.37 55.28 50.47 70.94 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 K 117 GLU A 371 GLU~? 9.29 O2 C B 5 K 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo 73.94 31.71 67.00 74.74 32.13 65.03 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 56.59 52.03 70.37 55.28 50.47 70.94 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 K 117 GLU A 391 GLU~? 23.54 N1 A B 4 K 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 73.94 31.71 67.00 74.74 32.13 65.03 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 56.59 52.03 70.37 55.28 50.47 70.94 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 K 117 GLU A 432 GLU~? 22.16 O4 U B 3 K 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 73.94 31.71 67.00 74.74 32.13 65.03 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 56.59 52.03 70.37 55.28 50.47 70.94 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 K 117 GLU A 436 GLU~? 23.50 O4 U B 3 K 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 73.94 31.71 67.00 74.74 32.13 65.03 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 56.59 52.03 70.37 55.28 50.47 70.94 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 K 117 GLU A 436 GLU~? 23.50 O4 U B 3 K 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 73.94 31.71 67.00 74.74 32.13 65.03 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 56.59 52.03 70.37 55.28 50.47 70.94 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 K 117 GLU A 449 GLU.? 11.55 O2 U B 3 K 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo 73.94 31.71 67.00 74.74 32.13 65.03 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo 56.59 52.03 70.37 55.28 50.47 70.94 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 K 117 GLU A 466 GLU~? 26.72 N2 G B 2 K 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo 73.94 31.71 67.00 74.74 32.13 65.03 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 56.59 52.03 70.37 55.28 50.47 70.94 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 K 117 GLU A 470 GLU~? 22.82 N2 G B 2 K 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo 73.94 31.71 67.00 74.74 32.13 65.03 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 56.59 52.03 70.37 55.28 50.47 70.94 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_10 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 K 117 GLU A 545 GLU~? 17.12 N3 U B 1 K 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo 73.94 31.71 67.00 74.74 32.13 65.03 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 56.59 52.03 70.37 55.28 50.47 70.94 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_10 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_10 naa= 2 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 L 117 GLU A 341 GLU~? 25.67 N6 A B 7 L 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 45.97 9.66 56.63 45.65 9.77 54.50 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 66.14 27.14 60.19 64.84 27.91 61.76 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 L 117 GLU A 351 GLU~? 20.29 O2' A B 4 L 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo 45.97 9.66 56.63 45.65 9.77 54.50 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 66.14 27.14 60.19 64.84 27.91 61.76 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 L 117 GLU A 351 GLU~? 20.29 O2' A B 4 L 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo 45.97 9.66 56.63 45.65 9.77 54.50 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 66.14 27.14 60.19 64.84 27.91 61.76 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 L 117 GLU A 371 GLU~? 9.29 O2 C B 5 L 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo 45.97 9.66 56.63 45.65 9.77 54.50 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 66.14 27.14 60.19 64.84 27.91 61.76 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 L 117 GLU A 391 GLU~? 23.54 N1 A B 4 L 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 45.97 9.66 56.63 45.65 9.77 54.50 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 66.14 27.14 60.19 64.84 27.91 61.76 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 L 117 GLU A 432 GLU~? 22.16 O4 U B 3 L 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 45.97 9.66 56.63 45.65 9.77 54.50 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 66.14 27.14 60.19 64.84 27.91 61.76 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 L 117 GLU A 436 GLU~? 23.50 O4 U B 3 L 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo 45.97 9.66 56.63 45.65 9.77 54.50 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 66.14 27.14 60.19 64.84 27.91 61.76 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 L 117 GLU A 436 GLU~? 23.50 O4 U B 3 L 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo 45.97 9.66 56.63 45.65 9.77 54.50 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 66.14 27.14 60.19 64.84 27.91 61.76 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 L 117 GLU A 449 GLU.? 11.55 O2 U B 3 L 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo 45.97 9.66 56.63 45.65 9.77 54.50 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo 66.14 27.14 60.19 64.84 27.91 61.76 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 L 117 GLU A 466 GLU~? 26.72 N2 G B 2 L 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo 45.97 9.66 56.63 45.65 9.77 54.50 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 66.14 27.14 60.19 64.84 27.91 61.76 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 L 117 GLU A 470 GLU~? 22.82 N2 G B 2 L 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo 45.97 9.66 56.63 45.65 9.77 54.50 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 66.14 27.14 60.19 64.84 27.91 61.76 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_11 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 L 117 GLU A 545 GLU~? 17.12 N3 U B 1 L 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo 45.97 9.66 56.63 45.65 9.77 54.50 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 66.14 27.14 60.19 64.84 27.91 61.76 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_11 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_11 naa= 2 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 M 117 GLU A 341 GLU~? 25.67 N6 A B 7 M 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 M 117 GLU A 351 GLU~? 20.29 O2' A B 4 M 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 M 117 GLU A 351 GLU~? 20.29 O2' A B 4 M 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 M 117 GLU A 371 GLU~? 9.29 O2 C B 5 M 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 M 117 GLU A 391 GLU~? 23.54 N1 A B 4 M 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 M 117 GLU A 432 GLU~? 22.16 O4 U B 3 M 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 M 117 GLU A 436 GLU~? 23.50 O4 U B 3 M 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 M 117 GLU A 436 GLU~? 23.50 O4 U B 3 M 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 M 117 GLU A 449 GLU.? 11.55 O2 U B 3 M 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 M 117 GLU A 466 GLU~? 26.72 N2 G B 2 M 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 M 117 GLU A 470 GLU~? 22.82 N2 G B 2 M 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_12 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 M 117 GLU A 545 GLU~? 17.12 N3 U B 1 M 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -34.38 -6.85 73.90 -33.29 -6.42 72.10 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -51.09 -26.52 66.24 -50.35 -27.42 68.03 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_12 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_12 naa= 2 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 N 117 GLU A 341 GLU~? 25.67 N6 A B 7 N 171 GLU A 432 GLU~? 22.16 O4 U B 3 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 N 117 GLU A 341 GLU~? 25.67 N6 A B 7 N 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 N 117 GLU A 351 GLU~? 20.29 O2' A B 4 N 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 N 117 GLU A 351 GLU~? 20.29 O2' A B 4 N 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 N 117 GLU A 391 GLU~? 23.54 N1 A B 4 N 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 N 117 GLU A 432 GLU~? 22.16 O4 U B 3 N 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 N 117 GLU A 436 GLU~? 23.50 O4 U B 3 N 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 N 117 GLU A 436 GLU~? 23.50 O4 U B 3 N 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 N 117 GLU A 449 GLU.? 11.55 O2 U B 3 N 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 N 117 GLU A 466 GLU~? 26.72 N2 G B 2 N 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 N 117 GLU A 470 GLU~? 22.82 N2 G B 2 N 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_13 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 N 117 GLU A 545 GLU~? 17.12 N3 U B 1 N 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -11.01 -32.16 87.50 -9.59 -32.79 85.97 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -26.32 -14.81 73.82 -27.93 -15.95 74.68 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_13 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_13 naa= 2 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 O 117 GLU A 341 GLU~? 25.67 N6 A B 7 O 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 O 117 GLU A 351 GLU~? 20.29 O2' A B 4 O 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 O 117 GLU A 351 GLU~? 20.29 O2' A B 4 O 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 O 117 GLU A 371 GLU~? 9.29 O2 C B 5 O 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 O 117 GLU A 391 GLU~? 23.54 N1 A B 4 O 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 O 117 GLU A 432 GLU~? 22.16 O4 U B 3 O 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 O 117 GLU A 436 GLU~? 23.50 O4 U B 3 O 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 O 117 GLU A 436 GLU~? 23.50 O4 U B 3 O 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 O 117 GLU A 449 GLU.? 11.55 O2 U B 3 O 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 O 117 GLU A 466 GLU~? 26.72 N2 G B 2 O 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 O 117 GLU A 470 GLU~? 22.82 N2 G B 2 O 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_14 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 O 117 GLU A 545 GLU~? 17.12 N3 U B 1 O 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -36.57 -58.55 82.26 -36.21 -59.62 80.41 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -16.77 -40.25 82.04 -18.38 -38.93 82.48 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_14 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_14 naa= 2 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 P 117 GLU A 341 GLU~? 25.67 N6 A B 7 P 171 GLU A 432 GLU~? 22.16 O4 U B 3 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 P 117 GLU A 341 GLU~? 25.67 N6 A B 7 P 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 P 117 GLU A 351 GLU~? 20.29 O2' A B 4 P 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 P 117 GLU A 351 GLU~? 20.29 O2' A B 4 P 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 P 117 GLU A 371 GLU~? 9.29 O2 C B 5 P 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 P 117 GLU A 391 GLU~? 23.54 N1 A B 4 P 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 P 117 GLU A 432 GLU~? 22.16 O4 U B 3 P 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 P 117 GLU A 436 GLU~? 23.50 O4 U B 3 P 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 P 117 GLU A 436 GLU~? 23.50 O4 U B 3 P 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 P 117 GLU A 449 GLU.? 11.55 O2 U B 3 P 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 P 117 GLU A 466 GLU~? 26.72 N2 G B 2 P 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 P 117 GLU A 470 GLU~? 22.82 N2 G B 2 P 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_15 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 13 2 # 13 P 117 GLU A 545 GLU~? 17.12 N3 U B 1 P 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -59.89 -33.26 68.70 -59.89 -33.19 66.53 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -41.60 -52.01 74.55 -40.83 -50.48 75.85 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_15 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 13 hits 1gt7_15 naa= 2 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 Q 117 GLU A 341 GLU~? 25.67 N6 A B 7 Q 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 Q 117 GLU A 351 GLU~? 20.29 O2' A B 4 Q 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 Q 117 GLU A 351 GLU~? 20.29 O2' A B 4 Q 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 Q 117 GLU A 371 GLU~? 9.29 O2 C B 5 Q 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 Q 117 GLU A 391 GLU~? 23.54 N1 A B 4 Q 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 Q 117 GLU A 432 GLU~? 22.16 O4 U B 3 Q 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 Q 117 GLU A 436 GLU~? 23.50 O4 U B 3 Q 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 Q 117 GLU A 436 GLU~? 23.50 O4 U B 3 Q 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 Q 117 GLU A 449 GLU.? 11.55 O2 U B 3 Q 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 Q 117 GLU A 466 GLU~? 26.72 N2 G B 2 Q 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 Q 117 GLU A 470 GLU~? 22.82 N2 G B 2 Q 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -77.43 49.49 75.25 -77.06 48.11 73.69 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -97.34 64.74 65.50 -98.24 64.34 67.42 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_16 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 Q 117 GLU A 545 GLU~? 17.12 N3 U B 1 Q 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -77.43 49.49 75.25 -77.06 48.11 73.69 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -97.34 64.74 65.50 -98.24 64.34 67.42 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_16 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_16 naa= 2 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 R 117 GLU A 341 GLU~? 25.67 N6 A B 7 R 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 R 117 GLU A 351 GLU~? 20.29 O2' A B 4 R 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 R 117 GLU A 351 GLU~? 20.29 O2' A B 4 R 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 R 117 GLU A 391 GLU~? 23.54 N1 A B 4 R 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 R 117 GLU A 432 GLU~? 22.16 O4 U B 3 R 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 R 117 GLU A 436 GLU~? 23.50 O4 U B 3 R 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 R 117 GLU A 436 GLU~? 23.50 O4 U B 3 R 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 R 117 GLU A 449 GLU.? 11.55 O2 U B 3 R 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 R 117 GLU A 466 GLU~? 26.72 N2 G B 2 R 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 R 117 GLU A 470 GLU~? 22.82 N2 G B 2 R 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -102.35 28.87 93.43 -103.07 27.30 92.22 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -85.39 41.55 76.77 -86.50 43.25 77.42 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_17 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 R 117 GLU A 545 GLU~? 17.12 N3 U B 1 R 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -102.35 28.87 93.43 -103.07 27.30 92.22 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -85.39 41.55 76.77 -86.50 43.25 77.42 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_17 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 11 hits 1gt7_17 naa= 2 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 S 117 GLU A 341 GLU~? 25.67 N6 A B 7 S 171 GLU A 432 GLU~? 22.16 O4 U B 3 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 S 117 GLU A 341 GLU~? 25.67 N6 A B 7 S 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 S 117 GLU A 351 GLU~? 20.29 O2' A B 4 S 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 S 117 GLU A 351 GLU~? 20.29 O2' A B 4 S 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 S 117 GLU A 391 GLU~? 23.54 N1 A B 4 S 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 S 117 GLU A 432 GLU~? 22.16 O4 U B 3 S 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 S 117 GLU A 436 GLU~? 23.50 O4 U B 3 S 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 S 117 GLU A 436 GLU~? 23.50 O4 U B 3 S 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 S 117 GLU A 449 GLU.? 11.55 O2 U B 3 S 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 S 117 GLU A 466 GLU~? 26.72 N2 G B 2 S 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 S 117 GLU A 470 GLU~? 22.82 N2 G B 2 S 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -128.80 53.44 84.81 -129.90 52.80 83.09 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -110.62 33.78 87.40 -109.26 35.43 87.52 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_18 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 S 117 GLU A 545 GLU~? 17.12 N3 U B 1 S 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -128.80 53.44 84.81 -129.90 52.80 83.09 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -110.62 33.78 87.40 -109.26 35.43 87.52 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_18 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_18 naa= 2 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 1 2 # 1 T 117 GLU A 341 GLU~? 25.67 N6 A B 7 T 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 2 2 # 2 T 117 GLU A 351 GLU~? 20.29 O2' A B 4 T 171 GLU A 391 GLU~? 23.54 N1 A B 4 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 3 2 # 3 T 117 GLU A 351 GLU~? 20.29 O2' A B 4 T 171 GLU A 436 GLU~? 23.50 O4 U B 3 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 4 2 # 4 T 117 GLU A 371 GLU~? 9.29 O2 C B 5 T 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 5 2 # 5 T 117 GLU A 391 GLU~? 23.54 N1 A B 4 T 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 6 2 # 6 T 117 GLU A 432 GLU~? 22.16 O4 U B 3 T 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 7 2 # 7 T 117 GLU A 436 GLU~? 23.50 O4 U B 3 T 171 GLU A 341 GLU~? 25.67 N6 A B 7 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 8 2 # 8 T 117 GLU A 436 GLU~? 23.50 O4 U B 3 T 171 GLU A 351 GLU~? 20.29 O2' A B 4 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 9 2 # 9 T 117 GLU A 449 GLU.? 11.55 O2 U B 3 T 171 GLU A 466 GLU~? 26.72 N2 G B 2 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 10 2 # 10 T 117 GLU A 466 GLU~? 26.72 N2 G B 2 T 171 GLU A 449 GLU.? 11.55 O2 U B 3 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 11 2 # 11 T 117 GLU A 470 GLU~? 22.82 N2 G B 2 T 171 GLU A 545 GLU~? 17.12 N3 U B 1 coo -103.87 73.97 66.64 -103.95 73.55 64.53 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -122.53 56.99 76.12 -120.96 56.46 77.45 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1gt7_19 RHAMNULOSE-1-PHOSPHATE ALDOLASE user 12 2 # 12 T 117 GLU A 545 GLU~? 17.12 N3 U B 1 T 171 GLU A 470 GLU~? 22.82 N2 G B 2 coo -103.87 73.97 66.64 -103.95 73.55 64.53 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo -122.53 56.99 76.12 -120.96 56.46 77.45 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1gt7_19 source 1gt7 RHAMNULOSE-1-PHOSPHATE ALDOLASE : 12 hits 1gt7_19 naa= 2 ULMN 2 1gtp_00 GTP CYCLOHYDROLASE I user 1 2 # 1 A 112 HIS A 420 HIS~? 9.42 N1 A B 4 A 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo -19.30 10.59 42.88 -19.19 10.44 44.97 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo -10.72 6.73 40.75 -11.10 5.60 42.48 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_00 GTP CYCLOHYDROLASE I user 2 2 # 2 A 112 HIS A 462 HIS~? 12.61 O4 U B 3 A 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo -19.30 10.59 42.88 -19.19 10.44 44.97 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo -10.72 6.73 40.75 -11.10 5.60 42.48 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_00 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_00 naa= 2 ULMN 2 1gtp_01 GTP CYCLOHYDROLASE I user 1 2 # 1 B 112 HIS A 420 HIS~? 9.42 N1 A B 4 B 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 13.44 32.86 46.10 13.22 32.50 48.15 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 12.85 23.76 43.10 11.60 23.60 44.77 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_01 GTP CYCLOHYDROLASE I user 2 2 # 2 B 112 HIS A 462 HIS~? 12.61 O4 U B 3 B 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 13.44 32.86 46.10 13.22 32.50 48.15 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 12.85 23.76 43.10 11.60 23.60 44.77 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_01 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_01 naa= 2 ULMN 2 1gtp_02 GTP CYCLOHYDROLASE I user 1 2 # 1 C 112 HIS A 420 HIS~? 9.42 N1 A B 4 C 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 44.61 7.85 49.45 44.05 7.79 51.47 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 36.06 6.14 45.54 35.41 7.16 47.25 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_02 GTP CYCLOHYDROLASE I user 2 2 # 2 C 112 HIS A 462 HIS~? 12.61 O4 U B 3 C 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 44.61 7.85 49.45 44.05 7.79 51.47 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 36.06 6.14 45.54 35.41 7.16 47.25 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_02 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_02 naa= 2 ULMN 2 1gtp_03 GTP CYCLOHYDROLASE I user 1 2 # 1 D 112 HIS A 420 HIS~? 9.42 N1 A B 4 D 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 31.01 -29.29 47.94 30.61 -29.04 49.99 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 26.72 -21.40 44.58 27.32 -20.63 46.44 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_03 GTP CYCLOHYDROLASE I user 2 2 # 2 D 112 HIS A 462 HIS~? 12.61 O4 U B 3 D 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 31.01 -29.29 47.94 30.61 -29.04 49.99 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 26.72 -21.40 44.58 27.32 -20.63 46.44 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_03 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_03 naa= 2 ULMN 2 1gtp_04 GTP CYCLOHYDROLASE I user 1 2 # 1 E 112 HIS A 420 HIS~? 9.42 N1 A B 4 E 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo -8.59 -28.02 43.96 -8.56 -27.74 46.04 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo -2.27 -21.25 41.65 -1.50 -21.73 43.53 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_04 GTP CYCLOHYDROLASE I user 2 2 # 2 E 112 HIS A 462 HIS~? 12.61 O4 U B 3 E 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo -8.59 -28.02 43.96 -8.56 -27.74 46.04 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo -2.27 -21.25 41.65 -1.50 -21.73 43.53 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_04 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_04 naa= 2 ULMN 2 1gtp_05 GTP CYCLOHYDROLASE I user 1 2 # 1 F 112 HIS A 420 HIS~? 9.42 N1 A B 4 F 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 3.35 -33.24 20.92 3.68 -32.93 18.87 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 5.49 -24.46 24.09 4.73 -23.90 22.22 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_05 GTP CYCLOHYDROLASE I user 2 2 # 2 F 112 HIS A 462 HIS~? 12.61 O4 U B 3 F 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 3.35 -33.24 20.92 3.68 -32.93 18.87 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 5.49 -24.46 24.09 4.73 -23.90 22.22 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_05 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_05 naa= 2 ULMN 2 1gtp_06 GTP CYCLOHYDROLASE I user 1 2 # 1 G 112 HIS A 420 HIS~? 9.42 N1 A B 4 G 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 41.34 -21.73 24.73 41.23 -21.53 22.64 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 33.43 -16.71 26.90 32.78 -17.49 25.06 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_06 GTP CYCLOHYDROLASE I user 2 2 # 2 G 112 HIS A 462 HIS~? 12.61 O4 U B 3 G 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 41.34 -21.73 24.73 41.23 -21.53 22.64 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 33.43 -16.71 26.90 32.78 -17.49 25.06 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_06 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_06 naa= 2 ULMN 2 1gtp_07 GTP CYCLOHYDROLASE I user 1 2 # 1 H 112 HIS A 420 HIS~? 9.42 N1 A B 4 H 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 42.76 17.81 25.00 42.64 17.59 22.92 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 35.22 12.31 27.12 35.82 11.32 25.37 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_07 GTP CYCLOHYDROLASE I user 2 2 # 2 H 112 HIS A 462 HIS~? 12.61 O4 U B 3 H 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 42.76 17.81 25.00 42.64 17.59 22.92 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 35.22 12.31 27.12 35.82 11.32 25.37 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_07 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_07 naa= 2 ULMN 2 1gtp_08 GTP CYCLOHYDROLASE I user 1 2 # 1 I 112 HIS A 420 HIS~? 9.42 N1 A B 4 I 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 5.06 31.31 21.03 5.34 31.03 18.97 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 7.97 22.79 24.30 9.23 22.89 22.63 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_08 GTP CYCLOHYDROLASE I user 2 2 # 2 I 112 HIS A 462 HIS~? 12.61 O4 U B 3 I 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 5.06 31.31 21.03 5.34 31.03 18.97 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 7.97 22.79 24.30 9.23 22.89 22.63 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_08 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_08 naa= 2 ULMN 2 1gtp_09 GTP CYCLOHYDROLASE I user 1 2 # 1 J 112 HIS A 420 HIS~? 9.42 N1 A B 4 J 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo -19.12 -0.23 18.74 -18.56 -0.20 16.72 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo -10.23 0.13 22.55 -9.79 1.18 20.79 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_09 GTP CYCLOHYDROLASE I user 2 2 # 2 J 112 HIS A 462 HIS~? 12.61 O4 U B 3 J 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo -19.12 -0.23 18.74 -18.56 -0.20 16.72 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo -10.23 0.13 22.55 -9.79 1.18 20.79 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_09 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_09 naa= 2 ULMN 2 1gtp_10 GTP CYCLOHYDROLASE I user 1 2 # 1 K 112 HIS A 420 HIS~? 9.42 N1 A B 4 K 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 115.38 -9.25 24.26 115.15 -8.88 22.21 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 114.90 -0.19 27.40 113.64 0.01 25.73 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_10 GTP CYCLOHYDROLASE I user 2 2 # 2 K 112 HIS A 462 HIS~? 12.61 O4 U B 3 K 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 115.38 -9.25 24.26 115.15 -8.88 22.21 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 114.90 -0.19 27.40 113.64 0.01 25.73 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_10 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_10 naa= 2 ULMN 2 1gtp_11 GTP CYCLOHYDROLASE I user 1 2 # 1 L 112 HIS A 420 HIS~? 9.42 N1 A B 4 L 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 146.67 15.79 21.24 146.10 15.89 19.23 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 138.07 17.42 25.26 137.38 16.48 23.52 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_11 GTP CYCLOHYDROLASE I user 2 2 # 2 L 112 HIS A 462 HIS~? 12.61 O4 U B 3 L 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 146.67 15.79 21.24 146.10 15.89 19.23 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 138.07 17.42 25.26 137.38 16.48 23.52 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_11 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_11 naa= 2 ULMN 2 1gtp_12 GTP CYCLOHYDROLASE I user 1 2 # 1 M 112 HIS A 420 HIS~? 9.42 N1 A B 4 M 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 133.10 52.96 23.49 132.71 52.73 21.44 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 128.81 44.98 26.77 129.41 44.24 24.90 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_12 GTP CYCLOHYDROLASE I user 2 2 # 2 M 112 HIS A 462 HIS~? 12.61 O4 U B 3 M 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 133.10 52.96 23.49 132.71 52.73 21.44 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 128.81 44.98 26.77 129.41 44.24 24.90 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_12 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_12 naa= 2 ULMN 2 1gtp_13 GTP CYCLOHYDROLASE I user 1 2 # 1 N 112 HIS A 420 HIS~? 9.42 N1 A B 4 N 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 93.52 51.87 27.73 93.55 51.63 25.65 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 99.78 44.89 29.86 100.54 45.42 27.98 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_13 GTP CYCLOHYDROLASE I user 2 2 # 2 N 112 HIS A 462 HIS~? 12.61 O4 U B 3 N 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 93.52 51.87 27.73 93.55 51.63 25.65 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 99.78 44.89 29.86 100.54 45.42 27.98 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_13 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_13 naa= 2 ULMN 2 1gtp_14 GTP CYCLOHYDROLASE I user 1 2 # 1 O 112 HIS A 420 HIS~? 9.42 N1 A B 4 O 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 82.80 13.05 27.96 82.93 13.27 25.88 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 91.35 16.83 30.19 90.96 17.97 28.47 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_14 GTP CYCLOHYDROLASE I user 2 2 # 2 O 112 HIS A 462 HIS~? 12.61 O4 U B 3 O 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 82.80 13.05 27.96 82.93 13.27 25.88 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 91.35 16.83 30.19 90.96 17.97 28.47 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_14 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_14 naa= 2 ULMN 2 1gtp_15 GTP CYCLOHYDROLASE I user 1 2 # 1 P 112 HIS A 420 HIS~? 9.42 N1 A B 4 P 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 83.09 23.31 52.31 83.65 23.26 54.33 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 91.93 23.06 48.44 92.37 21.97 50.18 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_15 GTP CYCLOHYDROLASE I user 2 2 # 2 P 112 HIS A 462 HIS~? 12.61 O4 U B 3 P 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 83.09 23.31 52.31 83.65 23.26 54.33 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 91.93 23.06 48.44 92.37 21.97 50.18 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_15 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_15 naa= 2 ULMN 2 1gtp_16 GTP CYCLOHYDROLASE I user 1 2 # 1 Q 112 HIS A 420 HIS~? 9.42 N1 A B 4 Q 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 105.62 56.38 50.76 105.93 55.97 52.79 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 107.76 47.69 47.32 107.01 47.08 49.18 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_16 GTP CYCLOHYDROLASE I user 2 2 # 2 Q 112 HIS A 462 HIS~? 12.61 O4 U B 3 Q 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 105.62 56.38 50.76 105.93 55.97 52.79 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 107.76 47.69 47.32 107.01 47.08 49.18 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_16 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_16 naa= 2 ULMN 2 1gtp_17 GTP CYCLOHYDROLASE I user 1 2 # 1 R 112 HIS A 420 HIS~? 9.42 N1 A B 4 R 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 143.58 44.92 46.44 143.51 44.69 48.52 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 135.63 40.00 44.20 134.99 40.73 46.06 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_17 GTP CYCLOHYDROLASE I user 2 2 # 2 R 112 HIS A 462 HIS~? 12.61 O4 U B 3 R 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 143.58 44.92 46.44 143.51 44.69 48.52 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 135.63 40.00 44.20 134.99 40.73 46.06 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_17 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_17 naa= 2 ULMN 2 1gtp_18 GTP CYCLOHYDROLASE I user 1 2 # 1 S 112 HIS A 420 HIS~? 9.42 N1 A B 4 S 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 144.96 5.41 45.48 144.89 5.58 47.57 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 137.42 10.92 43.51 138.01 11.87 45.29 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_18 GTP CYCLOHYDROLASE I user 2 2 # 2 S 112 HIS A 462 HIS~? 12.61 O4 U B 3 S 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 144.96 5.41 45.48 144.89 5.58 47.57 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 137.42 10.92 43.51 138.01 11.87 45.29 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_18 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_18 naa= 2 ULMN 2 1gtp_19 GTP CYCLOHYDROLASE I user 1 2 # 1 T 112 HIS A 420 HIS~? 9.42 N1 A B 4 T 179 HIS A 462 HIS~? 12.61 O4 U B 3 coo 107.20 -8.11 49.39 107.53 -7.86 51.44 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 110.10 0.48 46.24 111.41 0.30 47.87 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1gtp_19 GTP CYCLOHYDROLASE I user 2 2 # 2 T 112 HIS A 462 HIS~? 12.61 O4 U B 3 T 179 HIS A 420 HIS~? 9.42 N1 A B 4 coo 107.20 -8.11 49.39 107.53 -7.86 51.44 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 110.10 0.48 46.24 111.41 0.30 47.87 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1gtp_19 source 1gtp GTP CYCLOHYDROLASE I : 2 hits 1gtp_19 naa= 2 ULMN 2 1guf_02 2,4-DIENOYL-COA REDUCTASE user 1 2 # 1 A 70 SER A 238 SER~? 10.39 N3 U B 8 A 73 ASN A 244 ASN~? 2.92 O2 U B 8 coo 77.21 -22.12 54.64 77.58 -19.76 55.09 -22.98 -10.82 9.36 -25.25 -10.60 8.53 coo 77.81 -26.09 52.88 75.70 -26.37 52.92 -22.00 -14.42 11.48 -21.14 -16.18 12.31 ULMN 2 1guf_02 2,4-DIENOYL-COA REDUCTASE user 2 2 # 2 A 70 SER A 293 SER~? 11.00 O4 U B 8 A 73 ASN A 296 ASN~? 11.04 O4 U B 8 coo 77.21 -22.12 54.64 77.58 -19.76 55.09 -31.85 -17.52 5.96 -30.82 -15.35 6.33 coo 77.81 -26.09 52.88 75.70 -26.37 52.92 -34.93 -19.92 9.17 -33.77 -21.43 10.15 ULMN 2 1guf_02 2,4-DIENOYL-COA REDUCTASE user 3 2 # 3 A 70 SER A 358 SER~? 11.85 O2' A B 4 A 73 ASN A 411 ASN~? 8.65 O2 U B 3 coo 77.21 -22.12 54.64 77.58 -19.76 55.09 -11.48 -29.46 -11.79 -11.03 -27.35 -12.89 coo 77.81 -26.09 52.88 75.70 -26.37 52.92 -10.10 -34.70 -13.08 -9.74 -33.02 -11.82 ULMN 2 1guf_02 2,4-DIENOYL-COA REDUCTASE user 4 2 # 4 A 70 SER A 400 SER~? 19.17 C2 A B 4 A 73 ASN A 403 ASN~? 22.98 C2 A B 4 coo 77.21 -22.12 54.64 77.58 -19.76 55.09 -22.47 -32.63 -20.50 -21.62 -30.51 -19.76 coo 77.81 -26.09 52.88 75.70 -26.37 52.92 -19.84 -34.23 -23.62 -21.53 -34.55 -24.89 ULMN 2 1guf_02 2,4-DIENOYL-COA REDUCTASE user 5 2 # 5 A 70 SER A 423 SER~? 9.25 O4 U B 3 A 73 ASN A 424 ASN~? 14.16 N1 A B 4 coo 77.21 -22.12 54.64 77.58 -19.76 55.09 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 coo 77.81 -26.09 52.88 75.70 -26.37 52.92 -25.68 -44.49 -8.34 -27.48 -44.07 -7.29 1guf_02 source 1guf 2,4-DIENOYL-COA REDUCTASE : 5 hits 1guf_02 naa= 2 ULMN 2 1guf_03 2,4-DIENOYL-COA REDUCTASE user 1 2 # 1 B 70 SER A 238 SER~? 10.39 N3 U B 8 B 73 ASN A 244 ASN~? 2.92 O2 U B 8 coo 55.86 -22.40 16.44 56.99 -20.79 15.03 -22.98 -10.82 9.36 -25.25 -10.60 8.53 coo 53.20 -23.88 19.48 54.54 -25.51 19.88 -22.00 -14.42 11.48 -21.14 -16.18 12.31 ULMN 2 1guf_03 2,4-DIENOYL-COA REDUCTASE user 2 2 # 2 B 70 SER A 293 SER~? 11.00 O4 U B 8 B 73 ASN A 296 ASN~? 11.04 O4 U B 8 coo 55.86 -22.40 16.44 56.99 -20.79 15.03 -31.85 -17.52 5.96 -30.82 -15.35 6.33 coo 53.20 -23.88 19.48 54.54 -25.51 19.88 -34.93 -19.92 9.17 -33.77 -21.43 10.15 ULMN 2 1guf_03 2,4-DIENOYL-COA REDUCTASE user 3 2 # 3 B 70 SER A 358 SER~? 11.85 O2' A B 4 B 73 ASN A 411 ASN~? 8.65 O2 U B 3 coo 55.86 -22.40 16.44 56.99 -20.79 15.03 -11.48 -29.46 -11.79 -11.03 -27.35 -12.89 coo 53.20 -23.88 19.48 54.54 -25.51 19.88 -10.10 -34.70 -13.08 -9.74 -33.02 -11.82 ULMN 2 1guf_03 2,4-DIENOYL-COA REDUCTASE user 4 2 # 4 B 70 SER A 400 SER~? 19.17 C2 A B 4 B 73 ASN A 403 ASN~? 22.98 C2 A B 4 coo 55.86 -22.40 16.44 56.99 -20.79 15.03 -22.47 -32.63 -20.50 -21.62 -30.51 -19.76 coo 53.20 -23.88 19.48 54.54 -25.51 19.88 -19.84 -34.23 -23.62 -21.53 -34.55 -24.89 ULMN 2 1guf_03 2,4-DIENOYL-COA REDUCTASE user 5 2 # 5 B 70 SER A 423 SER~? 9.25 O4 U B 3 B 73 ASN A 424 ASN~? 14.16 N1 A B 4 coo 55.86 -22.40 16.44 56.99 -20.79 15.03 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 coo 53.20 -23.88 19.48 54.54 -25.51 19.88 -25.68 -44.49 -8.34 -27.48 -44.07 -7.29 1guf_03 source 1guf 2,4-DIENOYL-COA REDUCTASE : 5 hits 1guf_03 naa= 2 ULMN 2 1gz6_04 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 A 161 GLN A 307 GLN~? 23.72 N1 A B 7 A 168 LYS A 270 LYS~? 23.81 O4 U B 8 coo 30.61 60.18 43.12 32.20 58.75 43.39 -34.67 -14.00 -9.03 -36.52 -12.91 -8.84 coo 26.96 50.99 47.03 31.03 48.83 44.33 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 ULMN 2 1gz6_04 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 A 161 GLN A 329 GLN~? 6.26 O2' C B 5 A 168 LYS A 372 LYS~? 15.54 N6 A B 7 coo 30.61 60.18 43.12 32.20 58.75 43.39 -23.26 -28.01 -1.37 -22.04 -29.42 -0.36 coo 26.96 50.99 47.03 31.03 48.83 44.33 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 ULMN 2 1gz6_04 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 A 161 GLN A 387 GLN~? 25.03 N1 A B 4 A 168 LYS A 372 LYS~? 15.54 N6 A B 7 coo 30.61 60.18 43.12 32.20 58.75 43.39 -41.39 -37.99 -10.41 -39.61 -38.54 -9.35 coo 26.96 50.99 47.03 31.03 48.83 44.33 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 ULMN 2 1gz6_04 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 A 161 GLN A 419 GLN~? 2.92 O4 U B 3 A 168 LYS A 450 LYS.? 2.98 O2' G B 2 coo 30.61 60.18 43.12 32.20 58.75 43.39 -14.90 -43.65 -8.87 -13.68 -43.76 -7.12 coo 26.96 50.99 47.03 31.03 48.83 44.33 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 1gz6_04 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_04 naa= 2 ULMN 2 1gz6_05 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 B 161 GLN A 307 GLN~? 23.72 N1 A B 7 B 168 LYS A 270 LYS~? 23.81 O4 U B 8 coo 11.63 41.41 53.68 10.57 43.11 54.39 -34.67 -14.00 -9.03 -36.52 -12.91 -8.84 coo 15.72 50.86 51.22 10.77 52.35 51.39 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 ULMN 2 1gz6_05 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 B 161 GLN A 387 GLN~? 25.03 N1 A B 4 B 168 LYS A 372 LYS~? 15.54 N6 A B 7 coo 11.63 41.41 53.68 10.57 43.11 54.39 -41.39 -37.99 -10.41 -39.61 -38.54 -9.35 coo 15.72 50.86 51.22 10.77 52.35 51.39 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 ULMN 2 1gz6_05 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 B 161 GLN A 419 GLN~? 2.92 O4 U B 3 B 168 LYS A 450 LYS.? 2.98 O2' G B 2 coo 11.63 41.41 53.68 10.57 43.11 54.39 -14.90 -43.65 -8.87 -13.68 -43.76 -7.12 coo 15.72 50.86 51.22 10.77 52.35 51.39 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 1gz6_05 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_05 naa= 2 ULMN 2 1gz6_06 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 C 161 GLN A 307 GLN~? 23.72 N1 A B 7 C 168 LYS A 270 LYS~? 23.81 O4 U B 8 coo 9.35 43.88 85.05 8.40 42.18 84.19 -34.67 -14.00 -9.03 -36.52 -12.91 -8.84 coo 12.98 34.46 88.14 8.11 32.96 87.14 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 ULMN 2 1gz6_06 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 C 161 GLN A 387 GLN~? 25.03 N1 A B 4 C 168 LYS A 372 LYS~? 15.54 N6 A B 7 coo 9.35 43.88 85.05 8.40 42.18 84.19 -41.39 -37.99 -10.41 -39.61 -38.54 -9.35 coo 12.98 34.46 88.14 8.11 32.96 87.14 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 ULMN 2 1gz6_06 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 C 161 GLN A 419 GLN~? 2.92 O4 U B 3 C 168 LYS A 450 LYS.? 2.98 O2' G B 2 coo 9.35 43.88 85.05 8.40 42.18 84.19 -14.90 -43.65 -8.87 -13.68 -43.76 -7.12 coo 12.98 34.46 88.14 8.11 32.96 87.14 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 1gz6_06 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_06 naa= 2 ULMN 2 1gz6_07 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 D 161 GLN A 307 GLN~? 23.72 N1 A B 7 D 168 LYS A 270 LYS~? 23.81 O4 U B 8 coo 26.49 25.12 98.45 28.11 26.53 98.40 -34.67 -14.00 -9.03 -36.52 -12.91 -8.84 coo 23.46 34.31 94.02 27.08 36.46 97.29 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 ULMN 2 1gz6_07 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 2 # 2 D 161 GLN A 329 GLN~? 6.26 O2' C B 5 D 168 LYS A 372 LYS~? 15.54 N6 A B 7 coo 26.49 25.12 98.45 28.11 26.53 98.40 -23.26 -28.01 -1.37 -22.04 -29.42 -0.36 coo 23.46 34.31 94.02 27.08 36.46 97.29 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 ULMN 2 1gz6_07 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 2 # 3 D 161 GLN A 387 GLN~? 25.03 N1 A B 4 D 168 LYS A 372 LYS~? 15.54 N6 A B 7 coo 26.49 25.12 98.45 28.11 26.53 98.40 -41.39 -37.99 -10.41 -39.61 -38.54 -9.35 coo 23.46 34.31 94.02 27.08 36.46 97.29 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 ULMN 2 1gz6_07 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 2 # 4 D 161 GLN A 419 GLN~? 2.92 O4 U B 3 D 168 LYS A 450 LYS.? 2.98 O2' G B 2 coo 26.49 25.12 98.45 28.11 26.53 98.40 -14.90 -43.65 -8.87 -13.68 -43.76 -7.12 coo 23.46 34.31 94.02 27.08 36.46 97.29 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 1gz6_07 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_07 naa= 2 ULMN 2 1gz6_08 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 A 164 TYR A 361 TYR~? 4.83 OP1 U B 6 A 168 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 29.69 55.04 42.83 31.98 53.56 43.49 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 26.96 50.99 47.03 31.03 48.83 44.33 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1gz6_08 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_08 naa= 2 ULMN 2 1gz6_09 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 B 164 TYR A 361 TYR~? 4.83 OP1 U B 6 B 168 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 11.52 46.03 51.32 10.06 47.90 52.76 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 15.72 50.86 51.22 10.77 52.35 51.39 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1gz6_09 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_09 naa= 2 ULMN 2 1gz6_10 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 C 164 TYR A 361 TYR~? 4.83 OP1 U B 6 C 168 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 8.83 39.27 87.38 7.60 37.43 85.69 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 12.98 34.46 88.14 8.11 32.96 87.14 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1gz6_10 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_10 naa= 2 ULMN 2 1gz6_11 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 2 # 1 D 164 TYR A 361 TYR~? 4.83 OP1 U B 6 D 168 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 25.49 30.28 98.59 27.88 31.73 98.26 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 23.46 34.31 94.02 27.08 36.46 97.29 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1gz6_11 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 1 hits 1gz6_11 naa= 2 ULMN 2 1h3i_00 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 1 2 # 1 A 293 HIS A 420 HIS~? 9.42 N1 A B 4 A 335 TYR A 413 TYR.? 4.41 O2' A B 4 coo -2.26 -1.00 -46.64 -4.18 -1.85 -46.58 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 8.78 9.27 -52.41 7.07 9.24 -54.63 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 1h3i_00 source 1h3i HISTONE H3 LYSINE 4 SPECIFIC METHYLTRANSFERASE: 1 hits 1h3i_00 naa= 2 ULMN 2 1h3i_01 HISTONE H3 LYSINE 4 SPECIFIC METHYLTuser 1 2 # 1 B 293 HIS A 420 HIS~? 9.42 N1 A B 4 B 335 TYR A 413 TYR.? 4.41 O2' A B 4 coo 29.22 13.17 -7.68 31.08 14.14 -7.64 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 14.33 10.29 -1.79 15.33 11.66 0.43 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 1h3i_01 source 1h3i HISTONE H3 LYSINE 4 SPECIFIC METHYLTRANSFERASE: 1 hits 1h3i_01 naa= 2 ULMN 2 1h4g_00 XYLANASE user 1 2 # 1 A 94 GLU A 432 GLU~? 22.16 O4 U B 3 A 184 GLU A 522 GLU^? 23.38 O4 U B 3 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1h4g_00 XYLANASE user 2 2 # 2 A 94 GLU A 436 GLU~? 23.50 O4 U B 3 A 184 GLU A 466 GLU~? 26.72 N2 G B 2 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1h4g_00 XYLANASE user 3 2 # 3 A 94 GLU A 436 GLU~? 23.50 O4 U B 3 A 184 GLU A 470 GLU~? 22.82 N2 G B 2 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1h4g_00 XYLANASE user 4 2 # 4 A 94 GLU A 466 GLU~? 26.72 N2 G B 2 A 184 GLU A 436 GLU~? 23.50 O4 U B 3 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1h4g_00 XYLANASE user 5 2 # 5 A 94 GLU A 470 GLU~? 22.82 N2 G B 2 A 184 GLU A 436 GLU~? 23.50 O4 U B 3 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1h4g_00 XYLANASE user 6 2 # 6 A 94 GLU A 522 GLU^? 23.38 O4 U B 3 A 184 GLU A 432 GLU~? 22.16 O4 U B 3 coo -0.61 25.90 13.61 -2.32 25.64 14.83 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo -4.48 18.79 18.25 -4.56 20.59 17.17 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1h4g_00 source 1h4g XYLANASE : 6 hits 1h4g_00 naa= 2 ULMN 2 1h4g_01 XYLANASE user 1 2 # 1 B 94 GLU A 432 GLU~? 22.16 O4 U B 3 B 184 GLU A 522 GLU^? 23.38 O4 U B 3 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1h4g_01 XYLANASE user 2 2 # 2 B 94 GLU A 436 GLU~? 23.50 O4 U B 3 B 184 GLU A 466 GLU~? 26.72 N2 G B 2 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1h4g_01 XYLANASE user 3 2 # 3 B 94 GLU A 436 GLU~? 23.50 O4 U B 3 B 184 GLU A 470 GLU~? 22.82 N2 G B 2 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1h4g_01 XYLANASE user 4 2 # 4 B 94 GLU A 466 GLU~? 26.72 N2 G B 2 B 184 GLU A 436 GLU~? 23.50 O4 U B 3 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1h4g_01 XYLANASE user 5 2 # 5 B 94 GLU A 470 GLU~? 22.82 N2 G B 2 B 184 GLU A 436 GLU~? 23.50 O4 U B 3 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1h4g_01 XYLANASE user 6 2 # 6 B 94 GLU A 522 GLU^? 23.38 O4 U B 3 B 184 GLU A 432 GLU~? 22.16 O4 U B 3 coo -25.64 30.33 24.82 -24.05 29.57 23.64 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo -24.12 22.11 20.80 -23.56 23.90 21.78 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1h4g_01 source 1h4g XYLANASE : 6 hits 1h4g_01 naa= 2 ULMN 2 1hka_00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 1 2 # 1 82 ARG A 182 ARG.? 25.57 C2 A B 9 92 ARG A 180 ARG.? 21.90 C2 A B 9 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -27.13 -7.51 39.69 -28.96 -5.65 41.28 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -20.54 -3.44 35.42 -23.45 -2.48 35.38 ULMN 2 1hka_00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 2 2 # 2 82 ARG A 311 ARG.? 21.53 N1 A B 7 92 ARG A 314 ARG~? 20.43 C2 A B 7 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -28.14 -16.31 -12.56 -31.15 -16.30 -12.01 coo -19.84 19.95 38.99 -22.62 18.73 39.19 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1hka_00 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYuser 3 2 # 3 82 ARG A 541 ARG~? 18.28 O4 U B 1 92 ARG A 548 ARG~? 15.11 O2 U B 1 coo -23.57 14.27 45.50 -26.54 13.45 45.12 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 coo -19.84 19.95 38.99 -22.62 18.73 39.19 7.33 -63.34 -13.62 6.31 -60.85 -15.12 1hka_00 source 1hka 6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOK: 3 hits 1hka_00 naa= 2 ULMN 2 1hqc_02 RUVB user 1 2 # 1 A 146 THR A 543 THR~? 19.49 O4 U B 1 A 205 ARG A 566 ARG~? 21.74 O4 U B 1 coo 69.27 81.27 188.40 69.36 79.49 187.14 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 coo 60.88 74.26 187.44 62.57 76.37 185.94 -7.26 -74.81 -5.17 -4.76 -76.37 -4.31 ULMN 2 1hqc_02 RUVB user 2 2 # 2 A 146 THR A 561 THR~? 10.68 O4 U B 1 A 205 ARG A 517 ARG.? 17.55 O4 U B 1 coo 69.27 81.27 188.40 69.36 79.49 187.14 -7.66 -65.21 -2.98 -8.57 -63.47 -3.90 coo 60.88 74.26 187.44 62.57 76.37 185.94 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1hqc_02 source 1hqc RUVB : 2 hits 1hqc_02 naa= 2 ULMN 2 1hqc_03 RUVB user 1 2 # 1 B 146 THR A 543 THR~? 19.49 O4 U B 1 B 205 ARG A 566 ARG~? 21.74 O4 U B 1 coo 88.07 98.17 129.05 89.88 98.18 130.23 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 coo 95.53 106.44 130.09 93.33 104.73 131.40 -7.26 -74.81 -5.17 -4.76 -76.37 -4.31 ULMN 2 1hqc_03 RUVB user 2 2 # 2 B 146 THR A 561 THR~? 10.68 O4 U B 1 B 205 ARG A 517 ARG.? 17.55 O4 U B 1 coo 88.07 98.17 129.05 89.88 98.18 130.23 -7.66 -65.21 -2.98 -8.57 -63.47 -3.90 coo 95.53 106.44 130.09 93.33 104.73 131.40 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1hqc_03 source 1hqc RUVB : 2 hits 1hqc_03 naa= 2 ULMN 2 1hrd_00 GLUTAMATE DEHYDROGENASE user 1 2 # 1 A 125 LYS A 536 LYS~? 26.44 O4 U B 1 A 165 ASP A 533 ASP~? 24.95 O4 U B 1 coo -12.11 9.09 75.66 -16.07 12.06 73.09 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 coo -13.97 15.80 71.16 -15.66 15.86 72.38 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1hrd_00 GLUTAMATE DEHYDROGENASE user 2 2 # 2 A 125 LYS A 537 LYS~? 23.79 O4 U B 1 A 165 ASP A 533 ASP~? 24.95 O4 U B 1 coo -12.11 9.09 75.66 -16.07 12.06 73.09 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo -13.97 15.80 71.16 -15.66 15.86 72.38 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1hrd_00 source 1hrd GLUTAMATE DEHYDROGENASE : 2 hits 1hrd_00 naa= 2 ULMN 2 1hrd_01 GLUTAMATE DEHYDROGENASE user 1 2 # 1 B 125 LYS A 536 LYS~? 26.44 O4 U B 1 B 165 ASP A 533 ASP~? 24.95 O4 U B 1 coo -1.76 -27.80 63.57 -6.45 -30.23 62.00 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 coo -9.50 -29.26 65.93 -9.12 -30.88 64.62 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1hrd_01 GLUTAMATE DEHYDROGENASE user 2 2 # 2 B 125 LYS A 537 LYS~? 23.79 O4 U B 1 B 165 ASP A 533 ASP~? 24.95 O4 U B 1 coo -1.76 -27.80 63.57 -6.45 -30.23 62.00 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo -9.50 -29.26 65.93 -9.12 -30.88 64.62 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1hrd_01 source 1hrd GLUTAMATE DEHYDROGENASE : 2 hits 1hrd_01 naa= 2 ULMN 2 1hrd_02 GLUTAMATE DEHYDROGENASE user 1 2 # 1 C 125 LYS A 536 LYS~? 26.44 O4 U B 1 C 165 ASP A 533 ASP~? 24.95 O4 U B 1 coo 13.93 4.30 45.25 12.27 3.78 39.81 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 coo 13.73 -0.85 38.89 13.44 0.98 37.94 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1hrd_02 GLUTAMATE DEHYDROGENASE user 2 2 # 2 C 125 LYS A 537 LYS~? 23.79 O4 U B 1 C 165 ASP A 533 ASP~? 24.95 O4 U B 1 coo 13.93 4.30 45.25 12.27 3.78 39.81 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo 13.73 -0.85 38.89 13.44 0.98 37.94 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1hrd_02 source 1hrd GLUTAMATE DEHYDROGENASE : 2 hits 1hrd_02 naa= 2 ULMN 2 1hzd_06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 A 209 GLU A 178 GLU.? 16.07 O2' A B 9 A 217 GLY A 177 GLY.? 19.15 O2' A B 9 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 28.99 1.64 37.28 29.39 1.00 37.06 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1hzd_06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 A 209 GLU A 225 GLU~? 23.05 C2 A B 9 A 217 GLY A 229 GLY~? 19.93 O4 U B 8 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 28.99 1.64 37.28 29.39 1.00 37.06 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1hzd_06 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 A 209 GLU A 522 GLU^? 23.38 O4 U B 3 A 217 GLY A 523 GLY.? 29.31 O4 U B 3 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 28.99 1.64 37.28 29.39 1.00 37.06 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1hzd_06 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 3 hits 1hzd_06 naa= 2 ULMN 2 1hzd_07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 B 209 GLU A 178 GLU.? 16.07 O2' A B 9 B 217 GLY A 177 GLY.? 19.15 O2' A B 9 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1hzd_07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 B 209 GLU A 225 GLU~? 23.05 C2 A B 9 B 217 GLY A 229 GLY~? 19.93 O4 U B 8 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1hzd_07 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 B 209 GLU A 522 GLU^? 23.38 O4 U B 3 B 217 GLY A 523 GLY.? 29.31 O4 U B 3 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo -2.99 -12.62 29.03 -2.59 -12.91 29.65 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1hzd_07 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 3 hits 1hzd_07 naa= 2 ULMN 2 1hzd_08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 C 209 GLU A 178 GLU.? 16.07 O2' A B 9 C 217 GLY A 177 GLY.? 19.15 O2' A B 9 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1hzd_08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 C 209 GLU A 225 GLU~? 23.05 C2 A B 9 C 217 GLY A 229 GLY~? 19.93 O4 U B 8 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1hzd_08 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 C 209 GLU A 522 GLU^? 23.38 O4 U B 3 C 217 GLY A 523 GLY.? 29.31 O4 U B 3 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 23.85 -14.35 5.25 23.55 -14.97 5.60 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1hzd_08 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 3 hits 1hzd_08 naa= 2 ULMN 2 1hzd_09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 D 209 GLU A 178 GLU.? 16.07 O2' A B 9 D 217 GLY A 177 GLY.? 19.15 O2' A B 9 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1hzd_09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 D 209 GLU A 225 GLU~? 23.05 C2 A B 9 D 217 GLY A 229 GLY~? 19.93 O4 U B 8 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1hzd_09 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 D 209 GLU A 522 GLU^? 23.38 O4 U B 3 D 217 GLY A 523 GLY.? 29.31 O4 U B 3 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo -5.25 -0.99 7.23 -5.01 -0.44 6.72 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1hzd_09 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 3 hits 1hzd_09 naa= 2 ULMN 2 1hzd_10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 E 209 GLU A 178 GLU.? 16.07 O2' A B 9 E 217 GLY A 177 GLY.? 19.15 O2' A B 9 coo 10.22 22.22 35.51 8.60 22.81 34.29 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 8.99 16.32 35.57 8.40 16.60 35.14 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1hzd_10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 E 209 GLU A 225 GLU~? 23.05 C2 A B 9 E 217 GLY A 229 GLY~? 19.93 O4 U B 8 coo 10.22 22.22 35.51 8.60 22.81 34.29 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 8.99 16.32 35.57 8.40 16.60 35.14 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1hzd_10 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 E 209 GLU A 522 GLU^? 23.38 O4 U B 3 E 217 GLY A 523 GLY.? 29.31 O4 U B 3 coo 10.22 22.22 35.51 8.60 22.81 34.29 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 8.99 16.32 35.57 8.40 16.60 35.14 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1hzd_10 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 3 hits 1hzd_10 naa= 2 ULMN 2 1hzd_11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 F 209 GLU A 178 GLU.? 16.07 O2' A B 9 F 217 GLY A 177 GLY.? 19.15 O2' A B 9 coo 28.20 13.18 0.91 27.61 14.93 1.92 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo 28.90 10.06 6.12 28.78 10.83 6.32 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1hzd_11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 F 209 GLU A 225 GLU~? 23.05 C2 A B 9 F 217 GLY A 229 GLY~? 19.93 O4 U B 8 coo 28.20 13.18 0.91 27.61 14.93 1.92 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 28.90 10.06 6.12 28.78 10.83 6.32 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1hzd_11 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 3 2 # 3 F 209 GLU A 522 GLU^? 23.38 O4 U B 3 F 217 GLY A 523 GLY.? 29.31 O4 U B 3 coo 28.20 13.18 0.91 27.61 14.93 1.92 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 28.90 10.06 6.12 28.78 10.83 6.32 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 1hzd_11 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 3 hits 1hzd_11 naa= 2 ULMN 2 1hzd_12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 A 189 GLU A 432 GLU~? 22.16 O4 U B 3 A 209 GLU A 436 GLU~? 23.50 O4 U B 3 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1hzd_12 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 A 189 GLU A 436 GLU~? 23.50 O4 U B 3 A 209 GLU A 432 GLU~? 22.16 O4 U B 3 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1hzd_12 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_12 naa= 2 ULMN 2 1hzd_13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 B 189 GLU A 432 GLU~? 22.16 O4 U B 3 B 209 GLU A 436 GLU~? 23.50 O4 U B 3 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1hzd_13 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 B 189 GLU A 436 GLU~? 23.50 O4 U B 3 B 209 GLU A 432 GLU~? 22.16 O4 U B 3 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1hzd_13 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_13 naa= 2 ULMN 2 1hzd_14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 C 189 GLU A 432 GLU~? 22.16 O4 U B 3 C 209 GLU A 436 GLU~? 23.50 O4 U B 3 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1hzd_14 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 C 189 GLU A 436 GLU~? 23.50 O4 U B 3 C 209 GLU A 432 GLU~? 22.16 O4 U B 3 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1hzd_14 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_14 naa= 2 ULMN 2 1hzd_15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 D 189 GLU A 432 GLU~? 22.16 O4 U B 3 D 209 GLU A 436 GLU~? 23.50 O4 U B 3 coo -2.98 4.12 3.98 -4.11 2.53 4.76 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1hzd_15 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 D 189 GLU A 436 GLU~? 23.50 O4 U B 3 D 209 GLU A 432 GLU~? 22.16 O4 U B 3 coo -2.98 4.12 3.98 -4.11 2.53 4.76 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo -9.98 2.96 6.77 -8.83 4.39 5.71 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1hzd_15 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_15 naa= 2 ULMN 2 1hzd_16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 E 189 GLU A 432 GLU~? 22.16 O4 U B 3 E 209 GLU A 436 GLU~? 23.50 O4 U B 3 coo 4.93 18.46 31.25 6.09 18.34 33.00 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 10.22 22.22 35.51 8.60 22.81 34.29 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1hzd_16 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 E 189 GLU A 436 GLU~? 23.50 O4 U B 3 E 209 GLU A 432 GLU~? 22.16 O4 U B 3 coo 4.93 18.46 31.25 6.09 18.34 33.00 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 10.22 22.22 35.51 8.60 22.81 34.29 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1hzd_16 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_16 naa= 2 ULMN 2 1hzd_17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 2 # 1 F 189 GLU A 432 GLU~? 22.16 O4 U B 3 F 209 GLU A 436 GLU~? 23.50 O4 U B 3 coo 26.45 15.67 7.87 27.70 14.18 7.03 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 28.20 13.18 0.91 27.61 14.93 1.92 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1hzd_17 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 2 2 # 2 F 189 GLU A 436 GLU~? 23.50 O4 U B 3 F 209 GLU A 432 GLU~? 22.16 O4 U B 3 coo 26.45 15.67 7.87 27.70 14.18 7.03 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 28.20 13.18 0.91 27.61 14.93 1.92 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1hzd_17 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 2 hits 1hzd_17 naa= 2 ULMN 2 1hzf_01 COMPLEMENT FACTOR C4A user 1 2 # 1 A 991 CYH A 287 CYH~? 3.94 C2 A B 7 A 994 GLN A 291 GLN~? 3.07 N1 A B 7 coo 13.03 24.11 -1.08 11.37 21.93 -1.66 -22.34 -17.28 4.03 -20.33 -19.29 4.31 coo 14.04 19.23 -2.26 13.71 17.12 -2.30 -25.41 -21.67 3.96 -23.73 -22.78 4.60 ULMN 2 1hzf_01 COMPLEMENT FACTOR C4A user 2 2 # 2 A 991 CYH A 438 CYH~? 14.92 N3 U B 3 A 994 GLN A 406 GLN~? 15.85 O2 U B 3 coo 13.03 24.11 -1.08 11.37 21.93 -1.66 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 coo 14.04 19.23 -2.26 13.71 17.12 -2.30 -10.49 -40.11 -21.29 -8.73 -39.50 -22.31 1hzf_01 source 1hzf COMPLEMENT FACTOR C4A : 2 hits 1hzf_01 naa= 2 ULMN 2 1i1i_00 NEUROLYSIN user 1 2 # 1 P 503 GLU A 412 GLU.? 7.44 O2' U B 3 P 613 TYR A 413 TYR.? 4.41 O2' A B 4 coo 24.56 14.95 15.74 26.34 15.44 14.68 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 coo 22.44 18.36 18.57 25.20 18.77 18.75 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 1i1i_00 source 1i1i NEUROLYSIN : 1 hits 1i1i_00 naa= 2 ULMN 2 1i6p_00 CARBONIC ANHYDRASE user 1 2 # 1 A 44 ASP A 512 ASP~? 14.88 O6 G B 2 A 46 ARG A 517 ARG.? 17.55 O4 U B 1 coo 8.35 49.41 35.76 6.30 49.41 35.15 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 9.94 45.87 34.71 8.97 43.01 35.28 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 ULMN 2 1i6p_00 CARBONIC ANHYDRASE user 2 2 # 2 A 44 ASP A 512 ASP~? 14.88 O6 G B 2 A 46 ARG A 518 ARG.? 16.31 O6 G B 2 coo 8.35 49.41 35.76 6.30 49.41 35.15 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 9.94 45.87 34.71 8.97 43.01 35.28 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 1i6p_00 source 1i6p CARBONIC ANHYDRASE : 2 hits 1i6p_00 naa= 2 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 1 2 # 1 A 40 ALA A 198 ALA~? 10.01 C2 A B 9 A 45 CYH A 287 CYH~? 3.94 C2 A B 7 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -21.77 -8.35 19.36 -22.85 -7.90 18.40 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -22.34 -17.28 4.03 -20.33 -19.29 4.31 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 2 2 # 2 A 40 ALA A 286 ALA~? 9.33 O2 U B 8 A 45 CYH A 319 CYH~? 13.55 O2' C B 5 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -21.94 -14.07 6.03 -21.83 -12.81 5.17 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 3 2 # 3 A 40 ALA A 313 ALA~? 21.02 C2 A B 7 A 45 CYH A 363 CYH~? 7.33 N3 A B 4 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -18.12 -15.82 -13.54 -16.87 -15.08 -14.00 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 4 2 # 4 A 40 ALA A 324 ALA~? 7.80 C2 A B 7 A 45 CYH A 303 CYH~? 19.60 N6 A B 7 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -19.52 -20.29 -0.49 -19.10 -19.31 -1.56 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -36.71 -18.21 -3.45 -38.39 -20.40 -3.80 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 5 2 # 5 A 40 ALA A 333 ALA~? 10.37 N6 A B 7 A 45 CYH A 363 CYH~? 7.33 N3 A B 4 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -31.30 -29.10 -0.26 -30.41 -29.13 0.98 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 6 2 # 6 A 40 ALA A 375 ALA.? 21.84 N1 A B 4 A 45 CYH A 433 CYH~? 20.69 O4 U B 3 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -34.96 -40.68 -8.92 -35.76 -41.10 -10.17 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 7 2 # 7 A 40 ALA A 393 ALA~? 21.89 C2 A B 4 A 45 CYH A 363 CYH~? 7.33 N3 A B 4 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -32.51 -31.63 -15.83 -32.82 -31.01 -14.47 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 8 2 # 8 A 40 ALA A 393 ALA~? 21.89 C2 A B 4 A 45 CYH A 405 CYH~? 14.40 N3 U B 3 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -32.51 -31.63 -15.83 -32.82 -31.01 -14.47 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 9 2 # 9 A 40 ALA A 452 ALA~? 8.51 N2 G B 2 A 45 CYH A 433 CYH~? 20.69 O4 U B 3 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -8.76 -43.34 -13.26 -8.47 -43.16 -14.74 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 10 2 # 10 A 40 ALA A 459 ALA~? 11.80 N2 G B 2 A 45 CYH A 511 CYH~? 14.88 O4 U B 1 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -16.86 -50.20 -13.72 -16.14 -49.64 -14.90 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 11 2 # 11 A 40 ALA A 463 ALA~? 16.46 N2 G B 2 A 45 CYH A 511 CYH~? 14.88 O4 U B 1 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -21.13 -53.19 -15.20 -19.92 -53.53 -16.09 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 12 2 # 12 A 40 ALA A 469 ALA~? 22.09 N2 G B 2 A 45 CYH A 433 CYH~? 20.69 O4 U B 3 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -17.88 -59.65 -20.62 -18.93 -60.55 -21.31 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 13 2 # 13 A 40 ALA A 469 ALA~? 22.09 N2 G B 2 A 45 CYH A 438 CYH~? 14.92 N3 U B 3 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -17.88 -59.65 -20.62 -18.93 -60.55 -21.31 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 14 2 # 14 A 40 ALA A 469 ALA~? 22.09 N2 G B 2 A 45 CYH A 511 CYH~? 14.88 O4 U B 1 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -17.88 -59.65 -20.62 -18.93 -60.55 -21.31 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 15 2 # 15 A 40 ALA A 528 ALA~? 26.93 O6 G B 2 A 45 CYH A 505 CYH~? 8.75 N1 G B 2 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -21.92 -68.60 -14.66 -22.67 -69.76 -13.95 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 ULMN 2 1i8t_00 UDP-GALACTOPYRANOSE MUTASE user 16 2 # 16 A 40 ALA A 563 ALA~? 15.88 O4 U B 1 A 45 CYH A 505 CYH~? 8.75 N1 G B 2 coo -5.41 -8.88 -14.41 -4.72 -9.36 -13.13 -6.15 -70.58 -2.36 -4.88 -70.40 -1.53 coo -2.51 5.39 -21.31 -4.61 6.71 -22.64 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 1i8t_00 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 16 hits 1i8t_00 naa= 2 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 1 2 # 1 B 40 ALA A 198 ALA~? 10.01 C2 A B 9 B 45 CYH A 287 CYH~? 3.94 C2 A B 7 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -21.77 -8.35 19.36 -22.85 -7.90 18.40 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -22.34 -17.28 4.03 -20.33 -19.29 4.31 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 2 2 # 2 B 40 ALA A 286 ALA~? 9.33 O2 U B 8 B 45 CYH A 319 CYH~? 13.55 O2' C B 5 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -21.94 -14.07 6.03 -21.83 -12.81 5.17 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 3 2 # 3 B 40 ALA A 313 ALA~? 21.02 C2 A B 7 B 45 CYH A 363 CYH~? 7.33 N3 A B 4 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -18.12 -15.82 -13.54 -16.87 -15.08 -14.00 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 4 2 # 4 B 40 ALA A 324 ALA~? 7.80 C2 A B 7 B 45 CYH A 303 CYH~? 19.60 N6 A B 7 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -19.52 -20.29 -0.49 -19.10 -19.31 -1.56 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -36.71 -18.21 -3.45 -38.39 -20.40 -3.80 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 5 2 # 5 B 40 ALA A 333 ALA~? 10.37 N6 A B 7 B 45 CYH A 363 CYH~? 7.33 N3 A B 4 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -31.30 -29.10 -0.26 -30.41 -29.13 0.98 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 6 2 # 6 B 40 ALA A 375 ALA.? 21.84 N1 A B 4 B 45 CYH A 433 CYH~? 20.69 O4 U B 3 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -34.96 -40.68 -8.92 -35.76 -41.10 -10.17 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 7 2 # 7 B 40 ALA A 393 ALA~? 21.89 C2 A B 4 B 45 CYH A 363 CYH~? 7.33 N3 A B 4 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -32.51 -31.63 -15.83 -32.82 -31.01 -14.47 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 8 2 # 8 B 40 ALA A 393 ALA~? 21.89 C2 A B 4 B 45 CYH A 405 CYH~? 14.40 N3 U B 3 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -32.51 -31.63 -15.83 -32.82 -31.01 -14.47 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 9 2 # 9 B 40 ALA A 452 ALA~? 8.51 N2 G B 2 B 45 CYH A 433 CYH~? 20.69 O4 U B 3 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -8.76 -43.34 -13.26 -8.47 -43.16 -14.74 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 10 2 # 10 B 40 ALA A 459 ALA~? 11.80 N2 G B 2 B 45 CYH A 511 CYH~? 14.88 O4 U B 1 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -16.86 -50.20 -13.72 -16.14 -49.64 -14.90 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 11 2 # 11 B 40 ALA A 463 ALA~? 16.46 N2 G B 2 B 45 CYH A 511 CYH~? 14.88 O4 U B 1 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -21.13 -53.19 -15.20 -19.92 -53.53 -16.09 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 12 2 # 12 B 40 ALA A 469 ALA~? 22.09 N2 G B 2 B 45 CYH A 433 CYH~? 20.69 O4 U B 3 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -17.88 -59.65 -20.62 -18.93 -60.55 -21.31 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 13 2 # 13 B 40 ALA A 469 ALA~? 22.09 N2 G B 2 B 45 CYH A 438 CYH~? 14.92 N3 U B 3 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -17.88 -59.65 -20.62 -18.93 -60.55 -21.31 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 14 2 # 14 B 40 ALA A 469 ALA~? 22.09 N2 G B 2 B 45 CYH A 511 CYH~? 14.88 O4 U B 1 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -17.88 -59.65 -20.62 -18.93 -60.55 -21.31 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 15 2 # 15 B 40 ALA A 528 ALA~? 26.93 O6 G B 2 B 45 CYH A 505 CYH~? 8.75 N1 G B 2 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -21.92 -68.60 -14.66 -22.67 -69.76 -13.95 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 ULMN 2 1i8t_01 UDP-GALACTOPYRANOSE MUTASE user 16 2 # 16 B 40 ALA A 563 ALA~? 15.88 O4 U B 1 B 45 CYH A 505 CYH~? 8.75 N1 G B 2 coo -7.13 9.65 23.29 -5.86 9.28 22.46 -6.15 -70.58 -2.36 -4.88 -70.40 -1.53 coo -17.80 -1.17 28.51 -20.53 -0.47 28.70 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 1i8t_01 source 1i8t UDP-GALACTOPYRANOSE MUTASE : 16 hits 1i8t_01 naa= 2 ULMN 2 1idj_00 PECTIN LYASE A user 1 2 # 1 A 176 ARG A 392 ARG~? 29.32 C2 A B 4 A 236 ARG A 396 ARG~? 24.93 C2 A B 4 coo 23.79 24.41 46.33 21.03 24.63 45.00 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 coo 24.08 20.68 39.34 22.77 19.80 41.96 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1idj_00 PECTIN LYASE A user 2 2 # 2 A 176 ARG A 396 ARG~? 24.93 C2 A B 4 A 236 ARG A 392 ARG~? 29.32 C2 A B 4 coo 23.79 24.41 46.33 21.03 24.63 45.00 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo 24.08 20.68 39.34 22.77 19.80 41.96 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 1idj_00 source 1idj PECTIN LYASE A : 2 hits 1idj_00 naa= 2 ULMN 2 1idj_01 PECTIN LYASE A user 1 2 # 1 B 176 ARG A 392 ARG~? 29.32 C2 A B 4 B 236 ARG A 396 ARG~? 24.93 C2 A B 4 coo 34.55 75.64 62.53 31.79 75.41 63.86 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 coo 34.83 79.32 69.54 33.52 80.22 66.94 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1idj_01 PECTIN LYASE A user 2 2 # 2 B 176 ARG A 396 ARG~? 24.93 C2 A B 4 B 236 ARG A 392 ARG~? 29.32 C2 A B 4 coo 34.55 75.64 62.53 31.79 75.41 63.86 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo 34.83 79.32 69.54 33.52 80.22 66.94 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 1idj_01 source 1idj PECTIN LYASE A : 2 hits 1idj_01 naa= 2 ULMN 2 1idj_02 PECTIN LYASE A user 1 2 # 1 A 154 ASP A 345 ASP~? 24.06 C2 A B 4 A 236 ARG A 392 ARG~? 29.32 C2 A B 4 coo 23.38 30.01 45.27 22.92 28.01 45.81 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 24.08 20.68 39.34 22.77 19.80 41.96 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 ULMN 2 1idj_02 PECTIN LYASE A user 2 2 # 2 A 154 ASP A 488 ASP~? 18.76 O2 U B 1 A 236 ARG A 548 ARG~? 15.11 O2 U B 1 coo 23.38 30.01 45.27 22.92 28.01 45.81 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 24.08 20.68 39.34 22.77 19.80 41.96 7.33 -63.34 -13.62 6.31 -60.85 -15.12 1idj_02 source 1idj PECTIN LYASE A : 2 hits 1idj_02 naa= 2 ULMN 2 1idj_03 PECTIN LYASE A user 1 2 # 1 B 154 ASP A 345 ASP~? 24.06 C2 A B 4 B 236 ARG A 392 ARG~? 29.32 C2 A B 4 coo 34.14 70.03 63.55 33.67 72.04 63.02 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 34.83 79.32 69.54 33.52 80.22 66.94 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 ULMN 2 1idj_03 PECTIN LYASE A user 2 2 # 2 B 154 ASP A 488 ASP~? 18.76 O2 U B 1 B 236 ARG A 548 ARG~? 15.11 O2 U B 1 coo 34.14 70.03 63.55 33.67 72.04 63.02 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 34.83 79.32 69.54 33.52 80.22 66.94 7.33 -63.34 -13.62 6.31 -60.85 -15.12 1idj_03 source 1idj PECTIN LYASE A : 2 hits 1idj_03 naa= 2 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 2 # 1 133 ASP A 193 ASP~? 20.25 C2 A B 9 158 THR A 263 THR~? 26.03 O4 U B 8 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -22.85 0.02 23.71 -22.18 1.98 24.08 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -43.81 -9.09 6.81 -45.49 -9.19 5.45 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 2 # 2 133 ASP A 260 ASP.? 30.95 O4 U B 8 158 THR A 239 THR~? 10.72 O2 U B 8 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -48.66 -5.55 12.81 -49.71 -4.82 11.14 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -19.36 -10.64 8.19 -19.30 -8.96 6.83 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 2 # 3 133 ASP A 283 ASP~? 9.21 O2 U B 8 158 THR A 374 THR.? 15.78 N1 A B 4 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 2 # 4 133 ASP A 312 ASP~? 21.35 C2 A B 7 158 THR A 263 THR~? 26.03 O4 U B 8 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -43.81 -9.09 6.81 -45.49 -9.19 5.45 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 2 # 5 133 ASP A 345 ASP~? 24.06 C2 A B 4 158 THR A 239 THR~? 10.72 O2 U B 8 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -19.36 -10.64 8.19 -19.30 -8.96 6.83 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 2 # 6 133 ASP A 477 ASP~? 24.62 N2 G B 2 158 THR A 399 THR~? 23.00 C2 A B 4 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -25.04 -35.27 -21.32 -26.30 -34.73 -22.98 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 7 2 # 7 133 ASP A 484 ASP.? 22.65 O2 U B 1 158 THR A 508 THR~? 10.98 O6 G B 2 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -12.37 -61.03 -6.50 -12.20 -59.82 -4.73 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 8 2 # 8 133 ASP A 484 ASP.? 22.65 O2 U B 1 158 THR A 561 THR~? 10.68 O4 U B 1 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -7.66 -65.21 -2.98 -8.57 -63.47 -3.90 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 9 2 # 9 133 ASP A 488 ASP~? 18.76 O2 U B 1 158 THR A 402 THR~? 19.02 C2 A B 4 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -20.51 -37.79 -20.31 -22.46 -38.70 -20.49 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 10 2 # 10 133 ASP A 491 ASP~? 15.62 O2 U B 1 158 THR A 402 THR~? 19.02 C2 A B 4 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -20.51 -37.79 -20.31 -22.46 -38.70 -20.49 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 11 2 # 11 133 ASP A 512 ASP~? 14.88 O6 G B 2 158 THR A 368 THR~? 9.37 O2' C B 5 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 12 2 # 12 133 ASP A 533 ASP~? 24.95 O4 U B 1 158 THR A 402 THR~? 19.02 C2 A B 4 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -20.51 -37.79 -20.31 -22.46 -38.70 -20.49 ULMN 2 1inp_00 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 13 2 # 13 133 ASP A 533 ASP~? 24.95 O4 U B 1 158 THR A 410 THR~? 10.69 O2 U B 3 coo -28.29 -4.39 34.54 -29.89 -5.44 33.65 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -8.78 -38.96 -14.99 -8.22 -38.93 -17.11 1inp_00 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 13 hits 1inp_00 naa= 2 ULMN 2 1inp_01 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 2 # 1 37 LYS A 220 LYS~? 19.55 N1 A B 9 158 THR A 257 THR~? 19.75 N1 A B 9 coo 2.85 17.07 38.64 -1.64 15.65 41.27 -37.45 -8.35 20.48 -41.74 -12.81 21.44 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -42.71 -13.46 15.84 -41.70 -12.17 17.23 1inp_01 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 1 hits 1inp_01 naa= 2 ULMN 2 1inp_03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 2 # 1 79 GLU A 178 GLU.? 16.07 O2' A B 9 158 THR A 202 THR~? 8.86 O2' A B 9 coo -6.22 13.24 31.73 -5.30 13.57 33.58 -13.75 -9.60 33.46 -13.25 -11.02 34.94 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -17.21 -12.36 25.70 -16.28 -12.03 27.61 ULMN 2 1inp_03 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 2 # 2 79 GLU A 391 GLU~? 23.54 N1 A B 4 158 THR A 374 THR.? 15.78 N1 A B 4 coo -6.22 13.24 31.73 -5.30 13.57 33.58 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 1inp_03 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_03 naa= 2 ULMN 2 1ir3_00 INSULIN RECEPTOR user 1 2 # 1 A1132 ASP A 233 ASP~? 18.81 O2 U B 8 A1136 ARG A 230 ARG~? 20.03 C2 A B 9 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1ir3_00 INSULIN RECEPTOR user 2 2 # 2 A1132 ASP A 259 ASP.? 23.89 N1 A B 9 A1136 ARG A 265 ARG~? 21.55 N1 A B 9 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -38.98 -7.64 12.61 -41.54 -9.16 13.48 ULMN 2 1ir3_00 INSULIN RECEPTOR user 3 2 # 3 A1132 ASP A 312 ASP~? 21.35 C2 A B 7 A1136 ARG A 314 ARG~? 20.43 C2 A B 7 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1ir3_00 INSULIN RECEPTOR user 4 2 # 4 A1132 ASP A 345 ASP~? 24.06 C2 A B 4 A1136 ARG A 396 ARG~? 24.93 C2 A B 4 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1ir3_00 INSULIN RECEPTOR user 5 2 # 5 A1132 ASP A 425 ASP.? 18.06 O4 U B 3 A1136 ARG A 431 ARG~? 16.75 O4 U B 3 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1ir3_00 INSULIN RECEPTOR user 6 2 # 6 A1132 ASP A 488 ASP~? 18.76 O2 U B 1 A1136 ARG A 541 ARG~? 18.28 O4 U B 1 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 ULMN 2 1ir3_00 INSULIN RECEPTOR user 7 2 # 7 A1132 ASP A 491 ASP~? 15.62 O2 U B 1 A1136 ARG A 541 ARG~? 18.28 O4 U B 1 coo -27.05 34.58 17.12 -25.81 32.84 17.16 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo -21.15 30.60 15.10 -21.49 31.93 17.86 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 ULMN 2 1ir3_00 INSULIN RECEPTOR user 8 2 # 8 A1132 ASP A 491 ASP~? 15.62 O2 U B 1 A1136 ARG A 548 ARG~? 15.11 O2 U B 1 coo -27.05 34.58 17.12 -25.81 32.84 17.16 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo -21.15 30.60 15.10 -21.49 31.93 17.86 7.33 -63.34 -13.62 6.31 -60.85 -15.12 1ir3_00 source 1ir3 INSULIN RECEPTOR : 8 hits 1ir3_00 naa= 2 ULMN 2 1ir3_01 INSULIN RECEPTOR user 1 2 # 1 A1132 ASP A 321 ASP~? 8.41 N3 A B 7 A1134 ALA A 317 ALA~? 14.83 C2 A B 7 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -16.23 -18.49 -7.82 -15.90 -17.00 -7.75 ULMN 2 1ir3_01 INSULIN RECEPTOR user 2 2 # 2 A1132 ASP A 345 ASP~? 24.06 C2 A B 4 A1134 ALA A 348 ALA~? 19.98 C2 A B 4 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -23.75 -28.03 -17.62 -25.14 -28.52 -17.99 ULMN 2 1ir3_01 INSULIN RECEPTOR user 3 2 # 3 A1132 ASP A 345 ASP~? 24.06 C2 A B 4 A1134 ALA A 393 ALA~? 21.89 C2 A B 4 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -32.51 -31.63 -15.83 -32.82 -31.01 -14.47 ULMN 2 1ir3_01 INSULIN RECEPTOR user 4 2 # 4 A1132 ASP A 425 ASP.? 18.06 O4 U B 3 A1134 ALA A 428 ALA~? 20.19 O4 U B 3 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -27.79 -47.21 -14.49 -28.71 -48.42 -14.37 ULMN 2 1ir3_01 INSULIN RECEPTOR user 5 2 # 5 A1132 ASP A 426 ASP.? 18.90 N1 A B 4 A1134 ALA A 375 ALA.? 21.84 N1 A B 4 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -34.96 -40.68 -8.92 -35.76 -41.10 -10.17 ULMN 2 1ir3_01 INSULIN RECEPTOR user 6 2 # 6 A1132 ASP A 473 ASP~? 22.60 N2 G B 2 A1134 ALA A 469 ALA~? 22.09 N2 G B 2 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -17.88 -59.65 -20.62 -18.93 -60.55 -21.31 1ir3_01 source 1ir3 INSULIN RECEPTOR : 6 hits 1ir3_01 naa= 2 ULMN 2 1itq_00 RENAL DIPEPTIDASE user 1 2 # 1 A 152 HIS A 420 HIS~? 9.42 N1 A B 4 A 288 ASP A 376 ASP~? 17.17 N1 A B 4 coo 71.51 57.76 30.86 69.53 58.08 31.47 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 61.38 52.36 29.26 62.76 53.82 29.93 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1itq_00 RENAL DIPEPTIDASE user 2 2 # 2 A 152 HIS A 547 HIS~? 18.58 O4 U B 1 A 288 ASP A 491 ASP~? 15.62 O2 U B 1 coo 71.51 57.76 30.86 69.53 58.08 31.47 8.28 -67.57 -10.72 8.13 -67.19 -12.78 coo 61.38 52.36 29.26 62.76 53.82 29.93 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1itq_00 source 1itq RENAL DIPEPTIDASE : 2 hits 1itq_00 naa= 2 ULMN 2 1itq_01 RENAL DIPEPTIDASE user 1 2 # 1 B 152 HIS A 420 HIS~? 9.42 N1 A B 4 B 288 ASP A 376 ASP~? 17.17 N1 A B 4 coo 95.85 54.81 55.16 97.89 54.70 54.70 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 104.39 47.30 56.49 103.35 49.00 55.82 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 1itq_01 source 1itq RENAL DIPEPTIDASE : 1 hits 1itq_01 naa= 2 ULMN 2 1itx_02 GLYCOSYL HYDROLASE user 1 2 # 1 A 200 ASP A 200 ASP~? 9.45 O2' A B 9 A 204 GLU A 178 GLU.? 16.07 O2' A B 9 coo 1.52 9.98 32.08 2.12 9.01 30.34 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 7.79 1.83 27.81 9.08 3.25 26.92 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1itx_02 GLYCOSYL HYDROLASE user 2 2 # 2 A 200 ASP A 259 ASP.? 23.89 N1 A B 9 A 204 GLU A 225 GLU~? 23.05 C2 A B 9 coo 1.52 9.98 32.08 2.12 9.01 30.34 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 7.79 1.83 27.81 9.08 3.25 26.92 -36.18 -1.53 15.48 -36.93 -1.10 13.54 ULMN 2 1itx_02 GLYCOSYL HYDROLASE user 3 2 # 3 A 200 ASP A 425 ASP.? 18.06 O4 U B 3 A 204 GLU A 432 GLU~? 22.16 O4 U B 3 coo 1.52 9.98 32.08 2.12 9.01 30.34 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 7.79 1.83 27.81 9.08 3.25 26.92 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1itx_02 GLYCOSYL HYDROLASE user 4 2 # 4 A 200 ASP A 425 ASP.? 18.06 O4 U B 3 A 204 GLU A 522 GLU^? 23.38 O4 U B 3 coo 1.52 9.98 32.08 2.12 9.01 30.34 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 7.79 1.83 27.81 9.08 3.25 26.92 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1itx_02 GLYCOSYL HYDROLASE user 5 2 # 5 A 200 ASP A 473 ASP~? 22.60 N2 G B 2 A 204 GLU A 466 GLU~? 26.72 N2 G B 2 coo 1.52 9.98 32.08 2.12 9.01 30.34 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 7.79 1.83 27.81 9.08 3.25 26.92 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1itx_02 GLYCOSYL HYDROLASE user 6 2 # 6 A 200 ASP A 488 ASP~? 18.76 O2 U B 1 A 204 GLU A 545 GLU~? 17.12 N3 U B 1 coo 1.52 9.98 32.08 2.12 9.01 30.34 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 7.79 1.83 27.81 9.08 3.25 26.92 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1itx_02 GLYCOSYL HYDROLASE user 7 2 # 7 A 200 ASP A 526 ASP^? 28.45 O6 G B 2 A 204 GLU A 522 GLU^? 23.38 O4 U B 3 coo 1.52 9.98 32.08 2.12 9.01 30.34 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo 7.79 1.83 27.81 9.08 3.25 26.92 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1itx_02 source 1itx GLYCOSYL HYDROLASE : 7 hits 1itx_02 naa= 2 ULMN 2 1j49_02 D-LACTATE DEHYDROGENASE user 1 2 # 1 A 265 GLU A 457 GLU~? 3.32 N1 G B 2 A 297 HIS A 454 HIS~? 3.31 C5 U B 3 coo 47.07 34.33 103.36 48.88 33.52 104.12 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 51.04 30.36 104.92 51.06 31.23 106.83 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1j49_02 source 1j49 D-LACTATE DEHYDROGENASE : 1 hits 1j49_02 naa= 2 ULMN 2 1j49_03 D-LACTATE DEHYDROGENASE user 1 2 # 1 B 265 GLU A 457 GLU~? 3.32 N1 G B 2 B 297 HIS A 454 HIS~? 3.31 C5 U B 3 coo 80.24 24.01 79.32 80.63 24.74 81.26 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 80.60 28.06 83.54 82.56 27.56 84.07 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1j49_03 source 1j49 D-LACTATE DEHYDROGENASE : 1 hits 1j49_03 naa= 2 ULMN 2 1j53_01 DNA POLYMERASE III, EPSILON CHAIN user 1 2 # 1 A 14 GLU A 457 GLU~? 3.32 N1 G B 2 A 162 HIS A 454 HIS~? 3.31 C5 U B 3 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1j53_01 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 1 hits 1j53_01 naa= 2 ULMN 2 1jag_00 DEOXYGUANOSINE KINASE user 1 2 # 1 A 70 GLU A 225 GLU~? 23.05 C2 A B 9 A 142 ARG A 230 ARG~? 20.03 C2 A B 9 coo 41.69 114.28 15.66 40.58 112.97 16.94 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 35.72 115.53 15.77 35.79 117.41 13.37 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1jag_00 DEOXYGUANOSINE KINASE user 2 2 # 2 A 70 GLU A 407 GLU~? 15.45 O2 U B 3 A 142 ARG A 354 ARG~? 17.55 O2' A B 4 coo 41.69 114.28 15.66 40.58 112.97 16.94 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 35.72 115.53 15.77 35.79 117.41 13.37 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1jag_00 DEOXYGUANOSINE KINASE user 3 2 # 3 A 70 GLU A 432 GLU~? 22.16 O4 U B 3 A 142 ARG A 431 ARG~? 16.75 O4 U B 3 coo 41.69 114.28 15.66 40.58 112.97 16.94 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 35.72 115.53 15.77 35.79 117.41 13.37 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1jag_00 DEOXYGUANOSINE KINASE user 4 2 # 4 A 70 GLU A 474 GLU~? 16.68 N2 G B 2 A 142 ARG A 441 ARG.? 21.93 N2 G B 2 coo 41.69 114.28 15.66 40.58 112.97 16.94 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 35.72 115.53 15.77 35.79 117.41 13.37 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 1jag_00 source 1jag DEOXYGUANOSINE KINASE : 4 hits 1jag_00 naa= 2 ULMN 2 1jag_01 DEOXYGUANOSINE KINASE user 1 2 # 1 B 70 GLU A 225 GLU~? 23.05 C2 A B 9 B 142 ARG A 230 ARG~? 20.03 C2 A B 9 coo 31.07 79.69 19.07 32.57 81.08 19.72 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 36.62 78.39 16.92 35.66 76.33 14.89 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1jag_01 DEOXYGUANOSINE KINASE user 2 2 # 2 B 70 GLU A 407 GLU~? 15.45 O2 U B 3 B 142 ARG A 354 ARG~? 17.55 O2' A B 4 coo 31.07 79.69 19.07 32.57 81.08 19.72 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 36.62 78.39 16.92 35.66 76.33 14.89 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1jag_01 DEOXYGUANOSINE KINASE user 3 2 # 3 B 70 GLU A 432 GLU~? 22.16 O4 U B 3 B 142 ARG A 431 ARG~? 16.75 O4 U B 3 coo 31.07 79.69 19.07 32.57 81.08 19.72 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 36.62 78.39 16.92 35.66 76.33 14.89 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1jag_01 DEOXYGUANOSINE KINASE user 4 2 # 4 B 70 GLU A 474 GLU~? 16.68 N2 G B 2 B 142 ARG A 441 ARG.? 21.93 N2 G B 2 coo 31.07 79.69 19.07 32.57 81.08 19.72 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 36.62 78.39 16.92 35.66 76.33 14.89 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 1jag_01 source 1jag DEOXYGUANOSINE KINASE : 4 hits 1jag_01 naa= 2 ULMN 2 1jag_02 DEOXYGUANOSINE KINASE user 1 2 # 1 C 70 GLU A 225 GLU~? 23.05 C2 A B 9 C 142 ARG A 230 ARG~? 20.03 C2 A B 9 coo 55.48 107.82 136.32 56.60 106.34 135.24 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 61.38 109.25 135.73 61.32 111.53 137.75 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1jag_02 DEOXYGUANOSINE KINASE user 2 2 # 2 C 70 GLU A 407 GLU~? 15.45 O2 U B 3 C 142 ARG A 354 ARG~? 17.55 O2' A B 4 coo 55.48 107.82 136.32 56.60 106.34 135.24 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 61.38 109.25 135.73 61.32 111.53 137.75 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1jag_02 DEOXYGUANOSINE KINASE user 3 2 # 3 C 70 GLU A 432 GLU~? 22.16 O4 U B 3 C 142 ARG A 431 ARG~? 16.75 O4 U B 3 coo 55.48 107.82 136.32 56.60 106.34 135.24 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 61.38 109.25 135.73 61.32 111.53 137.75 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1jag_02 DEOXYGUANOSINE KINASE user 4 2 # 4 C 70 GLU A 474 GLU~? 16.68 N2 G B 2 C 142 ARG A 441 ARG.? 21.93 N2 G B 2 coo 55.48 107.82 136.32 56.60 106.34 135.24 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 61.38 109.25 135.73 61.32 111.53 137.75 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 1jag_02 source 1jag DEOXYGUANOSINE KINASE : 4 hits 1jag_02 naa= 2 ULMN 2 1jag_03 DEOXYGUANOSINE KINASE user 1 2 # 1 D 70 GLU A 225 GLU~? 23.05 C2 A B 9 D 142 ARG A 230 ARG~? 20.03 C2 A B 9 coo 67.23 73.46 138.83 65.67 74.68 137.98 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 61.78 72.49 141.39 62.87 70.87 143.74 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1jag_03 DEOXYGUANOSINE KINASE user 2 2 # 2 D 70 GLU A 407 GLU~? 15.45 O2 U B 3 D 142 ARG A 354 ARG~? 17.55 O2' A B 4 coo 67.23 73.46 138.83 65.67 74.68 137.98 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 61.78 72.49 141.39 62.87 70.87 143.74 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1jag_03 DEOXYGUANOSINE KINASE user 3 2 # 3 D 70 GLU A 432 GLU~? 22.16 O4 U B 3 D 142 ARG A 431 ARG~? 16.75 O4 U B 3 coo 67.23 73.46 138.83 65.67 74.68 137.98 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 61.78 72.49 141.39 62.87 70.87 143.74 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1jag_03 DEOXYGUANOSINE KINASE user 4 2 # 4 D 70 GLU A 474 GLU~? 16.68 N2 G B 2 D 142 ARG A 441 ARG.? 21.93 N2 G B 2 coo 67.23 73.46 138.83 65.67 74.68 137.98 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 61.78 72.49 141.39 62.87 70.87 143.74 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 1jag_03 source 1jag DEOXYGUANOSINE KINASE : 4 hits 1jag_03 naa= 2 ULMN 2 1jag_04 DEOXYGUANOSINE KINASE user 1 2 # 1 E 70 GLU A 225 GLU~? 23.05 C2 A B 9 E 142 ARG A 230 ARG~? 20.03 C2 A B 9 coo 59.48 65.31 58.13 60.88 63.94 57.24 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 65.31 66.97 58.90 64.71 69.12 60.98 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1jag_04 DEOXYGUANOSINE KINASE user 2 2 # 2 E 70 GLU A 407 GLU~? 15.45 O2 U B 3 E 142 ARG A 354 ARG~? 17.55 O2' A B 4 coo 59.48 65.31 58.13 60.88 63.94 57.24 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 65.31 66.97 58.90 64.71 69.12 60.98 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1jag_04 DEOXYGUANOSINE KINASE user 3 2 # 3 E 70 GLU A 432 GLU~? 22.16 O4 U B 3 E 142 ARG A 431 ARG~? 16.75 O4 U B 3 coo 59.48 65.31 58.13 60.88 63.94 57.24 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 65.31 66.97 58.90 64.71 69.12 60.98 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1jag_04 DEOXYGUANOSINE KINASE user 4 2 # 4 E 70 GLU A 474 GLU~? 16.68 N2 G B 2 E 142 ARG A 441 ARG.? 21.93 N2 G B 2 coo 59.48 65.31 58.13 60.88 63.94 57.24 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 65.31 66.97 58.90 64.71 69.12 60.98 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 1jag_04 source 1jag DEOXYGUANOSINE KINASE : 4 hits 1jag_04 naa= 2 ULMN 2 1jag_05 DEOXYGUANOSINE KINASE user 1 2 # 1 F 70 GLU A 225 GLU~? 23.05 C2 A B 9 F 142 ARG A 230 ARG~? 20.03 C2 A B 9 coo 72.50 31.52 60.99 71.07 32.72 59.92 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 66.72 30.06 62.29 67.42 28.32 64.70 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1jag_05 DEOXYGUANOSINE KINASE user 2 2 # 2 F 70 GLU A 407 GLU~? 15.45 O2 U B 3 F 142 ARG A 354 ARG~? 17.55 O2' A B 4 coo 72.50 31.52 60.99 71.07 32.72 59.92 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 66.72 30.06 62.29 67.42 28.32 64.70 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1jag_05 DEOXYGUANOSINE KINASE user 3 2 # 3 F 70 GLU A 432 GLU~? 22.16 O4 U B 3 F 142 ARG A 431 ARG~? 16.75 O4 U B 3 coo 72.50 31.52 60.99 71.07 32.72 59.92 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 66.72 30.06 62.29 67.42 28.32 64.70 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1jag_05 DEOXYGUANOSINE KINASE user 4 2 # 4 F 70 GLU A 474 GLU~? 16.68 N2 G B 2 F 142 ARG A 441 ARG.? 21.93 N2 G B 2 coo 72.50 31.52 60.99 71.07 32.72 59.92 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 66.72 30.06 62.29 67.42 28.32 64.70 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 1jag_05 source 1jag DEOXYGUANOSINE KINASE : 4 hits 1jag_05 naa= 2 ULMN 2 1jag_06 DEOXYGUANOSINE KINASE user 1 2 # 1 G 70 GLU A 225 GLU~? 23.05 C2 A B 9 G 142 ARG A 230 ARG~? 20.03 C2 A B 9 coo 23.29 16.67 58.82 24.61 15.29 57.84 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 29.15 18.37 59.04 28.72 20.55 61.13 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1jag_06 DEOXYGUANOSINE KINASE user 2 2 # 2 G 70 GLU A 407 GLU~? 15.45 O2 U B 3 G 142 ARG A 354 ARG~? 17.55 O2' A B 4 coo 23.29 16.67 58.82 24.61 15.29 57.84 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 29.15 18.37 59.04 28.72 20.55 61.13 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1jag_06 DEOXYGUANOSINE KINASE user 3 2 # 3 G 70 GLU A 432 GLU~? 22.16 O4 U B 3 G 142 ARG A 431 ARG~? 16.75 O4 U B 3 coo 23.29 16.67 58.82 24.61 15.29 57.84 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 29.15 18.37 59.04 28.72 20.55 61.13 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1jag_06 DEOXYGUANOSINE KINASE user 4 2 # 4 G 70 GLU A 474 GLU~? 16.68 N2 G B 2 G 142 ARG A 441 ARG.? 21.93 N2 G B 2 coo 23.29 16.67 58.82 24.61 15.29 57.84 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 29.15 18.37 59.04 28.72 20.55 61.13 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 1jag_06 source 1jag DEOXYGUANOSINE KINASE : 4 hits 1jag_06 naa= 2 ULMN 2 1jag_07 DEOXYGUANOSINE KINASE user 1 2 # 1 H 70 GLU A 225 GLU~? 23.05 C2 A B 9 H 142 ARG A 230 ARG~? 20.03 C2 A B 9 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1jag_07 DEOXYGUANOSINE KINASE user 2 2 # 2 H 70 GLU A 407 GLU~? 15.45 O2 U B 3 H 142 ARG A 354 ARG~? 17.55 O2' A B 4 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 ULMN 2 1jag_07 DEOXYGUANOSINE KINASE user 3 2 # 3 H 70 GLU A 432 GLU~? 22.16 O4 U B 3 H 142 ARG A 431 ARG~? 16.75 O4 U B 3 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1jag_07 DEOXYGUANOSINE KINASE user 4 2 # 4 H 70 GLU A 474 GLU~? 16.68 N2 G B 2 H 142 ARG A 441 ARG.? 21.93 N2 G B 2 coo 36.70 -17.02 61.11 35.17 -15.85 60.14 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 31.05 -18.48 62.92 31.95 -20.16 65.30 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 1jag_07 source 1jag DEOXYGUANOSINE KINASE : 4 hits 1jag_07 naa= 2 ULMN 2 1jfl_00 ASPARTATE RACEMASE user 1 2 # 1 A 82 CYH A 319 CYH~? 13.55 O2' C B 5 A 194 CYH A 281 CYH~? 10.64 C2 A B 7 coo 5.12 39.69 40.80 6.59 42.09 40.53 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 coo -3.10 40.02 37.52 -2.15 42.47 36.45 -21.84 -15.78 -0.10 -24.15 -16.31 -1.64 ULMN 2 1jfl_00 ASPARTATE RACEMASE user 2 2 # 2 A 82 CYH A 319 CYH~? 13.55 O2' C B 5 A 194 CYH A 357 CYH~? 11.67 N3 A B 4 coo 5.12 39.69 40.80 6.59 42.09 40.53 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 coo -3.10 40.02 37.52 -2.15 42.47 36.45 -15.20 -30.19 -11.77 -17.54 -31.24 -12.82 ULMN 2 1jfl_00 ASPARTATE RACEMASE user 3 2 # 3 A 82 CYH A 319 CYH~? 13.55 O2' C B 5 A 194 CYH A 363 CYH~? 7.33 N3 A B 4 coo 5.12 39.69 40.80 6.59 42.09 40.53 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 coo -3.10 40.02 37.52 -2.15 42.47 36.45 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 ULMN 2 1jfl_00 ASPARTATE RACEMASE user 4 2 # 4 A 82 CYH A 357 CYH~? 11.67 N3 A B 4 A 194 CYH A 319 CYH~? 13.55 O2' C B 5 coo 5.12 39.69 40.80 6.59 42.09 40.53 -15.20 -30.19 -11.77 -17.54 -31.24 -12.82 coo -3.10 40.02 37.52 -2.15 42.47 36.45 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 ULMN 2 1jfl_00 ASPARTATE RACEMASE user 5 2 # 5 A 82 CYH A 363 CYH~? 7.33 N3 A B 4 A 194 CYH A 319 CYH~? 13.55 O2' C B 5 coo 5.12 39.69 40.80 6.59 42.09 40.53 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 coo -3.10 40.02 37.52 -2.15 42.47 36.45 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 ULMN 2 1jfl_00 ASPARTATE RACEMASE user 6 2 # 6 A 82 CYH A 438 CYH~? 14.92 N3 U B 3 A 194 CYH A 433 CYH~? 20.69 O4 U B 3 coo 5.12 39.69 40.80 6.59 42.09 40.53 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 coo -3.10 40.02 37.52 -2.15 42.47 36.45 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 1jfl_00 ASPARTATE RACEMASE user 7 2 # 7 A 82 CYH A 505 CYH~? 8.75 N1 G B 2 A 194 CYH A 510 CYH~? 17.27 O4 U B 1 coo 5.12 39.69 40.80 6.59 42.09 40.53 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 coo -3.10 40.02 37.52 -2.15 42.47 36.45 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 ULMN 2 1jfl_00 ASPARTATE RACEMASE user 8 2 # 8 A 82 CYH A 505 CYH~? 8.75 N1 G B 2 A 194 CYH A 511 CYH~? 14.88 O4 U B 1 coo 5.12 39.69 40.80 6.59 42.09 40.53 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 coo -3.10 40.02 37.52 -2.15 42.47 36.45 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 1jfl_00 ASPARTATE RACEMASE user 9 2 # 9 A 82 CYH A 510 CYH~? 17.27 O4 U B 1 A 194 CYH A 505 CYH~? 8.75 N1 G B 2 coo 5.12 39.69 40.80 6.59 42.09 40.53 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo -3.10 40.02 37.52 -2.15 42.47 36.45 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 1jfl_00 source 1jfl ASPARTATE RACEMASE : 9 hits 1jfl_00 naa= 2 ULMN 2 1jfl_01 ASPARTATE RACEMASE user 1 2 # 1 B 82 CYH A 319 CYH~? 13.55 O2' C B 5 B 194 CYH A 281 CYH~? 10.64 C2 A B 7 coo -5.29 32.72 66.93 -4.71 30.16 67.97 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 coo -13.73 33.71 64.42 -14.06 31.22 65.70 -21.84 -15.78 -0.10 -24.15 -16.31 -1.64 ULMN 2 1jfl_01 ASPARTATE RACEMASE user 2 2 # 2 B 82 CYH A 319 CYH~? 13.55 O2' C B 5 B 194 CYH A 357 CYH~? 11.67 N3 A B 4 coo -5.29 32.72 66.93 -4.71 30.16 67.97 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 coo -13.73 33.71 64.42 -14.06 31.22 65.70 -15.20 -30.19 -11.77 -17.54 -31.24 -12.82 ULMN 2 1jfl_01 ASPARTATE RACEMASE user 3 2 # 3 B 82 CYH A 319 CYH~? 13.55 O2' C B 5 B 194 CYH A 363 CYH~? 7.33 N3 A B 4 coo -5.29 32.72 66.93 -4.71 30.16 67.97 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 coo -13.73 33.71 64.42 -14.06 31.22 65.70 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 ULMN 2 1jfl_01 ASPARTATE RACEMASE user 4 2 # 4 B 82 CYH A 357 CYH~? 11.67 N3 A B 4 B 194 CYH A 319 CYH~? 13.55 O2' C B 5 coo -5.29 32.72 66.93 -4.71 30.16 67.97 -15.20 -30.19 -11.77 -17.54 -31.24 -12.82 coo -13.73 33.71 64.42 -14.06 31.22 65.70 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 ULMN 2 1jfl_01 ASPARTATE RACEMASE user 5 2 # 5 B 82 CYH A 363 CYH~? 7.33 N3 A B 4 B 194 CYH A 319 CYH~? 13.55 O2' C B 5 coo -5.29 32.72 66.93 -4.71 30.16 67.97 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 coo -13.73 33.71 64.42 -14.06 31.22 65.70 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 ULMN 2 1jfl_01 ASPARTATE RACEMASE user 6 2 # 6 B 82 CYH A 438 CYH~? 14.92 N3 U B 3 B 194 CYH A 433 CYH~? 20.69 O4 U B 3 coo -5.29 32.72 66.93 -4.71 30.16 67.97 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 coo -13.73 33.71 64.42 -14.06 31.22 65.70 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 1jfl_01 ASPARTATE RACEMASE user 7 2 # 7 B 82 CYH A 505 CYH~? 8.75 N1 G B 2 B 194 CYH A 510 CYH~? 17.27 O4 U B 1 coo -5.29 32.72 66.93 -4.71 30.16 67.97 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 coo -13.73 33.71 64.42 -14.06 31.22 65.70 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 ULMN 2 1jfl_01 ASPARTATE RACEMASE user 8 2 # 8 B 82 CYH A 505 CYH~? 8.75 N1 G B 2 B 194 CYH A 511 CYH~? 14.88 O4 U B 1 coo -5.29 32.72 66.93 -4.71 30.16 67.97 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 coo -13.73 33.71 64.42 -14.06 31.22 65.70 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 1jfl_01 ASPARTATE RACEMASE user 9 2 # 9 B 82 CYH A 510 CYH~? 17.27 O4 U B 1 B 194 CYH A 505 CYH~? 8.75 N1 G B 2 coo -5.29 32.72 66.93 -4.71 30.16 67.97 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo -13.73 33.71 64.42 -14.06 31.22 65.70 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 1jfl_01 source 1jfl ASPARTATE RACEMASE : 9 hits 1jfl_01 naa= 2 ULMN 2 1jm6_00 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 1 2 # 1 A1239 HIS A 420 HIS~? 9.42 N1 A B 4 A1243 GLU A 371 GLU~? 9.29 O2 C B 5 coo 7.90 -1.75 34.47 6.34 -3.06 33.92 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 9.27 -6.20 35.02 7.86 -7.40 36.06 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 1jm6_00 source 1jm6 PYRUVATE DEHYDROGENASE KINASE, ISOZYME 2 : 1 hits 1jm6_00 naa= 2 ULMN 2 1jm6_01 PYRUVATE DEHYDROGENASE KINASE, ISOZYuser 1 2 # 1 B1239 HIS A 420 HIS~? 9.42 N1 A B 4 B1243 GLU A 371 GLU~? 9.29 O2 C B 5 coo 39.87 -17.78 10.40 40.06 -16.28 8.94 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 39.25 -13.41 11.81 40.77 -12.18 11.06 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 1jm6_01 source 1jm6 PYRUVATE DEHYDROGENASE KINASE, ISOZYME 2 : 1 hits 1jm6_01 naa= 2 ULMN 2 1jrp_04 XANTHINE DEHYDROGENASE user 1 2 # 1 B 310 ARG A 180 ARG.? 21.90 C2 A B 9 B 730 GLU A 187 GLU~? 20.71 C2 A B 9 coo 21.65 14.36 26.83 22.79 11.61 26.21 -20.54 -3.44 35.42 -23.45 -2.48 35.38 coo 22.19 14.33 19.31 20.96 13.74 20.93 -28.60 -2.71 32.18 -27.08 -3.13 33.60 ULMN 2 1jrp_04 XANTHINE DEHYDROGENASE user 2 2 # 2 B 310 ARG A 354 ARG~? 17.55 O2' A B 4 B 730 GLU A 407 GLU~? 15.45 O2 U B 3 coo 21.65 14.36 26.83 22.79 11.61 26.21 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo 22.19 14.33 19.31 20.96 13.74 20.93 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1jrp_04 XANTHINE DEHYDROGENASE user 3 2 # 3 B 310 ARG A 392 ARG~? 29.32 C2 A B 4 B 730 GLU A 341 GLU~? 25.67 N6 A B 7 coo 21.65 14.36 26.83 22.79 11.61 26.21 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 coo 22.19 14.33 19.31 20.96 13.74 20.93 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1jrp_04 XANTHINE DEHYDROGENASE user 4 2 # 4 B 310 ARG A 441 ARG.? 21.93 N2 G B 2 B 730 GLU A 474 GLU~? 16.68 N2 G B 2 coo 21.65 14.36 26.83 22.79 11.61 26.21 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo 22.19 14.33 19.31 20.96 13.74 20.93 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 1jrp_04 source 1jrp XANTHINE DEHYDROGENASE : 4 hits 1jrp_04 naa= 2 ULMN 2 1jrp_05 XANTHINE DEHYDROGENASE user 1 2 # 1 D 310 ARG A 180 ARG.? 21.90 C2 A B 9 D 730 GLU A 187 GLU~? 20.71 C2 A B 9 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -20.54 -3.44 35.42 -23.45 -2.48 35.38 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -28.60 -2.71 32.18 -27.08 -3.13 33.60 ULMN 2 1jrp_05 XANTHINE DEHYDROGENASE user 2 2 # 2 D 310 ARG A 354 ARG~? 17.55 O2' A B 4 D 730 GLU A 407 GLU~? 15.45 O2 U B 3 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1jrp_05 XANTHINE DEHYDROGENASE user 3 2 # 3 D 310 ARG A 392 ARG~? 29.32 C2 A B 4 D 730 GLU A 341 GLU~? 25.67 N6 A B 7 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1jrp_05 XANTHINE DEHYDROGENASE user 4 2 # 4 D 310 ARG A 431 ARG~? 16.75 O4 U B 3 D 730 GLU A 432 GLU~? 22.16 O4 U B 3 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1jrp_05 XANTHINE DEHYDROGENASE user 5 2 # 5 D 310 ARG A 441 ARG.? 21.93 N2 G B 2 D 730 GLU A 474 GLU~? 16.68 N2 G B 2 coo 4.69 -35.05 -10.07 6.51 -34.84 -7.57 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo -0.28 -31.99 -5.65 1.65 -31.50 -6.36 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 1jrp_05 source 1jrp XANTHINE DEHYDROGENASE : 5 hits 1jrp_05 naa= 2 ULMN 2 1jrp_06 XANTHINE DEHYDROGENASE user 1 2 # 1 F 310 ARG A 230 ARG~? 20.03 C2 A B 9 F 730 GLU A 225 GLU~? 23.05 C2 A B 9 coo 5.26 36.61 70.62 3.67 36.04 68.06 -30.18 1.36 11.96 -29.08 0.35 14.66 coo 8.70 41.35 66.26 6.78 41.28 67.16 -36.18 -1.53 15.48 -36.93 -1.10 13.54 ULMN 2 1jrp_06 XANTHINE DEHYDROGENASE user 2 2 # 2 F 310 ARG A 354 ARG~? 17.55 O2' A B 4 F 730 GLU A 407 GLU~? 15.45 O2 U B 3 coo 5.26 36.61 70.62 3.67 36.04 68.06 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo 8.70 41.35 66.26 6.78 41.28 67.16 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1jrp_06 XANTHINE DEHYDROGENASE user 3 2 # 3 F 310 ARG A 392 ARG~? 29.32 C2 A B 4 F 730 GLU A 341 GLU~? 25.67 N6 A B 7 coo 5.26 36.61 70.62 3.67 36.04 68.06 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 coo 8.70 41.35 66.26 6.78 41.28 67.16 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1jrp_06 XANTHINE DEHYDROGENASE user 4 2 # 4 F 310 ARG A 431 ARG~? 16.75 O4 U B 3 F 730 GLU A 432 GLU~? 22.16 O4 U B 3 coo 5.26 36.61 70.62 3.67 36.04 68.06 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 8.70 41.35 66.26 6.78 41.28 67.16 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1jrp_06 XANTHINE DEHYDROGENASE user 5 2 # 5 F 310 ARG A 441 ARG.? 21.93 N2 G B 2 F 730 GLU A 474 GLU~? 16.68 N2 G B 2 coo 5.26 36.61 70.62 3.67 36.04 68.06 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo 8.70 41.35 66.26 6.78 41.28 67.16 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 1jrp_06 source 1jrp XANTHINE DEHYDROGENASE : 5 hits 1jrp_06 naa= 2 ULMN 2 1jrp_07 XANTHINE DEHYDROGENASE user 1 2 # 1 H 310 ARG A 230 ARG~? 20.03 C2 A B 9 H 730 GLU A 225 GLU~? 23.05 C2 A B 9 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -30.18 1.36 11.96 -29.08 0.35 14.66 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -36.18 -1.53 15.48 -36.93 -1.10 13.54 ULMN 2 1jrp_07 XANTHINE DEHYDROGENASE user 2 2 # 2 H 310 ARG A 354 ARG~? 17.55 O2' A B 4 H 730 GLU A 407 GLU~? 15.45 O2 U B 3 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1jrp_07 XANTHINE DEHYDROGENASE user 3 2 # 3 H 310 ARG A 392 ARG~? 29.32 C2 A B 4 H 730 GLU A 341 GLU~? 25.67 N6 A B 7 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1jrp_07 XANTHINE DEHYDROGENASE user 4 2 # 4 H 310 ARG A 441 ARG.? 21.93 N2 G B 2 H 730 GLU A 474 GLU~? 16.68 N2 G B 2 coo -28.90 76.02 33.83 -29.02 73.00 34.22 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo -29.55 75.84 41.31 -28.10 75.67 39.75 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 1jrp_07 source 1jrp XANTHINE DEHYDROGENASE : 4 hits 1jrp_07 naa= 2 ULMN 2 1jrp_08 XANTHINE DEHYDROGENASE user 1 2 # 1 B 197 GLN A 276 GLN~? 19.14 O2 U B 8 B 342 ARG A 314 ARG~? 20.43 C2 A B 7 coo 12.40 11.20 14.87 13.43 12.44 16.24 -24.81 -5.96 0.11 -23.22 -4.85 -0.80 coo 20.56 18.81 16.07 21.88 18.50 13.41 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1jrp_08 XANTHINE DEHYDROGENASE user 2 2 # 2 B 197 GLN A 295 GLN~? 9.64 N6 A B 7 B 342 ARG A 288 ARG~? 3.45 C6 A B 7 coo 12.40 11.20 14.87 13.43 12.44 16.24 -33.09 -24.48 7.27 -31.59 -25.59 8.28 coo 20.56 18.81 16.07 21.88 18.50 13.41 -21.54 -21.02 8.30 -20.02 -23.61 8.96 1jrp_08 source 1jrp XANTHINE DEHYDROGENASE : 2 hits 1jrp_08 naa= 2 ULMN 2 1jrp_09 XANTHINE DEHYDROGENASE user 1 2 # 1 D 197 GLN A 276 GLN~? 19.14 O2 U B 8 D 342 ARG A 314 ARG~? 20.43 C2 A B 7 coo 0.11 -20.91 -6.95 -0.04 -22.94 -7.51 -24.81 -5.96 0.11 -23.22 -4.85 -0.80 coo -5.46 -30.74 -6.45 -6.82 -30.17 -3.84 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1jrp_09 XANTHINE DEHYDROGENASE user 2 2 # 2 D 197 GLN A 295 GLN~? 9.64 N6 A B 7 D 342 ARG A 288 ARG~? 3.45 C6 A B 7 coo 0.11 -20.91 -6.95 -0.04 -22.94 -7.51 -33.09 -24.48 7.27 -31.59 -25.59 8.28 coo -5.46 -30.74 -6.45 -6.82 -30.17 -3.84 -21.54 -21.02 8.30 -20.02 -23.61 8.96 1jrp_09 source 1jrp XANTHINE DEHYDROGENASE : 2 hits 1jrp_09 naa= 2 ULMN 2 1jrp_10 XANTHINE DEHYDROGENASE user 1 2 # 1 F 197 GLN A 276 GLN~? 19.14 O2 U B 8 F 342 ARG A 314 ARG~? 20.43 C2 A B 7 coo 4.07 51.31 67.51 4.98 49.46 68.21 -24.81 -5.96 0.11 -23.22 -4.85 -0.80 coo 13.05 44.40 67.13 14.11 45.54 64.65 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1jrp_10 XANTHINE DEHYDROGENASE user 2 2 # 2 F 197 GLN A 295 GLN~? 9.64 N6 A B 7 F 342 ARG A 288 ARG~? 3.45 C6 A B 7 coo 4.07 51.31 67.51 4.98 49.46 68.21 -33.09 -24.48 7.27 -31.59 -25.59 8.28 coo 13.05 44.40 67.13 14.11 45.54 64.65 -21.54 -21.02 8.30 -20.02 -23.61 8.96 1jrp_10 source 1jrp XANTHINE DEHYDROGENASE : 2 hits 1jrp_10 naa= 2 ULMN 2 1jrp_11 XANTHINE DEHYDROGENASE user 1 2 # 1 H 197 GLN A 276 GLN~? 19.14 O2 U B 8 H 342 ARG A 314 ARG~? 20.43 C2 A B 7 coo -19.15 76.76 45.68 -20.69 77.29 44.27 -24.81 -5.96 0.11 -23.22 -4.85 -0.80 coo -29.73 80.59 44.58 -30.82 79.63 47.24 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1jrp_11 XANTHINE DEHYDROGENASE user 2 2 # 2 H 197 GLN A 295 GLN~? 9.64 N6 A B 7 H 342 ARG A 288 ARG~? 3.45 C6 A B 7 coo -19.15 76.76 45.68 -20.69 77.29 44.27 -33.09 -24.48 7.27 -31.59 -25.59 8.28 coo -29.73 80.59 44.58 -30.82 79.63 47.24 -21.54 -21.02 8.30 -20.02 -23.61 8.96 1jrp_11 source 1jrp XANTHINE DEHYDROGENASE : 2 hits 1jrp_11 naa= 2 ULMN 2 1jxh_00 PHOSPHOMETHYLPYRIMIDINE KINASE user 1 2 # 1 A 176 LYS A 537 LYS~? 23.79 O4 U B 1 A 210 GLY A 478 GLY.? 19.78 N2 G B 2 coo 34.14 63.09 78.07 32.63 58.11 75.17 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo 33.03 52.38 67.66 33.41 53.06 67.61 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 1jxh_00 source 1jxh PHOSPHOMETHYLPYRIMIDINE KINASE : 1 hits 1jxh_00 naa= 2 ULMN 2 1jxh_01 PHOSPHOMETHYLPYRIMIDINE KINASE user 1 2 # 1 B 176 LYS A 537 LYS~? 23.79 O4 U B 1 B 210 GLY A 478 GLY.? 19.78 N2 G B 2 coo 37.67 14.56 60.47 35.43 19.31 63.31 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo 34.81 25.02 70.85 35.27 24.39 70.91 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 1jxh_01 source 1jxh PHOSPHOMETHYLPYRIMIDINE KINASE : 1 hits 1jxh_01 naa= 2 ULMN 2 1kae_00 HISTIDINOL DEHYDROGENASE user 1 2 # 1 A 326 GLU A 371 GLU~? 9.29 O2 C B 5 A 327 HIS A 420 HIS~? 9.42 N1 A B 4 coo 13.89 116.20 59.19 15.25 115.41 60.61 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 10.98 116.96 62.31 12.07 115.17 62.46 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1kae_00 source 1kae HISTIDINOL DEHYDROGENASE : 1 hits 1kae_00 naa= 2 ULMN 2 1kae_01 HISTIDINOL DEHYDROGENASE user 1 2 # 1 B 326 GLU A 371 GLU~? 9.29 O2 C B 5 B 327 HIS A 420 HIS~? 9.42 N1 A B 4 coo 16.56 100.37 30.04 17.64 101.54 28.62 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 14.04 98.68 26.87 14.57 100.69 26.53 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 1kae_01 source 1kae HISTIDINOL DEHYDROGENASE : 1 hits 1kae_01 naa= 2 ULMN 2 1kcz_00 BETA-METHYLASPARTASE user 1 2 # 1 A 194 HIS A 326 HIS~? 3.28 C5 A B 7 A 331 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 39.14 -7.49 11.72 40.95 -7.65 12.80 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 45.74 3.70 15.16 49.86 -1.10 14.66 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1kcz_00 source 1kcz BETA-METHYLASPARTASE : 1 hits 1kcz_00 naa= 2 ULMN 2 1kcz_01 BETA-METHYLASPARTASE user 1 2 # 1 B 194 HIS A 326 HIS~? 3.28 C5 A B 7 B 331 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 13.97 -7.54 29.73 12.23 -7.62 28.56 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 7.43 3.70 26.25 3.47 -1.18 26.49 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1kcz_01 source 1kcz BETA-METHYLASPARTASE : 1 hits 1kcz_01 naa= 2 ULMN 2 1kdg_00 CELLOBIOSE DEHYDROGENASE user 1 2 # 1 A 689 HIS A 420 HIS~? 9.42 N1 A B 4 A 732 ASN A 424 ASN~? 14.16 N1 A B 4 coo 24.46 23.36 17.42 25.88 24.61 18.33 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 27.06 24.40 21.98 27.51 26.43 21.46 -25.68 -44.49 -8.34 -27.48 -44.07 -7.29 1kdg_00 source 1kdg CELLOBIOSE DEHYDROGENASE : 1 hits 1kdg_00 naa= 2 ULMN 2 1kdg_01 CELLOBIOSE DEHYDROGENASE user 1 2 # 1 B 689 HIS A 420 HIS~? 9.42 N1 A B 4 B 732 ASN A 424 ASN~? 14.16 N1 A B 4 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -25.68 -44.49 -8.34 -27.48 -44.07 -7.29 1kdg_01 source 1kdg CELLOBIOSE DEHYDROGENASE : 1 hits 1kdg_01 naa= 2 ULMN 2 1kny_00 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 1 2 # 1 A 145 GLU A 208 GLU~? 4.03 N1 A B 9 A 149 LYS A 212 LYS.? 5.77 N6 A B 9 coo 38.29 43.93 28.58 37.89 45.59 29.77 -24.90 -17.89 21.91 -24.90 -19.66 23.08 coo 40.71 37.48 29.08 37.62 41.79 32.12 -32.17 -17.64 24.03 -27.48 -21.87 22.97 1kny_00 source 1kny KANAMYCIN NUCLEOTIDYLTRANSFERASE : 1 hits 1kny_00 naa= 2 ULMN 2 1kny_01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 1 2 # 1 B 145 GLU A 208 GLU~? 4.03 N1 A B 9 B 149 LYS A 212 LYS.? 5.77 N6 A B 9 coo 16.16 40.65 44.70 16.29 42.36 43.62 -24.90 -17.89 21.91 -24.90 -19.66 23.08 coo 15.03 33.77 42.69 17.13 39.10 39.90 -32.17 -17.64 24.03 -27.48 -21.87 22.97 ULMN 2 1kny_01 KANAMYCIN NUCLEOTIDYLTRANSFERASE user 2 2 # 2 B 145 GLU A 457 GLU~? 3.32 N1 G B 2 B 149 LYS A 458 LYS~? 5.39 O4 U B 3 coo 16.16 40.65 44.70 16.29 42.36 43.62 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 15.03 33.77 42.69 17.13 39.10 39.90 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 1kny_01 source 1kny KANAMYCIN NUCLEOTIDYLTRANSFERASE : 2 hits 1kny_01 naa= 2 ULMN 2 1kp2_00 ARGININOSUCCINATE SYNTHETASE user 1 2 # 1 A 106 ARG A 230 ARG~? 20.03 C2 A B 9 A 135 ASP A 233 ASP~? 18.81 O2 U B 8 coo 27.12 14.95 42.29 27.92 17.73 41.22 -30.18 1.36 11.96 -29.08 0.35 14.66 coo 31.19 14.02 39.72 30.95 15.42 41.26 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1kp2_00 ARGININOSUCCINATE SYNTHETASE user 2 2 # 2 A 106 ARG A 314 ARG~? 20.43 C2 A B 7 A 135 ASP A 312 ASP~? 21.35 C2 A B 7 coo 27.12 14.95 42.29 27.92 17.73 41.22 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 coo 31.19 14.02 39.72 30.95 15.42 41.26 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 ULMN 2 1kp2_00 ARGININOSUCCINATE SYNTHETASE user 3 2 # 3 A 106 ARG A 396 ARG~? 24.93 C2 A B 4 A 135 ASP A 345 ASP~? 24.06 C2 A B 4 coo 27.12 14.95 42.29 27.92 17.73 41.22 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 coo 31.19 14.02 39.72 30.95 15.42 41.26 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 ULMN 2 1kp2_00 ARGININOSUCCINATE SYNTHETASE user 4 2 # 4 A 106 ARG A 517 ARG.? 17.55 O4 U B 1 A 135 ASP A 512 ASP~? 14.88 O6 G B 2 coo 27.12 14.95 42.29 27.92 17.73 41.22 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 coo 31.19 14.02 39.72 30.95 15.42 41.26 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 1kp2_00 source 1kp2 ARGININOSUCCINATE SYNTHETASE : 4 hits 1kp2_00 naa= 2 ULMN 2 1kqc_04 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 A 14 LYS A 304 LYS~? 25.42 N1 A B 7 A 74 LYS A 270 LYS~? 23.81 O4 U B 8 coo 24.97 5.82 58.78 26.79 1.97 55.46 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo 19.46 3.44 61.93 23.95 1.12 60.13 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 1kqc_04 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_04 naa= 2 ULMN 2 1kqc_06 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 C 14 LYS A 304 LYS~? 25.42 N1 A B 7 C 74 LYS A 270 LYS~? 23.81 O4 U B 8 coo 17.59 37.25 25.80 19.64 34.15 21.60 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo 12.29 34.52 28.11 16.84 32.47 25.43 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 1kqc_06 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_06 naa= 2 ULMN 2 1kqc_07 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 D 14 LYS A 304 LYS~? 25.42 N1 A B 7 D 74 LYS A 270 LYS~? 23.81 O4 U B 8 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 1kqc_07 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_07 naa= 2 ULMN 2 1l0o_00 ANTI-SIGMA F FACTOR user 1 2 # 1 A 46 GLU A 341 GLU~? 25.67 N6 A B 7 A 105 ARG A 392 ARG~? 29.32 C2 A B 4 coo 4.64 17.62 61.98 3.43 16.11 62.87 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo -1.86 8.63 61.10 0.28 9.55 63.06 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 ULMN 2 1l0o_00 ANTI-SIGMA F FACTOR user 2 2 # 2 A 46 GLU A 371 GLU~? 9.29 O2 C B 5 A 105 ARG A 364 ARG~? 3.58 O2 C B 5 coo 4.64 17.62 61.98 3.43 16.11 62.87 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -1.86 8.63 61.10 0.28 9.55 63.06 -17.84 -32.65 -1.33 -19.23 -35.35 -1.33 ULMN 2 1l0o_00 ANTI-SIGMA F FACTOR user 3 2 # 3 A 46 GLU A 470 GLU~? 22.82 N2 G B 2 A 105 ARG A 441 ARG.? 21.93 N2 G B 2 coo 4.64 17.62 61.98 3.43 16.11 62.87 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -1.86 8.63 61.10 0.28 9.55 63.06 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 ULMN 2 1l0o_00 ANTI-SIGMA F FACTOR user 4 2 # 4 A 46 GLU A 522 GLU^? 23.38 O4 U B 3 A 105 ARG A 431 ARG~? 16.75 O4 U B 3 coo 4.64 17.62 61.98 3.43 16.11 62.87 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo -1.86 8.63 61.10 0.28 9.55 63.06 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 ULMN 2 1l0o_00 ANTI-SIGMA F FACTOR user 5 2 # 5 A 46 GLU A 522 GLU^? 23.38 O4 U B 3 A 105 ARG A 518 ARG.? 16.31 O6 G B 2 coo 4.64 17.62 61.98 3.43 16.11 62.87 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo -1.86 8.63 61.10 0.28 9.55 63.06 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 1l0o_00 source 1l0o ANTI-SIGMA F FACTOR : 5 hits 1l0o_00 naa= 2 ULMN 2 1l7n_00 PHOSPHOSERINE PHOSPHATASE user 1 2 # 1 A 11 ASP A 233 ASP~? 18.81 O2 U B 8 A 13 ASP A 232 ASP~? 21.56 O2 U B 8 coo 53.27 18.00 2.23 52.37 17.52 4.06 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 48.69 14.85 6.40 49.14 12.85 6.94 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 1l7n_00 PHOSPHOSERINE PHOSPHATASE user 2 2 # 2 A 11 ASP A 259 ASP.? 23.89 N1 A B 9 A 13 ASP A 260 ASP.? 30.95 O4 U B 8 coo 53.27 18.00 2.23 52.37 17.52 4.06 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 48.69 14.85 6.40 49.14 12.85 6.94 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 1l7n_00 PHOSPHOSERINE PHOSPHATASE user 3 2 # 3 A 11 ASP A 426 ASP.? 18.90 N1 A B 4 A 13 ASP A 425 ASP.? 18.06 O4 U B 3 coo 53.27 18.00 2.23 52.37 17.52 4.06 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 48.69 14.85 6.40 49.14 12.85 6.94 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1l7n_00 PHOSPHOSERINE PHOSPHATASE user 4 2 # 4 A 11 ASP A 473 ASP~? 22.60 N2 G B 2 A 13 ASP A 477 ASP~? 24.62 N2 G B 2 coo 53.27 18.00 2.23 52.37 17.52 4.06 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 48.69 14.85 6.40 49.14 12.85 6.94 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 ULMN 2 1l7n_00 PHOSPHOSERINE PHOSPHATASE user 5 2 # 5 A 11 ASP A 477 ASP~? 24.62 N2 G B 2 A 13 ASP A 473 ASP~? 22.60 N2 G B 2 coo 53.27 18.00 2.23 52.37 17.52 4.06 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 48.69 14.85 6.40 49.14 12.85 6.94 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1l7n_00 PHOSPHOSERINE PHOSPHATASE user 6 2 # 6 A 11 ASP A 488 ASP~? 18.76 O2 U B 1 A 13 ASP A 491 ASP~? 15.62 O2 U B 1 coo 53.27 18.00 2.23 52.37 17.52 4.06 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 48.69 14.85 6.40 49.14 12.85 6.94 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1l7n_00 source 1l7n PHOSPHOSERINE PHOSPHATASE : 6 hits 1l7n_00 naa= 2 ULMN 2 1l7n_01 PHOSPHOSERINE PHOSPHATASE user 1 2 # 1 B 511 ASP A 233 ASP~? 18.81 O2 U B 8 B 513 ASP A 232 ASP~? 21.56 O2 U B 8 coo 62.03 15.32 45.23 61.67 14.72 47.22 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 59.25 15.58 51.55 57.26 14.91 51.77 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 1l7n_01 PHOSPHOSERINE PHOSPHATASE user 2 2 # 2 B 511 ASP A 259 ASP.? 23.89 N1 A B 9 B 513 ASP A 260 ASP.? 30.95 O4 U B 8 coo 62.03 15.32 45.23 61.67 14.72 47.22 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 59.25 15.58 51.55 57.26 14.91 51.77 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 1l7n_01 PHOSPHOSERINE PHOSPHATASE user 3 2 # 3 B 511 ASP A 426 ASP.? 18.90 N1 A B 4 B 513 ASP A 425 ASP.? 18.06 O4 U B 3 coo 62.03 15.32 45.23 61.67 14.72 47.22 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 59.25 15.58 51.55 57.26 14.91 51.77 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1l7n_01 PHOSPHOSERINE PHOSPHATASE user 4 2 # 4 B 511 ASP A 473 ASP~? 22.60 N2 G B 2 B 513 ASP A 477 ASP~? 24.62 N2 G B 2 coo 62.03 15.32 45.23 61.67 14.72 47.22 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 59.25 15.58 51.55 57.26 14.91 51.77 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 ULMN 2 1l7n_01 PHOSPHOSERINE PHOSPHATASE user 5 2 # 5 B 511 ASP A 477 ASP~? 24.62 N2 G B 2 B 513 ASP A 473 ASP~? 22.60 N2 G B 2 coo 62.03 15.32 45.23 61.67 14.72 47.22 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 59.25 15.58 51.55 57.26 14.91 51.77 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1l7n_01 PHOSPHOSERINE PHOSPHATASE user 6 2 # 6 B 511 ASP A 488 ASP~? 18.76 O2 U B 1 B 513 ASP A 491 ASP~? 15.62 O2 U B 1 coo 62.03 15.32 45.23 61.67 14.72 47.22 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 59.25 15.58 51.55 57.26 14.91 51.77 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1l7n_01 source 1l7n PHOSPHOSERINE PHOSPHATASE : 6 hits 1l7n_01 naa= 2 ULMN 2 1lij_00 ADENOSINE KINASE user 1 2 # 1 A 136 ARG A 314 ARG~? 20.43 C2 A B 7 A 318 ASP A 279 ASP~? 17.12 C2 A B 7 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1lij_00 ADENOSINE KINASE user 2 2 # 2 A 136 ARG A 390 ARG~? 22.44 N1 A B 4 A 318 ASP A 376 ASP~? 17.17 N1 A B 4 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1lij_00 ADENOSINE KINASE user 3 2 # 3 A 136 ARG A 390 ARG~? 22.44 N1 A B 4 A 318 ASP A 426 ASP.? 18.90 N1 A B 4 coo 140.87 17.93 -10.99 141.89 20.68 -12.00 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 1lij_00 source 1lij ADENOSINE KINASE : 3 hits 1lij_00 naa= 2 ULMN 2 1lio_00 ADENOSINE KINASE user 1 2 # 1 A 136 ARG A 180 ARG.? 21.90 C2 A B 9 A 318 ASP A 200 ASP~? 9.45 O2' A B 9 coo 29.35 33.68 50.39 31.26 31.83 51.65 -20.54 -3.44 35.42 -23.45 -2.48 35.38 coo 32.11 22.71 40.58 33.42 24.22 39.78 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1lio_00 ADENOSINE KINASE user 2 2 # 2 A 136 ARG A 182 ARG.? 25.57 C2 A B 9 A 318 ASP A 190 ASP~? 22.39 C2 A B 9 coo 29.35 33.68 50.39 31.26 31.83 51.65 -27.13 -7.51 39.69 -28.96 -5.65 41.28 coo 32.11 22.71 40.58 33.42 24.22 39.78 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1lio_00 ADENOSINE KINASE user 3 2 # 3 A 136 ARG A 230 ARG~? 20.03 C2 A B 9 A 318 ASP A 190 ASP~? 22.39 C2 A B 9 coo 29.35 33.68 50.39 31.26 31.83 51.65 -30.18 1.36 11.96 -29.08 0.35 14.66 coo 32.11 22.71 40.58 33.42 24.22 39.78 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1lio_00 ADENOSINE KINASE user 4 2 # 4 A 136 ARG A 390 ARG~? 22.44 N1 A B 4 A 318 ASP A 345 ASP~? 24.06 C2 A B 4 coo 29.35 33.68 50.39 31.26 31.83 51.65 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo 32.11 22.71 40.58 33.42 24.22 39.78 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 ULMN 2 1lio_00 ADENOSINE KINASE user 5 2 # 5 A 136 ARG A 404 ARG~? 18.97 O2 U B 3 A 318 ASP A 359 ASP~? 8.63 O2' A B 4 coo 29.35 33.68 50.39 31.26 31.83 51.65 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 coo 32.11 22.71 40.58 33.42 24.22 39.78 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 1lio_00 ADENOSINE KINASE user 6 2 # 6 A 136 ARG A 431 ARG~? 16.75 O4 U B 3 A 318 ASP A 376 ASP~? 17.17 N1 A B 4 coo 29.35 33.68 50.39 31.26 31.83 51.65 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 32.11 22.71 40.58 33.42 24.22 39.78 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1lio_00 ADENOSINE KINASE user 7 2 # 7 A 136 ARG A 518 ARG.? 16.31 O6 G B 2 A 318 ASP A 473 ASP~? 22.60 N2 G B 2 coo 29.35 33.68 50.39 31.26 31.83 51.65 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 32.11 22.71 40.58 33.42 24.22 39.78 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1lio_00 ADENOSINE KINASE user 8 2 # 8 A 136 ARG A 541 ARG~? 18.28 O4 U B 1 A 318 ASP A 473 ASP~? 22.60 N2 G B 2 coo 29.35 33.68 50.39 31.26 31.83 51.65 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 coo 32.11 22.71 40.58 33.42 24.22 39.78 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1lio_00 ADENOSINE KINASE user 9 2 # 9 A 136 ARG A 541 ARG~? 18.28 O4 U B 1 A 318 ASP A 533 ASP~? 24.95 O4 U B 1 coo 29.35 33.68 50.39 31.26 31.83 51.65 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 coo 32.11 22.71 40.58 33.42 24.22 39.78 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1lio_00 source 1lio ADENOSINE KINASE : 9 hits 1lio_00 naa= 2 ULMN 2 1lz1_00 LYSOZYME (E.C.3.2.1.17) user 1 2 # 1 35 GLU A 470 GLU~? 22.82 N2 G B 2 53 ASP A 473 ASP~? 22.60 N2 G B 2 coo 13.77 10.94 24.74 13.94 8.84 25.14 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 8.07 6.88 28.19 9.18 5.27 28.79 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1lz1_00 LYSOZYME (E.C.3.2.1.17) user 2 2 # 2 35 GLU A 545 GLU~? 17.12 N3 U B 1 53 ASP A 491 ASP~? 15.62 O2 U B 1 coo 13.77 10.94 24.74 13.94 8.84 25.14 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 8.07 6.88 28.19 9.18 5.27 28.79 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1lz1_00 source 1lz1 LYSOZYME (E.C.3.2.1.17) : 2 hits 1lz1_00 naa= 2 ULMN 2 1m53_01 ISOMALTULOSE SYNTHASE user 1 2 # 1 A 241 ASP A 174 ASP.? 19.36 O2' A B 9 A 295 GLU A 178 GLU.? 16.07 O2' A B 9 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 16.11 33.72 80.99 14.10 33.54 81.63 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1m53_01 ISOMALTULOSE SYNTHASE user 2 2 # 2 A 241 ASP A 345 ASP~? 24.06 C2 A B 4 A 295 GLU A 341 GLU~? 25.67 N6 A B 7 coo 11.74 38.14 80.19 10.63 36.40 80.65 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 16.11 33.72 80.99 14.10 33.54 81.63 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1m53_01 ISOMALTULOSE SYNTHASE user 3 2 # 3 A 241 ASP A 491 ASP~? 15.62 O2 U B 1 A 295 GLU A 545 GLU~? 17.12 N3 U B 1 coo 11.74 38.14 80.19 10.63 36.40 80.65 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 16.11 33.72 80.99 14.10 33.54 81.63 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1m53_01 source 1m53 ISOMALTULOSE SYNTHASE : 3 hits 1m53_01 naa= 2 ULMN 2 1m54_01 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 B 119 LYS A 231 LYS~? 21.79 O2 U B 8 B 349 SER A 274 SER~? 19.09 N1 A B 7 coo -3.88 -2.87 -13.18 -0.74 -0.37 -16.39 -28.35 -2.55 6.15 -27.54 -2.37 -0.06 coo 4.35 6.26 -13.94 3.14 5.15 -12.15 -30.19 -9.75 -2.18 -32.45 -10.61 -2.45 ULMN 2 1m54_01 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 B 119 LYS A 270 LYS~? 23.81 O4 U B 8 B 349 SER A 300 SER~? 23.48 N6 A B 7 coo -3.88 -2.87 -13.18 -0.74 -0.37 -16.39 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 coo 4.35 6.26 -13.94 3.14 5.15 -12.15 -41.38 -17.70 -1.13 -43.08 -16.44 0.06 1m54_01 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 2 hits 1m54_01 naa= 2 ULMN 2 1m54_02 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 C 119 LYS A 231 LYS~? 21.79 O2 U B 8 C 349 SER A 274 SER~? 19.09 N1 A B 7 coo -20.84 30.72 17.88 -25.98 31.63 17.66 -28.35 -2.55 6.15 -27.54 -2.37 -0.06 coo -29.13 36.71 25.20 -26.79 36.20 25.00 -30.19 -9.75 -2.18 -32.45 -10.61 -2.45 1m54_02 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 1 hits 1m54_02 naa= 2 ULMN 2 1m54_03 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 D 119 LYS A 231 LYS~? 21.79 O2 U B 8 D 349 SER A 274 SER~? 19.09 N1 A B 7 coo -5.37 44.26 36.87 -2.80 48.80 34.89 -28.35 -2.55 6.15 -27.54 -2.37 -0.06 coo -0.72 48.15 25.83 -2.20 46.60 26.98 -30.19 -9.75 -2.18 -32.45 -10.61 -2.45 1m54_03 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 1 hits 1m54_03 naa= 2 ULMN 2 1m54_04 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 E 119 LYS A 231 LYS~? 21.79 O2 U B 8 E 349 SER A 274 SER~? 19.09 N1 A B 7 coo -4.84 35.54 84.77 -8.56 37.12 86.14 -28.35 -2.55 6.15 -27.54 -2.37 -0.06 coo -16.84 35.71 81.57 -14.88 34.62 80.63 -30.19 -9.75 -2.18 -32.45 -10.61 -2.45 ULMN 2 1m54_04 CYSTATHIONINE BETA-SYNTHASE user 2 2 # 2 E 119 LYS A 270 LYS~? 23.81 O4 U B 8 E 349 SER A 300 SER~? 23.48 N6 A B 7 coo -4.84 35.54 84.77 -8.56 37.12 86.14 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 coo -16.84 35.71 81.57 -14.88 34.62 80.63 -41.38 -17.70 -1.13 -43.08 -16.44 0.06 1m54_04 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 2 hits 1m54_04 naa= 2 ULMN 2 1m54_05 CYSTATHIONINE BETA-SYNTHASE user 1 2 # 1 F 119 LYS A 231 LYS~? 21.79 O2 U B 8 F 349 SER A 274 SER~? 19.09 N1 A B 7 coo -7.84 18.42 63.15 -7.36 13.76 64.43 -28.35 -2.55 6.15 -27.54 -2.37 -0.06 coo -1.89 11.37 72.02 -3.31 13.25 71.54 -30.19 -9.75 -2.18 -32.45 -10.61 -2.45 1m54_05 source 1m54 CYSTATHIONINE BETA-SYNTHASE : 1 hits 1m54_05 naa= 2 ULMN 2 1mek_01 PROTEIN DISULFIDE ISOMERASE user 1 2 # 1 36 CYH A 405 CYH~? 14.40 N3 U B 3 39 CYH A 438 CYH~? 14.92 N3 U B 3 coo -11.24 -12.22 -0.35 -9.10 -11.26 -1.75 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 coo -5.66 -10.94 -0.28 -7.80 -9.74 -1.48 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 ULMN 2 1mek_01 PROTEIN DISULFIDE ISOMERASE user 2 2 # 2 36 CYH A 438 CYH~? 14.92 N3 U B 3 39 CYH A 405 CYH~? 14.40 N3 U B 3 coo -11.24 -12.22 -0.35 -9.10 -11.26 -1.75 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 coo -5.66 -10.94 -0.28 -7.80 -9.74 -1.48 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 1mek_01 source 1mek PROTEIN DISULFIDE ISOMERASE : 2 hits 1mek_01 naa= 2 ULMN 2 1mht_00 HHAI METHYLTRANSFERASE user 1 2 # 1 A 81 CYH A 357 CYH~? 11.67 N3 A B 4 A 119 GLU A 407 GLU~? 15.45 O2 U B 3 coo -14.24 38.25 87.68 -17.04 38.68 87.49 -15.20 -30.19 -11.77 -17.54 -31.24 -12.82 coo -16.93 37.35 78.96 -17.46 37.15 81.01 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 1mht_00 source 1mht HHAI METHYLTRANSFERASE : 1 hits 1mht_00 naa= 2 ULMN 2 1mhy_00 METHANE MONOOXYGENASE HYDROXYLASE user 1 2 # 1 D 151 CYH A 319 CYH~? 13.55 O2' C B 5 D 213 THR A 368 THR~? 9.37 O2' C B 5 coo -42.45 81.56 14.53 -42.56 80.44 17.02 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 coo -44.48 73.73 25.06 -42.89 75.12 24.56 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 1mhy_00 source 1mhy METHANE MONOOXYGENASE HYDROXYLASE : 1 hits 1mhy_00 naa= 2 ULMN 2 1mj9_00 ESA1 PROTEIN user 1 2 # 1 A 304 SER A 358 SER~? 11.85 O2' A B 4 A 338 GLU A 407 GLU~? 15.45 O2 U B 3 coo -4.46 89.97 21.66 -6.05 90.10 19.82 -11.48 -29.46 -11.79 -11.03 -27.35 -12.89 coo -8.51 84.09 23.34 -9.53 85.71 22.43 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1mj9_00 ESA1 PROTEIN user 2 2 # 2 A 304 SER A 445 SER~? 14.11 N2 G B 2 A 338 GLU A 449 GLU.? 11.55 O2 U B 3 coo -4.46 89.97 21.66 -6.05 90.10 19.82 -4.27 -47.21 -20.02 -5.51 -46.10 -21.77 coo -8.51 84.09 23.34 -9.53 85.71 22.43 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1mj9_00 ESA1 PROTEIN user 3 2 # 3 A 304 SER A 453 SER~? 2.96 N2 G B 2 A 338 GLU A 457 GLU~? 3.32 N1 G B 2 coo -4.46 89.97 21.66 -6.05 90.10 19.82 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 coo -8.51 84.09 23.34 -9.53 85.71 22.43 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 1mj9_00 source 1mj9 ESA1 PROTEIN : 3 hits 1mj9_00 naa= 2 ULMN 2 1mok_00 ORF3 user 1 2 # 1 A 82 CYH A 405 CYH~? 14.40 N3 U B 3 A 87 CYH A 438 CYH~? 14.92 N3 U B 3 coo 51.06 11.31 20.53 50.33 8.67 19.53 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 coo 47.17 9.77 22.12 48.34 9.16 19.52 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 ULMN 2 1mok_00 ORF3 user 2 2 # 2 A 82 CYH A 438 CYH~? 14.92 N3 U B 3 A 87 CYH A 405 CYH~? 14.40 N3 U B 3 coo 51.06 11.31 20.53 50.33 8.67 19.53 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 coo 47.17 9.77 22.12 48.34 9.16 19.52 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 1mok_00 source 1mok ORF3 : 2 hits 1mok_00 naa= 2 ULMN 2 1mok_01 ORF3 user 1 2 # 1 B 82 CYH A 405 CYH~? 14.40 N3 U B 3 B 87 CYH A 438 CYH~? 14.92 N3 U B 3 coo 28.70 -21.33 28.97 29.60 -19.62 26.87 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 coo 32.44 -19.21 29.99 31.49 -20.15 27.41 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 ULMN 2 1mok_01 ORF3 user 2 2 # 2 B 82 CYH A 438 CYH~? 14.92 N3 U B 3 B 87 CYH A 405 CYH~? 14.40 N3 U B 3 coo 28.70 -21.33 28.97 29.60 -19.62 26.87 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 coo 32.44 -19.21 29.99 31.49 -20.15 27.41 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 1mok_01 source 1mok ORF3 : 2 hits 1mok_01 naa= 2 ULMN 2 1mok_02 ORF3 user 1 2 # 1 C 82 CYH A 405 CYH~? 14.40 N3 U B 3 C 87 CYH A 438 CYH~? 14.92 N3 U B 3 coo 115.04 69.28 73.09 113.97 71.81 73.99 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 coo 111.29 70.66 71.08 112.03 71.22 73.86 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 ULMN 2 1mok_02 ORF3 user 2 2 # 2 C 82 CYH A 438 CYH~? 14.92 N3 U B 3 C 87 CYH A 405 CYH~? 14.40 N3 U B 3 coo 115.04 69.28 73.09 113.97 71.81 73.99 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 coo 111.29 70.66 71.08 112.03 71.22 73.86 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 1mok_02 source 1mok ORF3 : 2 hits 1mok_02 naa= 2 ULMN 2 1mok_03 ORF3 user 1 2 # 1 D 82 CYH A 405 CYH~? 14.40 N3 U B 3 D 87 CYH A 438 CYH~? 14.92 N3 U B 3 coo 91.91 101.69 63.53 92.70 100.03 65.79 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 coo 95.74 99.54 62.93 94.66 100.48 65.46 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 ULMN 2 1mok_03 ORF3 user 2 2 # 2 D 82 CYH A 438 CYH~? 14.92 N3 U B 3 D 87 CYH A 405 CYH~? 14.40 N3 U B 3 coo 91.91 101.69 63.53 92.70 100.03 65.79 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 coo 95.74 99.54 62.93 94.66 100.48 65.46 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 1mok_03 source 1mok ORF3 : 2 hits 1mok_03 naa= 2 ULMN 2 1mqw_00 ADPR PYROPHOSPHATASE user 1 2 # 1 A 64 ARG A 441 ARG.? 21.93 N2 G B 2 A 142 GLU A 436 GLU~? 23.50 O4 U B 3 coo 26.57 14.26 3.78 24.66 16.62 4.01 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo 22.97 20.75 -2.81 21.68 22.37 -2.40 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1mqw_00 ADPR PYROPHOSPHATASE user 2 2 # 2 A 64 ARG A 518 ARG.? 16.31 O6 G B 2 A 142 GLU A 522 GLU^? 23.38 O4 U B 3 coo 26.57 14.26 3.78 24.66 16.62 4.01 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 22.97 20.75 -2.81 21.68 22.37 -2.40 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1mqw_00 ADPR PYROPHOSPHATASE user 3 2 # 3 A 64 ARG A 546 ARG~? 20.83 O4 U B 1 A 142 GLU A 545 GLU~? 17.12 N3 U B 1 coo 26.57 14.26 3.78 24.66 16.62 4.01 3.56 -71.20 -7.93 4.10 -73.33 -10.06 coo 22.97 20.75 -2.81 21.68 22.37 -2.40 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1mqw_00 source 1mqw ADPR PYROPHOSPHATASE : 3 hits 1mqw_00 naa= 2 ULMN 2 1mud_00 ADENINE GLYCOSYLASE user 1 2 # 1 A 37 GLU A 371 GLU~? 9.29 O2 C B 5 A 138 ASN A 424 ASN~? 14.16 N1 A B 4 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 -25.68 -44.49 -8.34 -27.48 -44.07 -7.29 ULMN 2 1mud_00 ADENINE GLYCOSYLASE user 2 2 # 2 A 37 GLU A 457 GLU~? 3.32 N1 G B 2 A 138 ASN A 500 ASN~? 3.20 O2 U B 1 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 -1.24 -54.54 -8.88 -1.32 -53.21 -7.22 ULMN 2 1mud_00 ADENINE GLYCOSYLASE user 3 2 # 3 A 37 GLU A 474 GLU~? 16.68 N2 G B 2 A 138 ASN A 442 ASN~? 17.19 N2 G B 2 coo -28.98 -13.86 16.88 -27.45 -12.37 16.83 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo -28.13 -6.05 12.73 -26.20 -6.06 13.74 -9.71 -46.16 -22.63 -10.09 -45.19 -24.51 1mud_00 source 1mud ADENINE GLYCOSYLASE : 3 hits 1mud_00 naa= 2 ULMN 2 1mvn_00 PPC DECARBOXYLASE ATHAL3A user 1 2 # 1 A 90 HIS A 326 HIS~? 3.28 C5 A B 7 A 175 SER A 217 SER~? 23.86 N1 A B 9 coo 40.70 24.20 -17.92 39.73 26.03 -17.59 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 73.56 14.52 -17.97 72.80 14.99 -15.70 -41.98 -7.62 23.00 -43.59 -6.51 21.56 ULMN 2 1mvn_00 PPC DECARBOXYLASE ATHAL3A user 2 2 # 2 A 90 HIS A 326 HIS~? 3.28 C5 A B 7 A 175 SER A 445 SER~? 14.11 N2 G B 2 coo 40.70 24.20 -17.92 39.73 26.03 -17.59 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 73.56 14.52 -17.97 72.80 14.99 -15.70 -4.27 -47.21 -20.02 -5.51 -46.10 -21.77 ULMN 2 1mvn_00 PPC DECARBOXYLASE ATHAL3A user 3 2 # 3 A 90 HIS A 420 HIS~? 9.42 N1 A B 4 A 175 SER A 238 SER~? 10.39 N3 U B 8 coo 40.70 24.20 -17.92 39.73 26.03 -17.59 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 73.56 14.52 -17.97 72.80 14.99 -15.70 -22.98 -10.82 9.36 -25.25 -10.60 8.53 ULMN 2 1mvn_00 PPC DECARBOXYLASE ATHAL3A user 4 2 # 4 A 90 HIS A 420 HIS~? 9.42 N1 A B 4 A 175 SER A 249 SER~? 6.30 N1 A B 9 coo 40.70 24.20 -17.92 39.73 26.03 -17.59 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 73.56 14.52 -17.97 72.80 14.99 -15.70 -30.50 -15.88 16.28 -28.91 -16.54 17.96 ULMN 2 1mvn_00 PPC DECARBOXYLASE ATHAL3A user 5 2 # 5 A 90 HIS A 420 HIS~? 9.42 N1 A B 4 A 175 SER A 567 SER.? 20.68 O4 U B 1 coo 40.70 24.20 -17.92 39.73 26.03 -17.59 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 73.56 14.52 -17.97 72.80 14.99 -15.70 -12.85 -74.56 -0.21 -11.29 -73.03 0.90 ULMN 2 1mvn_00 PPC DECARBOXYLASE ATHAL3A user 6 2 # 6 A 90 HIS A 482 HIS.? 27.32 N2 G B 2 A 175 SER A 358 SER~? 11.85 O2' A B 4 coo 40.70 24.20 -17.92 39.73 26.03 -17.59 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 73.56 14.52 -17.97 72.80 14.99 -15.70 -11.48 -29.46 -11.79 -11.03 -27.35 -12.89 ULMN 2 1mvn_00 PPC DECARBOXYLASE ATHAL3A user 7 2 # 7 A 90 HIS A 482 HIS.? 27.32 N2 G B 2 A 175 SER A 423 SER~? 9.25 O4 U B 3 coo 40.70 24.20 -17.92 39.73 26.03 -17.59 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 73.56 14.52 -17.97 72.80 14.99 -15.70 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 1mvn_00 source 1mvn PPC DECARBOXYLASE ATHAL3A : 7 hits 1mvn_00 naa= 2 ULMN 2 1myr_01 MYROSINASE user 1 2 # 1 187 GLN A 355 GLN~? 18.12 O2' A B 4 409 GLU A 351 GLU~? 20.29 O2' A B 4 coo 45.09 114.33 52.30 45.59 116.18 51.29 -13.50 -23.03 -15.57 -13.95 -20.94 -15.58 coo 42.69 118.64 56.27 44.58 118.34 55.45 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1myr_01 MYROSINASE user 2 2 # 2 187 GLN A 367 GLN~? 7.23 C2 A B 4 409 GLU A 371 GLU~? 9.29 O2 C B 5 coo 45.09 114.33 52.30 45.59 116.18 51.29 -21.49 -36.00 -4.91 -21.69 -37.66 -6.22 coo 42.69 118.64 56.27 44.58 118.34 55.45 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 1myr_01 source 1myr MYROSINASE : 2 hits 1myr_01 naa= 2 ULMN 2 1n20_00 (+)-BORNYL DIPHOSPHATE SYNTHASE user 1 2 # 1 A 323 TRP A 534 TRP~? 20.57 N2 G B 2 A 578 PHE A 531 PHE~? 20.43 O6 G B 2 coo 42.22 39.02 48.32 44.24 41.75 50.32 -13.87 -64.07 -18.86 -17.27 -62.50 -17.72 coo 48.42 44.12 48.01 47.31 44.28 45.42 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 1n20_00 source 1n20 (+)-BORNYL DIPHOSPHATE SYNTHASE : 1 hits 1n20_00 naa= 2 ULMN 2 1n20_01 (+)-BORNYL DIPHOSPHATE SYNTHASE user 1 2 # 1 B 323 TRP A 534 TRP~? 20.57 N2 G B 2 B 578 PHE A 531 PHE~? 20.43 O6 G B 2 coo 43.23 41.00 1.45 40.43 39.01 -0.47 -13.87 -64.07 -18.86 -17.27 -62.50 -17.72 coo 37.75 35.24 1.51 37.38 36.07 4.16 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 1n20_01 source 1n20 (+)-BORNYL DIPHOSPHATE SYNTHASE : 1 hits 1n20_01 naa= 2 ULMN 2 1n2c_00 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 E 12 GLY A 229 GLY~? 19.93 O4 U B 8 E 15 LYS A 268 LYS~? 23.13 O4 U B 8 coo -2.44 154.43 53.79 -2.04 154.61 53.14 -33.14 -3.29 10.82 -32.39 -3.35 10.56 coo -6.07 154.37 47.56 -2.16 152.62 49.36 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 1n2c_00 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 E 12 GLY A 261 GLY~? 25.55 O4 U B 8 E 15 LYS A 264 LYS~? 27.36 N1 A B 9 coo -2.44 154.43 53.79 -2.04 154.61 53.14 -44.19 -6.16 11.65 -44.45 -6.91 11.63 coo -6.07 154.37 47.56 -2.16 152.62 49.36 -41.84 -5.84 6.59 -43.28 -1.98 11.47 1n2c_00 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_00 naa= 2 ULMN 2 1n2c_01 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 F 12 GLY A 229 GLY~? 19.93 O4 U B 8 F 15 LYS A 268 LYS~? 23.13 O4 U B 8 coo 1.70 155.20 55.76 1.33 154.96 56.40 -33.14 -3.29 10.82 -32.39 -3.35 10.56 coo 5.42 154.93 61.93 2.65 152.21 59.38 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 1n2c_01 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 F 12 GLY A 261 GLY~? 25.55 O4 U B 8 F 15 LYS A 264 LYS~? 27.36 N1 A B 9 coo 1.70 155.20 55.76 1.33 154.96 56.40 -44.19 -6.16 11.65 -44.45 -6.91 11.63 coo 5.42 154.93 61.93 2.65 152.21 59.38 -41.84 -5.84 6.59 -43.28 -1.98 11.47 1n2c_01 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_01 naa= 2 ULMN 2 1n2c_02 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 G 12 GLY A 229 GLY~? 19.93 O4 U B 8 G 15 LYS A 268 LYS~? 23.13 O4 U B 8 coo 8.39 23.19 11.96 7.87 23.40 11.41 -33.14 -3.29 10.82 -32.39 -3.35 10.56 coo 10.78 26.96 6.29 7.40 27.17 9.46 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 1n2c_02 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 G 12 GLY A 261 GLY~? 25.55 O4 U B 8 G 15 LYS A 264 LYS~? 27.36 N1 A B 9 coo 8.39 23.19 11.96 7.87 23.40 11.41 -44.19 -6.16 11.65 -44.45 -6.91 11.63 coo 10.78 26.96 6.29 7.40 27.17 9.46 -41.84 -5.84 6.59 -43.28 -1.98 11.47 1n2c_02 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_02 naa= 2 ULMN 2 1n2c_03 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 H 12 GLY A 229 GLY~? 19.93 O4 U B 8 H 15 LYS A 268 LYS~? 23.13 O4 U B 8 coo 4.68 21.14 13.82 5.18 21.00 14.40 -33.14 -3.29 10.82 -32.39 -3.35 10.56 coo 2.21 17.68 19.65 4.60 21.51 18.60 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 1n2c_03 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 H 12 GLY A 261 GLY~? 25.55 O4 U B 8 H 15 LYS A 264 LYS~? 27.36 N1 A B 9 coo 4.68 21.14 13.82 5.18 21.00 14.40 -44.19 -6.16 11.65 -44.45 -6.91 11.63 coo 2.21 17.68 19.65 4.60 21.51 18.60 -41.84 -5.84 6.59 -43.28 -1.98 11.47 1n2c_03 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 2 hits 1n2c_03 naa= 2 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 D 153 CYH A 287 CYH~? 3.94 C2 A B 7 D 157 VAL A 289 VAL~? 7.61 O4 U B 8 coo 1.13 50.61 23.79 0.62 51.39 26.43 -22.34 -17.28 4.03 -20.33 -19.29 4.31 coo 2.55 45.49 21.08 2.56 44.84 23.18 -26.24 -16.06 7.56 -26.32 -13.96 8.25 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 D 153 CYH A 287 CYH~? 3.94 C2 A B 7 D 157 VAL A 327 VAL~? 7.31 N1 A B 7 coo 1.13 50.61 23.79 0.62 51.39 26.43 -22.34 -17.28 4.03 -20.33 -19.29 4.31 coo 2.55 45.49 21.08 2.56 44.84 23.18 -24.64 -21.87 -0.10 -24.72 -19.67 -0.15 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 D 153 CYH A 303 CYH~? 19.60 N6 A B 7 D 157 VAL A 306 VAL~? 16.11 N1 A B 7 coo 1.13 50.61 23.79 0.62 51.39 26.43 -36.71 -18.21 -3.45 -38.39 -20.40 -3.80 coo 2.55 45.49 21.08 2.56 44.84 23.18 -31.82 -17.74 -4.96 -32.44 -19.81 -5.13 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 D 153 CYH A 363 CYH~? 7.33 N3 A B 4 D 157 VAL A 365 VAL~? 9.33 O2' C B 5 coo 1.13 50.61 23.79 0.62 51.39 26.43 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 coo 2.55 45.49 21.08 2.56 44.84 23.18 -21.45 -29.03 -5.63 -21.58 -26.87 -5.90 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 D 153 CYH A 363 CYH~? 7.33 N3 A B 4 D 157 VAL A 366 VAL~? 10.94 C2 A B 4 coo 1.13 50.61 23.79 0.62 51.39 26.43 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 coo 2.55 45.49 21.08 2.56 44.84 23.18 -21.89 -31.14 -8.79 -20.85 -31.19 -10.70 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 6 2 # 6 D 153 CYH A 405 CYH~? 14.40 N3 U B 3 D 157 VAL A 401 VAL~? 15.22 C2 A B 4 coo 1.13 50.61 23.79 0.62 51.39 26.43 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 coo 2.55 45.49 21.08 2.56 44.84 23.18 -20.78 -34.85 -17.92 -21.15 -35.50 -15.90 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 7 2 # 7 D 153 CYH A 433 CYH~? 20.69 O4 U B 3 D 157 VAL A 429 VAL~? 22.12 O4 U B 3 coo 1.13 50.61 23.79 0.62 51.39 26.43 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 coo 2.55 45.49 21.08 2.56 44.84 23.18 -28.51 -45.68 -17.89 -29.87 -44.28 -18.90 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 8 2 # 8 D 153 CYH A 505 CYH~? 8.75 N1 G B 2 D 157 VAL A 503 VAL~? 10.00 O4 U B 1 coo 1.13 50.61 23.79 0.62 51.39 26.43 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 coo 2.55 45.49 21.08 2.56 44.84 23.18 -6.59 -57.16 -11.51 -4.99 -58.12 -12.62 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 9 2 # 9 D 153 CYH A 510 CYH~? 17.27 O4 U B 1 D 157 VAL A 514 VAL~? 21.79 O4 U B 1 coo 1.13 50.61 23.79 0.62 51.39 26.43 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo 2.55 45.49 21.08 2.56 44.84 23.18 -18.21 -68.83 -8.68 -16.64 -69.84 -9.79 ULMN 2 1n2c_07 NITROGENASE MOLYBDENUM-IRON PROTEIN user 10 2 # 10 D 153 CYH A 511 CYH~? 14.88 O4 U B 1 D 157 VAL A 514 VAL~? 21.79 O4 U B 1 coo 1.13 50.61 23.79 0.62 51.39 26.43 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 coo 2.55 45.49 21.08 2.56 44.84 23.18 -18.21 -68.83 -8.68 -16.64 -69.84 -9.79 1n2c_07 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 10 hits 1n2c_07 naa= 2 ULMN 2 1n2c_08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 A 154 CYH A 204 CYH~? 3.50 N3 A B 9 A 158 LEU A 207 LEU~? 8.75 C2 A B 9 coo 9.89 125.56 52.05 11.13 124.71 49.65 -21.15 -12.39 22.03 -20.85 -14.34 20.00 coo 7.79 131.42 52.52 9.06 131.14 50.79 -25.42 -11.33 22.91 -25.47 -9.15 22.89 ULMN 2 1n2c_08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 A 154 CYH A 204 CYH~? 3.50 N3 A B 9 A 158 LEU A 246 LEU~? 8.12 C2 A B 9 coo 9.89 125.56 52.05 11.13 124.71 49.65 -21.15 -12.39 22.03 -20.85 -14.34 20.00 coo 7.79 131.42 52.52 9.06 131.14 50.79 -25.82 -11.65 17.32 -27.01 -10.39 18.64 ULMN 2 1n2c_08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 A 154 CYH A 281 CYH~? 10.64 C2 A B 7 A 158 LEU A 282 LEU~? 11.66 C2 A B 7 coo 9.89 125.56 52.05 11.13 124.71 49.65 -21.84 -15.78 -0.10 -24.15 -16.31 -1.64 coo 7.79 131.42 52.52 9.06 131.14 50.79 -17.42 -14.53 -1.64 -17.24 -15.14 -3.72 ULMN 2 1n2c_08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 A 154 CYH A 303 CYH~? 19.60 N6 A B 7 A 158 LEU A 294 LEU~? 11.24 N6 A B 7 coo 9.89 125.56 52.05 11.13 124.71 49.65 -36.71 -18.21 -3.45 -38.39 -20.40 -3.80 coo 7.79 131.42 52.52 9.06 131.14 50.79 -31.42 -20.65 2.22 -30.60 -19.93 0.35 ULMN 2 1n2c_08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 A 154 CYH A 510 CYH~? 17.27 O4 U B 1 A 158 LEU A 507 LEU~? 11.48 O4 U B 1 coo 9.89 125.56 52.05 11.13 124.71 49.65 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo 7.79 131.42 52.52 9.06 131.14 50.79 -8.80 -61.88 -8.90 -7.96 -63.82 -8.44 ULMN 2 1n2c_08 NITROGENASE MOLYBDENUM-IRON PROTEIN user 6 2 # 6 A 154 CYH A 510 CYH~? 17.27 O4 U B 1 A 158 LEU A 538 LEU~? 14.81 O4 U B 1 coo 9.89 125.56 52.05 11.13 124.71 49.65 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo 7.79 131.42 52.52 9.06 131.14 50.79 -7.66 -64.97 -13.20 -8.22 -62.86 -13.55 1n2c_08 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 6 hits 1n2c_08 naa= 2 ULMN 2 1n2c_09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 C 154 CYH A 204 CYH~? 3.50 N3 A B 9 C 158 LEU A 207 LEU~? 8.75 C2 A B 9 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -21.15 -12.39 22.03 -20.85 -14.34 20.00 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -25.42 -11.33 22.91 -25.47 -9.15 22.89 ULMN 2 1n2c_09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 C 154 CYH A 204 CYH~? 3.50 N3 A B 9 C 158 LEU A 246 LEU~? 8.12 C2 A B 9 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -21.15 -12.39 22.03 -20.85 -14.34 20.00 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -25.82 -11.65 17.32 -27.01 -10.39 18.64 ULMN 2 1n2c_09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 C 154 CYH A 281 CYH~? 10.64 C2 A B 7 C 158 LEU A 282 LEU~? 11.66 C2 A B 7 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -21.84 -15.78 -0.10 -24.15 -16.31 -1.64 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -17.42 -14.53 -1.64 -17.24 -15.14 -3.72 ULMN 2 1n2c_09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 C 154 CYH A 303 CYH~? 19.60 N6 A B 7 C 158 LEU A 294 LEU~? 11.24 N6 A B 7 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -36.71 -18.21 -3.45 -38.39 -20.40 -3.80 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -31.42 -20.65 2.22 -30.60 -19.93 0.35 ULMN 2 1n2c_09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 C 154 CYH A 510 CYH~? 17.27 O4 U B 1 C 158 LEU A 507 LEU~? 11.48 O4 U B 1 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -8.80 -61.88 -8.90 -7.96 -63.82 -8.44 ULMN 2 1n2c_09 NITROGENASE MOLYBDENUM-IRON PROTEIN user 6 2 # 6 C 154 CYH A 510 CYH~? 17.27 O4 U B 1 C 158 LEU A 538 LEU~? 14.81 O4 U B 1 coo -2.34 47.38 28.79 -3.93 49.36 27.56 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo -0.52 42.39 25.49 -2.04 43.54 24.47 -7.66 -64.97 -13.20 -8.22 -62.86 -13.55 1n2c_09 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 6 hits 1n2c_09 naa= 2 ULMN 2 1n2c_11 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 F 10 LYS A 220 LYS~? 19.55 N1 A B 9 F 129 ASP A 259 ASP.? 23.89 N1 A B 9 coo -1.94 151.72 59.48 -5.47 151.68 55.29 -37.45 -8.35 20.48 -41.74 -12.81 21.44 coo 0.38 145.91 54.70 -0.99 147.21 53.73 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1n2c_11 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 F 10 LYS A 236 LYS~? 15.40 O2 U B 8 F 129 ASP A 233 ASP~? 18.81 O2 U B 8 coo -1.94 151.72 59.48 -5.47 151.68 55.29 -21.15 -5.56 9.63 -19.04 -2.89 13.94 coo 0.38 145.91 54.70 -0.99 147.21 53.73 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1n2c_11 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 F 10 LYS A 264 LYS~? 27.36 N1 A B 9 F 129 ASP A 260 ASP.? 30.95 O4 U B 8 coo -1.94 151.72 59.48 -5.47 151.68 55.29 -41.84 -5.84 6.59 -43.28 -1.98 11.47 coo 0.38 145.91 54.70 -0.99 147.21 53.73 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 1n2c_11 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 F 10 LYS A 372 LYS~? 15.54 N6 A B 7 F 129 ASP A 376 ASP~? 17.17 N1 A B 4 coo -1.94 151.72 59.48 -5.47 151.68 55.29 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 0.38 145.91 54.70 -0.99 147.21 53.73 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1n2c_11 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 F 10 LYS A 537 LYS~? 23.79 O4 U B 1 F 129 ASP A 533 ASP~? 24.95 O4 U B 1 coo -1.94 151.72 59.48 -5.47 151.68 55.29 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo 0.38 145.91 54.70 -0.99 147.21 53.73 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1n2c_11 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 5 hits 1n2c_11 naa= 2 ULMN 2 1n2c_12 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 G 10 LYS A 220 LYS~? 19.55 N1 A B 9 G 129 ASP A 259 ASP.? 23.89 N1 A B 9 coo 3.13 25.39 9.37 0.51 22.53 13.25 -37.45 -8.35 20.48 -41.74 -12.81 21.44 coo 3.03 29.98 15.78 2.55 27.96 16.26 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1n2c_12 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 G 10 LYS A 236 LYS~? 15.40 O2 U B 8 G 129 ASP A 233 ASP~? 18.81 O2 U B 8 coo 3.13 25.39 9.37 0.51 22.53 13.25 -21.15 -5.56 9.63 -19.04 -2.89 13.94 coo 3.03 29.98 15.78 2.55 27.96 16.26 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1n2c_12 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 G 10 LYS A 264 LYS~? 27.36 N1 A B 9 G 129 ASP A 260 ASP.? 30.95 O4 U B 8 coo 3.13 25.39 9.37 0.51 22.53 13.25 -41.84 -5.84 6.59 -43.28 -1.98 11.47 coo 3.03 29.98 15.78 2.55 27.96 16.26 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 1n2c_12 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 G 10 LYS A 372 LYS~? 15.54 N6 A B 7 G 129 ASP A 376 ASP~? 17.17 N1 A B 4 coo 3.13 25.39 9.37 0.51 22.53 13.25 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 3.03 29.98 15.78 2.55 27.96 16.26 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1n2c_12 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 G 10 LYS A 537 LYS~? 23.79 O4 U B 1 G 129 ASP A 533 ASP~? 24.95 O4 U B 1 coo 3.13 25.39 9.37 0.51 22.53 13.25 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo 3.03 29.98 15.78 2.55 27.96 16.26 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1n2c_12 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 5 hits 1n2c_12 naa= 2 ULMN 2 1n2c_13 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 H 10 LYS A 220 LYS~? 19.55 N1 A B 9 H 129 ASP A 259 ASP.? 23.89 N1 A B 9 coo 9.16 22.13 18.08 11.83 24.73 14.07 -37.45 -8.35 20.48 -41.74 -12.81 21.44 coo 6.32 29.49 17.94 7.41 29.04 16.17 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1n2c_13 NITROGENASE MOLYBDENUM-IRON PROTEIN user 2 2 # 2 H 10 LYS A 236 LYS~? 15.40 O2 U B 8 H 129 ASP A 233 ASP~? 18.81 O2 U B 8 coo 9.16 22.13 18.08 11.83 24.73 14.07 -21.15 -5.56 9.63 -19.04 -2.89 13.94 coo 6.32 29.49 17.94 7.41 29.04 16.17 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1n2c_13 NITROGENASE MOLYBDENUM-IRON PROTEIN user 3 2 # 3 H 10 LYS A 264 LYS~? 27.36 N1 A B 9 H 129 ASP A 260 ASP.? 30.95 O4 U B 8 coo 9.16 22.13 18.08 11.83 24.73 14.07 -41.84 -5.84 6.59 -43.28 -1.98 11.47 coo 6.32 29.49 17.94 7.41 29.04 16.17 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 1n2c_13 NITROGENASE MOLYBDENUM-IRON PROTEIN user 4 2 # 4 H 10 LYS A 372 LYS~? 15.54 N6 A B 7 H 129 ASP A 376 ASP~? 17.17 N1 A B 4 coo 9.16 22.13 18.08 11.83 24.73 14.07 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 6.32 29.49 17.94 7.41 29.04 16.17 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1n2c_13 NITROGENASE MOLYBDENUM-IRON PROTEIN user 5 2 # 5 H 10 LYS A 537 LYS~? 23.79 O4 U B 1 H 129 ASP A 533 ASP~? 24.95 O4 U B 1 coo 9.16 22.13 18.08 11.83 24.73 14.07 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo 6.32 29.49 17.94 7.41 29.04 16.17 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1n2c_13 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 5 hits 1n2c_13 naa= 2 ULMN 2 1n2c_15 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 E 15 LYS A 304 LYS~? 25.42 N1 A B 7 E 41 LYS A 338 LYS~? 26.90 N6 A B 7 coo -6.07 154.37 47.56 -2.16 152.62 49.36 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo -8.41 143.69 55.43 -6.79 147.82 55.36 -37.84 -25.02 -10.54 -41.92 -21.39 -11.77 1n2c_15 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 1 hits 1n2c_15 naa= 2 ULMN 2 1n2c_16 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 G 15 LYS A 304 LYS~? 25.42 N1 A B 7 G 41 LYS A 338 LYS~? 26.90 N6 A B 7 coo 10.78 26.96 6.29 7.40 27.17 9.46 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo 15.22 31.47 18.19 13.37 28.02 16.12 -37.84 -25.02 -10.54 -41.92 -21.39 -11.77 1n2c_16 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 1 hits 1n2c_16 naa= 2 ULMN 2 1n2c_17 NITROGENASE MOLYBDENUM-IRON PROTEIN user 1 2 # 1 H 15 LYS A 304 LYS~? 25.42 N1 A B 7 H 41 LYS A 338 LYS~? 26.90 N6 A B 7 coo 2.21 17.68 19.65 4.60 21.51 18.60 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo -5.78 27.65 15.36 -2.42 24.99 14.21 -37.84 -25.02 -10.54 -41.92 -21.39 -11.77 1n2c_17 source 1n2c NITROGENASE MOLYBDENUM-IRON PROTEIN : 1 hits 1n2c_17 naa= 2 ULMN 2 1naa_00 CELLOBIOSE DEHYDROGENASE user 1 2 # 1 A 689 HIS A 420 HIS~? 9.42 N1 A B 4 A 732 ASN A 424 ASN~? 14.16 N1 A B 4 coo 24.69 23.24 17.44 26.23 24.43 18.22 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 27.47 24.40 22.13 27.89 26.42 21.78 -25.68 -44.49 -8.34 -27.48 -44.07 -7.29 1naa_00 source 1naa CELLOBIOSE DEHYDROGENASE : 1 hits 1naa_00 naa= 2 ULMN 2 1naa_01 CELLOBIOSE DEHYDROGENASE user 1 2 # 1 B 689 HIS A 420 HIS~? 9.42 N1 A B 4 B 732 ASN A 424 ASN~? 14.16 N1 A B 4 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -25.68 -44.49 -8.34 -27.48 -44.07 -7.29 1naa_01 source 1naa CELLOBIOSE DEHYDROGENASE : 1 hits 1naa_01 naa= 2 ULMN 2 1ndi_02 CARNITINE ACETYLTRANSFERASE user 1 2 # 1 A 343 HIS A 496 HIS.? 9.17 O2 U B 1 A 554 SER A 453 SER~? 2.96 N2 G B 2 coo 31.51 35.76 91.64 29.77 35.09 90.70 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 24.54 30.87 84.61 26.81 31.67 85.10 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 1ndi_02 source 1ndi CARNITINE ACETYLTRANSFERASE : 1 hits 1ndi_02 naa= 2 ULMN 2 1ndi_03 CARNITINE ACETYLTRANSFERASE user 1 2 # 1 B 343 HIS A 496 HIS.? 9.17 O2 U B 1 B 554 SER A 453 SER~? 2.96 N2 G B 2 coo 15.05 2.97 49.11 16.83 2.62 48.07 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 21.79 0.25 40.42 20.02 -0.06 42.06 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 1ndi_03 source 1ndi CARNITINE ACETYLTRANSFERASE : 1 hits 1ndi_03 naa= 2 ULMN 2 1nid_00 NITRITE REDUCTASE user 1 2 # 1 A 64 PHE A 197 PHE~? 14.18 C2 A B 9 A 66 GLY A 192 GLY~? 20.40 C2 A B 9 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -26.86 1.96 22.05 -26.39 1.48 22.54 ULMN 2 1nid_00 NITRITE REDUCTASE user 2 2 # 2 A 64 PHE A 224 PHE~? 18.04 N1 A B 9 A 66 GLY A 229 GLY~? 19.93 O4 U B 8 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1nid_00 NITRITE REDUCTASE user 3 2 # 3 A 64 PHE A 234 PHE~? 13.85 O4 U B 8 A 66 GLY A 229 GLY~? 19.93 O4 U B 8 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -28.05 -7.34 7.82 -28.52 -9.83 6.65 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1nid_00 NITRITE REDUCTASE user 4 2 # 4 A 64 PHE A 242 PHE~? 4.53 O2' A B 9 A 66 GLY A 203 GLY~? 9.16 O2' A B 9 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -16.89 -13.25 18.12 -14.38 -14.20 18.85 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -20.04 -9.99 24.75 -19.86 -10.76 24.46 ULMN 2 1nid_00 NITRITE REDUCTASE user 5 2 # 5 A 64 PHE A 285 PHE~? 4.61 O2 U B 8 A 66 GLY A 243 GLY~? 7.99 O2 U B 8 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -21.59 -11.19 15.11 -21.41 -11.91 14.82 ULMN 2 1nid_00 NITRITE REDUCTASE user 6 2 # 6 A 64 PHE A 476 PHE~? 18.32 N2 G B 2 A 66 GLY A 478 GLY.? 19.78 N2 G B 2 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1nid_00 NITRITE REDUCTASE user 7 2 # 7 A 64 PHE A 495 PHE~? 11.36 O2 U B 1 A 66 GLY A 486 GLY.? 16.78 O2 U B 1 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1nid_00 NITRITE REDUCTASE user 8 2 # 8 A 64 PHE A 495 PHE~? 11.36 O2 U B 1 A 66 GLY A 499 GLY~? 6.97 N2 G B 2 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 ULMN 2 1nid_00 NITRITE REDUCTASE user 9 2 # 9 A 64 PHE A 531 PHE~? 20.43 O6 G B 2 A 66 GLY A 516 GLY.? 23.13 O6 G B 2 coo 27.80 -7.62 0.94 26.56 -8.62 3.26 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 coo 33.49 -3.21 -2.85 32.74 -3.30 -2.92 -22.27 -67.70 -4.93 -21.68 -67.22 -4.75 1nid_00 source 1nid NITRITE REDUCTASE : 9 hits 1nid_00 naa= 2 ULMN 2 1nid_01 NITRITE REDUCTASE user 1 2 # 1 A 98 ASP A 345 ASP~? 24.06 C2 A B 4 A 255 HIS A 454 HIS~? 3.31 C5 U B 3 coo 20.32 -11.73 7.16 18.14 -11.39 7.16 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 8.27 11.62 -8.39 7.16 12.84 -9.70 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 ULMN 2 1nid_01 NITRITE REDUCTASE user 2 2 # 2 A 98 ASP A 381 ASP.? 22.82 N6 A B 7 A 255 HIS A 352 HIS~? 21.18 O2' A B 4 coo 20.32 -11.73 7.16 18.14 -11.39 7.16 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 coo 8.27 11.62 -8.39 7.16 12.84 -9.70 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 ULMN 2 1nid_01 NITRITE REDUCTASE user 3 2 # 3 A 98 ASP A 425 ASP.? 18.06 O4 U B 3 A 255 HIS A 352 HIS~? 21.18 O2' A B 4 coo 20.32 -11.73 7.16 18.14 -11.39 7.16 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 8.27 11.62 -8.39 7.16 12.84 -9.70 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 ULMN 2 1nid_01 NITRITE REDUCTASE user 4 2 # 4 A 98 ASP A 425 ASP.? 18.06 O4 U B 3 A 255 HIS A 539 HIS~? 18.96 O4 U B 1 coo 20.32 -11.73 7.16 18.14 -11.39 7.16 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 8.27 11.62 -8.39 7.16 12.84 -9.70 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 ULMN 2 1nid_01 NITRITE REDUCTASE user 5 2 # 5 A 98 ASP A 526 ASP^? 28.45 O6 G B 2 A 255 HIS A 454 HIS~? 3.31 C5 U B 3 coo 20.32 -11.73 7.16 18.14 -11.39 7.16 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo 8.27 11.62 -8.39 7.16 12.84 -9.70 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1nid_01 source 1nid NITRITE REDUCTASE : 5 hits 1nid_01 naa= 2 ULMN 2 1nvm_00 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 1 2 # 1 A 21 HIS A 326 HIS~? 3.28 C5 A B 7 A 291 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 46.24 2.96 -38.57 46.96 2.66 -40.53 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 53.70 -0.77 -41.42 52.47 1.35 -42.74 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 ULMN 2 1nvm_00 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 2 2 # 2 A 21 HIS A 454 HIS~? 3.31 C5 U B 3 A 291 TYR A 416 TYR~? 3.28 C4 A B 4 coo 46.24 2.96 -38.57 46.96 2.66 -40.53 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 53.70 -0.77 -41.42 52.47 1.35 -42.74 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 ULMN 2 1nvm_00 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 3 2 # 3 A 21 HIS A 454 HIS~? 3.31 C5 U B 3 A 291 TYR A 501 TYR~? 3.43 C5 G B 2 coo 46.24 2.96 -38.57 46.96 2.66 -40.53 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 53.70 -0.77 -41.42 52.47 1.35 -42.74 -4.81 -51.44 -6.29 -2.96 -50.88 -4.27 1nvm_00 source 1nvm ACETALDEHYDE DEHYDROGENASE (ACYLATING) : 3 hits 1nvm_00 naa= 2 ULMN 2 1nvm_01 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 1 2 # 1 C 21 HIS A 326 HIS~? 3.28 C5 A B 7 C 291 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 55.94 12.00 -6.11 57.30 13.14 -5.00 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 59.01 20.09 -7.74 60.52 18.14 -6.48 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 ULMN 2 1nvm_01 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 2 2 # 2 C 21 HIS A 454 HIS~? 3.31 C5 U B 3 C 291 TYR A 416 TYR~? 3.28 C4 A B 4 coo 55.94 12.00 -6.11 57.30 13.14 -5.00 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 59.01 20.09 -7.74 60.52 18.14 -6.48 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 ULMN 2 1nvm_01 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 3 2 # 3 C 21 HIS A 454 HIS~? 3.31 C5 U B 3 C 291 TYR A 501 TYR~? 3.43 C5 G B 2 coo 55.94 12.00 -6.11 57.30 13.14 -5.00 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 59.01 20.09 -7.74 60.52 18.14 -6.48 -4.81 -51.44 -6.29 -2.96 -50.88 -4.27 ULMN 2 1nvm_01 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 4 2 # 4 C 21 HIS A 482 HIS.? 27.32 N2 G B 2 C 291 TYR A 479 TYR.? 25.88 N2 G B 2 coo 55.94 12.00 -6.11 57.30 13.14 -5.00 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 59.01 20.09 -7.74 60.52 18.14 -6.48 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1nvm_01 source 1nvm ACETALDEHYDE DEHYDROGENASE (ACYLATING) : 4 hits 1nvm_01 naa= 2 ULMN 2 1nvm_02 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 1 2 # 1 E 21 HIS A 326 HIS~? 3.28 C5 A B 7 E 291 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 46.92 3.99 45.41 48.75 3.83 44.38 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 54.51 0.50 47.83 54.42 2.79 46.24 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 ULMN 2 1nvm_02 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 2 2 # 2 E 21 HIS A 454 HIS~? 3.31 C5 U B 3 E 291 TYR A 416 TYR~? 3.28 C4 A B 4 coo 46.92 3.99 45.41 48.75 3.83 44.38 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 54.51 0.50 47.83 54.42 2.79 46.24 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 ULMN 2 1nvm_02 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 3 2 # 3 E 21 HIS A 454 HIS~? 3.31 C5 U B 3 E 291 TYR A 501 TYR~? 3.43 C5 G B 2 coo 46.92 3.99 45.41 48.75 3.83 44.38 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 54.51 0.50 47.83 54.42 2.79 46.24 -4.81 -51.44 -6.29 -2.96 -50.88 -4.27 1nvm_02 source 1nvm ACETALDEHYDE DEHYDROGENASE (ACYLATING) : 3 hits 1nvm_02 naa= 2 ULMN 2 1nvm_03 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 1 2 # 1 G 21 HIS A 326 HIS~? 3.28 C5 A B 7 G 291 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 32.26 8.54 77.01 32.44 9.50 78.87 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 35.19 16.55 78.88 35.58 14.39 80.56 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 ULMN 2 1nvm_03 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 2 2 # 2 G 21 HIS A 454 HIS~? 3.31 C5 U B 3 G 291 TYR A 416 TYR~? 3.28 C4 A B 4 coo 32.26 8.54 77.01 32.44 9.50 78.87 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 35.19 16.55 78.88 35.58 14.39 80.56 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 ULMN 2 1nvm_03 ACETALDEHYDE DEHYDROGENASE (ACYLATINuser 3 2 # 3 G 21 HIS A 454 HIS~? 3.31 C5 U B 3 G 291 TYR A 501 TYR~? 3.43 C5 G B 2 coo 32.26 8.54 77.01 32.44 9.50 78.87 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 35.19 16.55 78.88 35.58 14.39 80.56 -4.81 -51.44 -6.29 -2.96 -50.88 -4.27 1nvm_03 source 1nvm ACETALDEHYDE DEHYDROGENASE (ACYLATING) : 3 hits 1nvm_03 naa= 2 ULMN 2 1nzy_03 4-CHLOROBENZOYL COENZYME A DEHALOGENuser 1 2 # 1 A 137 TRP A 171 TRP~? 20.44 C2 A B 9 A 145 ASP A 193 ASP~? 20.25 C2 A B 9 coo 13.05 114.78 45.88 14.93 111.67 47.43 -21.68 1.98 29.02 -23.81 -1.31 29.37 coo 8.87 111.26 47.06 9.71 111.38 45.12 -22.85 0.02 23.71 -22.18 1.98 24.08 ULMN 2 1nzy_03 4-CHLOROBENZOYL COENZYME A DEHALOGENuser 2 2 # 2 A 137 TRP A 534 TRP~? 20.57 N2 G B 2 A 145 ASP A 473 ASP~? 22.60 N2 G B 2 coo 13.05 114.78 45.88 14.93 111.67 47.43 -13.87 -64.07 -18.86 -17.27 -62.50 -17.72 coo 8.87 111.26 47.06 9.71 111.38 45.12 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1nzy_03 source 1nzy 4-CHLOROBENZOYL COENZYME A DEHALOGENASE : 2 hits 1nzy_03 naa= 2 ULMN 2 1nzy_04 4-CHLOROBENZOYL COENZYME A DEHALOGENuser 1 2 # 1 C 137 TRP A 171 TRP~? 20.44 C2 A B 9 C 145 ASP A 193 ASP~? 20.25 C2 A B 9 coo 15.88 81.48 64.71 17.00 84.36 67.13 -21.68 1.98 29.02 -23.81 -1.31 29.37 coo 11.10 83.77 67.09 11.95 82.09 68.02 -22.85 0.02 23.71 -22.18 1.98 24.08 1nzy_04 source 1nzy 4-CHLOROBENZOYL COENZYME A DEHALOGENASE : 1 hits 1nzy_04 naa= 2 ULMN 2 1nzy_05 4-CHLOROBENZOYL COENZYME A DEHALOGENuser 1 2 # 1 B 137 TRP A 171 TRP~? 20.44 C2 A B 9 B 145 ASP A 193 ASP~? 20.25 C2 A B 9 coo 13.08 114.51 84.60 14.55 114.95 80.97 -21.68 1.98 29.02 -23.81 -1.31 29.37 coo 8.57 114.70 81.13 9.19 116.41 82.14 -22.85 0.02 23.71 -22.18 1.98 24.08 1nzy_05 source 1nzy 4-CHLOROBENZOYL COENZYME A DEHALOGENASE : 1 hits 1nzy_05 naa= 2 ULMN 2 1o8a_00 ANGIOTENSIN CONVERTING ENZYME user 1 2 # 1 A 411 GLU A 412 GLU.? 7.44 O2' U B 3 A 523 TYR A 413 TYR.? 4.41 O2' A B 4 coo 42.59 41.82 44.54 42.65 40.34 46.03 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 coo 39.81 39.01 41.64 39.68 38.13 44.30 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 1o8a_00 source 1o8a ANGIOTENSIN CONVERTING ENZYME : 1 hits 1o8a_00 naa= 2 ULMN 2 1oas_04 O-ACETYLSERINE SULFHYDRYLASE user 1 2 # 1 A 41 LYS A 270 LYS~? 23.81 O4 U B 8 A 300 SER A 300 SER~? 23.48 N6 A B 7 coo 17.84 11.94 36.57 13.01 10.24 35.93 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 coo 15.59 6.80 43.55 13.20 7.25 43.46 -41.38 -17.70 -1.13 -43.08 -16.44 0.06 1oas_04 source 1oas O-ACETYLSERINE SULFHYDRYLASE : 1 hits 1oas_04 naa= 2 ULMN 2 1oas_05 O-ACETYLSERINE SULFHYDRYLASE user 1 2 # 1 B 41 LYS A 270 LYS~? 23.81 O4 U B 8 B 300 SER A 300 SER~? 23.48 N6 A B 7 coo 27.89 7.89 59.43 27.49 11.76 62.82 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 coo 24.97 15.19 55.18 23.91 16.19 57.11 -41.38 -17.70 -1.13 -43.08 -16.44 0.06 1oas_05 source 1oas O-ACETYLSERINE SULFHYDRYLASE : 1 hits 1oas_05 naa= 2 ULMN 2 1odt_02 CEPHALOSPORIN C DEACETYLASE user 1 2 # 1 C 166 SER A 274 SER~? 19.09 N1 A B 7 C 298 HIS A 420 HIS~? 9.42 N1 A B 4 coo 43.52 66.08 46.50 43.81 67.66 48.38 -30.19 -9.75 -2.18 -32.45 -10.61 -2.45 coo 13.42 79.87 46.31 15.44 80.29 45.93 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1odt_02 CEPHALOSPORIN C DEACETYLASE user 2 2 # 2 C 166 SER A 400 SER~? 19.17 C2 A B 4 C 298 HIS A 527 HIS~? 25.85 N2 G B 2 coo 43.52 66.08 46.50 43.81 67.66 48.38 -22.47 -32.63 -20.50 -21.62 -30.51 -19.76 coo 13.42 79.87 46.31 15.44 80.29 45.93 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 ULMN 2 1odt_02 CEPHALOSPORIN C DEACETYLASE user 3 2 # 3 C 166 SER A 447 SER~? 8.51 N2 G B 2 C 298 HIS A 326 HIS~? 3.28 C5 A B 7 coo 43.52 66.08 46.50 43.81 67.66 48.38 -5.91 -48.86 -15.23 -7.17 -50.86 -15.80 coo 13.42 79.87 46.31 15.44 80.29 45.93 -20.60 -25.48 2.69 -19.23 -27.01 3.11 1odt_02 source 1odt CEPHALOSPORIN C DEACETYLASE : 3 hits 1odt_02 naa= 2 ULMN 2 1odt_03 CEPHALOSPORIN C DEACETYLASE user 1 2 # 1 H 166 SER A 274 SER~? 19.09 N1 A B 7 H 298 HIS A 420 HIS~? 9.42 N1 A B 4 coo 39.89 121.01 63.83 40.38 119.49 62.00 -30.19 -9.75 -2.18 -32.45 -10.61 -2.45 coo 11.89 103.25 63.94 13.96 103.24 64.24 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 ULMN 2 1odt_03 CEPHALOSPORIN C DEACETYLASE user 2 2 # 2 H 166 SER A 400 SER~? 19.17 C2 A B 4 H 298 HIS A 527 HIS~? 25.85 N2 G B 2 coo 39.89 121.01 63.83 40.38 119.49 62.00 -22.47 -32.63 -20.50 -21.62 -30.51 -19.76 coo 11.89 103.25 63.94 13.96 103.24 64.24 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 ULMN 2 1odt_03 CEPHALOSPORIN C DEACETYLASE user 3 2 # 3 H 166 SER A 447 SER~? 8.51 N2 G B 2 H 298 HIS A 326 HIS~? 3.28 C5 A B 7 coo 39.89 121.01 63.83 40.38 119.49 62.00 -5.91 -48.86 -15.23 -7.17 -50.86 -15.80 coo 11.89 103.25 63.94 13.96 103.24 64.24 -20.60 -25.48 2.69 -19.23 -27.01 3.11 1odt_03 source 1odt CEPHALOSPORIN C DEACETYLASE : 3 hits 1odt_03 naa= 2 ULMN 2 1ogo_00 DEXTRANASE user 1 2 # 1 X 376 ASP A 232 ASP~? 21.56 O2 U B 8 X 395 ASP A 233 ASP~? 18.81 O2 U B 8 coo 18.58 14.19 10.77 18.44 12.41 11.84 -24.56 0.12 7.49 -25.80 1.40 6.37 coo 16.42 13.96 7.23 14.37 13.48 7.58 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1ogo_00 DEXTRANASE user 2 2 # 2 X 376 ASP A 233 ASP~? 18.81 O2 U B 8 X 395 ASP A 232 ASP~? 21.56 O2 U B 8 coo 18.58 14.19 10.77 18.44 12.41 11.84 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 16.42 13.96 7.23 14.37 13.48 7.58 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 1ogo_00 DEXTRANASE user 3 2 # 3 X 376 ASP A 259 ASP.? 23.89 N1 A B 9 X 395 ASP A 260 ASP.? 30.95 O4 U B 8 coo 18.58 14.19 10.77 18.44 12.41 11.84 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 16.42 13.96 7.23 14.37 13.48 7.58 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 1ogo_00 DEXTRANASE user 4 2 # 4 X 376 ASP A 260 ASP.? 30.95 O4 U B 8 X 395 ASP A 259 ASP.? 23.89 N1 A B 9 coo 18.58 14.19 10.77 18.44 12.41 11.84 -48.66 -5.55 12.81 -49.71 -4.82 11.14 coo 16.42 13.96 7.23 14.37 13.48 7.58 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1ogo_00 DEXTRANASE user 5 2 # 5 X 376 ASP A 376 ASP~? 17.17 N1 A B 4 X 395 ASP A 426 ASP.? 18.90 N1 A B 4 coo 18.58 14.19 10.77 18.44 12.41 11.84 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 16.42 13.96 7.23 14.37 13.48 7.58 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 ULMN 2 1ogo_00 DEXTRANASE user 6 2 # 6 X 376 ASP A 426 ASP.? 18.90 N1 A B 4 X 395 ASP A 376 ASP~? 17.17 N1 A B 4 coo 18.58 14.19 10.77 18.44 12.41 11.84 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 16.42 13.96 7.23 14.37 13.48 7.58 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1ogo_00 DEXTRANASE user 7 2 # 7 X 376 ASP A 473 ASP~? 22.60 N2 G B 2 X 395 ASP A 477 ASP~? 24.62 N2 G B 2 coo 18.58 14.19 10.77 18.44 12.41 11.84 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 16.42 13.96 7.23 14.37 13.48 7.58 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 ULMN 2 1ogo_00 DEXTRANASE user 8 2 # 8 X 376 ASP A 477 ASP~? 24.62 N2 G B 2 X 395 ASP A 473 ASP~? 22.60 N2 G B 2 coo 18.58 14.19 10.77 18.44 12.41 11.84 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 16.42 13.96 7.23 14.37 13.48 7.58 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1ogo_00 DEXTRANASE user 9 2 # 9 X 376 ASP A 488 ASP~? 18.76 O2 U B 1 X 395 ASP A 491 ASP~? 15.62 O2 U B 1 coo 18.58 14.19 10.77 18.44 12.41 11.84 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 16.42 13.96 7.23 14.37 13.48 7.58 2.02 -59.32 -18.53 4.01 -59.49 -17.81 ULMN 2 1ogo_00 DEXTRANASE user 10 2 # 10 X 376 ASP A 491 ASP~? 15.62 O2 U B 1 X 395 ASP A 488 ASP~? 18.76 O2 U B 1 coo 18.58 14.19 10.77 18.44 12.41 11.84 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 16.42 13.96 7.23 14.37 13.48 7.58 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 1ogo_00 source 1ogo DEXTRANASE : 10 hits 1ogo_00 naa= 2 ULMN 2 1oj4_00 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 1 2 # 1 A 10 LYS A 536 LYS~? 26.44 O4 U B 1 A 141 ASP A 533 ASP~? 24.95 O4 U B 1 coo 19.64 15.23 16.08 25.15 14.66 17.29 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 coo 26.09 19.89 14.83 26.89 17.95 15.45 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1oj4_00 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 2 2 # 2 A 10 LYS A 537 LYS~? 23.79 O4 U B 1 A 141 ASP A 533 ASP~? 24.95 O4 U B 1 coo 19.64 15.23 16.08 25.15 14.66 17.29 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo 26.09 19.89 14.83 26.89 17.95 15.45 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1oj4_00 source 1oj4 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KIN: 2 hits 1oj4_00 naa= 2 ULMN 2 1oj4_01 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 1 2 # 1 B 10 LYS A 536 LYS~? 26.44 O4 U B 1 B 141 ASP A 533 ASP~? 24.95 O4 U B 1 coo 50.48 51.42 16.27 45.03 52.12 17.67 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 coo 43.77 47.07 15.43 43.03 49.06 15.86 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1oj4_01 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTuser 2 2 # 2 B 10 LYS A 537 LYS~? 23.79 O4 U B 1 B 141 ASP A 533 ASP~? 24.95 O4 U B 1 coo 50.48 51.42 16.27 45.03 52.12 17.67 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 coo 43.77 47.07 15.43 43.03 49.06 15.86 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1oj4_01 source 1oj4 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL KIN: 2 hits 1oj4_01 naa= 2 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 1 2 # 1 A 144 GLU A 341 GLU~? 25.67 N6 A B 7 A 153 GLU A 391 GLU~? 23.54 N1 A B 4 coo 5.94 27.66 26.60 4.79 28.74 25.22 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 11.22 39.04 26.68 10.07 39.51 28.37 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 2 2 # 2 A 144 GLU A 391 GLU~? 23.54 N1 A B 4 A 153 GLU A 341 GLU~? 25.67 N6 A B 7 coo 5.94 27.66 26.60 4.79 28.74 25.22 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 11.22 39.04 26.68 10.07 39.51 28.37 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 3 2 # 3 A 144 GLU A 412 GLU.? 7.44 O2' U B 3 A 153 GLU A 449 GLU.? 11.55 O2 U B 3 coo 5.94 27.66 26.60 4.79 28.74 25.22 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 coo 11.22 39.04 26.68 10.07 39.51 28.37 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 4 2 # 4 A 144 GLU A 436 GLU~? 23.50 O4 U B 3 A 153 GLU A 474 GLU~? 16.68 N2 G B 2 coo 5.94 27.66 26.60 4.79 28.74 25.22 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 11.22 39.04 26.68 10.07 39.51 28.37 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 5 2 # 5 A 144 GLU A 436 GLU~? 23.50 O4 U B 3 A 153 GLU A 522 GLU^? 23.38 O4 U B 3 coo 5.94 27.66 26.60 4.79 28.74 25.22 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 11.22 39.04 26.68 10.07 39.51 28.37 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 6 2 # 6 A 144 GLU A 449 GLU.? 11.55 O2 U B 3 A 153 GLU A 407 GLU~? 15.45 O2 U B 3 coo 5.94 27.66 26.60 4.79 28.74 25.22 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo 11.22 39.04 26.68 10.07 39.51 28.37 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 7 2 # 7 A 144 GLU A 449 GLU.? 11.55 O2 U B 3 A 153 GLU A 412 GLU.? 7.44 O2' U B 3 coo 5.94 27.66 26.60 4.79 28.74 25.22 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo 11.22 39.04 26.68 10.07 39.51 28.37 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 8 2 # 8 A 144 GLU A 470 GLU~? 22.82 N2 G B 2 A 153 GLU A 432 GLU~? 22.16 O4 U B 3 coo 5.94 27.66 26.60 4.79 28.74 25.22 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 11.22 39.04 26.68 10.07 39.51 28.37 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 9 2 # 9 A 144 GLU A 470 GLU~? 22.82 N2 G B 2 A 153 GLU A 522 GLU^? 23.38 O4 U B 3 coo 5.94 27.66 26.60 4.79 28.74 25.22 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 11.22 39.04 26.68 10.07 39.51 28.37 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 10 2 # 10 A 144 GLU A 474 GLU~? 16.68 N2 G B 2 A 153 GLU A 436 GLU~? 23.50 O4 U B 3 coo 5.94 27.66 26.60 4.79 28.74 25.22 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 11.22 39.04 26.68 10.07 39.51 28.37 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 11 2 # 11 A 144 GLU A 522 GLU^? 23.38 O4 U B 3 A 153 GLU A 436 GLU~? 23.50 O4 U B 3 coo 5.94 27.66 26.60 4.79 28.74 25.22 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 11.22 39.04 26.68 10.07 39.51 28.37 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1or8_00 SUBSTRATE PEPTIDE user 12 2 # 12 A 144 GLU A 522 GLU^? 23.38 O4 U B 3 A 153 GLU A 470 GLU~? 22.82 N2 G B 2 coo 5.94 27.66 26.60 4.79 28.74 25.22 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 11.22 39.04 26.68 10.07 39.51 28.37 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 1or8_00 source 1or8 SUBSTRATE PEPTIDE : 12 hits 1or8_00 naa= 2 ULMN 2 1ord_00 ORNITHINE DECARBOXYLASE user 1 2 # 1 A 223 HIS A 462 HIS~? 12.61 O4 U B 3 A 316 ASP A 425 ASP.? 18.06 O4 U B 3 coo 68.60 29.21 36.20 67.18 29.39 37.73 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 71.59 23.36 32.53 70.12 24.30 33.70 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1ord_00 ORNITHINE DECARBOXYLASE user 2 2 # 2 A 223 HIS A 482 HIS.? 27.32 N2 G B 2 A 316 ASP A 484 ASP.? 22.65 O2 U B 1 coo 68.60 29.21 36.20 67.18 29.39 37.73 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 71.59 23.36 32.53 70.12 24.30 33.70 7.90 -50.74 -23.88 8.67 -50.47 -25.84 ULMN 2 1ord_00 ORNITHINE DECARBOXYLASE user 3 2 # 3 A 223 HIS A 527 HIS~? 25.85 N2 G B 2 A 316 ASP A 526 ASP^? 28.45 O6 G B 2 coo 68.60 29.21 36.20 67.18 29.39 37.73 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 71.59 23.36 32.53 70.12 24.30 33.70 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 1ord_00 source 1ord ORNITHINE DECARBOXYLASE : 3 hits 1ord_00 naa= 2 ULMN 2 1ord_01 ORNITHINE DECARBOXYLASE user 1 2 # 1 B 223 HIS A 462 HIS~? 12.61 O4 U B 3 B 316 ASP A 425 ASP.? 18.06 O4 U B 3 coo 72.29 18.19 61.38 71.26 17.18 59.86 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 71.16 24.62 65.07 70.49 22.99 63.86 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1ord_01 ORNITHINE DECARBOXYLASE user 2 2 # 2 B 223 HIS A 482 HIS.? 27.32 N2 G B 2 B 316 ASP A 484 ASP.? 22.65 O2 U B 1 coo 72.29 18.19 61.38 71.26 17.18 59.86 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 71.16 24.62 65.07 70.49 22.99 63.86 7.90 -50.74 -23.88 8.67 -50.47 -25.84 ULMN 2 1ord_01 ORNITHINE DECARBOXYLASE user 3 2 # 3 B 223 HIS A 527 HIS~? 25.85 N2 G B 2 B 316 ASP A 526 ASP^? 28.45 O6 G B 2 coo 72.29 18.19 61.38 71.26 17.18 59.86 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 71.16 24.62 65.07 70.49 22.99 63.86 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 1ord_01 source 1ord ORNITHINE DECARBOXYLASE : 3 hits 1ord_01 naa= 2 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 1 2 # 1 A 73 LYS A 201 LYS~? 2.54 O3' A B 9 A 104 ASP A 232 ASP~? 21.56 O2 U B 8 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -15.93 -12.79 22.15 -13.89 -17.99 22.17 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 2 2 # 2 A 73 LYS A 201 LYS~? 2.54 O3' A B 9 A 104 ASP A 279 ASP~? 17.12 C2 A B 7 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -15.93 -12.79 22.15 -13.89 -17.99 22.17 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 3 2 # 3 A 73 LYS A 264 LYS~? 27.36 N1 A B 9 A 104 ASP A 279 ASP~? 17.12 C2 A B 7 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -41.84 -5.84 6.59 -43.28 -1.98 11.47 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 4 2 # 4 A 73 LYS A 304 LYS~? 25.42 N1 A B 7 A 104 ASP A 233 ASP~? 18.81 O2 U B 8 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 5 2 # 5 A 73 LYS A 372 LYS~? 15.54 N6 A B 7 A 104 ASP A 312 ASP~? 21.35 C2 A B 7 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -30.83 -34.31 -5.75 -33.13 -33.03 -1.87 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 6 2 # 6 A 73 LYS A 437 LYS~? 23.48 O4 U B 3 A 104 ASP A 359 ASP~? 8.63 O2' A B 4 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -18.39 -44.32 -24.62 -24.23 -41.99 -25.00 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 7 2 # 7 A 73 LYS A 458 LYS~? 5.39 O4 U B 3 A 104 ASP A 477 ASP~? 24.62 N2 G B 2 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 8 2 # 8 A 73 LYS A 458 LYS~? 5.39 O4 U B 3 A 104 ASP A 491 ASP~? 15.62 O2 U B 1 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 2.02 -59.32 -18.53 4.01 -59.49 -17.81 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 9 2 # 9 A 73 LYS A 521 LYS^? 31.39 O6 G B 2 A 104 ASP A 376 ASP~? 17.17 N1 A B 4 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -27.98 -64.66 -13.31 -32.01 -68.20 -11.05 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1oro_01 OROTATE PHOSPHORIBOSYLTRANSFERASE user 10 2 # 10 A 73 LYS A 557 LYS~? 2.76 O4 U B 1 A 104 ASP A 477 ASP~? 24.62 N2 G B 2 coo 31.47 -3.50 41.26 35.45 -5.61 44.66 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 coo 25.14 -17.11 23.95 24.26 -18.57 22.71 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 1oro_01 source 1oro OROTATE PHOSPHORIBOSYLTRANSFERASE : 10 hits 1oro_01 naa= 2 ULMN 2 1otg_00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 1 2 # 1 A 35 PHE A 224 PHE~? 18.04 N1 A B 9 A 41 ARG A 230 ARG~? 20.03 C2 A B 9 coo 20.83 81.45 8.08 22.53 83.03 6.59 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 18.84 70.08 4.69 16.77 72.07 3.55 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1otg_00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 2 2 # 2 A 35 PHE A 342 PHE~? 19.62 N1 A B 7 A 41 ARG A 396 ARG~? 24.93 C2 A B 4 coo 20.83 81.45 8.08 22.53 83.03 6.59 -30.61 -20.23 -12.56 -30.03 -19.19 -10.05 coo 18.84 70.08 4.69 16.77 72.07 3.55 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1otg_00 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 3 2 # 3 A 35 PHE A 531 PHE~? 20.43 O6 G B 2 A 41 ARG A 517 ARG.? 17.55 O4 U B 1 coo 20.83 81.45 8.08 22.53 83.03 6.59 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 coo 18.84 70.08 4.69 16.77 72.07 3.55 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1otg_00 source 1otg 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISOMERASE : 3 hits 1otg_00 naa= 2 ULMN 2 1otg_01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 1 2 # 1 B 35 PHE A 224 PHE~? 18.04 N1 A B 9 B 41 ARG A 230 ARG~? 20.03 C2 A B 9 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1otg_01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 2 2 # 2 B 35 PHE A 342 PHE~? 19.62 N1 A B 7 B 41 ARG A 396 ARG~? 24.93 C2 A B 4 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -30.61 -20.23 -12.56 -30.03 -19.19 -10.05 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1otg_01 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 3 2 # 3 B 35 PHE A 531 PHE~? 20.43 O6 G B 2 B 41 ARG A 517 ARG.? 17.55 O4 U B 1 coo 17.99 68.15 -20.87 17.37 70.55 -19.52 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 coo 28.06 62.63 -17.73 28.42 64.87 -19.93 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1otg_01 source 1otg 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISOMERASE : 3 hits 1otg_01 naa= 2 ULMN 2 1otg_02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 1 2 # 1 C 35 PHE A 221 PHE~? 23.88 N1 A B 9 C 41 ARG A 230 ARG~? 20.03 C2 A B 9 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1otg_02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 2 2 # 2 C 35 PHE A 234 PHE~? 13.85 O4 U B 8 C 41 ARG A 230 ARG~? 20.03 C2 A B 9 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -28.05 -7.34 7.82 -28.52 -9.83 6.65 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -30.18 1.36 11.96 -29.08 0.35 14.66 ULMN 2 1otg_02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 3 2 # 3 C 35 PHE A 342 PHE~? 19.62 N1 A B 7 C 41 ARG A 396 ARG~? 24.93 C2 A B 4 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -30.61 -20.23 -12.56 -30.03 -19.19 -10.05 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 ULMN 2 1otg_02 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISuser 4 2 # 4 C 35 PHE A 531 PHE~? 20.43 O6 G B 2 C 41 ARG A 517 ARG.? 17.55 O4 U B 1 coo 46.40 79.01 -10.71 44.33 79.70 -12.40 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 coo 43.33 73.68 -0.92 43.32 76.78 -0.74 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1otg_02 source 1otg 5-CARBOXYMETHYL-2-HYDROXYMUCONATE ISOMERASE : 4 hits 1otg_02 naa= 2 ULMN 2 1oxa_00 CYTOCHROME P450 ERYF user 1 2 # 1 246 SER A 184 SER~? 19.28 C2 A B 9 360 GLU A 187 GLU~? 20.71 C2 A B 9 coo -2.27 5.01 11.02 -1.56 7.27 11.54 -29.20 -7.32 31.77 -30.44 -5.23 31.93 coo 3.38 8.39 11.51 1.79 8.22 12.92 -28.60 -2.71 32.18 -27.08 -3.13 33.60 1oxa_00 source 1oxa CYTOCHROME P450 ERYF : 1 hits 1oxa_00 naa= 2 ULMN 2 1ozh_04 ACETOLACTATE SYNTHASE, CATABOLIC user 1 2 # 1 A 394 MET A 471 MET~? 14.72 N2 G B 2 A 422 MET A 472 MET~? 16.15 N2 G B 2 coo -16.41 3.00 0.80 -18.11 0.41 0.16 -14.36 -55.54 -20.42 -16.43 -53.13 -17.71 coo -11.47 2.45 1.11 -10.33 1.25 4.98 -12.94 -58.95 -19.51 -13.10 -60.15 -16.26 ULMN 2 1ozh_04 ACETOLACTATE SYNTHASE, CATABOLIC user 2 2 # 2 A 394 MET A 472 MET~? 16.15 N2 G B 2 A 422 MET A 471 MET~? 14.72 N2 G B 2 coo -16.41 3.00 0.80 -18.11 0.41 0.16 -12.94 -58.95 -19.51 -13.10 -60.15 -16.26 coo -11.47 2.45 1.11 -10.33 1.25 4.98 -14.36 -55.54 -20.42 -16.43 -53.13 -17.71 ULMN 2 1ozh_04 ACETOLACTATE SYNTHASE, CATABOLIC user 3 2 # 3 A 394 MET A 493 MET~? 11.47 N2 G B 2 A 422 MET A 494 MET~? 11.93 O4 U B 1 coo -16.41 3.00 0.80 -18.11 0.41 0.16 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 coo -11.47 2.45 1.11 -10.33 1.25 4.98 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 ULMN 2 1ozh_04 ACETOLACTATE SYNTHASE, CATABOLIC user 4 2 # 4 A 394 MET A 494 MET~? 11.93 O4 U B 1 A 422 MET A 493 MET~? 11.47 N2 G B 2 coo -16.41 3.00 0.80 -18.11 0.41 0.16 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 coo -11.47 2.45 1.11 -10.33 1.25 4.98 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 1ozh_04 source 1ozh ACETOLACTATE SYNTHASE, CATABOLIC : 4 hits 1ozh_04 naa= 2 ULMN 2 1ozh_05 ACETOLACTATE SYNTHASE, CATABOLIC user 1 2 # 1 B 394 MET A 471 MET~? 14.72 N2 G B 2 B 422 MET A 472 MET~? 16.15 N2 G B 2 coo 14.40 6.27 4.73 16.77 4.97 3.12 -14.36 -55.54 -20.42 -16.43 -53.13 -17.71 coo 9.72 5.07 3.36 8.35 7.54 0.25 -12.94 -58.95 -19.51 -13.10 -60.15 -16.26 ULMN 2 1ozh_05 ACETOLACTATE SYNTHASE, CATABOLIC user 2 2 # 2 B 394 MET A 472 MET~? 16.15 N2 G B 2 B 422 MET A 471 MET~? 14.72 N2 G B 2 coo 14.40 6.27 4.73 16.77 4.97 3.12 -12.94 -58.95 -19.51 -13.10 -60.15 -16.26 coo 9.72 5.07 3.36 8.35 7.54 0.25 -14.36 -55.54 -20.42 -16.43 -53.13 -17.71 ULMN 2 1ozh_05 ACETOLACTATE SYNTHASE, CATABOLIC user 3 2 # 3 B 394 MET A 493 MET~? 11.47 N2 G B 2 B 422 MET A 494 MET~? 11.93 O4 U B 1 coo 14.40 6.27 4.73 16.77 4.97 3.12 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 coo 9.72 5.07 3.36 8.35 7.54 0.25 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 ULMN 2 1ozh_05 ACETOLACTATE SYNTHASE, CATABOLIC user 4 2 # 4 B 394 MET A 494 MET~? 11.93 O4 U B 1 B 422 MET A 493 MET~? 11.47 N2 G B 2 coo 14.40 6.27 4.73 16.77 4.97 3.12 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 coo 9.72 5.07 3.36 8.35 7.54 0.25 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 1ozh_05 source 1ozh ACETOLACTATE SYNTHASE, CATABOLIC : 4 hits 1ozh_05 naa= 2 ULMN 2 1ozh_06 ACETOLACTATE SYNTHASE, CATABOLIC user 1 2 # 1 C 394 MET A 471 MET~? 14.72 N2 G B 2 C 422 MET A 472 MET~? 16.15 N2 G B 2 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 -14.36 -55.54 -20.42 -16.43 -53.13 -17.71 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 -12.94 -58.95 -19.51 -13.10 -60.15 -16.26 ULMN 2 1ozh_06 ACETOLACTATE SYNTHASE, CATABOLIC user 2 2 # 2 C 394 MET A 472 MET~? 16.15 N2 G B 2 C 422 MET A 471 MET~? 14.72 N2 G B 2 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 -12.94 -58.95 -19.51 -13.10 -60.15 -16.26 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 -14.36 -55.54 -20.42 -16.43 -53.13 -17.71 ULMN 2 1ozh_06 ACETOLACTATE SYNTHASE, CATABOLIC user 3 2 # 3 C 394 MET A 493 MET~? 11.47 N2 G B 2 C 422 MET A 494 MET~? 11.93 O4 U B 1 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 ULMN 2 1ozh_06 ACETOLACTATE SYNTHASE, CATABOLIC user 4 2 # 4 C 394 MET A 494 MET~? 11.93 O4 U B 1 C 422 MET A 493 MET~? 11.47 N2 G B 2 coo 4.39 -49.11 -11.79 2.89 -48.24 -9.11 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 coo 4.77 -45.59 -15.37 1.45 -45.63 -17.90 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 1ozh_06 source 1ozh ACETOLACTATE SYNTHASE, CATABOLIC : 4 hits 1ozh_06 naa= 2 ULMN 2 1ozh_07 ACETOLACTATE SYNTHASE, CATABOLIC user 1 2 # 1 D 394 MET A 471 MET~? 14.72 N2 G B 2 D 422 MET A 472 MET~? 16.15 N2 G B 2 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 -14.36 -55.54 -20.42 -16.43 -53.13 -17.71 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 -12.94 -58.95 -19.51 -13.10 -60.15 -16.26 ULMN 2 1ozh_07 ACETOLACTATE SYNTHASE, CATABOLIC user 2 2 # 2 D 394 MET A 472 MET~? 16.15 N2 G B 2 D 422 MET A 471 MET~? 14.72 N2 G B 2 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 -12.94 -58.95 -19.51 -13.10 -60.15 -16.26 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 -14.36 -55.54 -20.42 -16.43 -53.13 -17.71 ULMN 2 1ozh_07 ACETOLACTATE SYNTHASE, CATABOLIC user 3 2 # 3 D 394 MET A 493 MET~? 11.47 N2 G B 2 D 422 MET A 494 MET~? 11.93 O4 U B 1 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 ULMN 2 1ozh_07 ACETOLACTATE SYNTHASE, CATABOLIC user 4 2 # 4 D 394 MET A 494 MET~? 11.93 O4 U B 1 D 422 MET A 493 MET~? 11.47 N2 G B 2 coo 9.94 -32.45 -37.79 10.86 -29.43 -38.09 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 coo 9.27 -34.14 -33.16 12.87 -35.47 -31.47 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 1ozh_07 source 1ozh ACETOLACTATE SYNTHASE, CATABOLIC : 4 hits 1ozh_07 naa= 2 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 208 GLU~? 4.03 N1 A B 9 A 269 GLU A 267 GLU~? 24.62 O4 U B 8 coo 63.94 10.02 33.47 64.31 8.24 32.38 -24.90 -17.89 21.91 -24.90 -19.66 23.08 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 267 GLU~? 24.62 O4 U B 8 A 269 GLU A 208 GLU~? 4.03 N1 A B 9 coo 63.94 10.02 33.47 64.31 8.24 32.38 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -24.90 -17.89 21.91 -24.90 -19.66 23.08 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU A 341 GLU~? 25.67 N6 A B 7 A 269 GLU A 436 GLU~? 23.50 O4 U B 3 coo 63.94 10.02 33.47 64.31 8.24 32.38 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU A 351 GLU~? 20.29 O2' A B 4 A 269 GLU A 391 GLU~? 23.54 N1 A B 4 coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 A 160 GLU A 351 GLU~? 20.29 O2' A B 4 A 269 GLU A 436 GLU~? 23.50 O4 U B 3 coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 A 160 GLU A 371 GLU~? 9.29 O2 C B 5 A 269 GLU A 466 GLU~? 26.72 N2 G B 2 coo 63.94 10.02 33.47 64.31 8.24 32.38 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 A 160 GLU A 391 GLU~? 23.54 N1 A B 4 A 269 GLU A 351 GLU~? 20.29 O2' A B 4 coo 63.94 10.02 33.47 64.31 8.24 32.38 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 A 160 GLU A 407 GLU~? 15.45 O2 U B 3 A 269 GLU A 466 GLU~? 26.72 N2 G B 2 coo 63.94 10.02 33.47 64.31 8.24 32.38 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 9 2 # 9 A 160 GLU A 412 GLU.? 7.44 O2' U B 3 A 269 GLU A 432 GLU~? 22.16 O4 U B 3 coo 63.94 10.02 33.47 64.31 8.24 32.38 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 10 2 # 10 A 160 GLU A 412 GLU.? 7.44 O2' U B 3 A 269 GLU A 436 GLU~? 23.50 O4 U B 3 coo 63.94 10.02 33.47 64.31 8.24 32.38 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 11 2 # 11 A 160 GLU A 432 GLU~? 22.16 O4 U B 3 A 269 GLU A 412 GLU.? 7.44 O2' U B 3 coo 63.94 10.02 33.47 64.31 8.24 32.38 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 12 2 # 12 A 160 GLU A 436 GLU~? 23.50 O4 U B 3 A 269 GLU A 341 GLU~? 25.67 N6 A B 7 coo 63.94 10.02 33.47 64.31 8.24 32.38 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 13 2 # 13 A 160 GLU A 436 GLU~? 23.50 O4 U B 3 A 269 GLU A 351 GLU~? 20.29 O2' A B 4 coo 63.94 10.02 33.47 64.31 8.24 32.38 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 14 2 # 14 A 160 GLU A 436 GLU~? 23.50 O4 U B 3 A 269 GLU A 412 GLU.? 7.44 O2' U B 3 coo 63.94 10.02 33.47 64.31 8.24 32.38 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 15 2 # 15 A 160 GLU A 466 GLU~? 26.72 N2 G B 2 A 269 GLU A 371 GLU~? 9.29 O2 C B 5 coo 63.94 10.02 33.47 64.31 8.24 32.38 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 16 2 # 16 A 160 GLU A 466 GLU~? 26.72 N2 G B 2 A 269 GLU A 407 GLU~? 15.45 O2 U B 3 coo 63.94 10.02 33.47 64.31 8.24 32.38 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 17 2 # 17 A 160 GLU A 470 GLU~? 22.82 N2 G B 2 A 269 GLU A 371 GLU~? 9.29 O2 C B 5 coo 63.94 10.02 33.47 64.31 8.24 32.38 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 18 2 # 18 A 160 GLU A 474 GLU~? 16.68 N2 G B 2 A 269 GLU A 560 GLU~? 13.58 O4 U B 1 coo 63.94 10.02 33.47 64.31 8.24 32.38 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -4.75 -65.37 1.07 -4.31 -67.34 1.74 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 19 2 # 19 A 160 GLU A 522 GLU^? 23.38 O4 U B 3 A 269 GLU A 449 GLU.? 11.55 O2 U B 3 coo 63.94 10.02 33.47 64.31 8.24 32.38 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1pbg_04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 20 2 # 20 A 160 GLU A 560 GLU~? 13.58 O4 U B 1 A 269 GLU A 474 GLU~? 16.68 N2 G B 2 coo 63.94 10.02 33.47 64.31 8.24 32.38 -4.75 -65.37 1.07 -4.31 -67.34 1.74 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 1pbg_04 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 20 hits 1pbg_04 naa= 2 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 208 GLU~? 4.03 N1 A B 9 B 269 GLU A 267 GLU~? 24.62 O4 U B 8 coo 23.66 16.69 85.20 24.17 18.76 84.94 -24.90 -17.89 21.91 -24.90 -19.66 23.08 coo 21.20 8.49 59.63 20.88 8.62 57.55 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 267 GLU~? 24.62 O4 U B 8 B 269 GLU A 208 GLU~? 4.03 N1 A B 9 coo 23.66 16.69 85.20 24.17 18.76 84.94 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 coo 21.20 8.49 59.63 20.88 8.62 57.55 -24.90 -17.89 21.91 -24.90 -19.66 23.08 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU A 341 GLU~? 25.67 N6 A B 7 B 269 GLU A 436 GLU~? 23.50 O4 U B 3 coo 23.66 16.69 85.20 24.17 18.76 84.94 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 21.20 8.49 59.63 20.88 8.62 57.55 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU A 351 GLU~? 20.29 O2' A B 4 B 269 GLU A 391 GLU~? 23.54 N1 A B 4 coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 21.20 8.49 59.63 20.88 8.62 57.55 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 B 160 GLU A 351 GLU~? 20.29 O2' A B 4 B 269 GLU A 436 GLU~? 23.50 O4 U B 3 coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 21.20 8.49 59.63 20.88 8.62 57.55 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 B 160 GLU A 371 GLU~? 9.29 O2 C B 5 B 269 GLU A 466 GLU~? 26.72 N2 G B 2 coo 23.66 16.69 85.20 24.17 18.76 84.94 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 coo 21.20 8.49 59.63 20.88 8.62 57.55 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 B 160 GLU A 391 GLU~? 23.54 N1 A B 4 B 269 GLU A 351 GLU~? 20.29 O2' A B 4 coo 23.66 16.69 85.20 24.17 18.76 84.94 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 B 160 GLU A 407 GLU~? 15.45 O2 U B 3 B 269 GLU A 466 GLU~? 26.72 N2 G B 2 coo 23.66 16.69 85.20 24.17 18.76 84.94 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 21.20 8.49 59.63 20.88 8.62 57.55 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 9 2 # 9 B 160 GLU A 412 GLU.? 7.44 O2' U B 3 B 269 GLU A 432 GLU~? 22.16 O4 U B 3 coo 23.66 16.69 85.20 24.17 18.76 84.94 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 coo 21.20 8.49 59.63 20.88 8.62 57.55 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 10 2 # 10 B 160 GLU A 412 GLU.? 7.44 O2' U B 3 B 269 GLU A 436 GLU~? 23.50 O4 U B 3 coo 23.66 16.69 85.20 24.17 18.76 84.94 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 coo 21.20 8.49 59.63 20.88 8.62 57.55 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 11 2 # 11 B 160 GLU A 432 GLU~? 22.16 O4 U B 3 B 269 GLU A 412 GLU.? 7.44 O2' U B 3 coo 23.66 16.69 85.20 24.17 18.76 84.94 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 21.20 8.49 59.63 20.88 8.62 57.55 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 12 2 # 12 B 160 GLU A 436 GLU~? 23.50 O4 U B 3 B 269 GLU A 341 GLU~? 25.67 N6 A B 7 coo 23.66 16.69 85.20 24.17 18.76 84.94 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 21.20 8.49 59.63 20.88 8.62 57.55 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 13 2 # 13 B 160 GLU A 436 GLU~? 23.50 O4 U B 3 B 269 GLU A 351 GLU~? 20.29 O2' A B 4 coo 23.66 16.69 85.20 24.17 18.76 84.94 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 14 2 # 14 B 160 GLU A 436 GLU~? 23.50 O4 U B 3 B 269 GLU A 412 GLU.? 7.44 O2' U B 3 coo 23.66 16.69 85.20 24.17 18.76 84.94 -21.51 -49.22 -23.82 -23.48 -49.27 -24.62 coo 21.20 8.49 59.63 20.88 8.62 57.55 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 15 2 # 15 B 160 GLU A 466 GLU~? 26.72 N2 G B 2 B 269 GLU A 371 GLU~? 9.29 O2 C B 5 coo 23.66 16.69 85.20 24.17 18.76 84.94 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 21.20 8.49 59.63 20.88 8.62 57.55 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 16 2 # 16 B 160 GLU A 466 GLU~? 26.72 N2 G B 2 B 269 GLU A 407 GLU~? 15.45 O2 U B 3 coo 23.66 16.69 85.20 24.17 18.76 84.94 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 coo 21.20 8.49 59.63 20.88 8.62 57.55 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 17 2 # 17 B 160 GLU A 470 GLU~? 22.82 N2 G B 2 B 269 GLU A 371 GLU~? 9.29 O2 C B 5 coo 23.66 16.69 85.20 24.17 18.76 84.94 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 21.20 8.49 59.63 20.88 8.62 57.55 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 18 2 # 18 B 160 GLU A 474 GLU~? 16.68 N2 G B 2 B 269 GLU A 560 GLU~? 13.58 O4 U B 1 coo 23.66 16.69 85.20 24.17 18.76 84.94 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 coo 21.20 8.49 59.63 20.88 8.62 57.55 -4.75 -65.37 1.07 -4.31 -67.34 1.74 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 19 2 # 19 B 160 GLU A 522 GLU^? 23.38 O4 U B 3 B 269 GLU A 449 GLU.? 11.55 O2 U B 3 coo 23.66 16.69 85.20 24.17 18.76 84.94 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 21.20 8.49 59.63 20.88 8.62 57.55 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1pbg_05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 20 2 # 20 B 160 GLU A 560 GLU~? 13.58 O4 U B 1 B 269 GLU A 474 GLU~? 16.68 N2 G B 2 coo 23.66 16.69 85.20 24.17 18.76 84.94 -4.75 -65.37 1.07 -4.31 -67.34 1.74 coo 21.20 8.49 59.63 20.88 8.62 57.55 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 1pbg_05 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 20 hits 1pbg_05 naa= 2 ULMN 2 1peg_00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 1 2 # 1 A 178 TYR A 361 TYR~? 4.83 OP1 U B 6 A 283 TYR A 413 TYR.? 4.41 O2' A B 4 coo 29.64 7.69 5.12 29.91 9.25 2.80 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 25.32 16.13 3.80 24.28 14.46 1.84 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 ULMN 2 1peg_00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 2 2 # 2 A 178 TYR A 413 TYR.? 4.41 O2' A B 4 A 283 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 29.64 7.69 5.12 29.91 9.25 2.80 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 coo 25.32 16.13 3.80 24.28 14.46 1.84 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 1peg_00 source 1peg HISTONE H3 METHYLTRANSFERASE DIM-5 : 2 hits 1peg_00 naa= 2 ULMN 2 1peg_01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 1 2 # 1 B 178 TYR A 361 TYR~? 4.83 OP1 U B 6 B 283 TYR A 413 TYR.? 4.41 O2' A B 4 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 ULMN 2 1peg_01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 2 2 # 2 B 178 TYR A 413 TYR.? 4.41 O2' A B 4 B 283 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -10.34 -32.41 -6.98 -8.09 -31.22 -5.79 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 1peg_01 source 1peg HISTONE H3 METHYLTRANSFERASE DIM-5 : 2 hits 1peg_01 naa= 2 ULMN 2 1pgs_00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 1 2 # 1 60 ASP A 491 ASP~? 15.62 O2 U B 1 206 GLU A 545 GLU~? 17.12 N3 U B 1 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1pgs_00 source 1pgs PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSAMINYL) AS: 1 hits 1pgs_00 naa= 2 ULMN 2 1pii_01 N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOuser 1 2 # 1 260 CYH A 319 CYH~? 13.55 O2' C B 5 379 ASP A 312 ASP~? 21.35 C2 A B 7 coo 42.75 2.82 -9.23 44.92 1.06 -8.97 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 coo 41.40 -8.29 -7.85 42.85 -8.47 -9.32 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 ULMN 2 1pii_01 N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOuser 2 2 # 2 260 CYH A 510 CYH~? 17.27 O4 U B 1 379 ASP A 533 ASP~? 24.95 O4 U B 1 coo 42.75 2.82 -9.23 44.92 1.06 -8.97 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 coo 41.40 -8.29 -7.85 42.85 -8.47 -9.32 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1pii_01 source 1pii N-(5'PHOSPHORIBOSYL)ANTHRANILATE ISOMERASE (E.: 2 hits 1pii_01 naa= 2 ULMN 2 1pow_04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 2 # 1 A 394 VAL A 199 VAL~? 10.74 O2' A B 9 A 422 MET A 195 MET~? 15.11 C2 A B 9 coo 20.28 63.26 5.82 18.13 63.68 5.60 -18.26 -8.36 17.85 -18.13 -6.50 16.70 coo 19.32 67.77 3.69 20.14 66.07 0.03 -22.67 -3.42 18.15 -24.04 -3.50 15.21 ULMN 2 1pow_04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 2 # 2 A 394 VAL A 401 VAL~? 15.22 C2 A B 4 A 422 MET A 398 MET~? 15.73 C2 A B 4 coo 20.28 63.26 5.82 18.13 63.68 5.60 -20.78 -34.85 -17.92 -21.15 -35.50 -15.90 coo 19.32 67.77 3.69 20.14 66.07 0.03 -25.38 -36.04 -17.61 -25.22 -38.18 -15.09 ULMN 2 1pow_04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 2 # 3 A 394 VAL A 503 VAL~? 10.00 O4 U B 1 A 422 MET A 493 MET~? 11.47 N2 G B 2 coo 20.28 63.26 5.82 18.13 63.68 5.60 -6.59 -57.16 -11.51 -4.99 -58.12 -12.62 coo 19.32 67.77 3.69 20.14 66.07 0.03 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 ULMN 2 1pow_04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 2 # 4 A 394 VAL A 503 VAL~? 10.00 O4 U B 1 A 422 MET A 494 MET~? 11.93 O4 U B 1 coo 20.28 63.26 5.82 18.13 63.68 5.60 -6.59 -57.16 -11.51 -4.99 -58.12 -12.62 coo 19.32 67.77 3.69 20.14 66.07 0.03 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 1pow_04 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 4 hits 1pow_04 naa= 2 ULMN 2 1pow_05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 2 # 1 B 394 VAL A 199 VAL~? 10.74 O2' A B 9 B 422 MET A 195 MET~? 15.11 C2 A B 9 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -18.26 -8.36 17.85 -18.13 -6.50 16.70 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -22.67 -3.42 18.15 -24.04 -3.50 15.21 ULMN 2 1pow_05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 2 # 2 B 394 VAL A 401 VAL~? 15.22 C2 A B 4 B 422 MET A 398 MET~? 15.73 C2 A B 4 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -20.78 -34.85 -17.92 -21.15 -35.50 -15.90 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -25.38 -36.04 -17.61 -25.22 -38.18 -15.09 ULMN 2 1pow_05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 2 # 3 B 394 VAL A 503 VAL~? 10.00 O4 U B 1 B 422 MET A 493 MET~? 11.47 N2 G B 2 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -6.59 -57.16 -11.51 -4.99 -58.12 -12.62 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -1.44 -54.55 -14.95 -4.97 -54.40 -17.07 ULMN 2 1pow_05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 2 # 4 B 394 VAL A 503 VAL~? 10.00 O4 U B 1 B 422 MET A 494 MET~? 11.93 O4 U B 1 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -6.59 -57.16 -11.51 -4.99 -58.12 -12.62 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -0.43 -57.26 -12.45 -1.12 -61.33 -13.02 1pow_05 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 4 hits 1pow_05 naa= 2 ULMN 2 1ps1_00 PENTALENENE SYNTHASE user 1 2 # 1 A 77 PHE A 495 PHE~? 11.36 O2 U B 1 A 309 HIS A 547 HIS~? 18.58 O4 U B 1 coo 50.92 66.26 27.35 49.39 65.20 29.47 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo 40.83 63.47 32.68 42.69 62.61 32.19 8.28 -67.57 -10.72 8.13 -67.19 -12.78 1ps1_00 source 1ps1 PENTALENENE SYNTHASE : 1 hits 1ps1_00 naa= 2 ULMN 2 1ps1_01 PENTALENENE SYNTHASE user 1 2 # 1 B 77 PHE A 495 PHE~? 11.36 O2 U B 1 B 309 HIS A 547 HIS~? 18.58 O4 U B 1 coo 70.89 30.37 52.79 69.71 32.41 54.33 4.19 -57.76 -12.51 4.22 -60.51 -12.19 coo 69.54 37.51 61.78 69.32 37.78 59.70 8.28 -67.57 -10.72 8.13 -67.19 -12.78 1ps1_01 source 1ps1 PENTALENENE SYNTHASE : 1 hits 1ps1_01 naa= 2 ULMN 2 1psd_00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 1 2 # 1 A 269 GLU A 457 GLU~? 3.32 N1 G B 2 A 292 HIS A 454 HIS~? 3.31 C5 U B 3 coo 38.27 25.19 38.30 39.02 23.31 37.65 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 41.07 20.90 35.69 40.38 19.20 36.71 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1psd_00 source 1psd D-3-PHOSPHOGLYCERATE DEHYDROGENASE (PHOSPHOGLY: 1 hits 1psd_00 naa= 2 ULMN 2 1psd_01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 1 2 # 1 B 269 GLU A 457 GLU~? 3.32 N1 G B 2 B 292 HIS A 454 HIS~? 3.31 C5 U B 3 coo 73.23 38.34 28.02 73.78 36.50 28.89 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 73.82 33.94 31.43 75.53 32.98 30.68 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1psd_01 source 1psd D-3-PHOSPHOGLYCERATE DEHYDROGENASE (PHOSPHOGLY: 1 hits 1psd_01 naa= 2 ULMN 2 1pwv_01 LETHAL FACTOR user 1 2 # 1 B 687 GLU A 225 GLU~? 23.05 C2 A B 9 B 728 TYR A 218 TYR~? 23.65 C2 A B 9 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 105.30 6.94 120.65 104.99 4.15 120.81 -39.15 -2.15 23.93 -37.86 0.21 23.20 1pwv_01 source 1pwv LETHAL FACTOR : 1 hits 1pwv_01 naa= 2 ULMN 2 1q6l_00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 A 62 ASP A 193 ASP~? 20.25 C2 A B 9 A 64 LYS A 196 LYS~? 19.45 O2' A B 9 coo 61.71 14.20 19.64 60.68 14.94 21.37 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 55.72 12.42 20.66 58.31 17.81 21.97 -19.67 -3.42 20.50 -17.88 1.90 20.43 ULMN 2 1q6l_00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 A 62 ASP A 488 ASP~? 18.76 O2 U B 1 A 64 LYS A 487 LYS.? 20.83 N3 U B 1 coo 61.71 14.20 19.64 60.68 14.94 21.37 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 55.72 12.42 20.66 58.31 17.81 21.97 3.85 -58.89 -22.81 2.77 -64.79 -20.79 ULMN 2 1q6l_00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 2 # 3 A 62 ASP A 533 ASP~? 24.95 O4 U B 1 A 64 LYS A 536 LYS~? 26.44 O4 U B 1 coo 61.71 14.20 19.64 60.68 14.94 21.37 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 55.72 12.42 20.66 58.31 17.81 21.97 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 ULMN 2 1q6l_00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 2 # 4 A 62 ASP A 533 ASP~? 24.95 O4 U B 1 A 64 LYS A 537 LYS~? 23.79 O4 U B 1 coo 61.71 14.20 19.64 60.68 14.94 21.37 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 55.72 12.42 20.66 58.31 17.81 21.97 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 1q6l_00 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 4 hits 1q6l_00 naa= 2 ULMN 2 1q6l_01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 B 62 ASP A 193 ASP~? 20.25 C2 A B 9 B 64 LYS A 196 LYS~? 19.45 O2' A B 9 coo 45.81 14.64 11.83 45.04 13.82 13.65 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 48.63 16.35 17.25 45.95 10.72 16.28 -19.67 -3.42 20.50 -17.88 1.90 20.43 ULMN 2 1q6l_01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 B 62 ASP A 488 ASP~? 18.76 O2 U B 1 B 64 LYS A 487 LYS.? 20.83 N3 U B 1 coo 45.81 14.64 11.83 45.04 13.82 13.65 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 48.63 16.35 17.25 45.95 10.72 16.28 3.85 -58.89 -22.81 2.77 -64.79 -20.79 ULMN 2 1q6l_01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 2 # 3 B 62 ASP A 533 ASP~? 24.95 O4 U B 1 B 64 LYS A 536 LYS~? 26.44 O4 U B 1 coo 45.81 14.64 11.83 45.04 13.82 13.65 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 48.63 16.35 17.25 45.95 10.72 16.28 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 ULMN 2 1q6l_01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 2 # 4 B 62 ASP A 533 ASP~? 24.95 O4 U B 1 B 64 LYS A 537 LYS~? 23.79 O4 U B 1 coo 45.81 14.64 11.83 45.04 13.82 13.65 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 48.63 16.35 17.25 45.95 10.72 16.28 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 1q6l_01 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 4 hits 1q6l_01 naa= 2 ULMN 2 1q6x_02 CHOLINE O-ACETYLTRANSFERASE user 1 2 # 1 A 334 HIS A 496 HIS.? 9.17 O2 U B 1 A 550 SER A 453 SER~? 2.96 N2 G B 2 coo 38.40 88.96 58.48 39.26 87.53 59.75 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 46.35 85.43 65.37 45.80 86.30 63.18 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 1q6x_02 source 1q6x CHOLINE O-ACETYLTRANSFERASE : 1 hits 1q6x_02 naa= 2 ULMN 2 1q6x_03 CHOLINE O-ACETYLTRANSFERASE user 1 2 # 1 B 334 HIS A 496 HIS.? 9.17 O2 U B 1 B 550 SER A 453 SER~? 2.96 N2 G B 2 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 1q6x_03 source 1q6x CHOLINE O-ACETYLTRANSFERASE : 1 hits 1q6x_03 naa= 2 ULMN 2 1q91_00 5(3)-DEOXYRIBONUCLEOTIDASE user 1 2 # 1 A 41 ASP A 233 ASP~? 18.81 O2 U B 8 A 43 ASP A 232 ASP~? 21.56 O2 U B 8 coo 19.89 38.63 33.96 18.35 38.95 32.59 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 13.89 41.64 32.32 13.68 43.65 31.73 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 1q91_00 5(3)-DEOXYRIBONUCLEOTIDASE user 2 2 # 2 A 41 ASP A 259 ASP.? 23.89 N1 A B 9 A 43 ASP A 260 ASP.? 30.95 O4 U B 8 coo 19.89 38.63 33.96 18.35 38.95 32.59 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 13.89 41.64 32.32 13.68 43.65 31.73 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 1q91_00 5(3)-DEOXYRIBONUCLEOTIDASE user 3 2 # 3 A 41 ASP A 426 ASP.? 18.90 N1 A B 4 A 43 ASP A 425 ASP.? 18.06 O4 U B 3 coo 19.89 38.63 33.96 18.35 38.95 32.59 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 13.89 41.64 32.32 13.68 43.65 31.73 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1q91_00 5(3)-DEOXYRIBONUCLEOTIDASE user 4 2 # 4 A 41 ASP A 473 ASP~? 22.60 N2 G B 2 A 43 ASP A 477 ASP~? 24.62 N2 G B 2 coo 19.89 38.63 33.96 18.35 38.95 32.59 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 13.89 41.64 32.32 13.68 43.65 31.73 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 ULMN 2 1q91_00 5(3)-DEOXYRIBONUCLEOTIDASE user 5 2 # 5 A 41 ASP A 477 ASP~? 24.62 N2 G B 2 A 43 ASP A 473 ASP~? 22.60 N2 G B 2 coo 19.89 38.63 33.96 18.35 38.95 32.59 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 13.89 41.64 32.32 13.68 43.65 31.73 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1q91_00 5(3)-DEOXYRIBONUCLEOTIDASE user 6 2 # 6 A 41 ASP A 488 ASP~? 18.76 O2 U B 1 A 43 ASP A 491 ASP~? 15.62 O2 U B 1 coo 19.89 38.63 33.96 18.35 38.95 32.59 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 13.89 41.64 32.32 13.68 43.65 31.73 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1q91_00 source 1q91 5(3)-DEOXYRIBONUCLEOTIDASE : 6 hits 1q91_00 naa= 2 ULMN 2 1qam_00 ERMC' METHYLTRANSFERASE user 1 2 # 1 A 59 GLU A 341 GLU~? 25.67 N6 A B 7 A 101 ASN A 388 ASN~? 30.21 C2 A B 4 coo 17.21 39.80 29.23 17.83 38.53 27.67 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 coo 11.70 33.75 21.15 12.72 34.11 19.33 -41.56 -34.77 -16.36 -41.09 -34.74 -18.44 ULMN 2 1qam_00 ERMC' METHYLTRANSFERASE user 2 2 # 2 A 59 GLU A 391 GLU~? 23.54 N1 A B 4 A 101 ASN A 379 ASN~? 20.05 O2 C B 5 coo 17.21 39.80 29.23 17.83 38.53 27.67 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 11.70 33.75 21.15 12.72 34.11 19.33 -37.01 -37.91 -5.77 -35.68 -36.26 -5.44 ULMN 2 1qam_00 ERMC' METHYLTRANSFERASE user 3 2 # 3 A 59 GLU A 407 GLU~? 15.45 O2 U B 3 A 101 ASN A 403 ASN~? 22.98 C2 A B 4 coo 17.21 39.80 29.23 17.83 38.53 27.67 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 11.70 33.75 21.15 12.72 34.11 19.33 -19.84 -34.23 -23.62 -21.53 -34.55 -24.89 ULMN 2 1qam_00 ERMC' METHYLTRANSFERASE user 4 2 # 4 A 59 GLU A 449 GLU.? 11.55 O2 U B 3 A 101 ASN A 411 ASN~? 8.65 O2 U B 3 coo 17.21 39.80 29.23 17.83 38.53 27.67 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo 11.70 33.75 21.15 12.72 34.11 19.33 -10.10 -34.70 -13.08 -9.74 -33.02 -11.82 ULMN 2 1qam_00 ERMC' METHYLTRANSFERASE user 5 2 # 5 A 59 GLU A 449 GLU.? 11.55 O2 U B 3 A 101 ASN A 415 ASN~? 2.88 O2 U B 3 coo 17.21 39.80 29.23 17.83 38.53 27.67 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 coo 11.70 33.75 21.15 12.72 34.11 19.33 -11.62 -39.80 -10.44 -10.92 -39.73 -8.43 ULMN 2 1qam_00 ERMC' METHYLTRANSFERASE user 6 2 # 6 A 59 GLU A 457 GLU~? 3.32 N1 G B 2 A 101 ASN A 415 ASN~? 2.88 O2 U B 3 coo 17.21 39.80 29.23 17.83 38.53 27.67 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 11.70 33.75 21.15 12.72 34.11 19.33 -11.62 -39.80 -10.44 -10.92 -39.73 -8.43 1qam_00 source 1qam ERMC' METHYLTRANSFERASE : 6 hits 1qam_00 naa= 2 ULMN 2 1qd6_00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 1 2 # 1 C 142 HIS A 326 HIS~? 3.28 C5 A B 7 D 146 GLY A 252 GLY~? 12.46 O4 U B 8 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 15.87 13.94 20.94 16.37 13.66 20.42 -34.81 -16.94 13.94 -34.96 -16.13 14.08 ULMN 2 1qd6_00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 2 2 # 2 C 142 HIS A 454 HIS~? 3.31 C5 U B 3 D 146 GLY A 486 GLY.? 16.78 O2 U B 1 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 15.87 13.94 20.94 16.37 13.66 20.42 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1qd6_00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 3 2 # 3 C 142 HIS A 482 HIS.? 27.32 N2 G B 2 D 146 GLY A 499 GLY~? 6.97 N2 G B 2 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 15.87 13.94 20.94 16.37 13.66 20.42 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 ULMN 2 1qd6_00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 4 2 # 4 C 142 HIS A 527 HIS~? 25.85 N2 G B 2 D 146 GLY A 478 GLY.? 19.78 N2 G B 2 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 15.87 13.94 20.94 16.37 13.66 20.42 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1qd6_00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 5 2 # 5 C 142 HIS A 539 HIS~? 18.96 O4 U B 1 D 146 GLY A 486 GLY.? 16.78 O2 U B 1 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 coo 15.87 13.94 20.94 16.37 13.66 20.42 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1qd6_00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 6 2 # 6 C 142 HIS A 547 HIS~? 18.58 O4 U B 1 D 146 GLY A 478 GLY.? 19.78 N2 G B 2 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 8.28 -67.57 -10.72 8.13 -67.19 -12.78 coo 15.87 13.94 20.94 16.37 13.66 20.42 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 1qd6_00 source 1qd6 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA) : 6 hits 1qd6_00 naa= 2 ULMN 2 1qgx_00 3',5'-ADENOSINE BISPHOSPHATASE user 1 2 # 1 A 72 GLU A 391 GLU~? 23.54 N1 A B 4 A 147 THR A 374 THR.? 15.78 N1 A B 4 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 1qgx_00 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 1 hits 1qgx_00 naa= 2 ULMN 2 1qgx_01 3',5'-ADENOSINE BISPHOSPHATASE user 1 2 # 1 A 32 LYS A 196 LYS~? 19.45 O2' A B 9 A 147 THR A 202 THR~? 8.86 O2' A B 9 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -19.67 -3.42 20.50 -17.88 1.90 20.43 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -17.21 -12.36 25.70 -16.28 -12.03 27.61 ULMN 2 1qgx_01 3',5'-ADENOSINE BISPHOSPHATASE user 2 2 # 2 A 32 LYS A 231 LYS~? 21.79 O2 U B 8 A 147 THR A 239 THR~? 10.72 O2 U B 8 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -28.35 -2.55 6.15 -27.54 -2.37 -0.06 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -19.36 -10.64 8.19 -19.30 -8.96 6.83 ULMN 2 1qgx_01 3',5'-ADENOSINE BISPHOSPHATASE user 3 2 # 3 A 32 LYS A 338 LYS~? 26.90 N6 A B 7 A 147 THR A 383 THR~? 29.32 N6 A B 7 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -37.84 -25.02 -10.54 -41.92 -21.39 -11.77 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -45.70 -35.28 -8.64 -46.29 -33.20 -8.69 ULMN 2 1qgx_01 3',5'-ADENOSINE BISPHOSPHATASE user 4 2 # 4 A 32 LYS A 458 LYS~? 5.39 O4 U B 3 A 147 THR A 508 THR~? 10.98 O6 G B 2 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -12.37 -61.03 -6.50 -12.20 -59.82 -4.73 1qgx_01 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 4 hits 1qgx_01 naa= 2 ULMN 2 1qho_00 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 190 ASP~? 22.39 C2 A B 9 A 253 LEU A 183 LEU.? 16.53 C2 A B 9 coo 28.46 69.88 26.74 30.40 70.70 26.53 -31.44 0.79 27.21 -33.43 0.08 27.41 coo 18.60 67.37 33.24 17.63 66.99 31.31 -24.64 -7.44 32.15 -23.13 -5.95 31.71 ULMN 2 1qho_00 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 193 ASP~? 20.25 C2 A B 9 A 253 LEU A 185 LEU~? 14.08 C2 A B 9 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 18.60 67.37 33.24 17.63 66.99 31.31 -30.93 -8.72 27.48 -31.10 -9.12 25.35 ULMN 2 1qho_00 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP A 193 ASP~? 20.25 C2 A B 9 A 253 LEU A 223 LEU~? 13.97 C2 A B 9 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 18.60 67.37 33.24 17.63 66.99 31.31 -33.24 -8.02 19.00 -32.17 -8.88 20.71 ULMN 2 1qho_00 ALPHA-AMYLASE user 4 2 # 4 A 228 ASP A 193 ASP~? 20.25 C2 A B 9 A 253 LEU A 237 LEU~? 11.73 O2 U B 8 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 18.60 67.37 33.24 17.63 66.99 31.31 -23.73 -8.13 12.88 -23.76 -7.02 14.77 ULMN 2 1qho_00 ALPHA-AMYLASE user 5 2 # 5 A 228 ASP A 193 ASP~? 20.25 C2 A B 9 A 253 LEU A 246 LEU~? 8.12 C2 A B 9 coo 28.46 69.88 26.74 30.40 70.70 26.53 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 18.60 67.37 33.24 17.63 66.99 31.31 -25.82 -11.65 17.32 -27.01 -10.39 18.64 ULMN 2 1qho_00 ALPHA-AMYLASE user 6 2 # 6 A 228 ASP A 200 ASP~? 9.45 O2' A B 9 A 253 LEU A 194 LEU~? 13.92 C2 A B 9 coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 18.60 67.37 33.24 17.63 66.99 31.31 -26.41 -3.70 20.59 -27.33 -5.63 20.13 ULMN 2 1qho_00 ALPHA-AMYLASE user 7 2 # 7 A 228 ASP A 200 ASP~? 9.45 O2' A B 9 A 253 LEU A 237 LEU~? 11.73 O2 U B 8 coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 18.60 67.37 33.24 17.63 66.99 31.31 -23.73 -8.13 12.88 -23.76 -7.02 14.77 ULMN 2 1qho_00 ALPHA-AMYLASE user 8 2 # 8 A 228 ASP A 200 ASP~? 9.45 O2' A B 9 A 253 LEU A 246 LEU~? 8.12 C2 A B 9 coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 18.60 67.37 33.24 17.63 66.99 31.31 -25.82 -11.65 17.32 -27.01 -10.39 18.64 ULMN 2 1qho_00 ALPHA-AMYLASE user 9 2 # 9 A 228 ASP A 233 ASP~? 18.81 O2 U B 8 A 253 LEU A 189 LEU~? 16.68 C2 A B 9 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 18.60 67.37 33.24 17.63 66.99 31.31 -31.54 -3.59 24.24 -31.74 -5.46 23.15 ULMN 2 1qho_00 ALPHA-AMYLASE user 10 2 # 10 A 228 ASP A 233 ASP~? 18.81 O2 U B 8 A 253 LEU A 223 LEU~? 13.97 C2 A B 9 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 18.60 67.37 33.24 17.63 66.99 31.31 -33.24 -8.02 19.00 -32.17 -8.88 20.71 ULMN 2 1qho_00 ALPHA-AMYLASE user 11 2 # 11 A 228 ASP A 233 ASP~? 18.81 O2 U B 8 A 253 LEU A 269 LEU~? 15.46 O4 U B 8 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 18.60 67.37 33.24 17.63 66.99 31.31 -34.40 -10.02 6.25 -32.98 -11.27 7.25 ULMN 2 1qho_00 ALPHA-AMYLASE user 12 2 # 12 A 228 ASP A 279 ASP~? 17.12 C2 A B 7 A 253 LEU A 305 LEU~? 15.30 N1 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 18.60 67.37 33.24 17.63 66.99 31.31 -32.20 -15.57 -1.13 -32.34 -14.53 0.75 ULMN 2 1qho_00 ALPHA-AMYLASE user 13 2 # 13 A 228 ASP A 279 ASP~? 17.12 C2 A B 7 A 253 LEU A 309 LEU.? 14.77 N1 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 18.60 67.37 33.24 17.63 66.99 31.31 -27.47 -16.86 -7.24 -27.07 -18.25 -5.60 ULMN 2 1qho_00 ALPHA-AMYLASE user 14 2 # 14 A 228 ASP A 298 ASP~? 21.17 O4 U B 8 A 253 LEU A 294 LEU~? 11.24 N6 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -41.82 -17.47 4.14 -42.95 -17.27 5.91 coo 18.60 67.37 33.24 17.63 66.99 31.31 -31.42 -20.65 2.22 -30.60 -19.93 0.35 ULMN 2 1qho_00 ALPHA-AMYLASE user 15 2 # 15 A 228 ASP A 298 ASP~? 21.17 O4 U B 8 A 253 LEU A 305 LEU~? 15.30 N1 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -41.82 -17.47 4.14 -42.95 -17.27 5.91 coo 18.60 67.37 33.24 17.63 66.99 31.31 -32.20 -15.57 -1.13 -32.34 -14.53 0.75 ULMN 2 1qho_00 ALPHA-AMYLASE user 16 2 # 16 A 228 ASP A 321 ASP~? 8.41 N3 A B 7 A 253 LEU A 309 LEU.? 14.77 N1 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo 18.60 67.37 33.24 17.63 66.99 31.31 -27.47 -16.86 -7.24 -27.07 -18.25 -5.60 ULMN 2 1qho_00 ALPHA-AMYLASE user 17 2 # 17 A 228 ASP A 321 ASP~? 8.41 N3 A B 7 A 253 LEU A 315 LEU~? 16.51 C2 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo 18.60 67.37 33.24 17.63 66.99 31.31 -22.44 -18.38 -10.73 -24.05 -19.64 -9.97 ULMN 2 1qho_00 ALPHA-AMYLASE user 18 2 # 18 A 228 ASP A 345 ASP~? 24.06 C2 A B 4 A 253 LEU A 309 LEU.? 14.77 N1 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 18.60 67.37 33.24 17.63 66.99 31.31 -27.47 -16.86 -7.24 -27.07 -18.25 -5.60 ULMN 2 1qho_00 ALPHA-AMYLASE user 19 2 # 19 A 228 ASP A 345 ASP~? 24.06 C2 A B 4 A 253 LEU A 315 LEU~? 16.51 C2 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 18.60 67.37 33.24 17.63 66.99 31.31 -22.44 -18.38 -10.73 -24.05 -19.64 -9.97 ULMN 2 1qho_00 ALPHA-AMYLASE user 20 2 # 20 A 228 ASP A 359 ASP~? 8.63 O2' A B 4 A 253 LEU A 315 LEU~? 16.51 C2 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 18.60 67.37 33.24 17.63 66.99 31.31 -22.44 -18.38 -10.73 -24.05 -19.64 -9.97 ULMN 2 1qho_00 ALPHA-AMYLASE user 21 2 # 21 A 228 ASP A 359 ASP~? 8.63 O2' A B 4 A 253 LEU A 353 LEU~? 16.08 C2 A B 4 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 18.60 67.37 33.24 17.63 66.99 31.31 -18.98 -28.80 -16.91 -19.62 -30.83 -16.41 ULMN 2 1qho_00 ALPHA-AMYLASE user 22 2 # 22 A 228 ASP A 359 ASP~? 8.63 O2' A B 4 A 253 LEU A 408 LEU~? 12.22 O2 U B 3 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 18.60 67.37 33.24 17.63 66.99 31.31 -14.96 -35.94 -15.48 -16.03 -34.05 -15.57 ULMN 2 1qho_00 ALPHA-AMYLASE user 23 2 # 23 A 228 ASP A 426 ASP.? 18.90 N1 A B 4 A 253 LEU A 382 LEU.? 24.51 N6 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 18.60 67.37 33.24 17.63 66.99 31.31 -41.45 -35.56 -7.22 -39.75 -34.32 -6.72 ULMN 2 1qho_00 ALPHA-AMYLASE user 24 2 # 24 A 228 ASP A 473 ASP~? 22.60 N2 G B 2 A 253 LEU A 444 LEU~? 14.23 N2 G B 2 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 18.60 67.37 33.24 17.63 66.99 31.31 -4.67 -51.47 -21.22 -2.66 -52.29 -21.01 ULMN 2 1qho_00 ALPHA-AMYLASE user 25 2 # 25 A 228 ASP A 473 ASP~? 22.60 N2 G B 2 A 253 LEU A 490 LEU~? 15.49 O4 U B 1 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 18.60 67.37 33.24 17.63 66.99 31.31 -3.12 -60.15 -18.00 -4.61 -61.08 -16.78 ULMN 2 1qho_00 ALPHA-AMYLASE user 26 2 # 26 A 228 ASP A 473 ASP~? 22.60 N2 G B 2 A 253 LEU A 538 LEU~? 14.81 O4 U B 1 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 18.60 67.37 33.24 17.63 66.99 31.31 -7.66 -64.97 -13.20 -8.22 -62.86 -13.55 ULMN 2 1qho_00 ALPHA-AMYLASE user 27 2 # 27 A 228 ASP A 477 ASP~? 24.62 N2 G B 2 A 253 LEU A 443 LEU~? 13.05 N2 G B 2 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 18.60 67.37 33.24 17.63 66.99 31.31 -9.87 -51.42 -19.82 -12.04 -51.54 -19.56 ULMN 2 1qho_00 ALPHA-AMYLASE user 28 2 # 28 A 228 ASP A 477 ASP~? 24.62 N2 G B 2 A 253 LEU A 444 LEU~? 14.23 N2 G B 2 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 18.60 67.37 33.24 17.63 66.99 31.31 -4.67 -51.47 -21.22 -2.66 -52.29 -21.01 ULMN 2 1qho_00 ALPHA-AMYLASE user 29 2 # 29 A 228 ASP A 477 ASP~? 24.62 N2 G B 2 A 253 LEU A 538 LEU~? 14.81 O4 U B 1 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 18.60 67.37 33.24 17.63 66.99 31.31 -7.66 -64.97 -13.20 -8.22 -62.86 -13.55 ULMN 2 1qho_00 ALPHA-AMYLASE user 30 2 # 30 A 228 ASP A 484 ASP.? 22.65 O2 U B 1 A 253 LEU A 444 LEU~? 14.23 N2 G B 2 coo 28.46 69.88 26.74 30.40 70.70 26.53 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo 18.60 67.37 33.24 17.63 66.99 31.31 -4.67 -51.47 -21.22 -2.66 -52.29 -21.01 ULMN 2 1qho_00 ALPHA-AMYLASE user 31 2 # 31 A 228 ASP A 491 ASP~? 15.62 O2 U B 1 A 253 LEU A 538 LEU~? 14.81 O4 U B 1 coo 28.46 69.88 26.74 30.40 70.70 26.53 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 18.60 67.37 33.24 17.63 66.99 31.31 -7.66 -64.97 -13.20 -8.22 -62.86 -13.55 ULMN 2 1qho_00 ALPHA-AMYLASE user 32 2 # 32 A 228 ASP A 512 ASP~? 14.88 O6 G B 2 A 253 LEU A 465 LEU~? 22.53 N2 G B 2 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 18.60 67.37 33.24 17.63 66.99 31.31 -23.72 -60.04 -17.11 -23.59 -60.80 -15.05 ULMN 2 1qho_00 ALPHA-AMYLASE user 33 2 # 33 A 228 ASP A 512 ASP~? 14.88 O6 G B 2 A 253 LEU A 538 LEU~? 14.81 O4 U B 1 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 18.60 67.37 33.24 17.63 66.99 31.31 -7.66 -64.97 -13.20 -8.22 -62.86 -13.55 ULMN 2 1qho_00 ALPHA-AMYLASE user 34 2 # 34 A 228 ASP A 512 ASP~? 14.88 O6 G B 2 A 253 LEU A 562 LEU~? 14.49 O4 U B 1 coo 28.46 69.88 26.74 30.40 70.70 26.53 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 18.60 67.37 33.24 17.63 66.99 31.31 -6.28 -68.44 -6.33 -6.65 -67.65 -8.32 ULMN 2 1qho_00 ALPHA-AMYLASE user 35 2 # 35 A 228 ASP A 526 ASP^? 28.45 O6 G B 2 A 253 LEU A 468 LEU~? 17.46 N2 G B 2 coo 28.46 69.88 26.74 30.40 70.70 26.53 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo 18.60 67.37 33.24 17.63 66.99 31.31 -19.18 -57.57 -16.85 -18.04 -58.18 -15.13 ULMN 2 1qho_00 ALPHA-AMYLASE user 36 2 # 36 A 228 ASP A 533 ASP~? 24.95 O4 U B 1 A 253 LEU A 465 LEU~? 22.53 N2 G B 2 coo 28.46 69.88 26.74 30.40 70.70 26.53 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 18.60 67.37 33.24 17.63 66.99 31.31 -23.72 -60.04 -17.11 -23.59 -60.80 -15.05 ULMN 2 1qho_00 ALPHA-AMYLASE user 37 2 # 37 A 228 ASP A 533 ASP~? 24.95 O4 U B 1 A 253 LEU A 468 LEU~? 17.46 N2 G B 2 coo 28.46 69.88 26.74 30.40 70.70 26.53 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 18.60 67.37 33.24 17.63 66.99 31.31 -19.18 -57.57 -16.85 -18.04 -58.18 -15.13 ULMN 2 1qho_00 ALPHA-AMYLASE user 38 2 # 38 A 228 ASP A 533 ASP~? 24.95 O4 U B 1 A 253 LEU A 507 LEU~? 11.48 O4 U B 1 coo 28.46 69.88 26.74 30.40 70.70 26.53 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 18.60 67.37 33.24 17.63 66.99 31.31 -8.80 -61.88 -8.90 -7.96 -63.82 -8.44 1qho_00 source 1qho ALPHA-AMYLASE : 38 hits 1qho_00 naa= 2 ULMN 2 1qho_02 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 174 ASP.? 19.36 O2' A B 9 A 256 GLU A 178 GLU.? 16.07 O2' A B 9 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1qho_02 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 345 ASP~? 24.06 C2 A B 4 A 256 GLU A 341 GLU~? 25.67 N6 A B 7 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 30.54 71.65 32.58 31.73 72.26 30.92 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1qho_02 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP A 491 ASP~? 15.62 O2 U B 1 A 256 GLU A 545 GLU~? 17.12 N3 U B 1 coo 28.46 69.88 26.74 30.40 70.70 26.53 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 30.54 71.65 32.58 31.73 72.26 30.92 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1qho_02 source 1qho ALPHA-AMYLASE : 3 hits 1qho_02 naa= 2 ULMN 2 1qj2_02 CARBON MONOXIDE DEHYDROGENASE user 1 2 # 1 B 240 GLN A 276 GLN~? 19.14 O2 U B 8 B 387 ARG A 314 ARG~? 20.43 C2 A B 7 coo 41.56 93.59 65.64 41.16 91.60 64.94 -24.81 -5.96 0.11 -23.22 -4.85 -0.80 coo 33.50 85.40 62.90 31.25 87.48 62.36 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1qj2_02 CARBON MONOXIDE DEHYDROGENASE user 2 2 # 2 B 240 GLN A 295 GLN~? 9.64 N6 A B 7 B 387 ARG A 288 ARG~? 3.45 C6 A B 7 coo 41.56 93.59 65.64 41.16 91.60 64.94 -33.09 -24.48 7.27 -31.59 -25.59 8.28 coo 33.50 85.40 62.90 31.25 87.48 62.36 -21.54 -21.02 8.30 -20.02 -23.61 8.96 ULMN 2 1qj2_02 CARBON MONOXIDE DEHYDROGENASE user 3 2 # 3 B 240 GLN A 329 GLN~? 6.26 O2' C B 5 B 387 ARG A 288 ARG~? 3.45 C6 A B 7 coo 41.56 93.59 65.64 41.16 91.60 64.94 -23.26 -28.01 -1.37 -22.04 -29.42 -0.36 coo 33.50 85.40 62.90 31.25 87.48 62.36 -21.54 -21.02 8.30 -20.02 -23.61 8.96 ULMN 2 1qj2_02 CARBON MONOXIDE DEHYDROGENASE user 4 2 # 4 B 240 GLN A 406 GLN~? 15.85 O2 U B 3 B 387 ARG A 404 ARG~? 18.97 O2 U B 3 coo 41.56 93.59 65.64 41.16 91.60 64.94 -10.49 -40.11 -21.29 -8.73 -39.50 -22.31 coo 33.50 85.40 62.90 31.25 87.48 62.36 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 1qj2_02 source 1qj2 CARBON MONOXIDE DEHYDROGENASE : 4 hits 1qj2_02 naa= 2 ULMN 2 1qj2_03 CARBON MONOXIDE DEHYDROGENASE user 1 2 # 1 H 240 GLN A 276 GLN~? 19.14 O2 U B 8 H 387 ARG A 314 ARG~? 20.43 C2 A B 7 coo 41.71 128.87 87.62 42.13 130.32 89.13 -24.81 -5.96 0.11 -23.22 -4.85 -0.80 coo 49.59 134.55 94.31 52.01 134.13 92.45 -19.95 -11.13 -9.54 -22.76 -10.04 -10.19 ULMN 2 1qj2_03 CARBON MONOXIDE DEHYDROGENASE user 2 2 # 2 H 240 GLN A 295 GLN~? 9.64 N6 A B 7 H 387 ARG A 288 ARG~? 3.45 C6 A B 7 coo 41.71 128.87 87.62 42.13 130.32 89.13 -33.09 -24.48 7.27 -31.59 -25.59 8.28 coo 49.59 134.55 94.31 52.01 134.13 92.45 -21.54 -21.02 8.30 -20.02 -23.61 8.96 ULMN 2 1qj2_03 CARBON MONOXIDE DEHYDROGENASE user 3 2 # 3 H 240 GLN A 406 GLN~? 15.85 O2 U B 3 H 387 ARG A 404 ARG~? 18.97 O2 U B 3 coo 41.71 128.87 87.62 42.13 130.32 89.13 -10.49 -40.11 -21.29 -8.73 -39.50 -22.31 coo 49.59 134.55 94.31 52.01 134.13 92.45 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 1qj2_03 source 1qj2 CARBON MONOXIDE DEHYDROGENASE : 3 hits 1qj2_03 naa= 2 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 1 2 # 1 A 221 ASP A 190 ASP~? 22.39 C2 A B 9 A 401 ASP A 193 ASP~? 20.25 C2 A B 9 coo 25.04 36.98 34.15 26.35 36.27 32.62 -31.44 0.79 27.21 -33.43 0.08 27.41 coo 33.28 34.18 40.93 33.02 35.91 42.11 -22.85 0.02 23.71 -22.18 1.98 24.08 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 2 2 # 2 A 221 ASP A 193 ASP~? 20.25 C2 A B 9 A 401 ASP A 190 ASP~? 22.39 C2 A B 9 coo 25.04 36.98 34.15 26.35 36.27 32.62 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 33.28 34.18 40.93 33.02 35.91 42.11 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 3 2 # 3 A 221 ASP A 193 ASP~? 20.25 C2 A B 9 A 401 ASP A 200 ASP~? 9.45 O2' A B 9 coo 25.04 36.98 34.15 26.35 36.27 32.62 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 33.28 34.18 40.93 33.02 35.91 42.11 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 4 2 # 4 A 221 ASP A 200 ASP~? 9.45 O2' A B 9 A 401 ASP A 193 ASP~? 20.25 C2 A B 9 coo 25.04 36.98 34.15 26.35 36.27 32.62 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 33.28 34.18 40.93 33.02 35.91 42.11 -22.85 0.02 23.71 -22.18 1.98 24.08 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 5 2 # 5 A 221 ASP A 233 ASP~? 18.81 O2 U B 8 A 401 ASP A 193 ASP~? 20.25 C2 A B 9 coo 25.04 36.98 34.15 26.35 36.27 32.62 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 33.28 34.18 40.93 33.02 35.91 42.11 -22.85 0.02 23.71 -22.18 1.98 24.08 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 6 2 # 6 A 221 ASP A 279 ASP~? 17.12 C2 A B 7 A 401 ASP A 321 ASP~? 8.41 N3 A B 7 coo 25.04 36.98 34.15 26.35 36.27 32.62 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 33.28 34.18 40.93 33.02 35.91 42.11 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 7 2 # 7 A 221 ASP A 321 ASP~? 8.41 N3 A B 7 A 401 ASP A 279 ASP~? 17.12 C2 A B 7 coo 25.04 36.98 34.15 26.35 36.27 32.62 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo 33.28 34.18 40.93 33.02 35.91 42.11 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 8 2 # 8 A 221 ASP A 376 ASP~? 17.17 N1 A B 4 A 401 ASP A 381 ASP.? 22.82 N6 A B 7 coo 25.04 36.98 34.15 26.35 36.27 32.62 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 33.28 34.18 40.93 33.02 35.91 42.11 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 9 2 # 9 A 221 ASP A 376 ASP~? 17.17 N1 A B 4 A 401 ASP A 425 ASP.? 18.06 O4 U B 3 coo 25.04 36.98 34.15 26.35 36.27 32.62 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 33.28 34.18 40.93 33.02 35.91 42.11 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 10 2 # 10 A 221 ASP A 381 ASP.? 22.82 N6 A B 7 A 401 ASP A 376 ASP~? 17.17 N1 A B 4 coo 25.04 36.98 34.15 26.35 36.27 32.62 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 coo 33.28 34.18 40.93 33.02 35.91 42.11 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 11 2 # 11 A 221 ASP A 425 ASP.? 18.06 O4 U B 3 A 401 ASP A 376 ASP~? 17.17 N1 A B 4 coo 25.04 36.98 34.15 26.35 36.27 32.62 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 33.28 34.18 40.93 33.02 35.91 42.11 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 12 2 # 12 A 221 ASP A 491 ASP~? 15.62 O2 U B 1 A 401 ASP A 484 ASP.? 22.65 O2 U B 1 coo 25.04 36.98 34.15 26.35 36.27 32.62 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 33.28 34.18 40.93 33.02 35.91 42.11 7.90 -50.74 -23.88 8.67 -50.47 -25.84 ULMN 2 1qk2_02 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 13 2 # 13 A 221 ASP A 533 ASP~? 24.95 O4 U B 1 A 401 ASP A 477 ASP~? 24.62 N2 G B 2 coo 25.04 36.98 34.15 26.35 36.27 32.62 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 33.28 34.18 40.93 33.02 35.91 42.11 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 1qk2_02 source 1qk2 CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH I: 13 hits 1qk2_02 naa= 2 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 1 2 # 1 B 221 ASP A 190 ASP~? 22.39 C2 A B 9 B 401 ASP A 193 ASP~? 20.25 C2 A B 9 coo 39.21 84.85 78.75 40.59 84.11 77.32 -31.44 0.79 27.21 -33.43 0.08 27.41 coo 47.27 82.90 85.84 46.75 84.63 86.91 -22.85 0.02 23.71 -22.18 1.98 24.08 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 2 2 # 2 B 221 ASP A 193 ASP~? 20.25 C2 A B 9 B 401 ASP A 190 ASP~? 22.39 C2 A B 9 coo 39.21 84.85 78.75 40.59 84.11 77.32 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 47.27 82.90 85.84 46.75 84.63 86.91 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 3 2 # 3 B 221 ASP A 193 ASP~? 20.25 C2 A B 9 B 401 ASP A 200 ASP~? 9.45 O2' A B 9 coo 39.21 84.85 78.75 40.59 84.11 77.32 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 47.27 82.90 85.84 46.75 84.63 86.91 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 4 2 # 4 B 221 ASP A 200 ASP~? 9.45 O2' A B 9 B 401 ASP A 193 ASP~? 20.25 C2 A B 9 coo 39.21 84.85 78.75 40.59 84.11 77.32 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 47.27 82.90 85.84 46.75 84.63 86.91 -22.85 0.02 23.71 -22.18 1.98 24.08 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 5 2 # 5 B 221 ASP A 279 ASP~? 17.12 C2 A B 7 B 401 ASP A 321 ASP~? 8.41 N3 A B 7 coo 39.21 84.85 78.75 40.59 84.11 77.32 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 47.27 82.90 85.84 46.75 84.63 86.91 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 6 2 # 6 B 221 ASP A 321 ASP~? 8.41 N3 A B 7 B 401 ASP A 279 ASP~? 17.12 C2 A B 7 coo 39.21 84.85 78.75 40.59 84.11 77.32 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo 47.27 82.90 85.84 46.75 84.63 86.91 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 7 2 # 7 B 221 ASP A 376 ASP~? 17.17 N1 A B 4 B 401 ASP A 381 ASP.? 22.82 N6 A B 7 coo 39.21 84.85 78.75 40.59 84.11 77.32 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 47.27 82.90 85.84 46.75 84.63 86.91 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 8 2 # 8 B 221 ASP A 376 ASP~? 17.17 N1 A B 4 B 401 ASP A 425 ASP.? 18.06 O4 U B 3 coo 39.21 84.85 78.75 40.59 84.11 77.32 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 47.27 82.90 85.84 46.75 84.63 86.91 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 9 2 # 9 B 221 ASP A 381 ASP.? 22.82 N6 A B 7 B 401 ASP A 376 ASP~? 17.17 N1 A B 4 coo 39.21 84.85 78.75 40.59 84.11 77.32 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 coo 47.27 82.90 85.84 46.75 84.63 86.91 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1qk2_03 CELLOBIOHYDROLASE CEL6A (FORMERLY CAuser 10 2 # 10 B 221 ASP A 425 ASP.? 18.06 O4 U B 3 B 401 ASP A 376 ASP~? 17.17 N1 A B 4 coo 39.21 84.85 78.75 40.59 84.11 77.32 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 47.27 82.90 85.84 46.75 84.63 86.91 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 1qk2_03 source 1qk2 CELLOBIOHYDROLASE CEL6A (FORMERLY CALLED CBH I: 10 hits 1qk2_03 naa= 2 ULMN 2 1qlh_00 ALCOHOL DEHYDROGENASE user 1 2 # 1 A 48 SER A 423 SER~? 9.25 O4 U B 3 A 51 HIS A 462 HIS~? 12.61 O4 U B 3 coo 3.80 7.50 22.51 3.35 9.20 24.18 -21.76 -47.19 -8.71 -19.60 -46.86 -7.67 coo 3.61 3.70 24.10 5.06 4.06 25.58 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1qlh_00 ALCOHOL DEHYDROGENASE user 2 2 # 2 A 48 SER A 453 SER~? 2.96 N2 G B 2 A 51 HIS A 454 HIS~? 3.31 C5 U B 3 coo 3.80 7.50 22.51 3.35 9.20 24.18 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 coo 3.61 3.70 24.10 5.06 4.06 25.58 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 ULMN 2 1qlh_00 ALCOHOL DEHYDROGENASE user 3 2 # 3 A 48 SER A 540 SER~? 21.72 O4 U B 1 A 51 HIS A 539 HIS~? 18.96 O4 U B 1 coo 3.80 7.50 22.51 3.35 9.20 24.18 -3.65 -70.26 -15.04 -4.94 -71.68 -16.53 coo 3.61 3.70 24.10 5.06 4.06 25.58 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 1qlh_00 source 1qlh ALCOHOL DEHYDROGENASE : 3 hits 1qlh_00 naa= 2 ULMN 2 1qz9_00 KYNURENINASE user 1 2 # 1 A 129 PHE A 197 PHE~? 14.18 C2 A B 9 A 201 ASP A 200 ASP~? 9.45 O2' A B 9 coo 23.39 49.81 32.16 21.33 51.68 32.26 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 1qz9_00 KYNURENINASE user 2 2 # 2 A 129 PHE A 221 PHE~? 23.88 N1 A B 9 A 201 ASP A 259 ASP.? 23.89 N1 A B 9 coo 23.39 49.81 32.16 21.33 51.68 32.26 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 25.52 45.12 37.98 23.98 46.65 37.85 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1qz9_00 KYNURENINASE user 3 2 # 3 A 129 PHE A 224 PHE~? 18.04 N1 A B 9 A 201 ASP A 259 ASP.? 23.89 N1 A B 9 coo 23.39 49.81 32.16 21.33 51.68 32.26 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo 25.52 45.12 37.98 23.98 46.65 37.85 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 1qz9_00 KYNURENINASE user 4 2 # 4 A 129 PHE A 285 PHE~? 4.61 O2 U B 8 A 201 ASP A 283 ASP~? 9.21 O2 U B 8 coo 23.39 49.81 32.16 21.33 51.68 32.26 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 25.52 45.12 37.98 23.98 46.65 37.85 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 1qz9_00 KYNURENINASE user 5 2 # 5 A 129 PHE A 476 PHE~? 18.32 N2 G B 2 A 201 ASP A 473 ASP~? 22.60 N2 G B 2 coo 23.39 49.81 32.16 21.33 51.68 32.26 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo 25.52 45.12 37.98 23.98 46.65 37.85 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1qz9_00 KYNURENINASE user 6 2 # 6 A 129 PHE A 476 PHE~? 18.32 N2 G B 2 A 201 ASP A 533 ASP~? 24.95 O4 U B 1 coo 23.39 49.81 32.16 21.33 51.68 32.26 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo 25.52 45.12 37.98 23.98 46.65 37.85 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1qz9_00 KYNURENINASE user 7 2 # 7 A 129 PHE A 531 PHE~? 20.43 O6 G B 2 A 201 ASP A 526 ASP^? 28.45 O6 G B 2 coo 23.39 49.81 32.16 21.33 51.68 32.26 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 coo 25.52 45.12 37.98 23.98 46.65 37.85 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 1qz9_00 source 1qz9 KYNURENINASE : 7 hits 1qz9_00 naa= 2 ULMN 2 1r16_00 ADP-RIBOSYL CYCLASE user 1 2 # 1 A 98 GLU A 351 GLU~? 20.29 O2' A B 4 A 179 GLU A 407 GLU~? 15.45 O2 U B 3 coo 34.76 2.28 18.45 36.75 1.46 18.65 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1r16_00 ADP-RIBOSYL CYCLASE user 2 2 # 2 A 98 GLU A 407 GLU~? 15.45 O2 U B 3 A 179 GLU A 351 GLU~? 20.29 O2' A B 4 coo 34.76 2.28 18.45 36.75 1.46 18.65 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1r16_00 ADP-RIBOSYL CYCLASE user 3 2 # 3 A 98 GLU A 432 GLU~? 22.16 O4 U B 3 A 179 GLU A 470 GLU~? 22.82 N2 G B 2 coo 34.76 2.28 18.45 36.75 1.46 18.65 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1r16_00 ADP-RIBOSYL CYCLASE user 4 2 # 4 A 98 GLU A 470 GLU~? 22.82 N2 G B 2 A 179 GLU A 432 GLU~? 22.16 O4 U B 3 coo 34.76 2.28 18.45 36.75 1.46 18.65 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1r16_00 ADP-RIBOSYL CYCLASE user 5 2 # 5 A 98 GLU A 522 GLU^? 23.38 O4 U B 3 A 179 GLU A 432 GLU~? 22.16 O4 U B 3 coo 34.76 2.28 18.45 36.75 1.46 18.65 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1r16_00 source 1r16 ADP-RIBOSYL CYCLASE : 5 hits 1r16_00 naa= 2 ULMN 2 1r16_01 ADP-RIBOSYL CYCLASE user 1 2 # 1 B 98 GLU A 351 GLU~? 20.29 O2' A B 4 B 179 GLU A 407 GLU~? 15.45 O2 U B 3 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1r16_01 ADP-RIBOSYL CYCLASE user 2 2 # 2 B 98 GLU A 407 GLU~? 15.45 O2 U B 3 B 179 GLU A 351 GLU~? 20.29 O2' A B 4 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1r16_01 ADP-RIBOSYL CYCLASE user 3 2 # 3 B 98 GLU A 432 GLU~? 22.16 O4 U B 3 B 179 GLU A 522 GLU^? 23.38 O4 U B 3 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1r16_01 ADP-RIBOSYL CYCLASE user 4 2 # 4 B 98 GLU A 522 GLU^? 23.38 O4 U B 3 B 179 GLU A 432 GLU~? 22.16 O4 U B 3 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 1r16_01 source 1r16 ADP-RIBOSYL CYCLASE : 4 hits 1r16_01 naa= 2 ULMN 2 1r44_00 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 A 71 ARG A 431 ARG~? 16.75 O4 U B 3 A 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo 29.52 23.28 0.51 26.83 22.05 1.22 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 18.49 20.71 4.77 20.29 21.80 4.49 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1r44_00 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 A 71 ARG A 518 ARG.? 16.31 O6 G B 2 A 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo 29.52 23.28 0.51 26.83 22.05 1.22 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 18.49 20.71 4.77 20.29 21.80 4.49 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1r44_00 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 2 hits 1r44_00 naa= 2 ULMN 2 1r44_01 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 B 71 ARG A 431 ARG~? 16.75 O4 U B 3 B 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo 25.64 17.80 33.30 23.89 16.05 31.49 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 20.92 9.87 25.44 22.46 10.92 26.39 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1r44_01 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 B 71 ARG A 518 ARG.? 16.31 O6 G B 2 B 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo 25.64 17.80 33.30 23.89 16.05 31.49 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 20.92 9.87 25.44 22.46 10.92 26.39 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1r44_01 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 2 hits 1r44_01 naa= 2 ULMN 2 1r44_02 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 C 71 ARG A 431 ARG~? 16.75 O4 U B 3 C 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1r44_02 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 C 71 ARG A 518 ARG.? 16.31 O6 G B 2 C 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 0.79 12.24 58.58 -0.51 13.53 57.59 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1r44_02 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 2 hits 1r44_02 naa= 2 ULMN 2 1r44_03 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 D 71 ARG A 431 ARG~? 16.75 O4 U B 3 D 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 2.99 23.21 78.86 1.22 24.31 78.95 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1r44_03 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 D 71 ARG A 518 ARG.? 16.31 O6 G B 2 D 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 2.99 23.21 78.86 1.22 24.31 78.95 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1r44_03 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 2 hits 1r44_03 naa= 2 ULMN 2 1r44_04 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 E 71 ARG A 431 ARG~? 16.75 O4 U B 3 E 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1r44_04 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 E 71 ARG A 518 ARG.? 16.31 O6 G B 2 E 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo -2.51 13.58 115.60 -2.82 11.62 114.90 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1r44_04 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 2 hits 1r44_04 naa= 2 ULMN 2 1r44_05 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 F 71 ARG A 431 ARG~? 16.75 O4 U B 3 F 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1r44_05 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 F 71 ARG A 518 ARG.? 16.31 O6 G B 2 F 181 GLU A 522 GLU^? 23.38 O4 U B 3 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo -18.48 11.33 132.65 -18.10 9.35 133.28 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1r44_05 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 2 hits 1r44_05 naa= 2 ULMN 2 1r76_00 PECTATE LYASE user 1 2 # 1 A 172 ASN A 325 ASN~? 6.34 O2' C B 5 A 307 ARG A 288 ARG~? 3.45 C6 A B 7 coo 22.99 58.57 18.19 23.89 56.65 18.30 -19.09 -24.77 -2.46 -18.64 -25.98 -0.78 coo 20.34 46.40 20.83 22.83 48.18 20.99 -21.54 -21.02 8.30 -20.02 -23.61 8.96 ULMN 2 1r76_00 PECTATE LYASE user 2 2 # 2 A 172 ASN A 339 ASN~? 21.35 N6 A B 7 A 307 ARG A 311 ARG.? 21.53 N1 A B 7 coo 22.99 58.57 18.19 23.89 56.65 18.30 -36.51 -21.69 -7.31 -38.59 -21.46 -7.03 coo 20.34 46.40 20.83 22.83 48.18 20.99 -28.14 -16.31 -12.56 -31.15 -16.30 -12.01 ULMN 2 1r76_00 PECTATE LYASE user 3 2 # 3 A 172 ASN A 388 ASN~? 30.21 C2 A B 4 A 307 ARG A 396 ARG~? 24.93 C2 A B 4 coo 22.99 58.57 18.19 23.89 56.65 18.30 -41.56 -34.77 -16.36 -41.09 -34.74 -18.44 coo 20.34 46.40 20.83 22.83 48.18 20.99 -31.48 -29.51 -20.52 -33.26 -28.93 -18.10 1r76_00 source 1r76 PECTATE LYASE : 3 hits 1r76_00 naa= 2 ULMN 2 1ra0_00 CYTOSINE DEAMINASE user 1 2 # 1 A 156 GLN A 329 GLN~? 6.26 O2' C B 5 A 217 GLU A 371 GLU~? 9.29 O2 C B 5 coo 0.57 24.33 98.25 1.75 23.60 99.87 -23.26 -28.01 -1.37 -22.04 -29.42 -0.36 coo 5.48 17.66 105.85 5.34 19.71 105.34 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 1ra0_00 source 1ra0 CYTOSINE DEAMINASE : 1 hits 1ra0_00 naa= 2 ULMN 2 1rql_00 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 A 126 THR A 374 THR.? 15.78 N1 A B 4 A 160 ARG A 390 ARG~? 22.44 N1 A B 4 coo 51.19 2.52 10.94 50.16 2.43 9.01 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 coo 51.97 0.60 16.16 51.18 3.08 14.54 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 1rql_00 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 A 126 THR A 543 THR~? 19.49 O4 U B 1 A 160 ARG A 546 ARG~? 20.83 O4 U B 1 coo 51.19 2.52 10.94 50.16 2.43 9.01 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 coo 51.97 0.60 16.16 51.18 3.08 14.54 3.56 -71.20 -7.93 4.10 -73.33 -10.06 1rql_00 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 2 hits 1rql_00 naa= 2 ULMN 2 1rql_01 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 B 126 THR A 374 THR.? 15.78 N1 A B 4 B 160 ARG A 390 ARG~? 22.44 N1 A B 4 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 1rql_01 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 B 126 THR A 543 THR~? 19.49 O4 U B 1 B 160 ARG A 546 ARG~? 20.83 O4 U B 1 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 3.56 -71.20 -7.93 4.10 -73.33 -10.06 1rql_01 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 2 hits 1rql_01 naa= 2 ULMN 2 1rtf_01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 2 # 1 B 195 SER A 175 SER.? 24.03 O2' A B 9 B 196 GLY A 177 GLY.? 19.15 O2' A B 9 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -12.62 -2.84 38.44 -12.61 -4.34 40.34 coo 0.64 25.09 37.94 0.51 25.31 37.16 -11.49 -3.96 33.13 -11.79 -4.69 33.50 ULMN 2 1rtf_01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 2 # 2 B 195 SER A 214 SER.? 18.42 N1 A B 9 B 196 GLY A 213 GLY.? 13.55 N1 A B 9 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -37.68 -15.21 27.51 -38.60 -16.43 29.39 coo 0.64 25.09 37.94 0.51 25.31 37.16 -34.31 -16.88 27.08 -34.50 -16.53 26.36 ULMN 2 1rtf_01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 2 # 3 B 195 SER A 249 SER~? 6.30 N1 A B 9 B 196 GLY A 252 GLY~? 12.46 O4 U B 8 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -30.50 -15.88 16.28 -28.91 -16.54 17.96 coo 0.64 25.09 37.94 0.51 25.31 37.16 -34.81 -16.94 13.94 -34.96 -16.13 14.08 ULMN 2 1rtf_01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 2 # 4 B 195 SER A 254 SER~? 17.72 O4 U B 8 B 196 GLY A 252 GLY~? 12.46 O4 U B 8 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -38.02 -12.50 13.78 -37.98 -10.97 11.92 coo 0.64 25.09 37.94 0.51 25.31 37.16 -34.81 -16.94 13.94 -34.96 -16.13 14.08 ULMN 2 1rtf_01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 2 # 5 B 195 SER A 515 SER~? 19.83 O4 U B 1 B 196 GLY A 516 GLY.? 23.13 O6 G B 2 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -18.72 -69.11 -4.92 -17.74 -67.34 -3.57 coo 0.64 25.09 37.94 0.51 25.31 37.16 -22.27 -67.70 -4.93 -21.68 -67.22 -4.75 ULMN 2 1rtf_01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 2 # 6 B 195 SER A 554 SER~? 4.73 N3 U B 1 B 196 GLY A 555 GLY~? 7.41 O4 U B 1 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -0.46 -57.65 -4.36 0.71 -56.86 -6.34 coo 0.64 25.09 37.94 0.51 25.31 37.16 0.73 -60.94 -5.84 0.48 -60.78 -5.06 1rtf_01 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 6 hits 1rtf_01 naa= 2 ULMN 2 1s2k_00 ALA-ILE-HIS TRIPEPTIDE user 1 2 # 1 A 53 GLN A 387 GLN~? 25.03 N1 A B 4 A 136 GLU A 391 GLU~? 23.54 N1 A B 4 coo 80.69 40.00 16.06 79.05 40.72 17.21 -41.39 -37.99 -10.41 -39.61 -38.54 -9.35 coo 71.34 40.73 18.57 73.36 41.35 18.80 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1s2k_00 ALA-ILE-HIS TRIPEPTIDE user 2 2 # 2 A 53 GLN A 406 GLN~? 15.85 O2 U B 3 A 136 GLU A 449 GLU.? 11.55 O2 U B 3 coo 80.69 40.00 16.06 79.05 40.72 17.21 -10.49 -40.11 -21.29 -8.73 -39.50 -22.31 coo 71.34 40.73 18.57 73.36 41.35 18.80 -4.18 -43.09 -16.19 -4.52 -41.22 -17.09 ULMN 2 1s2k_00 ALA-ILE-HIS TRIPEPTIDE user 3 2 # 3 A 53 GLN A 419 GLN~? 2.92 O4 U B 3 A 136 GLU A 457 GLU~? 3.32 N1 G B 2 coo 80.69 40.00 16.06 79.05 40.72 17.21 -14.90 -43.65 -8.87 -13.68 -43.76 -7.12 coo 71.34 40.73 18.57 73.36 41.35 18.80 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 1s2k_00 source 1s2k ALA-ILE-HIS TRIPEPTIDE : 3 hits 1s2k_00 naa= 2 ULMN 2 1snz_00 ALDOSE 1-EPIMERASE user 1 2 # 1 A 176 HIS A 420 HIS~? 9.42 N1 A B 4 A 307 GLU A 371 GLU~? 9.29 O2 C B 5 coo -11.45 7.93 45.89 -12.23 7.21 44.11 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1snz_00 ALDOSE 1-EPIMERASE user 2 2 # 2 A 176 HIS A 454 HIS~? 3.31 C5 U B 3 A 307 GLU A 457 GLU~? 3.32 N1 G B 2 coo -11.45 7.93 45.89 -12.23 7.21 44.11 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 1snz_00 source 1snz ALDOSE 1-EPIMERASE : 2 hits 1snz_00 naa= 2 ULMN 2 1snz_01 ALDOSE 1-EPIMERASE user 1 2 # 1 B 176 HIS A 420 HIS~? 9.42 N1 A B 4 B 307 GLU A 371 GLU~? 9.29 O2 C B 5 coo 24.63 93.76 22.10 25.63 93.50 23.91 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 26.56 90.05 20.00 27.80 91.02 21.36 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 1snz_01 ALDOSE 1-EPIMERASE user 2 2 # 2 B 176 HIS A 454 HIS~? 3.31 C5 U B 3 B 307 GLU A 457 GLU~? 3.32 N1 G B 2 coo 24.63 93.76 22.10 25.63 93.50 23.91 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 26.56 90.05 20.00 27.80 91.02 21.36 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 1snz_01 source 1snz ALDOSE 1-EPIMERASE : 2 hits 1snz_01 naa= 2 ULMN 2 1sox_00 SULFITE OXIDASE user 1 2 # 1 A 138 ARG A 288 ARG~? 3.45 C6 A B 7 A 322 TYR A 245 TYR~? 3.47 C5 A B 9 coo 29.11 98.43 27.28 31.52 97.24 28.79 -21.54 -21.02 8.30 -20.02 -23.61 8.96 coo 28.34 90.08 25.08 29.22 92.59 25.94 -22.48 -17.46 16.07 -20.67 -19.47 15.36 1sox_00 source 1sox SULFITE OXIDASE : 1 hits 1sox_00 naa= 2 ULMN 2 1sox_01 SULFITE OXIDASE user 1 2 # 1 B 138 ARG A 288 ARG~? 3.45 C6 A B 7 B 322 TYR A 245 TYR~? 3.47 C5 A B 9 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -21.54 -21.02 8.30 -20.02 -23.61 8.96 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -22.48 -17.46 16.07 -20.67 -19.47 15.36 1sox_01 source 1sox SULFITE OXIDASE : 1 hits 1sox_01 naa= 2 ULMN 2 1stc_00 CAMP-DEPENDENT PROTEIN KINASE user 1 2 # 1 E 166 ASP A 259 ASP.? 23.89 N1 A B 9 E 170 GLU A 225 GLU~? 23.05 C2 A B 9 coo 5.36 16.20 22.10 3.88 17.00 23.31 -46.22 -8.67 16.01 -44.22 -8.07 15.57 coo 2.36 26.80 21.76 1.58 25.84 20.04 -36.18 -1.53 15.48 -36.93 -1.10 13.54 ULMN 2 1stc_00 CAMP-DEPENDENT PROTEIN KINASE user 2 2 # 2 E 166 ASP A 298 ASP~? 21.17 O4 U B 8 E 170 GLU A 267 GLU~? 24.62 O4 U B 8 coo 5.36 16.20 22.10 3.88 17.00 23.31 -41.82 -17.47 4.14 -42.95 -17.27 5.91 coo 2.36 26.80 21.76 1.58 25.84 20.04 -40.06 -6.47 1.67 -40.21 -7.73 -0.02 ULMN 2 1stc_00 CAMP-DEPENDENT PROTEIN KINASE user 3 2 # 3 E 166 ASP A 425 ASP.? 18.06 O4 U B 3 E 170 GLU A 432 GLU~? 22.16 O4 U B 3 coo 5.36 16.20 22.10 3.88 17.00 23.31 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 2.36 26.80 21.76 1.58 25.84 20.04 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 1stc_00 CAMP-DEPENDENT PROTEIN KINASE user 4 2 # 4 E 166 ASP A 425 ASP.? 18.06 O4 U B 3 E 170 GLU A 522 GLU^? 23.38 O4 U B 3 coo 5.36 16.20 22.10 3.88 17.00 23.31 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 2.36 26.80 21.76 1.58 25.84 20.04 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1stc_00 CAMP-DEPENDENT PROTEIN KINASE user 5 2 # 5 E 166 ASP A 473 ASP~? 22.60 N2 G B 2 E 170 GLU A 466 GLU~? 26.72 N2 G B 2 coo 5.36 16.20 22.10 3.88 17.00 23.31 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 2.36 26.80 21.76 1.58 25.84 20.04 -23.82 -57.38 -23.46 -25.51 -56.95 -24.67 ULMN 2 1stc_00 CAMP-DEPENDENT PROTEIN KINASE user 6 2 # 6 E 166 ASP A 488 ASP~? 18.76 O2 U B 1 E 170 GLU A 545 GLU~? 17.12 N3 U B 1 coo 5.36 16.20 22.10 3.88 17.00 23.31 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 2.36 26.80 21.76 1.58 25.84 20.04 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1stc_00 CAMP-DEPENDENT PROTEIN KINASE user 7 2 # 7 E 166 ASP A 526 ASP^? 28.45 O6 G B 2 E 170 GLU A 522 GLU^? 23.38 O4 U B 3 coo 5.36 16.20 22.10 3.88 17.00 23.31 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo 2.36 26.80 21.76 1.58 25.84 20.04 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1stc_00 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 7 hits 1stc_00 naa= 2 ULMN 2 1stc_01 CAMP-DEPENDENT PROTEIN KINASE user 1 2 # 1 E 166 ASP A 193 ASP~? 20.25 C2 A B 9 E 168 LYS A 196 LYS~? 19.45 O2' A B 9 coo 5.36 16.20 22.10 3.88 17.00 23.31 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 5.06 22.32 18.11 1.02 22.08 22.74 -19.67 -3.42 20.50 -17.88 1.90 20.43 ULMN 2 1stc_01 CAMP-DEPENDENT PROTEIN KINASE user 2 2 # 2 E 166 ASP A 233 ASP~? 18.81 O2 U B 8 E 168 LYS A 236 LYS~? 15.40 O2 U B 8 coo 5.36 16.20 22.10 3.88 17.00 23.31 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 5.06 22.32 18.11 1.02 22.08 22.74 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 1stc_01 CAMP-DEPENDENT PROTEIN KINASE user 3 2 # 3 E 166 ASP A 260 ASP.? 30.95 O4 U B 8 E 168 LYS A 264 LYS~? 27.36 N1 A B 9 coo 5.36 16.20 22.10 3.88 17.00 23.31 -48.66 -5.55 12.81 -49.71 -4.82 11.14 coo 5.06 22.32 18.11 1.02 22.08 22.74 -41.84 -5.84 6.59 -43.28 -1.98 11.47 ULMN 2 1stc_01 CAMP-DEPENDENT PROTEIN KINASE user 4 2 # 4 E 166 ASP A 533 ASP~? 24.95 O4 U B 1 E 168 LYS A 537 LYS~? 23.79 O4 U B 1 coo 5.36 16.20 22.10 3.88 17.00 23.31 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 5.06 22.32 18.11 1.02 22.08 22.74 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 1stc_01 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 4 hits 1stc_01 naa= 2 ULMN 2 1t0u_00 URIDINE PHOSPHORYLASE user 1 2 # 1 A 8 HIS A 454 HIS~? 3.31 C5 U B 3 A 80 GLU A 457 GLU~? 3.32 N1 G B 2 coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 1t0u_00 source 1t0u URIDINE PHOSPHORYLASE : 1 hits 1t0u_00 naa= 2 ULMN 2 1tdj_00 BIOSYNTHETIC THREONINE DEAMINASE user 1 2 # 1 62 LYS A 231 LYS~? 21.79 O2 U B 8 288 SER A 274 SER~? 19.09 N1 A B 7 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -28.35 -2.55 6.15 -27.54 -2.37 -0.06 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -30.19 -9.75 -2.18 -32.45 -10.61 -2.45 1tdj_00 source 1tdj BIOSYNTHETIC THREONINE DEAMINASE : 1 hits 1tdj_00 naa= 2 ULMN 2 1tdj_02 BIOSYNTHETIC THREONINE DEAMINASE user 1 2 # 1 62 LYS A 220 LYS~? 19.55 N1 A B 9 315 SER A 214 SER.? 18.42 N1 A B 9 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -37.45 -8.35 20.48 -41.74 -12.81 21.44 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -37.68 -15.21 27.51 -38.60 -16.43 29.39 ULMN 2 1tdj_02 BIOSYNTHETIC THREONINE DEAMINASE user 2 2 # 2 62 LYS A 304 LYS~? 25.42 N1 A B 7 315 SER A 300 SER~? 23.48 N6 A B 7 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -41.38 -17.70 -1.13 -43.08 -16.44 0.06 ULMN 2 1tdj_02 BIOSYNTHETIC THREONINE DEAMINASE user 3 2 # 3 62 LYS A 330 LYS~? 6.92 N6 A B 7 315 SER A 292 SER~? 7.16 O4 U B 8 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -28.12 -25.40 0.86 -29.08 -26.03 5.63 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -29.52 -19.91 7.81 -29.73 -19.17 10.12 1tdj_02 source 1tdj BIOSYNTHETIC THREONINE DEAMINASE : 3 hits 1tdj_02 naa= 2 ULMN 2 1teh_00 HUMAN CHICHI ALCOHOL DEHYDROGENASE user 1 2 # 1 A 47 HIS A 527 HIS~? 25.85 N2 G B 2 A 48 THR A 520 THR.? 24.39 O6 G B 2 coo 19.48 46.71 6.01 18.00 45.25 6.29 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 18.23 48.52 1.91 16.89 50.17 1.48 -24.42 -64.64 -12.07 -23.58 -66.57 -11.57 1teh_00 source 1teh HUMAN CHICHI ALCOHOL DEHYDROGENASE : 1 hits 1teh_00 naa= 2 ULMN 2 1teh_01 HUMAN CHICHI ALCOHOL DEHYDROGENASE user 1 2 # 1 B 47 HIS A 527 HIS~? 25.85 N2 G B 2 B 48 THR A 520 THR.? 24.39 O6 G B 2 coo 20.93 8.91 26.51 19.58 7.34 26.17 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 23.42 10.24 22.80 22.81 11.85 21.53 -24.42 -64.64 -12.07 -23.58 -66.57 -11.57 1teh_01 source 1teh HUMAN CHICHI ALCOHOL DEHYDROGENASE : 1 hits 1teh_01 naa= 2 ULMN 2 1tht_00 THIOESTERASE user 1 2 # 1 A 114 SER A 453 SER~? 2.96 N2 G B 2 A 241 HIS A 454 HIS~? 3.31 C5 U B 3 coo 16.60 41.02 19.48 18.96 41.23 20.11 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 coo 21.64 42.49 16.30 20.20 41.39 17.28 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1tht_00 source 1tht THIOESTERASE : 1 hits 1tht_00 naa= 2 ULMN 2 1tht_01 THIOESTERASE user 1 2 # 1 B 114 SER A 453 SER~? 2.96 N2 G B 2 B 241 HIS A 454 HIS~? 3.31 C5 U B 3 coo 22.54 -2.32 19.28 20.22 -2.50 20.19 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 coo 17.49 -3.87 16.17 18.95 -2.77 17.03 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1tht_01 source 1tht THIOESTERASE : 1 hits 1tht_01 naa= 2 ULMN 2 1tml_01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 1 2 # 1 117 ASP A 193 ASP~? 20.25 C2 A B 9 265 ASP A 233 ASP~? 18.81 O2 U B 8 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 1tml_01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 2 2 # 2 117 ASP A 233 ASP~? 18.81 O2 U B 8 265 ASP A 193 ASP~? 20.25 C2 A B 9 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -22.85 0.02 23.71 -22.18 1.98 24.08 ULMN 2 1tml_01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 3 2 # 3 117 ASP A 279 ASP~? 17.12 C2 A B 7 265 ASP A 321 ASP~? 8.41 N3 A B 7 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1tml_01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 4 2 # 4 117 ASP A 321 ASP~? 8.41 N3 A B 7 265 ASP A 279 ASP~? 17.12 C2 A B 7 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 1tml_01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 5 2 # 5 117 ASP A 376 ASP~? 17.17 N1 A B 4 265 ASP A 381 ASP.? 22.82 N6 A B 7 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 ULMN 2 1tml_01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 6 2 # 6 117 ASP A 381 ASP.? 22.82 N6 A B 7 265 ASP A 376 ASP~? 17.17 N1 A B 4 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 1tml_01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 7 2 # 7 117 ASP A 477 ASP~? 24.62 N2 G B 2 265 ASP A 533 ASP~? 24.95 O4 U B 1 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1tml_01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 8 2 # 8 117 ASP A 533 ASP~? 24.95 O4 U B 1 265 ASP A 477 ASP~? 24.62 N2 G B 2 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 1tml_01 source 1tml ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1.4) : 8 hits 1tml_01 naa= 2 ULMN 2 1trk_04 TRANSKETOLASE (E.C.2.2.1.1) user 1 2 # 1 A 418 GLU A 457 GLU~? 3.32 N1 G B 2 A 481 HIS A 462 HIS~? 12.61 O4 U B 3 coo 14.10 66.39 26.65 14.11 68.21 25.54 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 14.95 77.09 31.69 15.34 77.40 29.70 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1trk_04 TRANSKETOLASE (E.C.2.2.1.1) user 2 2 # 2 A 418 GLU A 470 GLU~? 22.82 N2 G B 2 A 481 HIS A 527 HIS~? 25.85 N2 G B 2 coo 14.10 66.39 26.65 14.11 68.21 25.54 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 14.95 77.09 31.69 15.34 77.40 29.70 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 1trk_04 source 1trk TRANSKETOLASE (E.C.2.2.1.1) : 2 hits 1trk_04 naa= 2 ULMN 2 1trk_05 TRANSKETOLASE (E.C.2.2.1.1) user 1 2 # 1 B 418 GLU A 457 GLU~? 3.32 N1 G B 2 B 481 HIS A 462 HIS~? 12.61 O4 U B 3 coo -2.49 65.64 20.85 -1.68 63.95 19.85 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo -6.49 54.97 24.37 -5.59 54.90 22.55 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 ULMN 2 1trk_05 TRANSKETOLASE (E.C.2.2.1.1) user 2 2 # 2 B 418 GLU A 470 GLU~? 22.82 N2 G B 2 B 481 HIS A 527 HIS~? 25.85 N2 G B 2 coo -2.49 65.64 20.85 -1.68 63.95 19.85 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo -6.49 54.97 24.37 -5.59 54.90 22.55 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 1trk_05 source 1trk TRANSKETOLASE (E.C.2.2.1.1) : 2 hits 1trk_05 naa= 2 ULMN 2 1uas_00 ALPHA-GALACTOSIDASE user 1 2 # 1 A 130 ASP A 473 ASP~? 22.60 N2 G B 2 A 185 ASP A 533 ASP~? 24.95 O4 U B 1 coo 8.81 3.41 29.07 10.49 4.61 29.53 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 17.44 9.63 28.94 15.61 8.68 29.31 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1uas_00 ALPHA-GALACTOSIDASE user 2 2 # 2 A 130 ASP A 533 ASP~? 24.95 O4 U B 1 A 185 ASP A 473 ASP~? 22.60 N2 G B 2 coo 8.81 3.41 29.07 10.49 4.61 29.53 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 17.44 9.63 28.94 15.61 8.68 29.31 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1uas_00 source 1uas ALPHA-GALACTOSIDASE : 2 hits 1uas_00 naa= 2 ULMN 2 1uok_01 OLIGO-1,6-GLUCOSIDASE user 1 2 # 1 199 ASP A 174 ASP.? 19.36 O2' A B 9 255 GLU A 178 GLU.? 16.07 O2' A B 9 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 52.57 37.12 10.17 53.37 35.95 11.75 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1uok_01 OLIGO-1,6-GLUCOSIDASE user 2 2 # 2 199 ASP A 345 ASP~? 24.06 C2 A B 4 255 GLU A 341 GLU~? 25.67 N6 A B 7 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 52.57 37.12 10.17 53.37 35.95 11.75 -34.04 -26.28 -14.50 -35.82 -26.43 -15.65 ULMN 2 1uok_01 OLIGO-1,6-GLUCOSIDASE user 3 2 # 3 199 ASP A 491 ASP~? 15.62 O2 U B 1 255 GLU A 545 GLU~? 17.12 N3 U B 1 coo 49.16 35.16 15.19 51.08 34.43 15.65 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 52.57 37.12 10.17 53.37 35.95 11.75 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1uok_01 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_01 naa= 2 ULMN 2 1uox_00 URATE OXIDASE user 1 2 # 1 28 THR A 349 THR~? 23.30 O2' A B 4 76 PRO A 310 PRO.? 17.14 C2 A B 7 coo 16.78 65.34 48.92 15.62 64.41 47.34 -22.17 -25.42 -19.90 -22.55 -23.33 -20.27 coo 23.62 58.48 37.29 23.51 60.61 36.65 -23.35 -14.77 -8.44 -25.36 -14.30 -9.30 ULMN 2 1uox_00 URATE OXIDASE user 2 2 # 2 28 THR A 368 THR~? 9.37 O2' C B 5 76 PRO A 336 PRO~? 19.21 N6 A B 7 coo 16.78 65.34 48.92 15.62 64.41 47.34 -24.90 -32.82 -4.53 -24.89 -31.65 -2.74 coo 23.62 58.48 37.29 23.51 60.61 36.65 -39.34 -25.39 -4.08 -37.30 -26.16 -4.65 1uox_00 source 1uox URATE OXIDASE : 2 hits 1uox_00 naa= 2 ULMN 2 1uqt_00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 1 2 # 1 A 154 HIS A 462 HIS~? 12.61 O4 U B 3 A 361 ASP A 426 ASP.? 18.90 N1 A B 4 coo 38.53 29.77 11.27 37.61 30.69 9.62 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 36.69 27.02 21.98 35.77 25.65 20.58 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 ULMN 2 1uqt_00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 2 2 # 2 A 154 HIS A 496 HIS.? 9.17 O2 U B 1 A 361 ASP A 491 ASP~? 15.62 O2 U B 1 coo 38.53 29.77 11.27 37.61 30.69 9.62 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 36.69 27.02 21.98 35.77 25.65 20.58 2.02 -59.32 -18.53 4.01 -59.49 -17.81 ULMN 2 1uqt_00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 3 2 # 3 A 154 HIS A 527 HIS~? 25.85 N2 G B 2 A 361 ASP A 473 ASP~? 22.60 N2 G B 2 coo 38.53 29.77 11.27 37.61 30.69 9.62 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 36.69 27.02 21.98 35.77 25.65 20.58 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1uqt_00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 4 2 # 4 A 154 HIS A 527 HIS~? 25.85 N2 G B 2 A 361 ASP A 533 ASP~? 24.95 O4 U B 1 coo 38.53 29.77 11.27 37.61 30.69 9.62 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 36.69 27.02 21.98 35.77 25.65 20.58 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1uqt_00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 5 2 # 5 A 154 HIS A 539 HIS~? 18.96 O4 U B 1 A 361 ASP A 533 ASP~? 24.95 O4 U B 1 coo 38.53 29.77 11.27 37.61 30.69 9.62 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 coo 36.69 27.02 21.98 35.77 25.65 20.58 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1uqt_00 source 1uqt ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE : 5 hits 1uqt_00 naa= 2 ULMN 2 1uqt_01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 1 2 # 1 B 154 HIS A 462 HIS~? 12.61 O4 U B 3 B 361 ASP A 426 ASP.? 18.90 N1 A B 4 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -21.10 -50.90 -9.49 -20.96 -50.71 -7.41 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 ULMN 2 1uqt_01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 2 2 # 2 B 154 HIS A 496 HIS.? 9.17 O2 U B 1 B 361 ASP A 491 ASP~? 15.62 O2 U B 1 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 2.02 -59.32 -18.53 4.01 -59.49 -17.81 ULMN 2 1uqt_01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 3 2 # 3 B 154 HIS A 527 HIS~? 25.85 N2 G B 2 B 361 ASP A 473 ASP~? 22.60 N2 G B 2 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 1uqt_01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 4 2 # 4 B 154 HIS A 527 HIS~? 25.85 N2 G B 2 B 361 ASP A 533 ASP~? 24.95 O4 U B 1 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1uqt_01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 5 2 # 5 B 154 HIS A 539 HIS~? 18.96 O4 U B 1 B 361 ASP A 533 ASP~? 24.95 O4 U B 1 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1uqt_01 source 1uqt ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE : 5 hits 1uqt_01 naa= 2 ULMN 2 1uro_00 UROPORPHYRINOGEN DECARBOXYLASE user 1 2 # 1 A 86 ASP A 190 ASP~? 22.39 C2 A B 9 A 164 TYR A 218 TYR~? 23.65 C2 A B 9 coo 9.32 71.14 66.67 9.35 73.22 66.22 -31.44 0.79 27.21 -33.43 0.08 27.41 coo 10.68 80.16 70.30 11.55 80.13 67.63 -39.15 -2.15 23.93 -37.86 0.21 23.20 1uro_00 source 1uro UROPORPHYRINOGEN DECARBOXYLASE : 1 hits 1uro_00 naa= 2 ULMN 2 1uw8_02 OXALATE DECARBOXYLASE OXDC user 1 2 # 1 A 92 ARG A 354 ARG~? 17.55 O2' A B 4 A 162 GLU A 351 GLU~? 20.29 O2' A B 4 coo 22.28 19.87 14.60 19.43 20.27 13.40 -11.78 -26.96 -19.41 -10.39 -24.67 -17.92 coo 20.49 15.91 11.17 19.72 15.53 13.15 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 1uw8_02 OXALATE DECARBOXYLASE OXDC user 2 2 # 2 A 92 ARG A 390 ARG~? 22.44 N1 A B 4 A 162 GLU A 391 GLU~? 23.54 N1 A B 4 coo 22.28 19.87 14.60 19.43 20.27 13.40 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 coo 20.49 15.91 11.17 19.72 15.53 13.15 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1uw8_02 OXALATE DECARBOXYLASE OXDC user 3 2 # 3 A 92 ARG A 404 ARG~? 18.97 O2 U B 3 A 162 GLU A 407 GLU~? 15.45 O2 U B 3 coo 22.28 19.87 14.60 19.43 20.27 13.40 -16.37 -30.85 -20.00 -14.07 -29.56 -21.58 coo 20.49 15.91 11.17 19.72 15.53 13.15 -11.40 -33.06 -18.15 -12.16 -31.21 -18.90 ULMN 2 1uw8_02 OXALATE DECARBOXYLASE OXDC user 4 2 # 4 A 92 ARG A 541 ARG~? 18.28 O4 U B 1 A 162 GLU A 545 GLU~? 17.12 N3 U B 1 coo 22.28 19.87 14.60 19.43 20.27 13.40 -0.36 -64.62 -16.58 -0.85 -63.19 -19.27 coo 20.49 15.91 11.17 19.72 15.53 13.15 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1uw8_02 OXALATE DECARBOXYLASE OXDC user 5 2 # 5 A 92 ARG A 548 ARG~? 15.11 O2 U B 1 A 162 GLU A 545 GLU~? 17.12 N3 U B 1 coo 22.28 19.87 14.60 19.43 20.27 13.40 7.33 -63.34 -13.62 6.31 -60.85 -15.12 coo 20.49 15.91 11.17 19.72 15.53 13.15 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1uw8_02 source 1uw8 OXALATE DECARBOXYLASE OXDC : 5 hits 1uw8_02 naa= 2 ULMN 2 1vid_00 CATECHOL O-METHYLTRANSFERASE user 1 2 # 1 144 LYS A 557 LYS~? 2.76 O4 U B 1 199 GLU A 457 GLU~? 3.32 N1 G B 2 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 1vid_00 source 1vid CATECHOL O-METHYLTRANSFERASE : 1 hits 1vid_00 naa= 2 ULMN 2 1vlb_01 ALDEHYDE OXIDOREDUCTASE user 1 2 # 1 A 501 ARG A 182 ARG.? 25.57 C2 A B 9 A 869 GLU A 187 GLU~? 20.71 C2 A B 9 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -27.13 -7.51 39.69 -28.96 -5.65 41.28 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -28.60 -2.71 32.18 -27.08 -3.13 33.60 ULMN 2 1vlb_01 ALDEHYDE OXIDOREDUCTASE user 2 2 # 2 A 501 ARG A 431 ARG~? 16.75 O4 U B 3 A 869 GLU A 522 GLU^? 23.38 O4 U B 3 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 1vlb_01 ALDEHYDE OXIDOREDUCTASE user 3 2 # 3 A 501 ARG A 441 ARG.? 21.93 N2 G B 2 A 869 GLU A 470 GLU~? 22.82 N2 G B 2 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 ULMN 2 1vlb_01 ALDEHYDE OXIDOREDUCTASE user 4 2 # 4 A 501 ARG A 441 ARG.? 21.93 N2 G B 2 A 869 GLU A 474 GLU~? 16.68 N2 G B 2 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -13.03 -49.34 -28.80 -15.83 -48.47 -27.84 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -10.18 -53.98 -23.61 -11.07 -52.06 -23.42 ULMN 2 1vlb_01 ALDEHYDE OXIDOREDUCTASE user 5 2 # 5 A 501 ARG A 518 ARG.? 16.31 O6 G B 2 A 869 GLU A 522 GLU^? 23.38 O4 U B 3 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -20.42 -61.04 -9.32 -20.17 -58.09 -10.11 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 1vlb_01 source 1vlb ALDEHYDE OXIDOREDUCTASE : 5 hits 1vlb_01 naa= 2 ULMN 2 1vq1_02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 2 # 1 A 151 ASP A 233 ASP~? 18.81 O2 U B 8 A 197 ASN A 240 ASN.? 9.01 O2 U B 8 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -18.56 -9.78 12.83 -17.16 -9.65 14.42 ULMN 2 1vq1_02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 2 # 2 A 151 ASP A 512 ASP~? 14.88 O6 G B 2 A 197 ASN A 564 ASN~? 16.11 O4 U B 1 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -9.37 -67.93 0.09 -10.86 -67.67 1.59 1vq1_02 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_02 naa= 2 ULMN 2 1vq1_03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 2 # 1 B 151 ASP A 233 ASP~? 18.81 O2 U B 8 B 197 ASN A 240 ASN.? 9.01 O2 U B 8 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -18.56 -9.78 12.83 -17.16 -9.65 14.42 ULMN 2 1vq1_03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 2 # 2 B 151 ASP A 512 ASP~? 14.88 O6 G B 2 B 197 ASN A 564 ASN~? 16.11 O4 U B 1 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -9.37 -67.93 0.09 -10.86 -67.67 1.59 1vq1_03 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_03 naa= 2 ULMN 2 1w0h_00 3-5 EXONUCLEASE ERI1 user 1 2 # 1 A 136 GLU A 457 GLU~? 3.32 N1 G B 2 A 293 HIS A 454 HIS~? 3.31 C5 U B 3 coo 9.79 77.23 39.90 9.95 75.15 39.48 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 coo 8.49 71.12 42.20 8.38 69.13 41.54 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 1w0h_00 source 1w0h 3-5 EXONUCLEASE ERI1 : 1 hits 1w0h_00 naa= 2 ULMN 2 1wnw_00 HEME OXYGENASE user 1 2 # 1 A 136 ASN A 240 ASN.? 9.01 O2 U B 8 A 140 GLY A 243 GLY~? 7.99 O2 U B 8 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -18.56 -9.78 12.83 -17.16 -9.65 14.42 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -21.59 -11.19 15.11 -21.41 -11.91 14.82 ULMN 2 1wnw_00 HEME OXYGENASE user 2 2 # 2 A 136 ASN A 244 ASN~? 2.92 O2 U B 8 A 140 GLY A 243 GLY~? 7.99 O2 U B 8 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -22.00 -14.42 11.48 -21.14 -16.18 12.31 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -21.59 -11.19 15.11 -21.41 -11.91 14.82 ULMN 2 1wnw_00 HEME OXYGENASE user 3 2 # 3 A 136 ASN A 296 ASN~? 11.04 O4 U B 8 A 140 GLY A 252 GLY~? 12.46 O4 U B 8 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -34.93 -19.92 9.17 -33.77 -21.43 10.15 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -34.81 -16.94 13.94 -34.96 -16.13 14.08 ULMN 2 1wnw_00 HEME OXYGENASE user 4 2 # 4 A 136 ASN A 500 ASN~? 3.20 O2 U B 1 A 140 GLY A 499 GLY~? 6.97 N2 G B 2 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -1.24 -54.54 -8.88 -1.32 -53.21 -7.22 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 1wnw_00 source 1wnw HEME OXYGENASE : 4 hits 1wnw_00 naa= 2 ULMN 2 1wnw_01 HEME OXYGENASE user 1 2 # 1 B 136 ASN A 240 ASN.? 9.01 O2 U B 8 B 140 GLY A 243 GLY~? 7.99 O2 U B 8 coo 10.41 13.55 22.30 12.49 13.88 22.44 -18.56 -9.78 12.83 -17.16 -9.65 14.42 coo 12.77 16.12 18.53 12.82 15.99 17.73 -21.59 -11.19 15.11 -21.41 -11.91 14.82 ULMN 2 1wnw_01 HEME OXYGENASE user 2 2 # 2 B 136 ASN A 244 ASN~? 2.92 O2 U B 8 B 140 GLY A 243 GLY~? 7.99 O2 U B 8 coo 10.41 13.55 22.30 12.49 13.88 22.44 -22.00 -14.42 11.48 -21.14 -16.18 12.31 coo 12.77 16.12 18.53 12.82 15.99 17.73 -21.59 -11.19 15.11 -21.41 -11.91 14.82 ULMN 2 1wnw_01 HEME OXYGENASE user 3 2 # 3 B 136 ASN A 296 ASN~? 11.04 O4 U B 8 B 140 GLY A 252 GLY~? 12.46 O4 U B 8 coo 10.41 13.55 22.30 12.49 13.88 22.44 -34.93 -19.92 9.17 -33.77 -21.43 10.15 coo 12.77 16.12 18.53 12.82 15.99 17.73 -34.81 -16.94 13.94 -34.96 -16.13 14.08 ULMN 2 1wnw_01 HEME OXYGENASE user 4 2 # 4 B 136 ASN A 500 ASN~? 3.20 O2 U B 1 B 140 GLY A 499 GLY~? 6.97 N2 G B 2 coo 10.41 13.55 22.30 12.49 13.88 22.44 -1.24 -54.54 -8.88 -1.32 -53.21 -7.22 coo 12.77 16.12 18.53 12.82 15.99 17.73 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 1wnw_01 source 1wnw HEME OXYGENASE : 4 hits 1wnw_01 naa= 2 ULMN 2 1wnw_02 HEME OXYGENASE user 1 2 # 1 C 136 ASN A 240 ASN.? 9.01 O2 U B 8 C 140 GLY A 243 GLY~? 7.99 O2 U B 8 coo 26.63 1.54 53.35 24.49 1.91 53.34 -18.56 -9.78 12.83 -17.16 -9.65 14.42 coo 23.86 0.66 57.49 23.81 0.02 58.00 -21.59 -11.19 15.11 -21.41 -11.91 14.82 ULMN 2 1wnw_02 HEME OXYGENASE user 2 2 # 2 C 136 ASN A 244 ASN~? 2.92 O2 U B 8 C 140 GLY A 243 GLY~? 7.99 O2 U B 8 coo 26.63 1.54 53.35 24.49 1.91 53.34 -22.00 -14.42 11.48 -21.14 -16.18 12.31 coo 23.86 0.66 57.49 23.81 0.02 58.00 -21.59 -11.19 15.11 -21.41 -11.91 14.82 ULMN 2 1wnw_02 HEME OXYGENASE user 3 2 # 3 C 136 ASN A 296 ASN~? 11.04 O4 U B 8 C 140 GLY A 252 GLY~? 12.46 O4 U B 8 coo 26.63 1.54 53.35 24.49 1.91 53.34 -34.93 -19.92 9.17 -33.77 -21.43 10.15 coo 23.86 0.66 57.49 23.81 0.02 58.00 -34.81 -16.94 13.94 -34.96 -16.13 14.08 ULMN 2 1wnw_02 HEME OXYGENASE user 4 2 # 4 C 136 ASN A 500 ASN~? 3.20 O2 U B 1 C 140 GLY A 499 GLY~? 6.97 N2 G B 2 coo 26.63 1.54 53.35 24.49 1.91 53.34 -1.24 -54.54 -8.88 -1.32 -53.21 -7.22 coo 23.86 0.66 57.49 23.81 0.02 58.00 -3.03 -51.55 -12.35 -2.79 -51.66 -11.57 1wnw_02 source 1wnw HEME OXYGENASE : 4 hits 1wnw_02 naa= 2 ULMN 2 1x7d_00 ORNITHINE CYCLODEAMINASE user 1 2 # 1 A 56 GLU A 545 GLU~? 17.12 N3 U B 1 A 228 ASP A 491 ASP~? 15.62 O2 U B 1 coo 27.49 35.40 20.60 28.62 36.02 22.28 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 33.88 38.22 25.20 34.46 38.14 23.17 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1x7d_00 source 1x7d ORNITHINE CYCLODEAMINASE : 1 hits 1x7d_00 naa= 2 ULMN 2 1x7d_01 ORNITHINE CYCLODEAMINASE user 1 2 # 1 B 56 GLU A 545 GLU~? 17.12 N3 U B 1 B 228 ASP A 491 ASP~? 15.62 O2 U B 1 coo 8.97 35.22 21.27 7.95 33.38 21.10 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 2.71 29.91 19.58 2.03 31.89 19.36 2.02 -59.32 -18.53 4.01 -59.49 -17.81 1x7d_01 source 1x7d ORNITHINE CYCLODEAMINASE : 1 hits 1x7d_01 naa= 2 ULMN 2 1xgm_00 METHIONINE AMINOPEPTIDASE user 1 2 # 1 A 165 SER A 172 SER~? 16.88 O2' A B 9 A 187 GLU A 178 GLU.? 16.07 O2' A B 9 coo 8.34 44.73 23.71 9.07 45.54 21.52 -20.21 -2.49 31.33 -19.35 -3.14 29.13 coo 6.50 51.89 29.29 8.22 51.77 30.59 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1xgm_00 METHIONINE AMINOPEPTIDASE user 2 2 # 2 A 165 SER A 254 SER~? 17.72 O4 U B 8 A 187 GLU A 225 GLU~? 23.05 C2 A B 9 coo 8.34 44.73 23.71 9.07 45.54 21.52 -38.02 -12.50 13.78 -37.98 -10.97 11.92 coo 6.50 51.89 29.29 8.22 51.77 30.59 -36.18 -1.53 15.48 -36.93 -1.10 13.54 ULMN 2 1xgm_00 METHIONINE AMINOPEPTIDASE user 3 2 # 3 A 165 SER A 384 SER~? 33.14 N1 A B 4 A 187 GLU A 391 GLU~? 23.54 N1 A B 4 coo 8.34 44.73 23.71 9.07 45.54 21.52 -45.44 -36.79 -12.14 -47.15 -38.50 -12.39 coo 6.50 51.89 29.29 8.22 51.77 30.59 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1xgm_00 METHIONINE AMINOPEPTIDASE user 4 2 # 4 A 165 SER A 540 SER~? 21.72 O4 U B 1 A 187 GLU A 545 GLU~? 17.12 N3 U B 1 coo 8.34 44.73 23.71 9.07 45.54 21.52 -3.65 -70.26 -15.04 -4.94 -71.68 -16.53 coo 6.50 51.89 29.29 8.22 51.77 30.59 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1xgm_00 METHIONINE AMINOPEPTIDASE user 5 2 # 5 A 165 SER A 550 SER~? 14.27 O4 U B 1 A 187 GLU A 545 GLU~? 17.12 N3 U B 1 coo 8.34 44.73 23.71 9.07 45.54 21.52 4.96 -63.97 -4.54 6.61 -65.75 -4.82 coo 6.50 51.89 29.29 8.22 51.77 30.59 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1xgm_00 source 1xgm METHIONINE AMINOPEPTIDASE : 5 hits 1xgm_00 naa= 2 ULMN 2 1xgm_01 METHIONINE AMINOPEPTIDASE user 1 2 # 1 B 165 SER A 172 SER~? 16.88 O2' A B 9 B 187 GLU A 178 GLU.? 16.07 O2' A B 9 coo 12.53 42.28 15.16 11.35 44.10 16.30 -20.21 -2.49 31.33 -19.35 -3.14 29.13 coo 12.85 44.05 6.07 11.44 42.52 5.44 -13.75 -9.60 33.46 -13.25 -11.02 34.94 ULMN 2 1xgm_01 METHIONINE AMINOPEPTIDASE user 2 2 # 2 B 165 SER A 254 SER~? 17.72 O4 U B 8 B 187 GLU A 225 GLU~? 23.05 C2 A B 9 coo 12.53 42.28 15.16 11.35 44.10 16.30 -38.02 -12.50 13.78 -37.98 -10.97 11.92 coo 12.85 44.05 6.07 11.44 42.52 5.44 -36.18 -1.53 15.48 -36.93 -1.10 13.54 ULMN 2 1xgm_01 METHIONINE AMINOPEPTIDASE user 3 2 # 3 B 165 SER A 384 SER~? 33.14 N1 A B 4 B 187 GLU A 391 GLU~? 23.54 N1 A B 4 coo 12.53 42.28 15.16 11.35 44.10 16.30 -45.44 -36.79 -12.14 -47.15 -38.50 -12.39 coo 12.85 44.05 6.07 11.44 42.52 5.44 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 ULMN 2 1xgm_01 METHIONINE AMINOPEPTIDASE user 4 2 # 4 B 165 SER A 540 SER~? 21.72 O4 U B 1 B 187 GLU A 545 GLU~? 17.12 N3 U B 1 coo 12.53 42.28 15.16 11.35 44.10 16.30 -3.65 -70.26 -15.04 -4.94 -71.68 -16.53 coo 12.85 44.05 6.07 11.44 42.52 5.44 2.66 -64.95 -14.46 4.45 -64.54 -15.50 ULMN 2 1xgm_01 METHIONINE AMINOPEPTIDASE user 5 2 # 5 B 165 SER A 550 SER~? 14.27 O4 U B 1 B 187 GLU A 545 GLU~? 17.12 N3 U B 1 coo 12.53 42.28 15.16 11.35 44.10 16.30 4.96 -63.97 -4.54 6.61 -65.75 -4.82 coo 12.85 44.05 6.07 11.44 42.52 5.44 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1xgm_01 source 1xgm METHIONINE AMINOPEPTIDASE : 5 hits 1xgm_01 naa= 2 ULMN 2 1xqd_00 CYTOCHROME P450 55A1 user 1 2 # 1 A 242 ALA A 256 ALA~? 17.16 N6 A B 9 A 243 THR A 257 THR~? 19.75 N1 A B 9 coo 7.23 22.00 24.48 6.68 23.42 24.57 -41.07 -16.80 15.01 -40.29 -17.48 16.14 coo 9.58 21.79 21.50 11.25 23.03 20.90 -42.71 -13.46 15.84 -41.70 -12.17 17.23 ULMN 2 1xqd_00 CYTOCHROME P450 55A1 user 2 2 # 2 A 242 ALA A 286 ALA~? 9.33 O2 U B 8 A 243 THR A 239 THR~? 10.72 O2 U B 8 coo 7.23 22.00 24.48 6.68 23.42 24.57 -21.94 -14.07 6.03 -21.83 -12.81 5.17 coo 9.58 21.79 21.50 11.25 23.03 20.90 -19.36 -10.64 8.19 -19.30 -8.96 6.83 ULMN 2 1xqd_00 CYTOCHROME P450 55A1 user 3 2 # 3 A 242 ALA A 348 ALA~? 19.98 C2 A B 4 A 243 THR A 349 THR~? 23.30 O2' A B 4 coo 7.23 22.00 24.48 6.68 23.42 24.57 -23.75 -28.03 -17.62 -25.14 -28.52 -17.99 coo 9.58 21.79 21.50 11.25 23.03 20.90 -22.17 -25.42 -19.90 -22.55 -23.33 -20.27 ULMN 2 1xqd_00 CYTOCHROME P450 55A1 user 4 2 # 4 A 242 ALA A 375 ALA.? 21.84 N1 A B 4 A 243 THR A 374 THR.? 15.78 N1 A B 4 coo 7.23 22.00 24.48 6.68 23.42 24.57 -34.96 -40.68 -8.92 -35.76 -41.10 -10.17 coo 9.58 21.79 21.50 11.25 23.03 20.90 -31.65 -38.74 -8.91 -29.97 -40.05 -8.52 ULMN 2 1xqd_00 CYTOCHROME P450 55A1 user 5 2 # 5 A 242 ALA A 385 ALA~? 31.51 N6 A B 7 A 243 THR A 383 THR~? 29.32 N6 A B 7 coo 7.23 22.00 24.48 6.68 23.42 24.57 -44.85 -33.34 -13.62 -45.83 -32.17 -13.62 coo 9.58 21.79 21.50 11.25 23.03 20.90 -45.70 -35.28 -8.64 -46.29 -33.20 -8.69 ULMN 2 1xqd_00 CYTOCHROME P450 55A1 user 6 2 # 6 A 242 ALA A 386 ALA~? 26.42 N6 A B 7 A 243 THR A 383 THR~? 29.32 N6 A B 7 coo 7.23 22.00 24.48 6.68 23.42 24.57 -42.10 -32.58 -11.13 -42.27 -32.34 -9.63 coo 9.58 21.79 21.50 11.25 23.03 20.90 -45.70 -35.28 -8.64 -46.29 -33.20 -8.69 ULMN 2 1xqd_00 CYTOCHROME P450 55A1 user 7 2 # 7 A 242 ALA A 409 ALA~? 10.24 O2 U B 3 A 243 THR A 410 THR~? 10.69 O2 U B 3 coo 7.23 22.00 24.48 6.68 23.42 24.57 -12.52 -39.70 -14.88 -12.84 -40.87 -15.81 coo 9.58 21.79 21.50 11.25 23.03 20.90 -8.78 -38.96 -14.99 -8.22 -38.93 -17.11 ULMN 2 1xqd_00 CYTOCHROME P450 55A1 user 8 2 # 8 A 242 ALA A 452 ALA~? 8.51 N2 G B 2 A 243 THR A 410 THR~? 10.69 O2 U B 3 coo 7.23 22.00 24.48 6.68 23.42 24.57 -8.76 -43.34 -13.26 -8.47 -43.16 -14.74 coo 9.58 21.79 21.50 11.25 23.03 20.90 -8.78 -38.96 -14.99 -8.22 -38.93 -17.11 ULMN 2 1xqd_00 CYTOCHROME P450 55A1 user 9 2 # 9 A 242 ALA A 528 ALA~? 26.93 O6 G B 2 A 243 THR A 520 THR.? 24.39 O6 G B 2 coo 7.23 22.00 24.48 6.68 23.42 24.57 -21.92 -68.60 -14.66 -22.67 -69.76 -13.95 coo 9.58 21.79 21.50 11.25 23.03 20.90 -24.42 -64.64 -12.07 -23.58 -66.57 -11.57 1xqd_00 source 1xqd CYTOCHROME P450 55A1 : 9 hits 1xqd_00 naa= 2 ULMN 2 1xqd_01 CYTOCHROME P450 55A1 user 1 2 # 1 A 286 SER A 186 SER~? 19.81 C2 A B 9 A 393 ASP A 190 ASP~? 22.39 C2 A B 9 coo 13.16 26.08 17.48 14.86 26.70 19.08 -32.13 -4.51 28.38 -34.48 -4.98 28.75 coo 8.26 27.79 16.87 9.99 28.97 17.08 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 1xqd_01 CYTOCHROME P450 55A1 user 2 2 # 2 A 286 SER A 530 SER~? 25.46 N2 G B 2 A 393 ASP A 533 ASP~? 24.95 O4 U B 1 coo 13.16 26.08 17.48 14.86 26.70 19.08 -18.33 -66.93 -18.45 -19.81 -66.03 -20.11 coo 8.26 27.79 16.87 9.99 28.97 17.08 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 1xqd_01 source 1xqd CYTOCHROME P450 55A1 : 2 hits 1xqd_01 naa= 2 ULMN 2 1xs1_00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 128 ASP A 190 ASP~? 22.39 C2 A B 9 A 130 GLY A 192 GLY~? 20.40 C2 A B 9 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -31.44 0.79 27.21 -33.43 0.08 27.41 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -26.86 1.96 22.05 -26.39 1.48 22.54 ULMN 2 1xs1_00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 A 128 ASP A 233 ASP~? 18.81 O2 U B 8 A 130 GLY A 229 GLY~? 19.93 O4 U B 8 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1xs1_00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 A 128 ASP A 484 ASP.? 22.65 O2 U B 1 A 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo -16.14 7.55 9.89 -16.27 5.86 11.13 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -17.69 11.71 5.97 -16.98 11.70 6.47 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 A 128 ASP A 488 ASP~? 18.76 O2 U B 1 A 130 GLY A 478 GLY.? 19.78 N2 G B 2 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1xs1_00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 A 128 ASP A 488 ASP~? 18.76 O2 U B 1 A 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -17.69 11.71 5.97 -16.98 11.70 6.47 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 A 128 ASP A 512 ASP~? 14.88 O6 G B 2 A 130 GLY A 516 GLY.? 23.13 O6 G B 2 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -22.27 -67.70 -4.93 -21.68 -67.22 -4.75 ULMN 2 1xs1_00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 A 128 ASP A 526 ASP^? 28.45 O6 G B 2 A 130 GLY A 524 GLY.? 31.86 O6 G B 2 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -33.20 -64.53 -15.76 -32.47 -64.29 -16.01 1xs1_00 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 7 hits 1xs1_00 naa= 2 ULMN 2 1xs1_01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 128 ASP A 190 ASP~? 22.39 C2 A B 9 B 130 GLY A 192 GLY~? 20.40 C2 A B 9 coo 8.08 5.58 9.89 6.73 6.58 11.12 -31.44 0.79 27.21 -33.43 0.08 27.41 coo 12.76 4.19 5.97 12.32 3.80 6.57 -26.86 1.96 22.05 -26.39 1.48 22.54 ULMN 2 1xs1_01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 B 128 ASP A 233 ASP~? 18.81 O2 U B 8 B 130 GLY A 229 GLY~? 19.93 O4 U B 8 coo 8.08 5.58 9.89 6.73 6.58 11.12 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 12.76 4.19 5.97 12.32 3.80 6.57 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1xs1_01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 B 128 ASP A 484 ASP.? 22.65 O2 U B 1 B 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo 8.08 5.58 9.89 6.73 6.58 11.12 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo 12.76 4.19 5.97 12.32 3.80 6.57 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 B 128 ASP A 488 ASP~? 18.76 O2 U B 1 B 130 GLY A 478 GLY.? 19.78 N2 G B 2 coo 8.08 5.58 9.89 6.73 6.58 11.12 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 12.76 4.19 5.97 12.32 3.80 6.57 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1xs1_01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 B 128 ASP A 488 ASP~? 18.76 O2 U B 1 B 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo 8.08 5.58 9.89 6.73 6.58 11.12 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 12.76 4.19 5.97 12.32 3.80 6.57 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 B 128 ASP A 512 ASP~? 14.88 O6 G B 2 B 130 GLY A 516 GLY.? 23.13 O6 G B 2 coo 8.08 5.58 9.89 6.73 6.58 11.12 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 12.76 4.19 5.97 12.32 3.80 6.57 -22.27 -67.70 -4.93 -21.68 -67.22 -4.75 ULMN 2 1xs1_01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 B 128 ASP A 526 ASP^? 28.45 O6 G B 2 B 130 GLY A 524 GLY.? 31.86 O6 G B 2 coo 8.08 5.58 9.89 6.73 6.58 11.12 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo 12.76 4.19 5.97 12.32 3.80 6.57 -33.20 -64.53 -15.76 -32.47 -64.29 -16.01 1xs1_01 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 7 hits 1xs1_01 naa= 2 ULMN 2 1xs1_02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 C 128 ASP A 190 ASP~? 22.39 C2 A B 9 C 130 GLY A 192 GLY~? 20.40 C2 A B 9 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -31.44 0.79 27.21 -33.43 0.08 27.41 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -26.86 1.96 22.05 -26.39 1.48 22.54 ULMN 2 1xs1_02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 C 128 ASP A 233 ASP~? 18.81 O2 U B 8 C 130 GLY A 229 GLY~? 19.93 O4 U B 8 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1xs1_02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 C 128 ASP A 484 ASP.? 22.65 O2 U B 1 C 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 C 128 ASP A 488 ASP~? 18.76 O2 U B 1 C 130 GLY A 478 GLY.? 19.78 N2 G B 2 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1xs1_02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 C 128 ASP A 488 ASP~? 18.76 O2 U B 1 C 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 C 128 ASP A 512 ASP~? 14.88 O6 G B 2 C 130 GLY A 516 GLY.? 23.13 O6 G B 2 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -22.27 -67.70 -4.93 -21.68 -67.22 -4.75 ULMN 2 1xs1_02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 C 128 ASP A 526 ASP^? 28.45 O6 G B 2 C 130 GLY A 524 GLY.? 31.86 O6 G B 2 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -33.20 -64.53 -15.76 -32.47 -64.29 -16.01 1xs1_02 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 7 hits 1xs1_02 naa= 2 ULMN 2 1xs1_03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 128 ASP A 190 ASP~? 22.39 C2 A B 9 D 130 GLY A 192 GLY~? 20.40 C2 A B 9 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -31.44 0.79 27.21 -33.43 0.08 27.41 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -26.86 1.96 22.05 -26.39 1.48 22.54 ULMN 2 1xs1_03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 D 128 ASP A 233 ASP~? 18.81 O2 U B 8 D 130 GLY A 229 GLY~? 19.93 O4 U B 8 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1xs1_03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 D 128 ASP A 484 ASP.? 22.65 O2 U B 1 D 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 D 128 ASP A 488 ASP~? 18.76 O2 U B 1 D 130 GLY A 478 GLY.? 19.78 N2 G B 2 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1xs1_03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 D 128 ASP A 488 ASP~? 18.76 O2 U B 1 D 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 D 128 ASP A 512 ASP~? 14.88 O6 G B 2 D 130 GLY A 516 GLY.? 23.13 O6 G B 2 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -22.27 -67.70 -4.93 -21.68 -67.22 -4.75 ULMN 2 1xs1_03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 D 128 ASP A 526 ASP^? 28.45 O6 G B 2 D 130 GLY A 524 GLY.? 31.86 O6 G B 2 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -33.20 -64.53 -15.76 -32.47 -64.29 -16.01 1xs1_03 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 7 hits 1xs1_03 naa= 2 ULMN 2 1xs1_04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 128 ASP A 190 ASP~? 22.39 C2 A B 9 E 130 GLY A 192 GLY~? 20.40 C2 A B 9 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -31.44 0.79 27.21 -33.43 0.08 27.41 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -26.86 1.96 22.05 -26.39 1.48 22.54 ULMN 2 1xs1_04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 E 128 ASP A 233 ASP~? 18.81 O2 U B 8 E 130 GLY A 229 GLY~? 19.93 O4 U B 8 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1xs1_04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 E 128 ASP A 484 ASP.? 22.65 O2 U B 1 E 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo -5.69 16.82 71.43 -4.17 15.98 70.17 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -8.93 20.40 75.02 -9.14 19.76 74.49 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 E 128 ASP A 488 ASP~? 18.76 O2 U B 1 E 130 GLY A 478 GLY.? 19.78 N2 G B 2 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1xs1_04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 E 128 ASP A 488 ASP~? 18.76 O2 U B 1 E 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -8.93 20.40 75.02 -9.14 19.76 74.49 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 E 128 ASP A 512 ASP~? 14.88 O6 G B 2 E 130 GLY A 516 GLY.? 23.13 O6 G B 2 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -22.27 -67.70 -4.93 -21.68 -67.22 -4.75 ULMN 2 1xs1_04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 E 128 ASP A 526 ASP^? 28.45 O6 G B 2 E 130 GLY A 524 GLY.? 31.86 O6 G B 2 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -33.20 -64.53 -15.76 -32.47 -64.29 -16.01 1xs1_04 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 7 hits 1xs1_04 naa= 2 ULMN 2 1xs1_05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 128 ASP A 190 ASP~? 22.39 C2 A B 9 F 130 GLY A 192 GLY~? 20.40 C2 A B 9 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -31.44 0.79 27.21 -33.43 0.08 27.41 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -26.86 1.96 22.05 -26.39 1.48 22.54 ULMN 2 1xs1_05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 F 128 ASP A 233 ASP~? 18.81 O2 U B 8 F 130 GLY A 229 GLY~? 19.93 O4 U B 8 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 1xs1_05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 F 128 ASP A 484 ASP.? 22.65 O2 U B 1 F 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 F 128 ASP A 488 ASP~? 18.76 O2 U B 1 F 130 GLY A 478 GLY.? 19.78 N2 G B 2 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 1xs1_05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 F 128 ASP A 488 ASP~? 18.76 O2 U B 1 F 130 GLY A 486 GLY.? 16.78 O2 U B 1 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 1xs1_05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 F 128 ASP A 512 ASP~? 14.88 O6 G B 2 F 130 GLY A 516 GLY.? 23.13 O6 G B 2 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -22.27 -67.70 -4.93 -21.68 -67.22 -4.75 ULMN 2 1xs1_05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 F 128 ASP A 526 ASP^? 28.45 O6 G B 2 F 130 GLY A 524 GLY.? 31.86 O6 G B 2 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -33.20 -64.53 -15.76 -32.47 -64.29 -16.01 1xs1_05 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 7 hits 1xs1_05 naa= 2 ULMN 2 1xs1_13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 111 SER A 254 SER~? 17.72 O4 U B 8 A 115 ARG A 265 ARG~? 21.55 N1 A B 9 coo 6.26 6.70 20.48 8.06 5.10 20.15 -38.02 -12.50 13.78 -37.98 -10.97 11.92 coo 10.04 5.32 23.68 11.46 4.45 21.05 -38.98 -7.64 12.61 -41.54 -9.16 13.48 ULMN 2 1xs1_13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 A 111 SER A 515 SER~? 19.83 O4 U B 1 A 115 ARG A 517 ARG.? 17.55 O4 U B 1 coo 6.26 6.70 20.48 8.06 5.10 20.15 -18.72 -69.11 -4.92 -17.74 -67.34 -3.57 coo 10.04 5.32 23.68 11.46 4.45 21.05 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1xs1_13 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_13 naa= 2 ULMN 2 1xs1_14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 111 SER A 254 SER~? 17.72 O4 U B 8 B 115 ARG A 265 ARG~? 21.55 N1 A B 9 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -38.02 -12.50 13.78 -37.98 -10.97 11.92 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -38.98 -7.64 12.61 -41.54 -9.16 13.48 ULMN 2 1xs1_14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 B 111 SER A 515 SER~? 19.83 O4 U B 1 B 115 ARG A 517 ARG.? 17.55 O4 U B 1 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -18.72 -69.11 -4.92 -17.74 -67.34 -3.57 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1xs1_14 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_14 naa= 2 ULMN 2 1xs1_15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 111 SER A 254 SER~? 17.72 O4 U B 8 D 115 ARG A 265 ARG~? 21.55 N1 A B 9 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -38.02 -12.50 13.78 -37.98 -10.97 11.92 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -38.98 -7.64 12.61 -41.54 -9.16 13.48 ULMN 2 1xs1_15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 D 111 SER A 515 SER~? 19.83 O4 U B 1 D 115 ARG A 517 ARG.? 17.55 O4 U B 1 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -18.72 -69.11 -4.92 -17.74 -67.34 -3.57 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1xs1_15 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_15 naa= 2 ULMN 2 1xs1_16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 111 SER A 254 SER~? 17.72 O4 U B 8 E 115 ARG A 265 ARG~? 21.55 N1 A B 9 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -38.02 -12.50 13.78 -37.98 -10.97 11.92 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -38.98 -7.64 12.61 -41.54 -9.16 13.48 ULMN 2 1xs1_16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 E 111 SER A 515 SER~? 19.83 O4 U B 1 E 115 ARG A 517 ARG.? 17.55 O4 U B 1 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -18.72 -69.11 -4.92 -17.74 -67.34 -3.57 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1xs1_16 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_16 naa= 2 ULMN 2 1xs1_17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 111 SER A 254 SER~? 17.72 O4 U B 8 F 115 ARG A 265 ARG~? 21.55 N1 A B 9 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -38.02 -12.50 13.78 -37.98 -10.97 11.92 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -38.98 -7.64 12.61 -41.54 -9.16 13.48 ULMN 2 1xs1_17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 F 111 SER A 515 SER~? 19.83 O4 U B 1 F 115 ARG A 517 ARG.? 17.55 O4 U B 1 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -18.72 -69.11 -4.92 -17.74 -67.34 -3.57 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -18.32 -64.42 -0.81 -15.81 -66.01 -1.62 1xs1_17 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_17 naa= 2 ULMN 2 1xva_02 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 A 175 ARG A 288 ARG~? 3.45 C6 A B 7 A 242 TYR A 245 TYR~? 3.47 C5 A B 9 coo 56.19 79.96 8.87 56.06 80.16 11.92 -21.54 -21.02 8.30 -20.02 -23.61 8.96 coo 63.28 81.69 5.71 63.99 80.11 7.80 -22.48 -17.46 16.07 -20.67 -19.47 15.36 ULMN 2 1xva_02 GLYCINE N-METHYLTRANSFERASE user 2 2 # 2 A 175 ARG A 364 ARG~? 3.58 O2 C B 5 A 242 TYR A 416 TYR~? 3.28 C4 A B 4 coo 56.19 79.96 8.87 56.06 80.16 11.92 -17.84 -32.65 -1.33 -19.23 -35.35 -1.33 coo 63.28 81.69 5.71 63.99 80.11 7.80 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 1xva_02 source 1xva GLYCINE N-METHYLTRANSFERASE : 2 hits 1xva_02 naa= 2 ULMN 2 1y9m_00 EXO-INULINASE user 1 2 # 1 A 41 ASP A 491 ASP~? 15.62 O2 U B 1 A 241 GLU A 545 GLU~? 17.12 N3 U B 1 coo 24.90 6.62 22.11 24.45 8.58 22.70 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 19.12 12.64 24.04 21.16 13.15 23.94 2.66 -64.95 -14.46 4.45 -64.54 -15.50 1y9m_00 source 1y9m EXO-INULINASE : 1 hits 1y9m_00 naa= 2 ULMN 2 1ybv_04 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 A 175 HIS A 496 HIS.? 9.17 O2 U B 1 A 182 LYS A 450 LYS.? 2.98 O2' G B 2 coo 85.29 7.35 12.75 85.49 9.14 13.81 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 85.30 6.17 22.83 87.26 11.02 23.50 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 ULMN 2 1ybv_04 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 A 175 HIS A 539 HIS~? 18.96 O4 U B 1 A 182 LYS A 544 LYS~? 22.64 O4 U B 1 coo 85.29 7.35 12.75 85.49 9.14 13.81 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 coo 85.30 6.17 22.83 87.26 11.02 23.50 2.51 -69.72 -14.20 -0.06 -70.01 -19.70 1ybv_04 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_04 naa= 2 ULMN 2 1ybv_05 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 B 175 HIS A 496 HIS.? 9.17 O2 U B 1 B 182 LYS A 450 LYS.? 2.98 O2' G B 2 coo 57.35 -5.59 36.67 57.15 -3.72 37.60 1.07 -50.04 -13.54 1.05 -47.95 -13.74 coo 57.40 2.23 30.19 55.43 5.44 33.87 -3.57 -42.88 -10.27 -2.50 -40.93 -5.28 ULMN 2 1ybv_05 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 B 175 HIS A 539 HIS~? 18.96 O4 U B 1 B 182 LYS A 544 LYS~? 22.64 O4 U B 1 coo 57.35 -5.59 36.67 57.15 -3.72 37.60 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 coo 57.40 2.23 30.19 55.43 5.44 33.87 2.51 -69.72 -14.20 -0.06 -70.01 -19.70 1ybv_05 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_05 naa= 2 ULMN 2 1ybv_06 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 A 178 TYR A 361 TYR~? 4.83 OP1 U B 6 A 182 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 87.67 8.69 17.10 86.62 10.83 18.52 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 85.30 6.17 22.83 87.26 11.02 23.50 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1ybv_06 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 1 hits 1ybv_06 naa= 2 ULMN 2 1ybv_07 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 B 178 TYR A 361 TYR~? 4.83 OP1 U B 6 B 182 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 57.40 2.23 30.19 55.43 5.44 33.87 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 1ybv_07 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 1 hits 1ybv_07 naa= 2 ULMN 2 1ycf_04 NITRIC OXIDE REDUCTASE user 1 2 # 1 A 25 HIS A 326 HIS~? 3.28 C5 A B 7 A 195 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 106.34 45.08-158.07 106.22 43.60-156.59 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 107.73 45.82-148.69 107.70 43.47-150.21 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 ULMN 2 1ycf_04 NITRIC OXIDE REDUCTASE user 2 2 # 2 A 25 HIS A 454 HIS~? 3.31 C5 U B 3 A 195 TYR A 416 TYR~? 3.28 C4 A B 4 coo 106.34 45.08-158.07 106.22 43.60-156.59 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 107.73 45.82-148.69 107.70 43.47-150.21 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 ULMN 2 1ycf_04 NITRIC OXIDE REDUCTASE user 3 2 # 3 A 25 HIS A 454 HIS~? 3.31 C5 U B 3 A 195 TYR A 501 TYR~? 3.43 C5 G B 2 coo 106.34 45.08-158.07 106.22 43.60-156.59 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 107.73 45.82-148.69 107.70 43.47-150.21 -4.81 -51.44 -6.29 -2.96 -50.88 -4.27 ULMN 2 1ycf_04 NITRIC OXIDE REDUCTASE user 4 2 # 4 A 25 HIS A 482 HIS.? 27.32 N2 G B 2 A 195 TYR A 479 TYR.? 25.88 N2 G B 2 coo 106.34 45.08-158.07 106.22 43.60-156.59 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 107.73 45.82-148.69 107.70 43.47-150.21 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ycf_04 source 1ycf NITRIC OXIDE REDUCTASE : 4 hits 1ycf_04 naa= 2 ULMN 2 1ycf_05 NITRIC OXIDE REDUCTASE user 1 2 # 1 B 25 HIS A 326 HIS~? 3.28 C5 A B 7 B 195 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 96.60 74.58-169.45 95.48 75.58-170.91 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 98.52 74.63-178.64 97.12 76.54-177.16 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 ULMN 2 1ycf_05 NITRIC OXIDE REDUCTASE user 2 2 # 2 B 25 HIS A 454 HIS~? 3.31 C5 U B 3 B 195 TYR A 416 TYR~? 3.28 C4 A B 4 coo 96.60 74.58-169.45 95.48 75.58-170.91 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 98.52 74.63-178.64 97.12 76.54-177.16 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 ULMN 2 1ycf_05 NITRIC OXIDE REDUCTASE user 3 2 # 3 B 25 HIS A 454 HIS~? 3.31 C5 U B 3 B 195 TYR A 501 TYR~? 3.43 C5 G B 2 coo 96.60 74.58-169.45 95.48 75.58-170.91 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 98.52 74.63-178.64 97.12 76.54-177.16 -4.81 -51.44 -6.29 -2.96 -50.88 -4.27 ULMN 2 1ycf_05 NITRIC OXIDE REDUCTASE user 4 2 # 4 B 25 HIS A 482 HIS.? 27.32 N2 G B 2 B 195 TYR A 479 TYR.? 25.88 N2 G B 2 coo 96.60 74.58-169.45 95.48 75.58-170.91 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 98.52 74.63-178.64 97.12 76.54-177.16 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ycf_05 source 1ycf NITRIC OXIDE REDUCTASE : 4 hits 1ycf_05 naa= 2 ULMN 2 1ycf_06 NITRIC OXIDE REDUCTASE user 1 2 # 1 C 25 HIS A 326 HIS~? 3.28 C5 A B 7 C 195 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 ULMN 2 1ycf_06 NITRIC OXIDE REDUCTASE user 2 2 # 2 C 25 HIS A 454 HIS~? 3.31 C5 U B 3 C 195 TYR A 416 TYR~? 3.28 C4 A B 4 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 ULMN 2 1ycf_06 NITRIC OXIDE REDUCTASE user 3 2 # 3 C 25 HIS A 454 HIS~? 3.31 C5 U B 3 C 195 TYR A 501 TYR~? 3.43 C5 G B 2 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -4.81 -51.44 -6.29 -2.96 -50.88 -4.27 ULMN 2 1ycf_06 NITRIC OXIDE REDUCTASE user 4 2 # 4 C 25 HIS A 482 HIS.? 27.32 N2 G B 2 C 195 TYR A 479 TYR.? 25.88 N2 G B 2 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ycf_06 source 1ycf NITRIC OXIDE REDUCTASE : 4 hits 1ycf_06 naa= 2 ULMN 2 1ycf_07 NITRIC OXIDE REDUCTASE user 1 2 # 1 D 25 HIS A 326 HIS~? 3.28 C5 A B 7 D 195 TYR A 361 TYR~? 4.83 OP1 U B 6 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 ULMN 2 1ycf_07 NITRIC OXIDE REDUCTASE user 2 2 # 2 D 25 HIS A 454 HIS~? 3.31 C5 U B 3 D 195 TYR A 416 TYR~? 3.28 C4 A B 4 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 ULMN 2 1ycf_07 NITRIC OXIDE REDUCTASE user 3 2 # 3 D 25 HIS A 454 HIS~? 3.31 C5 U B 3 D 195 TYR A 501 TYR~? 3.43 C5 G B 2 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -4.81 -51.44 -6.29 -2.96 -50.88 -4.27 ULMN 2 1ycf_07 NITRIC OXIDE REDUCTASE user 4 2 # 4 D 25 HIS A 482 HIS.? 27.32 N2 G B 2 D 195 TYR A 479 TYR.? 25.88 N2 G B 2 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 5.38 -51.43 -31.03 5.15 -51.35 -33.11 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 1ycf_07 source 1ycf NITRIC OXIDE REDUCTASE : 4 hits 1ycf_07 naa= 2 ULMN 2 1ylu_02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 A 14 LYS A 304 LYS~? 25.42 N1 A B 7 A 74 LYS A 270 LYS~? 23.81 O4 U B 8 coo 18.28 7.83 36.39 22.82 8.75 39.52 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo 14.16 13.09 37.03 20.00 12.44 37.49 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 1ylu_02 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1ylu_02 naa= 2 ULMN 2 1ylu_03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 B 14 LYS A 304 LYS~? 25.42 N1 A B 7 B 74 LYS A 270 LYS~? 23.81 O4 U B 8 coo 13.51 0.92 76.10 12.98 6.13 74.68 -36.06 -14.49 -3.93 -40.27 -12.46 -6.66 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 1ylu_03 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1ylu_03 naa= 2 ULMN 2 1zrz_00 PROTEIN KINASE C, IOTA user 1 2 # 1 A 369 ASP A 283 ASP~? 9.21 O2 U B 8 A 373 ASP A 321 ASP~? 8.41 N3 A B 7 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1zrz_00 PROTEIN KINASE C, IOTA user 2 2 # 2 A 369 ASP A 321 ASP~? 8.41 N3 A B 7 A 373 ASP A 283 ASP~? 9.21 O2 U B 8 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 1zrz_00 PROTEIN KINASE C, IOTA user 3 2 # 3 A 369 ASP A 321 ASP~? 8.41 N3 A B 7 A 373 ASP A 359 ASP~? 8.63 O2' A B 4 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 1zrz_00 PROTEIN KINASE C, IOTA user 4 2 # 4 A 369 ASP A 359 ASP~? 8.63 O2' A B 4 A 373 ASP A 321 ASP~? 8.41 N3 A B 7 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 1zrz_00 PROTEIN KINASE C, IOTA user 5 2 # 5 A 369 ASP A 473 ASP~? 22.60 N2 G B 2 A 373 ASP A 533 ASP~? 24.95 O4 U B 1 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 1zrz_00 PROTEIN KINASE C, IOTA user 6 2 # 6 A 369 ASP A 533 ASP~? 24.95 O4 U B 1 A 373 ASP A 473 ASP~? 22.60 N2 G B 2 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 1zrz_00 source 1zrz PROTEIN KINASE C, IOTA : 6 hits 1zrz_00 naa= 2 ULMN 2 1zrz_01 PROTEIN KINASE C, IOTA user 1 2 # 1 A 369 ASP A 533 ASP~? 24.95 O4 U B 1 A 371 LYS A 536 LYS~? 26.44 O4 U B 1 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 1zrz_01 source 1zrz PROTEIN KINASE C, IOTA : 1 hits 1zrz_01 naa= 2 ULMN 2 1zym_00 ENZYME I user 1 2 # 1 A 168 THR A 349 THR~? 23.30 O2' A B 4 A 189 HIS A 352 HIS~? 21.18 O2' A B 4 coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -22.17 -25.42 -19.90 -22.55 -23.33 -20.27 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 ULMN 2 1zym_00 ENZYME I user 2 2 # 2 A 168 THR A 543 THR~? 19.49 O4 U B 1 A 189 HIS A 539 HIS~? 18.96 O4 U B 1 coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 1zym_00 source 1zym ENZYME I : 2 hits 1zym_00 naa= 2 ULMN 2 1zym_01 ENZYME I user 1 2 # 1 B 168 THR A 349 THR~? 23.30 O2' A B 4 B 189 HIS A 352 HIS~? 21.18 O2' A B 4 coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -22.17 -25.42 -19.90 -22.55 -23.33 -20.27 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 ULMN 2 1zym_01 ENZYME I user 2 2 # 2 B 168 THR A 543 THR~? 19.49 O4 U B 1 B 189 HIS A 539 HIS~? 18.96 O4 U B 1 coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -0.06 -70.35 -11.45 -0.98 -72.30 -11.57 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -6.28 -71.18 -10.96 -5.46 -72.72 -9.81 1zym_01 source 1zym ENZYME I : 2 hits 1zym_01 naa= 2 ULMN 2 206l_00 LYSOZYME user 1 2 # 1 A 11 GLU A 412 GLU.? 7.44 O2' U B 3 A 20 ASP A 359 ASP~? 8.63 O2' A B 4 coo 40.46 12.70 11.55 39.54 14.42 10.81 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 coo 39.78 21.54 11.61 37.90 22.43 11.16 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 206l_00 source 206l LYSOZYME : 1 hits 206l_00 naa= 2 ULMN 2 2a0n_00 4.01.03.0000 user 1 2 # 1 A 11 ASP A 174 ASP.? 19.36 O2' A B 9 A 130 ASP A 200 ASP~? 9.45 O2' A B 9 coo 25.89 89.29 37.40 24.53 87.99 36.37 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 22.18 80.79 26.12 23.22 81.35 27.91 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 2a0n_00 4.01.03.0000 user 2 2 # 2 A 11 ASP A 200 ASP~? 9.45 O2' A B 9 A 130 ASP A 174 ASP.? 19.36 O2' A B 9 coo 25.89 89.29 37.40 24.53 87.99 36.37 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 22.18 80.79 26.12 23.22 81.35 27.91 -15.98 -5.04 37.28 -14.70 -6.54 36.49 ULMN 2 2a0n_00 4.01.03.0000 user 3 2 # 3 A 11 ASP A 279 ASP~? 17.12 C2 A B 7 A 130 ASP A 312 ASP~? 21.35 C2 A B 7 coo 25.89 89.29 37.40 24.53 87.99 36.37 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo 22.18 80.79 26.12 23.22 81.35 27.91 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 ULMN 2 2a0n_00 4.01.03.0000 user 4 2 # 4 A 11 ASP A 312 ASP~? 21.35 C2 A B 7 A 130 ASP A 279 ASP~? 17.12 C2 A B 7 coo 25.89 89.29 37.40 24.53 87.99 36.37 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo 22.18 80.79 26.12 23.22 81.35 27.91 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 2a0n_00 source 2a0n 4.01.03.0000 : 4 hits 2a0n_00 naa= 2 ULMN 2 2acy_00 ACYLPHOSPHATASE user 1 2 # 1 23 ARG A 392 ARG~? 29.32 C2 A B 4 41 ASN A 388 ASN~? 30.21 C2 A B 4 coo 16.80 -14.98 16.98 17.50 -17.52 18.58 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 coo 21.33 -14.94 17.25 19.91 -14.30 18.68 -41.56 -34.77 -16.36 -41.09 -34.74 -18.44 2acy_00 source 2acy ACYLPHOSPHATASE : 1 hits 2acy_00 naa= 2 ULMN 2 2amg_00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 190 ASP~? 22.39 C2 A B 9 218 GLY A 192 GLY~? 20.40 C2 A B 9 coo 27.89 102.52 14.98 29.35 101.92 13.57 -31.44 0.79 27.21 -33.43 0.08 27.41 coo 21.10 106.02 13.04 21.16 106.76 12.59 -26.86 1.96 22.05 -26.39 1.48 22.54 ULMN 2 2amg_00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 2 # 2 193 ASP A 200 ASP~? 9.45 O2' A B 9 218 GLY A 243 GLY~? 7.99 O2 U B 8 coo 27.89 102.52 14.98 29.35 101.92 13.57 -16.63 -8.21 22.33 -15.39 -8.76 23.94 coo 21.10 106.02 13.04 21.16 106.76 12.59 -21.59 -11.19 15.11 -21.41 -11.91 14.82 ULMN 2 2amg_00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 2 # 3 193 ASP A 232 ASP~? 21.56 O2 U B 8 218 GLY A 229 GLY~? 19.93 O4 U B 8 coo 27.89 102.52 14.98 29.35 101.92 13.57 -24.56 0.12 7.49 -25.80 1.40 6.37 coo 21.10 106.02 13.04 21.16 106.76 12.59 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 2amg_00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 2 # 4 193 ASP A 233 ASP~? 18.81 O2 U B 8 218 GLY A 229 GLY~? 19.93 O4 U B 8 coo 27.89 102.52 14.98 29.35 101.92 13.57 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 21.10 106.02 13.04 21.16 106.76 12.59 -33.14 -3.29 10.82 -32.39 -3.35 10.56 ULMN 2 2amg_00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 2 # 5 193 ASP A 321 ASP~? 8.41 N3 A B 7 218 GLY A 362 GLY~? 9.16 C4' C B 5 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo 21.10 106.02 13.04 21.16 106.76 12.59 -16.83 -27.47 -7.16 -16.64 -28.16 -6.72 ULMN 2 2amg_00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 2 # 6 193 ASP A 473 ASP~? 22.60 N2 G B 2 218 GLY A 478 GLY.? 19.78 N2 G B 2 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 21.10 106.02 13.04 21.16 106.76 12.59 -5.51 -57.24 -25.20 -5.14 -57.92 -25.40 ULMN 2 2amg_00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 2 # 7 193 ASP A 484 ASP.? 22.65 O2 U B 1 218 GLY A 486 GLY.? 16.78 O2 U B 1 coo 27.89 102.52 14.98 29.35 101.92 13.57 7.90 -50.74 -23.88 8.67 -50.47 -25.84 coo 21.10 106.02 13.04 21.16 106.76 12.59 4.98 -56.31 -20.25 4.98 -55.96 -21.01 ULMN 2 2amg_00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 2 # 8 193 ASP A 526 ASP^? 28.45 O6 G B 2 218 GLY A 523 GLY.? 29.31 O4 U B 3 coo 27.89 102.52 14.98 29.35 101.92 13.57 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo 21.10 106.02 13.04 21.16 106.76 12.59 -32.45 -60.81 -15.78 -32.10 -61.53 -15.64 ULMN 2 2amg_00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 2 # 9 193 ASP A 526 ASP^? 28.45 O6 G B 2 218 GLY A 524 GLY.? 31.86 O6 G B 2 coo 27.89 102.52 14.98 29.35 101.92 13.57 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo 21.10 106.02 13.04 21.16 106.76 12.59 -33.20 -64.53 -15.76 -32.47 -64.29 -16.01 2amg_00 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 9 hits 2amg_00 naa= 2 ULMN 2 2amg_03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 491 ASP~? 15.62 O2 U B 1 219 GLU A 545 GLU~? 17.12 N3 U B 1 coo 27.89 102.52 14.98 29.35 101.92 13.57 2.02 -59.32 -18.53 4.01 -59.49 -17.81 coo 25.84 105.87 9.06 27.86 105.55 8.74 2.66 -64.95 -14.46 4.45 -64.54 -15.50 2amg_03 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 1 hits 2amg_03 naa= 2 ULMN 2 2bmi_00 CLASS B BETA-LACTAMASE user 1 2 # 1 A 86 ASP A 283 ASP~? 9.21 O2 U B 8 A 176 ASN A 240 ASN.? 9.01 O2 U B 8 coo 3.77 27.43 22.56 5.17 28.98 22.54 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 10.49 32.46 17.76 9.08 34.05 17.38 -18.56 -9.78 12.83 -17.16 -9.65 14.42 ULMN 2 2bmi_00 CLASS B BETA-LACTAMASE user 2 2 # 2 A 86 ASP A 283 ASP~? 9.21 O2 U B 8 A 176 ASN A 244 ASN~? 2.92 O2 U B 8 coo 3.77 27.43 22.56 5.17 28.98 22.54 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 10.49 32.46 17.76 9.08 34.05 17.38 -22.00 -14.42 11.48 -21.14 -16.18 12.31 ULMN 2 2bmi_00 CLASS B BETA-LACTAMASE user 3 2 # 3 A 86 ASP A 298 ASP~? 21.17 O4 U B 8 A 176 ASN A 258 ASN.? 23.39 O4 U B 8 coo 3.77 27.43 22.56 5.17 28.98 22.54 -41.82 -17.47 4.14 -42.95 -17.27 5.91 coo 10.49 32.46 17.76 9.08 34.05 17.38 -46.92 -14.31 13.78 -45.92 -15.90 12.78 ULMN 2 2bmi_00 CLASS B BETA-LACTAMASE user 4 2 # 4 A 86 ASP A 359 ASP~? 8.63 O2' A B 4 A 176 ASN A 325 ASN~? 6.34 O2' C B 5 coo 3.77 27.43 22.56 5.17 28.98 22.54 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 10.49 32.46 17.76 9.08 34.05 17.38 -19.09 -24.77 -2.46 -18.64 -25.98 -0.78 2bmi_00 source 2bmi CLASS B BETA-LACTAMASE : 4 hits 2bmi_00 naa= 2 ULMN 2 2bmi_01 CLASS B BETA-LACTAMASE user 1 2 # 1 B 86 ASP A 283 ASP~? 9.21 O2 U B 8 B 176 ASN A 240 ASN.? 9.01 O2 U B 8 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -18.56 -9.78 12.83 -17.16 -9.65 14.42 ULMN 2 2bmi_01 CLASS B BETA-LACTAMASE user 2 2 # 2 B 86 ASP A 283 ASP~? 9.21 O2 U B 8 B 176 ASN A 244 ASN~? 2.92 O2 U B 8 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -22.00 -14.42 11.48 -21.14 -16.18 12.31 ULMN 2 2bmi_01 CLASS B BETA-LACTAMASE user 3 2 # 3 B 86 ASP A 298 ASP~? 21.17 O4 U B 8 B 176 ASN A 258 ASN.? 23.39 O4 U B 8 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -41.82 -17.47 4.14 -42.95 -17.27 5.91 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -46.92 -14.31 13.78 -45.92 -15.90 12.78 ULMN 2 2bmi_01 CLASS B BETA-LACTAMASE user 4 2 # 4 B 86 ASP A 359 ASP~? 8.63 O2' A B 4 B 176 ASN A 325 ASN~? 6.34 O2' C B 5 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -19.09 -24.77 -2.46 -18.64 -25.98 -0.78 ULMN 2 2bmi_01 CLASS B BETA-LACTAMASE user 5 2 # 5 B 86 ASP A 426 ASP.? 18.90 N1 A B 4 B 176 ASN A 379 ASN~? 20.05 O2 C B 5 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -37.01 -37.91 -5.77 -35.68 -36.26 -5.44 ULMN 2 2bmi_01 CLASS B BETA-LACTAMASE user 6 2 # 6 B 86 ASP A 512 ASP~? 14.88 O6 G B 2 B 176 ASN A 564 ASN~? 16.11 O4 U B 1 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -9.37 -67.93 0.09 -10.86 -67.67 1.59 2bmi_01 source 2bmi CLASS B BETA-LACTAMASE : 6 hits 2bmi_01 naa= 2 ULMN 2 2c7v_00 PTERIDINE REDUCTASE user 1 2 # 1 A 171 PHE A 206 PHE~? 11.98 C2 A B 9 A 178 LYS A 212 LYS.? 5.77 N6 A B 9 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -24.24 -10.97 28.11 -26.44 -9.51 29.03 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -32.17 -17.64 24.03 -27.48 -21.87 22.97 ULMN 2 2c7v_00 PTERIDINE REDUCTASE user 2 2 # 2 A 171 PHE A 242 PHE~? 4.53 O2' A B 9 A 178 LYS A 236 LYS~? 15.40 O2 U B 8 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -16.89 -13.25 18.12 -14.38 -14.20 18.85 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 2c7v_00 PTERIDINE REDUCTASE user 3 2 # 3 A 171 PHE A 285 PHE~? 4.61 O2 U B 8 A 178 LYS A 201 LYS~? 2.54 O3' A B 9 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -15.93 -12.79 22.15 -13.89 -17.99 22.17 ULMN 2 2c7v_00 PTERIDINE REDUCTASE user 4 2 # 4 A 171 PHE A 285 PHE~? 4.61 O2 U B 8 A 178 LYS A 236 LYS~? 15.40 O2 U B 8 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 2c7v_00 PTERIDINE REDUCTASE user 5 2 # 5 A 171 PHE A 451 PHE~? 4.67 O2 U B 3 A 178 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 ULMN 2 2c7v_00 PTERIDINE REDUCTASE user 6 2 # 6 A 171 PHE A 552 PHE~? 9.25 O2 U B 1 A 178 LYS A 557 LYS~? 2.76 O4 U B 1 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 5.76 -57.72 -6.14 7.98 -57.47 -7.85 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 2c7v_00 source 2c7v PTERIDINE REDUCTASE : 6 hits 2c7v_00 naa= 2 ULMN 2 2c7v_01 PTERIDINE REDUCTASE user 1 2 # 1 B 171 PHE A 206 PHE~? 11.98 C2 A B 9 B 178 LYS A 212 LYS.? 5.77 N6 A B 9 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -24.24 -10.97 28.11 -26.44 -9.51 29.03 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -32.17 -17.64 24.03 -27.48 -21.87 22.97 ULMN 2 2c7v_01 PTERIDINE REDUCTASE user 2 2 # 2 B 171 PHE A 242 PHE~? 4.53 O2' A B 9 B 178 LYS A 236 LYS~? 15.40 O2 U B 8 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -16.89 -13.25 18.12 -14.38 -14.20 18.85 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 2c7v_01 PTERIDINE REDUCTASE user 3 2 # 3 B 171 PHE A 285 PHE~? 4.61 O2 U B 8 B 178 LYS A 201 LYS~? 2.54 O3' A B 9 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -15.93 -12.79 22.15 -13.89 -17.99 22.17 ULMN 2 2c7v_01 PTERIDINE REDUCTASE user 4 2 # 4 B 171 PHE A 285 PHE~? 4.61 O2 U B 8 B 178 LYS A 236 LYS~? 15.40 O2 U B 8 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 2c7v_01 PTERIDINE REDUCTASE user 5 2 # 5 B 171 PHE A 451 PHE~? 4.67 O2 U B 3 B 178 LYS A 360 LYS~? 2.92 OP1 C B 5 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 ULMN 2 2c7v_01 PTERIDINE REDUCTASE user 6 2 # 6 B 171 PHE A 552 PHE~? 9.25 O2 U B 1 B 178 LYS A 557 LYS~? 2.76 O4 U B 1 coo -21.65 17.34 10.98 -21.84 19.41 9.11 5.76 -57.72 -6.14 7.98 -57.47 -7.85 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 2c7v_01 source 2c7v PTERIDINE REDUCTASE : 6 hits 2c7v_01 naa= 2 ULMN 2 2c7v_02 PTERIDINE REDUCTASE user 1 2 # 1 C 171 PHE A 206 PHE~? 11.98 C2 A B 9 C 178 LYS A 212 LYS.? 5.77 N6 A B 9 coo 6.32 17.53 24.32 6.46 19.72 26.09 -24.24 -10.97 28.11 -26.44 -9.51 29.03 coo 3.63 7.30 27.09 2.92 9.52 32.06 -32.17 -17.64 24.03 -27.48 -21.87 22.97 ULMN 2 2c7v_02 PTERIDINE REDUCTASE user 2 2 # 2 C 171 PHE A 242 PHE~? 4.53 O2' A B 9 C 178 LYS A 236 LYS~? 15.40 O2 U B 8 coo 6.32 17.53 24.32 6.46 19.72 26.09 -16.89 -13.25 18.12 -14.38 -14.20 18.85 coo 3.63 7.30 27.09 2.92 9.52 32.06 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 2c7v_02 PTERIDINE REDUCTASE user 3 2 # 3 C 171 PHE A 285 PHE~? 4.61 O2 U B 8 C 178 LYS A 201 LYS~? 2.54 O3' A B 9 coo 6.32 17.53 24.32 6.46 19.72 26.09 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 3.63 7.30 27.09 2.92 9.52 32.06 -15.93 -12.79 22.15 -13.89 -17.99 22.17 ULMN 2 2c7v_02 PTERIDINE REDUCTASE user 4 2 # 4 C 171 PHE A 285 PHE~? 4.61 O2 U B 8 C 178 LYS A 236 LYS~? 15.40 O2 U B 8 coo 6.32 17.53 24.32 6.46 19.72 26.09 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo 3.63 7.30 27.09 2.92 9.52 32.06 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 2c7v_02 PTERIDINE REDUCTASE user 5 2 # 5 C 171 PHE A 451 PHE~? 4.67 O2 U B 3 C 178 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 6.32 17.53 24.32 6.46 19.72 26.09 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo 3.63 7.30 27.09 2.92 9.52 32.06 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 ULMN 2 2c7v_02 PTERIDINE REDUCTASE user 6 2 # 6 C 171 PHE A 552 PHE~? 9.25 O2 U B 1 C 178 LYS A 557 LYS~? 2.76 O4 U B 1 coo 6.32 17.53 24.32 6.46 19.72 26.09 5.76 -57.72 -6.14 7.98 -57.47 -7.85 coo 3.63 7.30 27.09 2.92 9.52 32.06 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 2c7v_02 source 2c7v PTERIDINE REDUCTASE : 6 hits 2c7v_02 naa= 2 ULMN 2 2c7v_03 PTERIDINE REDUCTASE user 1 2 # 1 D 171 PHE A 206 PHE~? 11.98 C2 A B 9 D 178 LYS A 212 LYS.? 5.77 N6 A B 9 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -24.24 -10.97 28.11 -26.44 -9.51 29.03 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -32.17 -17.64 24.03 -27.48 -21.87 22.97 ULMN 2 2c7v_03 PTERIDINE REDUCTASE user 2 2 # 2 D 171 PHE A 242 PHE~? 4.53 O2' A B 9 D 178 LYS A 236 LYS~? 15.40 O2 U B 8 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -16.89 -13.25 18.12 -14.38 -14.20 18.85 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 2c7v_03 PTERIDINE REDUCTASE user 3 2 # 3 D 171 PHE A 285 PHE~? 4.61 O2 U B 8 D 178 LYS A 201 LYS~? 2.54 O3' A B 9 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -15.93 -12.79 22.15 -13.89 -17.99 22.17 ULMN 2 2c7v_03 PTERIDINE REDUCTASE user 4 2 # 4 D 171 PHE A 285 PHE~? 4.61 O2 U B 8 D 178 LYS A 236 LYS~? 15.40 O2 U B 8 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -21.15 -5.56 9.63 -19.04 -2.89 13.94 ULMN 2 2c7v_03 PTERIDINE REDUCTASE user 5 2 # 5 D 171 PHE A 451 PHE~? 4.67 O2 U B 3 D 178 LYS A 360 LYS~? 2.92 OP1 C B 5 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -6.34 -39.08 -9.89 -4.40 -37.47 -8.63 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 ULMN 2 2c7v_03 PTERIDINE REDUCTASE user 6 2 # 6 D 171 PHE A 552 PHE~? 9.25 O2 U B 1 D 178 LYS A 557 LYS~? 2.76 O4 U B 1 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 5.76 -57.72 -6.14 7.98 -57.47 -7.85 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -3.09 -61.39 -2.07 -4.29 -55.63 -1.28 2c7v_03 source 2c7v PTERIDINE REDUCTASE : 6 hits 2c7v_03 naa= 2 ULMN 2 2c7v_04 PTERIDINE REDUCTASE user 1 2 # 1 A 174 TYR A 361 TYR~? 4.83 OP1 U B 6 A 178 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 2c7v_04 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_04 naa= 2 ULMN 2 2c7v_05 PTERIDINE REDUCTASE user 1 2 # 1 B 174 TYR A 361 TYR~? 4.83 OP1 U B 6 B 178 LYS A 360 LYS~? 2.92 OP1 C B 5 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 2c7v_05 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_05 naa= 2 ULMN 2 2c7v_06 PTERIDINE REDUCTASE user 1 2 # 1 C 174 TYR A 361 TYR~? 4.83 OP1 U B 6 C 178 LYS A 360 LYS~? 2.92 OP1 C B 5 coo 5.94 13.28 27.17 3.53 13.05 28.58 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 3.63 7.30 27.09 2.92 9.52 32.06 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 2c7v_06 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_06 naa= 2 ULMN 2 2c7v_07 PTERIDINE REDUCTASE user 1 2 # 1 D 174 TYR A 361 TYR~? 4.83 OP1 U B 6 D 178 LYS A 360 LYS~? 2.92 OP1 C B 5 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -12.16 -29.81 -4.92 -7.97 -30.31 -1.15 2c7v_07 source 2c7v PTERIDINE REDUCTASE : 1 hits 2c7v_07 naa= 2 ULMN 2 2cpo_00 CHLOROPEROXIDASE user 1 2 # 1 105 HIS A 420 HIS~? 9.42 N1 A B 4 183 GLU A 371 GLU~? 9.29 O2 C B 5 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -22.39 -40.81 -7.07 -24.44 -40.70 -6.62 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 2cpo_00 CHLOROPEROXIDASE user 2 2 # 2 105 HIS A 547 HIS~? 18.58 O4 U B 1 183 GLU A 545 GLU~? 17.12 N3 U B 1 coo 12.48 24.12 -9.88 11.36 24.64 -8.18 8.28 -67.57 -10.72 8.13 -67.19 -12.78 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 2.66 -64.95 -14.46 4.45 -64.54 -15.50 2cpo_00 source 2cpo CHLOROPEROXIDASE : 2 hits 2cpo_00 naa= 2 ULMN 2 2cpu_00 ALPHA-AMYLASE user 1 2 # 1 A 197 ASP A 174 ASP.? 19.36 O2' A B 9 A 236 ASP A 193 ASP~? 20.25 C2 A B 9 coo 12.51 17.07 49.46 12.44 16.89 47.35 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -22.85 0.02 23.71 -22.18 1.98 24.08 ULMN 2 2cpu_00 ALPHA-AMYLASE user 2 2 # 2 A 197 ASP A 193 ASP~? 20.25 C2 A B 9 A 236 ASP A 174 ASP.? 19.36 O2' A B 9 coo 12.51 17.07 49.46 12.44 16.89 47.35 -22.85 0.02 23.71 -22.18 1.98 24.08 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -15.98 -5.04 37.28 -14.70 -6.54 36.49 ULMN 2 2cpu_00 ALPHA-AMYLASE user 3 2 # 3 A 197 ASP A 193 ASP~? 20.25 C2 A B 9 A 236 ASP A 232 ASP~? 21.56 O2 U B 8 coo 12.51 17.07 49.46 12.44 16.89 47.35 -22.85 0.02 23.71 -22.18 1.98 24.08 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 2cpu_00 ALPHA-AMYLASE user 4 2 # 4 A 197 ASP A 233 ASP~? 18.81 O2 U B 8 A 236 ASP A 190 ASP~? 22.39 C2 A B 9 coo 12.51 17.07 49.46 12.44 16.89 47.35 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 2cpu_00 ALPHA-AMYLASE user 5 2 # 5 A 197 ASP A 233 ASP~? 18.81 O2 U B 8 A 236 ASP A 200 ASP~? 9.45 O2' A B 9 coo 12.51 17.07 49.46 12.44 16.89 47.35 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 2cpu_00 ALPHA-AMYLASE user 6 2 # 6 A 197 ASP A 233 ASP~? 18.81 O2 U B 8 A 236 ASP A 279 ASP~? 17.12 C2 A B 7 coo 12.51 17.07 49.46 12.44 16.89 47.35 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 ULMN 2 2cpu_00 ALPHA-AMYLASE user 7 2 # 7 A 197 ASP A 279 ASP~? 17.12 C2 A B 7 A 236 ASP A 233 ASP~? 18.81 O2 U B 8 coo 12.51 17.07 49.46 12.44 16.89 47.35 -20.38 -9.09 -1.03 -19.84 -7.89 -2.68 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 2cpu_00 ALPHA-AMYLASE user 8 2 # 8 A 197 ASP A 283 ASP~? 9.21 O2 U B 8 A 236 ASP A 232 ASP~? 21.56 O2 U B 8 coo 12.51 17.07 49.46 12.44 16.89 47.35 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 2cpu_00 ALPHA-AMYLASE user 9 2 # 9 A 197 ASP A 283 ASP~? 9.21 O2 U B 8 A 236 ASP A 233 ASP~? 18.81 O2 U B 8 coo 12.51 17.07 49.46 12.44 16.89 47.35 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -25.74 -2.21 12.01 -24.93 -0.35 12.67 ULMN 2 2cpu_00 ALPHA-AMYLASE user 10 2 # 10 A 197 ASP A 298 ASP~? 21.17 O4 U B 8 A 236 ASP A 260 ASP.? 30.95 O4 U B 8 coo 12.51 17.07 49.46 12.44 16.89 47.35 -41.82 -17.47 4.14 -42.95 -17.27 5.91 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -48.66 -5.55 12.81 -49.71 -4.82 11.14 ULMN 2 2cpu_00 ALPHA-AMYLASE user 11 2 # 11 A 197 ASP A 312 ASP~? 21.35 C2 A B 7 A 236 ASP A 321 ASP~? 8.41 N3 A B 7 coo 12.51 17.07 49.46 12.44 16.89 47.35 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 2cpu_00 ALPHA-AMYLASE user 12 2 # 12 A 197 ASP A 312 ASP~? 21.35 C2 A B 7 A 236 ASP A 345 ASP~? 24.06 C2 A B 4 coo 12.51 17.07 49.46 12.44 16.89 47.35 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 ULMN 2 2cpu_00 ALPHA-AMYLASE user 13 2 # 13 A 197 ASP A 345 ASP~? 24.06 C2 A B 4 A 236 ASP A 312 ASP~? 21.35 C2 A B 7 coo 12.51 17.07 49.46 12.44 16.89 47.35 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 ULMN 2 2cpu_00 ALPHA-AMYLASE user 14 2 # 14 A 197 ASP A 512 ASP~? 14.88 O6 G B 2 A 236 ASP A 533 ASP~? 24.95 O4 U B 1 coo 12.51 17.07 49.46 12.44 16.89 47.35 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 2cpu_00 ALPHA-AMYLASE user 15 2 # 15 A 197 ASP A 526 ASP^? 28.45 O6 G B 2 A 236 ASP A 512 ASP~? 14.88 O6 G B 2 coo 12.51 17.07 49.46 12.44 16.89 47.35 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 ULMN 2 2cpu_00 ALPHA-AMYLASE user 16 2 # 16 A 197 ASP A 533 ASP~? 24.95 O4 U B 1 A 236 ASP A 512 ASP~? 14.88 O6 G B 2 coo 12.51 17.07 49.46 12.44 16.89 47.35 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 2cpu_00 source 2cpu ALPHA-AMYLASE : 16 hits 2cpu_00 naa= 2 ULMN 2 2dhn_00 7,8-DIHYDRONEOPTERIN ALDOLASE user 1 2 # 1 22 GLU A 225 GLU~? 23.05 C2 A B 9 100 LYS A 268 LYS~? 23.13 O4 U B 8 coo 48.89 50.87 68.09 48.88 49.14 69.31 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo 41.76 43.63 69.91 46.12 48.11 71.43 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 2dhn_00 7,8-DIHYDRONEOPTERIN ALDOLASE user 2 2 # 2 22 GLU A 545 GLU~? 17.12 N3 U B 1 100 LYS A 487 LYS.? 20.83 N3 U B 1 coo 48.89 50.87 68.09 48.88 49.14 69.31 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 41.76 43.63 69.91 46.12 48.11 71.43 3.85 -58.89 -22.81 2.77 -64.79 -20.79 2dhn_00 source 2dhn 7,8-DIHYDRONEOPTERIN ALDOLASE : 2 hits 2dhn_00 naa= 2 ULMN 2 2ebn_00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 1 2 # 1 130 ASP A 174 ASP.? 19.36 O2' A B 9 132 GLU A 178 GLU.? 16.07 O2' A B 9 coo 25.19 32.92 18.85 27.07 32.05 18.66 -15.98 -5.04 37.28 -14.70 -6.54 36.49 coo 30.29 33.92 17.74 30.60 31.83 17.87 -13.75 -9.60 33.46 -13.25 -11.02 34.94 2ebn_00 source 2ebn ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1 (E.C.3.2.: 1 hits 2ebn_00 naa= 2 ULMN 2 2eng_00 ENDOGLUCANASE V user 1 2 # 1 10 ASP A 193 ASP~? 20.25 C2 A B 9 121 ASP A 190 ASP~? 22.39 C2 A B 9 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -22.85 0.02 23.71 -22.18 1.98 24.08 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 2eng_00 ENDOGLUCANASE V user 2 2 # 2 10 ASP A 321 ASP~? 8.41 N3 A B 7 121 ASP A 283 ASP~? 9.21 O2 U B 8 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 2eng_00 ENDOGLUCANASE V user 3 2 # 3 10 ASP A 359 ASP~? 8.63 O2' A B 4 121 ASP A 321 ASP~? 8.41 N3 A B 7 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -15.75 -20.08 -2.40 -14.93 -19.12 -0.71 ULMN 2 2eng_00 ENDOGLUCANASE V user 4 2 # 4 10 ASP A 376 ASP~? 17.17 N1 A B 4 121 ASP A 381 ASP.? 22.82 N6 A B 7 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 ULMN 2 2eng_00 ENDOGLUCANASE V user 5 2 # 5 10 ASP A 381 ASP.? 22.82 N6 A B 7 121 ASP A 376 ASP~? 17.17 N1 A B 4 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 ULMN 2 2eng_00 ENDOGLUCANASE V user 6 2 # 6 10 ASP A 473 ASP~? 22.60 N2 G B 2 121 ASP A 533 ASP~? 24.95 O4 U B 1 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 2eng_00 ENDOGLUCANASE V user 7 2 # 7 10 ASP A 477 ASP~? 24.62 N2 G B 2 121 ASP A 488 ASP~? 18.76 O2 U B 1 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 ULMN 2 2eng_00 ENDOGLUCANASE V user 8 2 # 8 10 ASP A 488 ASP~? 18.76 O2 U B 1 121 ASP A 477 ASP~? 24.62 N2 G B 2 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 2eng_00 source 2eng ENDOGLUCANASE V : 8 hits 2eng_00 naa= 2 ULMN 2 2eql_00 LYSOZYME (APO FORM) user 1 2 # 1 35 GLU A 470 GLU~? 22.82 N2 G B 2 53 ASP A 473 ASP~? 22.60 N2 G B 2 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -18.49 -56.34 -24.73 -19.54 -54.68 -25.54 coo 24.12 3.58 26.55 22.78 2.48 27.73 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 2eql_00 LYSOZYME (APO FORM) user 2 2 # 2 35 GLU A 545 GLU~? 17.12 N3 U B 1 53 ASP A 491 ASP~? 15.62 O2 U B 1 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 2.66 -64.95 -14.46 4.45 -64.54 -15.50 coo 24.12 3.58 26.55 22.78 2.48 27.73 2.02 -59.32 -18.53 4.01 -59.49 -17.81 2eql_00 source 2eql LYSOZYME (APO FORM) : 2 hits 2eql_00 naa= 2 ULMN 2 2fmn_00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 A 28 GLU A 225 GLU~? 23.05 C2 A B 9 A 120 ASP A 259 ASP.? 23.89 N1 A B 9 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 2fmn_00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 A 28 GLU A 391 GLU~? 23.54 N1 A B 4 A 120 ASP A 376 ASP~? 17.17 N1 A B 4 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 2fmn_00 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 2 hits 2fmn_00 naa= 2 ULMN 2 2fmn_01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 B 28 GLU A 225 GLU~? 23.05 C2 A B 9 B 120 ASP A 259 ASP.? 23.89 N1 A B 9 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 2fmn_01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 B 28 GLU A 391 GLU~? 23.54 N1 A B 4 B 120 ASP A 376 ASP~? 17.17 N1 A B 4 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 2fmn_01 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 2 hits 2fmn_01 naa= 2 ULMN 2 2fmn_02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 C 28 GLU A 225 GLU~? 23.05 C2 A B 9 C 120 ASP A 259 ASP.? 23.89 N1 A B 9 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -36.18 -1.53 15.48 -36.93 -1.10 13.54 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 2fmn_02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 C 28 GLU A 391 GLU~? 23.54 N1 A B 4 C 120 ASP A 376 ASP~? 17.17 N1 A B 4 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -36.19 -38.42 -16.35 -35.46 -39.66 -14.79 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 2fmn_02 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 2 hits 2fmn_02 naa= 2 ULMN 2 2gsa_00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 A 150 TYR A 262 TYR~? 21.79 O4 U B 8 A 245 ASP A 259 ASP.? 23.89 N1 A B 9 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 2gsa_00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 A 150 TYR A 479 TYR.? 25.88 N2 G B 2 A 245 ASP A 477 ASP~? 24.62 N2 G B 2 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -1.92 -57.32 -30.34 0.35 -57.24 -32.00 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -8.59 -60.87 -26.32 -8.05 -61.65 -28.20 2gsa_00 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_00 naa= 2 ULMN 2 2gsa_01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 262 TYR~? 21.79 O4 U B 8 B 245 ASP A 259 ASP.? 23.89 N1 A B 9 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -46.22 -8.67 16.01 -44.22 -8.07 15.57 2gsa_01 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_01 naa= 2 ULMN 2 2gsa_03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 262 TYR~? 21.79 O4 U B 8 B 245 ASP A 259 ASP.? 23.89 N1 A B 9 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -43.88 -12.23 10.07 -43.03 -14.64 8.96 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -46.22 -8.67 16.01 -44.22 -8.07 15.57 2gsa_03 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_03 naa= 2 ULMN 2 2gsa_05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 157 PHE A 221 PHE~? 23.88 N1 A B 9 B 245 ASP A 259 ASP.? 23.89 N1 A B 9 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 2gsa_05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 157 PHE A 272 PHE~? 19.44 O4 U B 8 B 245 ASP A 232 ASP~? 21.56 O2 U B 8 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -30.89 -5.38 4.64 -32.03 -3.22 6.00 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 2gsa_05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 B 157 PHE A 476 PHE~? 18.32 N2 G B 2 B 245 ASP A 533 ASP~? 24.95 O4 U B 1 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 ULMN 2 2gsa_05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 2 # 4 B 157 PHE A 531 PHE~? 20.43 O6 G B 2 B 245 ASP A 512 ASP~? 14.88 O6 G B 2 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 ULMN 2 2gsa_05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 2 # 5 B 157 PHE A 531 PHE~? 20.43 O6 G B 2 B 245 ASP A 526 ASP^? 28.45 O6 G B 2 coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -18.76 -64.74 -13.55 -20.01 -62.22 -13.42 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 2gsa_05 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 5 hits 2gsa_05 naa= 2 ULMN 2 2jcw_00 CU/ZN SUPEROXIDE DISMUTASE user 1 2 # 1 63 HIS A 326 HIS~? 3.28 C5 A B 7 143 ARG A 288 ARG~? 3.45 C6 A B 7 coo 7.37 21.96 20.34 6.83 20.29 19.19 -20.60 -25.48 2.69 -19.23 -27.01 3.11 coo 2.05 15.79 24.54 1.75 18.84 24.36 -21.54 -21.02 8.30 -20.02 -23.61 8.96 2jcw_00 source 2jcw CU/ZN SUPEROXIDE DISMUTASE : 1 hits 2jcw_00 naa= 2 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 1 2 # 1 37 ILE A 228 ILE~? 15.22 O4 U B 8 42 CYH A 204 CYH~? 3.50 N3 A B 9 coo 23.96 38.25 125.15 23.87 37.68 123.87 -32.27 -8.02 11.06 -32.89 -9.20 11.61 coo 36.88 46.86 127.06 36.03 46.98 124.43 -21.15 -12.39 22.03 -20.85 -14.34 20.00 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 2 2 # 2 37 ILE A 251 ILE~? 11.34 O4 U B 8 42 CYH A 204 CYH~? 3.50 N3 A B 9 coo 23.96 38.25 125.15 23.87 37.68 123.87 -32.55 -14.31 11.07 -32.16 -14.25 9.66 coo 36.88 46.86 127.06 36.03 46.98 124.43 -21.15 -12.39 22.03 -20.85 -14.34 20.00 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 3 2 # 3 37 ILE A 251 ILE~? 11.34 O4 U B 8 42 CYH A 281 CYH~? 10.64 C2 A B 7 coo 23.96 38.25 125.15 23.87 37.68 123.87 -32.55 -14.31 11.07 -32.16 -14.25 9.66 coo 36.88 46.86 127.06 36.03 46.98 124.43 -21.84 -15.78 -0.10 -24.15 -16.31 -1.64 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 4 2 # 4 37 ILE A 253 ILE~? 13.63 N1 A B 9 42 CYH A 204 CYH~? 3.50 N3 A B 9 coo 23.96 38.25 125.15 23.87 37.68 123.87 -36.07 -14.00 17.62 -35.68 -13.71 18.94 coo 36.88 46.86 127.06 36.03 46.98 124.43 -21.15 -12.39 22.03 -20.85 -14.34 20.00 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 5 2 # 5 37 ILE A 318 ILE~? 11.56 C2 A B 7 42 CYH A 357 CYH~? 11.67 N3 A B 4 coo 23.96 38.25 125.15 23.87 37.68 123.87 -20.56 -18.79 -5.51 -21.73 -18.15 -5.01 coo 36.88 46.86 127.06 36.03 46.98 124.43 -15.20 -30.19 -11.77 -17.54 -31.24 -12.82 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 6 2 # 6 37 ILE A 335 ILE~? 15.59 N6 A B 7 42 CYH A 287 CYH~? 3.94 C2 A B 7 coo 23.96 38.25 125.15 23.87 37.68 123.87 -34.43 -23.87 -3.13 -35.10 -22.67 -2.70 coo 36.88 46.86 127.06 36.03 46.98 124.43 -22.34 -17.28 4.03 -20.33 -19.29 4.31 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 7 2 # 7 37 ILE A 335 ILE~? 15.59 N6 A B 7 42 CYH A 319 CYH~? 13.55 O2' C B 5 coo 23.96 38.25 125.15 23.87 37.68 123.87 -34.43 -23.87 -3.13 -35.10 -22.67 -2.70 coo 36.88 46.86 127.06 36.03 46.98 124.43 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 8 2 # 8 37 ILE A 356 ILE~? 13.48 O2' A B 4 42 CYH A 281 CYH~? 10.64 C2 A B 7 coo 23.96 38.25 125.15 23.87 37.68 123.87 -17.62 -26.35 -11.64 -18.87 -25.82 -11.26 coo 36.88 46.86 127.06 36.03 46.98 124.43 -21.84 -15.78 -0.10 -24.15 -16.31 -1.64 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 9 2 # 9 37 ILE A 356 ILE~? 13.48 O2' A B 4 42 CYH A 405 CYH~? 14.40 N3 U B 3 coo 23.96 38.25 125.15 23.87 37.68 123.87 -17.62 -26.35 -11.64 -18.87 -25.82 -11.26 coo 36.88 46.86 127.06 36.03 46.98 124.43 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 10 2 # 10 37 ILE A 369 ILE~? 14.31 O2' C B 5 42 CYH A 303 CYH~? 19.60 N6 A B 7 coo 23.96 38.25 125.15 23.87 37.68 123.87 -26.26 -30.73 -8.67 -26.35 -29.53 -9.48 coo 36.88 46.86 127.06 36.03 46.98 124.43 -36.71 -18.21 -3.45 -38.39 -20.40 -3.80 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 11 2 # 11 37 ILE A 369 ILE~? 14.31 O2' C B 5 42 CYH A 405 CYH~? 14.40 N3 U B 3 coo 23.96 38.25 125.15 23.87 37.68 123.87 -26.26 -30.73 -8.67 -26.35 -29.53 -9.48 coo 36.88 46.86 127.06 36.03 46.98 124.43 -16.02 -38.15 -19.35 -16.81 -40.66 -18.55 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 12 2 # 12 37 ILE A 370 ILE~? 11.92 C2 A B 4 42 CYH A 319 CYH~? 13.55 O2' C B 5 coo 23.96 38.25 125.15 23.87 37.68 123.87 -25.29 -35.94 -9.48 -24.41 -36.62 -10.47 coo 36.88 46.86 127.06 36.03 46.98 124.43 -19.06 -22.90 -6.50 -21.10 -23.17 -8.40 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 13 2 # 13 37 ILE A 417 ILE~? 8.15 C2 A B 4 42 CYH A 433 CYH~? 20.69 O4 U B 3 coo 23.96 38.25 125.15 23.87 37.68 123.87 -18.29 -36.65 -10.23 -18.76 -35.34 -10.40 coo 36.88 46.86 127.06 36.03 46.98 124.43 -23.16 -44.63 -21.31 -23.42 -41.99 -22.17 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 14 2 # 14 37 ILE A 434 ILE~? 14.55 O4 U B 3 42 CYH A 363 CYH~? 7.33 N3 A B 4 coo 23.96 38.25 125.15 23.87 37.68 123.87 -19.81 -43.58 -17.92 -19.50 -42.82 -16.80 coo 36.88 46.86 127.06 36.03 46.98 124.43 -16.93 -31.24 -7.47 -14.81 -32.24 -8.90 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 15 2 # 15 37 ILE A 475 ILE~? 14.48 N2 G B 2 42 CYH A 438 CYH~? 14.92 N3 U B 3 coo 23.96 38.25 125.15 23.87 37.68 123.87 -8.38 -57.35 -19.36 -7.58 -56.27 -18.98 coo 36.88 46.86 127.06 36.03 46.98 124.43 -15.53 -43.60 -22.27 -14.50 -42.21 -20.10 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 16 2 # 16 37 ILE A 475 ILE~? 14.48 N2 G B 2 42 CYH A 511 CYH~? 14.88 O4 U B 1 coo 23.96 38.25 125.15 23.87 37.68 123.87 -8.38 -57.35 -19.36 -7.58 -56.27 -18.98 coo 36.88 46.86 127.06 36.03 46.98 124.43 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 17 2 # 17 37 ILE A 529 ILE~? 29.31 O6 G B 2 42 CYH A 511 CYH~? 14.88 O4 U B 1 coo 23.96 38.25 125.15 23.87 37.68 123.87 -20.60 -70.90 -18.73 -20.69 -71.06 -20.19 coo 36.88 46.86 127.06 36.03 46.98 124.43 -14.22 -65.74 -7.10 -11.48 -66.00 -6.76 ULMN 2 2npx_00 NADH PEROXIDASE (E.C.1.11.1.1) WITH user 18 2 # 18 37 ILE A 559 ILE~? 12.13 O4 U B 1 42 CYH A 510 CYH~? 17.27 O4 U B 1 coo 23.96 38.25 125.15 23.87 37.68 123.87 -0.94 -66.38 -4.29 0.38 -66.98 -4.46 coo 36.88 46.86 127.06 36.03 46.98 124.43 -14.84 -63.96 -10.39 -13.70 -63.47 -12.86 2npx_00 source 2npx NADH PEROXIDASE (E.C.1.11.1.1) WITH CYS 42 OXI: 18 hits 2npx_00 naa= 2 ULMN 2 2oat_00 ORNITHINE AMINOTRANSFERASE user 1 2 # 1 A 178 TRP A 534 TRP~? 20.57 N2 G B 2 A 263 ASP A 473 ASP~? 22.60 N2 G B 2 coo 48.96 45.07 19.49 48.62 41.39 18.16 -13.87 -64.07 -18.86 -17.27 -62.50 -17.72 coo 54.43 44.82 23.74 55.21 45.06 21.80 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 2oat_00 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_00 naa= 2 ULMN 2 2oat_01 ORNITHINE AMINOTRANSFERASE user 1 2 # 1 B 178 TRP A 534 TRP~? 20.57 N2 G B 2 B 263 ASP A 473 ASP~? 22.60 N2 G B 2 coo 45.83 31.15 4.65 45.88 34.74 6.24 -13.87 -64.07 -18.86 -17.27 -62.50 -17.72 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 2oat_01 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_01 naa= 2 ULMN 2 2oat_02 ORNITHINE AMINOTRANSFERASE user 1 2 # 1 C 178 TRP A 534 TRP~? 20.57 N2 G B 2 C 263 ASP A 473 ASP~? 22.60 N2 G B 2 coo 20.52 16.65 4.15 17.32 18.91 4.39 -13.87 -64.07 -18.86 -17.27 -62.50 -17.72 coo 19.84 12.02 9.33 18.68 11.23 7.75 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 2oat_02 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_02 naa= 2 ULMN 2 2pec_00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 1 2 # 1 131 ASP A 345 ASP~? 24.06 C2 A B 4 218 ARG A 311 ARG.? 21.53 N1 A B 7 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -28.14 -16.31 -12.56 -31.15 -16.30 -12.01 ULMN 2 2pec_00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 2 2 # 2 131 ASP A 345 ASP~? 24.06 C2 A B 4 218 ARG A 392 ARG~? 29.32 C2 A B 4 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -28.92 -24.87 -17.69 -30.55 -26.19 -17.93 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -37.93 -32.47 -20.18 -39.06 -30.10 -18.54 ULMN 2 2pec_00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 3 2 # 3 131 ASP A 381 ASP.? 22.82 N6 A B 7 218 ARG A 390 ARG~? 22.44 N1 A B 4 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -42.59 -36.92 -1.84 -40.82 -35.77 -2.02 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -35.53 -36.08 -9.77 -35.84 -38.24 -11.93 ULMN 2 2pec_00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 4 2 # 4 131 ASP A 488 ASP~? 18.76 O2 U B 1 218 ARG A 548 ARG~? 15.11 O2 U B 1 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 7.33 -63.34 -13.62 6.31 -60.85 -15.12 2pec_00 source 2pec PECTATE LYASE C (PLC) (E.C.4.2.2.2) : 4 hits 2pec_00 naa= 2 ULMN 2 2phk_00 MC-PEPTIDE user 1 2 # 1 A 149 ASP A 359 ASP~? 8.63 O2' A B 4 A 153 GLU A 412 GLU.? 7.44 O2' U B 3 coo 41.42 17.90 44.98 43.39 18.36 45.61 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 51.07 15.29 42.97 50.55 17.18 42.21 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 ULMN 2 2phk_00 MC-PEPTIDE user 2 2 # 2 A 149 ASP A 376 ASP~? 17.17 N1 A B 4 A 153 GLU A 371 GLU~? 9.29 O2 C B 5 coo 41.42 17.90 44.98 43.39 18.36 45.61 -32.93 -42.49 -5.03 -32.51 -40.56 -4.24 coo 51.07 15.29 42.97 50.55 17.18 42.21 -25.95 -37.52 -4.60 -24.96 -37.40 -2.73 ULMN 2 2phk_00 MC-PEPTIDE user 3 2 # 3 A 149 ASP A 425 ASP.? 18.06 O4 U B 3 A 153 GLU A 522 GLU^? 23.38 O4 U B 3 coo 41.42 17.90 44.98 43.39 18.36 45.61 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 51.07 15.29 42.97 50.55 17.18 42.21 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 2phk_00 MC-PEPTIDE user 4 2 # 4 A 149 ASP A 488 ASP~? 18.76 O2 U B 1 A 153 GLU A 545 GLU~? 17.12 N3 U B 1 coo 41.42 17.90 44.98 43.39 18.36 45.61 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 51.07 15.29 42.97 50.55 17.18 42.21 2.66 -64.95 -14.46 4.45 -64.54 -15.50 2phk_00 source 2phk MC-PEPTIDE : 4 hits 2phk_00 naa= 2 ULMN 2 2phk_01 MC-PEPTIDE user 1 2 # 1 A 149 ASP A 193 ASP~? 20.25 C2 A B 9 A 151 LYS A 196 LYS~? 19.45 O2' A B 9 coo 41.42 17.90 44.98 43.39 18.36 45.61 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 45.75 16.58 39.61 47.43 18.26 45.54 -19.67 -3.42 20.50 -17.88 1.90 20.43 ULMN 2 2phk_01 MC-PEPTIDE user 2 2 # 2 A 149 ASP A 533 ASP~? 24.95 O4 U B 1 A 151 LYS A 536 LYS~? 26.44 O4 U B 1 coo 41.42 17.90 44.98 43.39 18.36 45.61 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 45.75 16.58 39.61 47.43 18.26 45.54 -9.78 -70.18 -15.12 -11.70 -73.12 -19.74 ULMN 2 2phk_01 MC-PEPTIDE user 3 2 # 3 A 149 ASP A 533 ASP~? 24.95 O4 U B 1 A 151 LYS A 537 LYS~? 23.79 O4 U B 1 coo 41.42 17.90 44.98 43.39 18.36 45.61 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 coo 45.75 16.58 39.61 47.43 18.26 45.54 -7.69 -67.72 -17.18 -9.13 -66.83 -22.49 2phk_01 source 2phk MC-PEPTIDE : 3 hits 2phk_01 naa= 2 ULMN 2 2qf7_00 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 A 549 ASP A 193 ASP~? 20.25 C2 A B 9 A 655 ASP A 232 ASP~? 21.56 O2 U B 8 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 2qf7_00 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 A 549 ASP A 233 ASP~? 18.81 O2 U B 8 A 655 ASP A 190 ASP~? 22.39 C2 A B 9 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 2qf7_00 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 A 549 ASP A 283 ASP~? 9.21 O2 U B 8 A 655 ASP A 200 ASP~? 9.45 O2' A B 9 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 2qf7_00 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 A 549 ASP A 312 ASP~? 21.35 C2 A B 7 A 655 ASP A 283 ASP~? 9.21 O2 U B 8 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 2qf7_00 PYRUVATE CARBOXYLASE PROTEIN user 5 2 # 5 A 549 ASP A 312 ASP~? 21.35 C2 A B 7 A 655 ASP A 359 ASP~? 8.63 O2' A B 4 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 2qf7_00 PYRUVATE CARBOXYLASE PROTEIN user 6 2 # 6 A 549 ASP A 359 ASP~? 8.63 O2' A B 4 A 655 ASP A 283 ASP~? 9.21 O2 U B 8 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 2qf7_00 PYRUVATE CARBOXYLASE PROTEIN user 7 2 # 7 A 549 ASP A 359 ASP~? 8.63 O2' A B 4 A 655 ASP A 312 ASP~? 21.35 C2 A B 7 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 ULMN 2 2qf7_00 PYRUVATE CARBOXYLASE PROTEIN user 8 2 # 8 A 549 ASP A 425 ASP.? 18.06 O4 U B 3 A 655 ASP A 512 ASP~? 14.88 O6 G B 2 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 ULMN 2 2qf7_00 PYRUVATE CARBOXYLASE PROTEIN user 9 2 # 9 A 549 ASP A 473 ASP~? 22.60 N2 G B 2 A 655 ASP A 526 ASP^? 28.45 O6 G B 2 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 2qf7_00 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 9 hits 2qf7_00 naa= 2 ULMN 2 2qf7_01 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 B 549 ASP A 193 ASP~? 20.25 C2 A B 9 B 655 ASP A 232 ASP~? 21.56 O2 U B 8 coo 76.34 71.89 30.92 75.58 70.99 29.16 -22.85 0.02 23.71 -22.18 1.98 24.08 coo 66.54 57.43 28.71 66.94 55.81 27.41 -24.56 0.12 7.49 -25.80 1.40 6.37 ULMN 2 2qf7_01 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 B 549 ASP A 233 ASP~? 18.81 O2 U B 8 B 655 ASP A 190 ASP~? 22.39 C2 A B 9 coo 76.34 71.89 30.92 75.58 70.99 29.16 -25.74 -2.21 12.01 -24.93 -0.35 12.67 coo 66.54 57.43 28.71 66.94 55.81 27.41 -31.44 0.79 27.21 -33.43 0.08 27.41 ULMN 2 2qf7_01 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 B 549 ASP A 312 ASP~? 21.35 C2 A B 7 B 655 ASP A 283 ASP~? 9.21 O2 U B 8 coo 76.34 71.89 30.92 75.58 70.99 29.16 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo 66.54 57.43 28.71 66.94 55.81 27.41 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 2qf7_01 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 B 549 ASP A 312 ASP~? 21.35 C2 A B 7 B 655 ASP A 359 ASP~? 8.63 O2' A B 4 coo 76.34 71.89 30.92 75.58 70.99 29.16 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 coo 66.54 57.43 28.71 66.94 55.81 27.41 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 ULMN 2 2qf7_01 PYRUVATE CARBOXYLASE PROTEIN user 5 2 # 5 B 549 ASP A 359 ASP~? 8.63 O2' A B 4 B 655 ASP A 283 ASP~? 9.21 O2 U B 8 coo 76.34 71.89 30.92 75.58 70.99 29.16 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 66.54 57.43 28.71 66.94 55.81 27.41 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 2qf7_01 PYRUVATE CARBOXYLASE PROTEIN user 6 2 # 6 B 549 ASP A 359 ASP~? 8.63 O2' A B 4 B 655 ASP A 312 ASP~? 21.35 C2 A B 7 coo 76.34 71.89 30.92 75.58 70.99 29.16 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 66.54 57.43 28.71 66.94 55.81 27.41 -21.35 -13.56 -14.90 -21.46 -12.38 -13.14 ULMN 2 2qf7_01 PYRUVATE CARBOXYLASE PROTEIN user 7 2 # 7 B 549 ASP A 425 ASP.? 18.06 O4 U B 3 B 655 ASP A 512 ASP~? 14.88 O6 G B 2 coo 76.34 71.89 30.92 75.58 70.99 29.16 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 66.54 57.43 28.71 66.94 55.81 27.41 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 ULMN 2 2qf7_01 PYRUVATE CARBOXYLASE PROTEIN user 8 2 # 8 B 549 ASP A 473 ASP~? 22.60 N2 G B 2 B 655 ASP A 526 ASP^? 28.45 O6 G B 2 coo 76.34 71.89 30.92 75.58 70.99 29.16 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 coo 66.54 57.43 28.71 66.94 55.81 27.41 -27.33 -68.60 -15.65 -26.13 -68.93 -13.94 2qf7_01 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 8 hits 2qf7_01 naa= 2 ULMN 2 2thi_00 THIAMINASE I user 1 2 # 1 A 113 CYH A 505 CYH~? 8.75 N1 G B 2 A 241 GLU A 457 GLU~? 3.32 N1 G B 2 coo 34.48 86.17 8.89 35.98 87.52 6.88 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 coo 41.40 85.25 6.42 39.33 85.57 6.74 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 2thi_00 source 2thi THIAMINASE I : 1 hits 2thi_00 naa= 2 ULMN 2 2thi_01 THIAMINASE I user 1 2 # 1 B 113 CYH A 505 CYH~? 8.75 N1 G B 2 B 241 GLU A 457 GLU~? 3.32 N1 G B 2 coo 6.76 34.20 8.77 5.34 32.83 6.71 -10.70 -56.49 -8.45 -12.68 -54.65 -9.18 coo -0.20 35.10 6.38 1.89 34.79 6.65 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 2thi_01 source 2thi THIAMINASE I : 1 hits 2thi_01 naa= 2 ULMN 2 2toh_00 TYROSINE 3-MONOOXYGENASE user 1 2 # 1 A 331 HIS A 454 HIS~? 3.31 C5 U B 3 A 395 SER A 453 SER~? 2.96 N2 G B 2 coo 76.89 62.57 43.06 74.99 62.50 42.14 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo 75.56 65.50 47.86 75.54 65.13 45.50 -7.75 -46.76 -11.90 -5.98 -46.34 -10.23 2toh_00 source 2toh TYROSINE 3-MONOOXYGENASE : 1 hits 2toh_00 naa= 2 ULMN 2 2tpl_00 TYROSINE PHENOL-LYASE user 1 2 # 1 A 123 PHE A 197 PHE~? 14.18 C2 A B 9 A 214 ASP A 200 ASP~? 9.45 O2' A B 9 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 2tpl_00 TYROSINE PHENOL-LYASE user 2 2 # 2 A 123 PHE A 221 PHE~? 23.88 N1 A B 9 A 214 ASP A 259 ASP.? 23.89 N1 A B 9 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 2tpl_00 TYROSINE PHENOL-LYASE user 3 2 # 3 A 123 PHE A 224 PHE~? 18.04 N1 A B 9 A 214 ASP A 259 ASP.? 23.89 N1 A B 9 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 2tpl_00 TYROSINE PHENOL-LYASE user 4 2 # 4 A 123 PHE A 242 PHE~? 4.53 O2' A B 9 A 214 ASP A 200 ASP~? 9.45 O2' A B 9 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -16.89 -13.25 18.12 -14.38 -14.20 18.85 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 2tpl_00 TYROSINE PHENOL-LYASE user 5 2 # 5 A 123 PHE A 285 PHE~? 4.61 O2 U B 8 A 214 ASP A 283 ASP~? 9.21 O2 U B 8 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 2tpl_00 TYROSINE PHENOL-LYASE user 6 2 # 6 A 123 PHE A 476 PHE~? 18.32 N2 G B 2 A 214 ASP A 473 ASP~? 22.60 N2 G B 2 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 ULMN 2 2tpl_00 TYROSINE PHENOL-LYASE user 7 2 # 7 A 123 PHE A 476 PHE~? 18.32 N2 G B 2 A 214 ASP A 533 ASP~? 24.95 O4 U B 1 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -14.56 -68.79 -19.27 -13.14 -68.69 -20.82 2tpl_00 source 2tpl TYROSINE PHENOL-LYASE : 7 hits 2tpl_00 naa= 2 ULMN 2 2tpl_01 TYROSINE PHENOL-LYASE user 1 2 # 1 B 123 PHE A 197 PHE~? 14.18 C2 A B 9 B 214 ASP A 200 ASP~? 9.45 O2' A B 9 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -22.03 -5.74 24.67 -21.86 -4.23 27.01 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -16.63 -8.21 22.33 -15.39 -8.76 23.94 ULMN 2 2tpl_01 TYROSINE PHENOL-LYASE user 2 2 # 2 B 123 PHE A 221 PHE~? 23.88 N1 A B 9 B 214 ASP A 259 ASP.? 23.89 N1 A B 9 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -39.67 -2.92 18.42 -40.24 -0.76 16.73 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 2tpl_01 TYROSINE PHENOL-LYASE user 3 2 # 3 B 123 PHE A 224 PHE~? 18.04 N1 A B 9 B 214 ASP A 259 ASP.? 23.89 N1 A B 9 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -37.23 -7.70 15.52 -38.51 -10.01 16.36 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -46.22 -8.67 16.01 -44.22 -8.07 15.57 ULMN 2 2tpl_01 TYROSINE PHENOL-LYASE user 4 2 # 4 B 123 PHE A 285 PHE~? 4.61 O2 U B 8 B 214 ASP A 283 ASP~? 9.21 O2 U B 8 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -17.29 -15.05 9.64 -14.77 -15.72 10.64 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -18.31 -12.98 3.59 -17.36 -12.32 5.35 ULMN 2 2tpl_01 TYROSINE PHENOL-LYASE user 5 2 # 5 B 123 PHE A 476 PHE~? 18.32 N2 G B 2 B 214 ASP A 473 ASP~? 22.60 N2 G B 2 coo -26.81 18.98 9.83 -25.06 17.93 7.94 -8.95 -62.31 -19.99 -9.56 -62.61 -17.31 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -13.42 -59.86 -24.27 -14.80 -61.47 -24.05 2tpl_01 source 2tpl TYROSINE PHENOL-LYASE : 5 hits 2tpl_01 naa= 2 ULMN 2 3pca_01 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 N 447 TYR A 361 TYR~? 4.83 OP1 U B 6 N 457 ARG A 364 ARG~? 3.58 O2 C B 5 coo 10.05 43.90 8.55 11.74 45.69 9.93 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 10.54 37.95 11.06 8.06 36.82 12.51 -17.84 -32.65 -1.33 -19.23 -35.35 -1.33 ULMN 2 3pca_01 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 N 447 TYR A 416 TYR~? 3.28 C4 A B 4 N 457 ARG A 364 ARG~? 3.58 O2 C B 5 coo 10.05 43.90 8.55 11.74 45.69 9.93 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 coo 10.54 37.95 11.06 8.06 36.82 12.51 -17.84 -32.65 -1.33 -19.23 -35.35 -1.33 3pca_01 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 2 hits 3pca_01 naa= 2 ULMN 2 3pca_02 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 O 447 TYR A 361 TYR~? 4.83 OP1 U B 6 O 457 ARG A 364 ARG~? 3.58 O2 C B 5 coo 43.82 8.53 10.01 45.63 9.88 11.69 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo 38.02 11.23 10.58 36.95 12.66 8.07 -17.84 -32.65 -1.33 -19.23 -35.35 -1.33 3pca_02 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 1 hits 3pca_02 naa= 2 ULMN 2 3pca_04 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 Q 447 TYR A 361 TYR~? 4.83 OP1 U B 6 Q 457 ARG A 364 ARG~? 3.58 O2 C B 5 coo -10.11 -43.85 8.55 -11.75 -45.67 9.94 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo -10.52 -38.03 11.19 -7.90 -36.98 12.68 -17.84 -32.65 -1.33 -19.23 -35.35 -1.33 3pca_04 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 1 hits 3pca_04 naa= 2 ULMN 2 3pca_05 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 R 447 TYR A 361 TYR~? 4.83 OP1 U B 6 R 457 ARG A 364 ARG~? 3.58 O2 C B 5 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -14.06 -26.52 -1.95 -12.09 -26.70 -0.01 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -17.84 -32.65 -1.33 -19.23 -35.35 -1.33 ULMN 2 3pca_05 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 R 447 TYR A 416 TYR~? 3.28 C4 A B 4 R 457 ARG A 364 ARG~? 3.58 O2 C B 5 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -13.84 -38.78 -5.47 -11.49 -39.37 -4.08 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -17.84 -32.65 -1.33 -19.23 -35.35 -1.33 3pca_05 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 2 hits 3pca_05 naa= 2 ULMN 2 4mdh_00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 A 158 ASP A 283 ASP~? 9.21 O2 U B 8 A 185 ASN A 240 ASN.? 9.01 O2 U B 8 coo 18.62 26.83 58.17 18.48 28.64 57.08 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 11.83 33.94 58.73 11.65 35.30 57.09 -18.56 -9.78 12.83 -17.16 -9.65 14.42 ULMN 2 4mdh_00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 A 158 ASP A 283 ASP~? 9.21 O2 U B 8 A 185 ASN A 244 ASN~? 2.92 O2 U B 8 coo 18.62 26.83 58.17 18.48 28.64 57.08 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 11.83 33.94 58.73 11.65 35.30 57.09 -22.00 -14.42 11.48 -21.14 -16.18 12.31 ULMN 2 4mdh_00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 2 # 3 A 158 ASP A 298 ASP~? 21.17 O4 U B 8 A 185 ASN A 258 ASN.? 23.39 O4 U B 8 coo 18.62 26.83 58.17 18.48 28.64 57.08 -41.82 -17.47 4.14 -42.95 -17.27 5.91 coo 11.83 33.94 58.73 11.65 35.30 57.09 -46.92 -14.31 13.78 -45.92 -15.90 12.78 ULMN 2 4mdh_00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 2 # 4 A 158 ASP A 298 ASP~? 21.17 O4 U B 8 A 185 ASN A 296 ASN~? 11.04 O4 U B 8 coo 18.62 26.83 58.17 18.48 28.64 57.08 -41.82 -17.47 4.14 -42.95 -17.27 5.91 coo 11.83 33.94 58.73 11.65 35.30 57.09 -34.93 -19.92 9.17 -33.77 -21.43 10.15 ULMN 2 4mdh_00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 2 # 5 A 158 ASP A 359 ASP~? 8.63 O2' A B 4 A 185 ASN A 325 ASN~? 6.34 O2' C B 5 coo 18.62 26.83 58.17 18.48 28.64 57.08 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 11.83 33.94 58.73 11.65 35.30 57.09 -19.09 -24.77 -2.46 -18.64 -25.98 -0.78 ULMN 2 4mdh_00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 2 # 6 A 158 ASP A 426 ASP.? 18.90 N1 A B 4 A 185 ASN A 379 ASN~? 20.05 O2 C B 5 coo 18.62 26.83 58.17 18.48 28.64 57.08 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 11.83 33.94 58.73 11.65 35.30 57.09 -37.01 -37.91 -5.77 -35.68 -36.26 -5.44 ULMN 2 4mdh_00 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 7 2 # 7 A 158 ASP A 512 ASP~? 14.88 O6 G B 2 A 185 ASN A 564 ASN~? 16.11 O4 U B 1 coo 18.62 26.83 58.17 18.48 28.64 57.08 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 11.83 33.94 58.73 11.65 35.30 57.09 -9.37 -67.93 0.09 -10.86 -67.67 1.59 4mdh_00 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 7 hits 4mdh_00 naa= 2 ULMN 2 4mdh_01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 B 158 ASP A 260 ASP.? 30.95 O4 U B 8 B 185 ASN A 258 ASN.? 23.39 O4 U B 8 coo 44.53 16.44 28.54 44.89 18.45 28.77 -48.66 -5.55 12.81 -49.71 -4.82 11.14 coo 54.37 18.81 28.31 54.76 20.47 29.61 -46.92 -14.31 13.78 -45.92 -15.90 12.78 ULMN 2 4mdh_01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 B 158 ASP A 283 ASP~? 9.21 O2 U B 8 B 185 ASN A 240 ASN.? 9.01 O2 U B 8 coo 44.53 16.44 28.54 44.89 18.45 28.77 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 54.37 18.81 28.31 54.76 20.47 29.61 -18.56 -9.78 12.83 -17.16 -9.65 14.42 ULMN 2 4mdh_01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 2 # 3 B 158 ASP A 283 ASP~? 9.21 O2 U B 8 B 185 ASN A 244 ASN~? 2.92 O2 U B 8 coo 44.53 16.44 28.54 44.89 18.45 28.77 -18.31 -12.98 3.59 -17.36 -12.32 5.35 coo 54.37 18.81 28.31 54.76 20.47 29.61 -22.00 -14.42 11.48 -21.14 -16.18 12.31 ULMN 2 4mdh_01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 2 # 4 B 158 ASP A 298 ASP~? 21.17 O4 U B 8 B 185 ASN A 296 ASN~? 11.04 O4 U B 8 coo 44.53 16.44 28.54 44.89 18.45 28.77 -41.82 -17.47 4.14 -42.95 -17.27 5.91 coo 54.37 18.81 28.31 54.76 20.47 29.61 -34.93 -19.92 9.17 -33.77 -21.43 10.15 ULMN 2 4mdh_01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 5 2 # 5 B 158 ASP A 359 ASP~? 8.63 O2' A B 4 B 185 ASN A 325 ASN~? 6.34 O2' C B 5 coo 44.53 16.44 28.54 44.89 18.45 28.77 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 54.37 18.81 28.31 54.76 20.47 29.61 -19.09 -24.77 -2.46 -18.64 -25.98 -0.78 ULMN 2 4mdh_01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 6 2 # 6 B 158 ASP A 426 ASP.? 18.90 N1 A B 4 B 185 ASN A 379 ASN~? 20.05 O2 C B 5 coo 44.53 16.44 28.54 44.89 18.45 28.77 -30.95 -44.62 -8.74 -32.14 -45.79 -7.41 coo 54.37 18.81 28.31 54.76 20.47 29.61 -37.01 -37.91 -5.77 -35.68 -36.26 -5.44 ULMN 2 4mdh_01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 7 2 # 7 B 158 ASP A 512 ASP~? 14.88 O6 G B 2 B 185 ASN A 564 ASN~? 16.11 O4 U B 1 coo 44.53 16.44 28.54 44.89 18.45 28.77 -17.61 -62.57 -5.58 -16.61 -61.70 -3.92 coo 54.37 18.81 28.31 54.76 20.47 29.61 -9.37 -67.93 0.09 -10.86 -67.67 1.59 4mdh_01 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 7 hits 4mdh_01 naa= 2 ULMN 2 5cpa_00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 2 # 1 127 ARG A 431 ARG~? 16.75 O4 U B 3 270 GLU A 522 GLU^? 23.38 O4 U B 3 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -23.17 -48.85 -13.81 -25.31 -49.91 -11.91 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 5cpa_00 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 1 hits 5cpa_00 naa= 2 ULMN 2 5enl_02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 2 # 1 191 HIS A 352 HIS~? 21.18 O2' A B 4 345 LYS A 270 LYS~? 23.81 O4 U B 8 coo 87.81 42.65 46.75 88.49 40.86 45.92 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 coo 103.66 43.57 23.68 98.86 47.65 23.32 -34.59 -10.25 1.84 -37.84 -8.42 -2.07 ULMN 2 5enl_02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 2 # 2 191 HIS A 527 HIS~? 25.85 N2 G B 2 345 LYS A 544 LYS~? 22.64 O4 U B 1 coo 87.81 42.65 46.75 88.49 40.86 45.92 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo 103.66 43.57 23.68 98.86 47.65 23.32 2.51 -69.72 -14.20 -0.06 -70.01 -19.70 5enl_02 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 2 hits 5enl_02 naa= 2 ULMN 2 5enl_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 2 # 1 242 LYS A 209 LYS~? 11.26 C2 A B 9 345 LYS A 284 LYS.? 5.29 OP1 U B 8 coo 99.51 55.26 43.28 102.26 58.28 46.19 -27.43 -16.88 26.23 -24.36 -18.13 30.86 coo 103.66 43.57 23.68 98.86 47.65 23.32 -16.65 -16.94 5.44 -12.34 -19.40 9.40 ULMN 2 5enl_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 2 # 2 242 LYS A 212 LYS.? 5.77 N6 A B 9 345 LYS A 268 LYS~? 23.13 O4 U B 8 coo 99.51 55.26 43.28 102.26 58.28 46.19 -32.17 -17.64 24.03 -27.48 -21.87 22.97 coo 103.66 43.57 23.68 98.86 47.65 23.32 -36.22 -5.92 4.46 -36.10 -1.68 8.58 ULMN 2 5enl_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 3 2 # 3 242 LYS A 236 LYS~? 15.40 O2 U B 8 345 LYS A 330 LYS~? 6.92 N6 A B 7 coo 99.51 55.26 43.28 102.26 58.28 46.19 -21.15 -5.56 9.63 -19.04 -2.89 13.94 coo 103.66 43.57 23.68 98.86 47.65 23.32 -28.12 -25.40 0.86 -29.08 -26.03 5.63 ULMN 2 5enl_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 4 2 # 4 242 LYS A 268 LYS~? 23.13 O4 U B 8 345 LYS A 330 LYS~? 6.92 N6 A B 7 coo 99.51 55.26 43.28 102.26 58.28 46.19 -36.22 -5.92 4.46 -36.10 -1.68 8.58 coo 103.66 43.57 23.68 98.86 47.65 23.32 -28.12 -25.40 0.86 -29.08 -26.03 5.63 ULMN 2 5enl_03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 5 2 # 5 242 LYS A 556 LYS~? 9.38 OP2 U B 1 345 LYS A 458 LYS~? 5.39 O4 U B 3 coo 99.51 55.26 43.28 102.26 58.28 46.19 0.47 -62.65 -2.47 5.80 -61.35 0.58 coo 103.66 43.57 23.68 98.86 47.65 23.32 -16.09 -49.36 -10.10 -15.25 -47.03 -5.63 5enl_03 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 5 hits 5enl_03 naa= 2 ULMN 2 7nn9_00 NEURAMINIDASE N9 user 1 2 # 1 151 ASP A 359 ASP~? 8.63 O2' A B 4 277 GLU A 412 GLU.? 7.44 O2' U B 3 coo 25.08 13.39 65.77 24.68 15.22 66.73 -12.56 -26.65 -8.24 -12.24 -25.63 -6.41 coo 24.99 20.41 57.94 24.48 20.83 59.94 -7.17 -33.28 -8.91 -5.57 -31.98 -8.41 ULMN 2 7nn9_00 NEURAMINIDASE N9 user 2 2 # 2 151 ASP A 425 ASP.? 18.06 O4 U B 3 277 GLU A 432 GLU~? 22.16 O4 U B 3 coo 25.08 13.39 65.77 24.68 15.22 66.73 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 24.99 20.41 57.94 24.48 20.83 59.94 -25.38 -49.45 -18.64 -26.92 -50.66 -19.35 ULMN 2 7nn9_00 NEURAMINIDASE N9 user 3 2 # 3 151 ASP A 425 ASP.? 18.06 O4 U B 3 277 GLU A 522 GLU^? 23.38 O4 U B 3 coo 25.08 13.39 65.77 24.68 15.22 66.73 -28.68 -49.53 -9.05 -27.30 -51.11 -8.73 coo 24.99 20.41 57.94 24.48 20.83 59.94 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 7nn9_00 NEURAMINIDASE N9 user 4 2 # 4 151 ASP A 488 ASP~? 18.76 O2 U B 1 277 GLU A 545 GLU~? 17.12 N3 U B 1 coo 25.08 13.39 65.77 24.68 15.22 66.73 -0.60 -59.65 -22.78 -0.45 -60.99 -21.12 coo 24.99 20.41 57.94 24.48 20.83 59.94 2.66 -64.95 -14.46 4.45 -64.54 -15.50 7nn9_00 source 7nn9 NEURAMINIDASE N9 : 4 hits 7nn9_00 naa= 2 ULMN 2 7odc_01 ORNITHINE DECARBOXYLASE user 1 2 # 1 A 197 HIS A 352 HIS~? 21.18 O2' A B 4 A 274 GLU A 351 GLU~? 20.29 O2' A B 4 coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -19.96 -22.19 -17.02 -20.57 -20.37 -17.85 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -15.22 -22.27 -20.05 -13.30 -23.17 -20.08 ULMN 2 7odc_01 ORNITHINE DECARBOXYLASE user 2 2 # 2 A 197 HIS A 454 HIS~? 3.31 C5 U B 3 A 274 GLU A 457 GLU~? 3.32 N1 G B 2 coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -9.36 -45.14 -7.29 -7.81 -45.29 -5.89 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -10.41 -50.83 -9.17 -9.57 -50.49 -7.25 ULMN 2 7odc_01 ORNITHINE DECARBOXYLASE user 3 2 # 3 A 197 HIS A 527 HIS~? 25.85 N2 G B 2 A 274 GLU A 522 GLU^? 23.38 O4 U B 3 coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -23.95 -63.83 -18.04 -25.27 -62.69 -19.20 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -28.23 -58.96 -15.66 -26.66 -57.55 -15.85 ULMN 2 7odc_01 ORNITHINE DECARBOXYLASE user 4 2 # 4 A 197 HIS A 547 HIS~? 18.58 O4 U B 1 A 274 GLU A 545 GLU~? 17.12 N3 U B 1 coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 8.28 -67.57 -10.72 8.13 -67.19 -12.78 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 2.66 -64.95 -14.46 4.45 -64.54 -15.50 7odc_01 source 7odc ORNITHINE DECARBOXYLASE : 4 hits 7odc_01 naa= 2